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ABSTRACT 
 
 
This thesis describes the isolation and structure elucidation of ten novel secondary 
metabolites from one fungus, four lichens, three algae, two plants and one sponge.  The 
structures of these compounds were elucidated by a combination of spectroscopic and 
chemical methods.  This thesis also reports two new crystal structures, the 
identification of two new methylsilylated derivatives as well as the isolation of thirty 
seven previously reported compounds in which the complete structural assignment by 
1D and 2D NMR has been carried out on known compounds with incomplete or no 
NMR spectroscopic data.  Biological screening of crude extracts and isolated natural 
products has also been presented.  Furthermore, the application of chemical profiling 
techniques including GCxGC and HPLC-NMR were utilised to assist with the natural 
product dereplication process and monitor chemical degradations in situ and to 
identify the presence of new natural products and artefacts. In total, fifteen separate 
terrestrial and marine organisms were investigated. 
Crude extracts of the red, bracket fungus Pycnoporus cinnabarinus, collected 
from five separate Australian localities were subjected to a chemical and biological 
profiling study.  Subsequent detailed investigation of two of these specimens resulted 
in the isolation of the new phenoxazone pigment, pycnoporin (2.8), together with 
cinnabarin (2.1), tramesanguin (2.2), and cinnabarinic acid (2.3).  Ergosterol peroxide 
(2.11) was also identified from one of the specimens studied.  Compounds 2.1-2.3 and 
2.8 were elucidated by detailed spectroscopic analyses, which included the application 
of elevated temperature-controlled NMR experiments.  In addition to the isolation and 
characterisation of 2.8, this study describes the first successful HPLC purification 
strategy and complete 2D NMR spectroscopic characterisation for compounds 2.1-2.3.  
Also reported are the antioxidant and anti-inflammatory activities for the crude 
extracts of one of the P. cinnabarinus specimens.  Compounds 2.1-2.3, 2.8 and 2.11 
displayed varying degrees of antitumour activity while ergosterol peroxide (2.11) also 
showed slight antimicrobial and antiviral activities.  This is the first report 
documenting the significant antitumour activity of cinnabarin (2.1). 
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ergosterol peroxide (2.11) 
 
Chemical investigation of the Australian plant Haemodorum simplex resulted in 
the isolation of three new phenylphenalenones, haemodorone (3.10), haemodorol (3.11) 
and haemodorose (3.12), together with the previously reported compounds (3.5), 
dilatrin (3.6) and xiphidone (3.8).  As a result of this study the first complete 2D NMR 
characterisation for all of the compounds isolated, including several chemical shift 
reassignments for dilatrin (3.6) has now be documented.  In addition this is one of the 
few reports to discuss the isolation of new phenylphenalenones from an Australian 
medicinal plant.  The crude extract of both the bulbaceous and aerial components of 
the plant exhibited varying degrees of antibacterial, antifungal and antiviral activity 
and only the bulbs displayed potent antitumour activity. 
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The crude extract of the roots from the Australian medicinal plant Dianella 
callicarpa (Liliaceae) displayed significant antimicrobial and antiviral activities.  This 
prompted a chemical investigation, resulting in the isolation of the new naphthalene 
glycoside, dianellose (4.10), together with dianellin (4.1), dianellidin (4.2), dianellinone 
(4.3), stellalderol (4.9) and 5-hydroxydianellin (4.11).  The structures for compounds 
4.1, 4.9 and 4.10 were secured by detailed spectroscopic analyses, while compounds 
4.2, 4.3 and 4.11 were identified on the basis of comparisons to literature data.  Whilst 
the chemistry of genus of Dianella has previously been investigated this is the first 
isolation of stellalderol (4.9) from this genus, together with the first chemical and 
biological evaluation of the callicarpa species.  A detailed biological evaluation of the 
isolated compounds established that 4.2 and 4.3 showed antiviral and antimicrobial 
properties and that compounds 4.1, 4.9 and 4.10 displayed moderate antitumour 
activities. 
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Chemical investigation of the terrestrial lichen, Chrysothrix xanthina, has yielded 
the pulvinic acid derivative pinastric acid (5.4).  The structure of 5.4 was secured by 
detailed spectroscopic analysis as well as via a single X-ray diffraction study.  This is 
the first report of the X-ray structure and 2D NMR assignment of pinastric acid (5.4).  
Pinastric acid (5.4) displayed antitumour, antiviral and antimicrobial (both 
antibacterial and antifungal) activities.  Furthermore, the application of GCxGC was 
used to chemically profile the crude extract resulting in the identification of the novel 
derivative, monotrimethylsilyl pinastric acid (5.32).  Whilst the antiviral and 
antimicrobial activities are consistent with previous findings of 5.4 this is the first 
report of the antitumour properties for the compound. 
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               pinastric acid (5.4)                               monotrimethylsilyl pinastric acid (5.32) 
 
A detailed chemical and spectroscopic investigation of the terrestrial lichen 
Candelaria concolor, has yielded several lichenic metabolites belonging to the pulvinic 
acid series, as well as several depside derivatives including vulpinic acid (5.3), pulvinic 
dilactone (5.7) and calycin (5.12).  The chemical transformation of (5.7) to pulvinic acid 
(5.2) is reported for the first time as is the conversion of atranorin (5.20) to 5-
chloroatranorin (5.21) and then finally to 5,5′-dichloroatranorin (5.22) under very mild 
conditions.  In addition, the application of GCxGC was also used to chemically profile 
the crude extract resulting in the identification of the novel derivative, 
monotrimethylsilyl vulpinic acid (5.34).  Also presented is the complete 1D and 2D 
NMR assignment for compounds 5.2, 5.3, 5.7 and 5.22 including partial NMR chemical 
shift assignment for the unstable depside 5.21.  Previously, these metabolites had only 
been partially assigned by NMR spectroscopy. 
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Phytochemical investigation of the Australian lichen Ramalina glaucescens 
resulted in the isolation of a new halogenated depside derivative, 5-chlorosekikaic acid 
(5.23), together with several other lichen constituents including: (+)-usnic acid (5.1), 
atranorin (5.20), sekikaic acid (5.24) and parietin (5.25), the latter of which was isolated 
from the associated (co-occurring) lichen, X. parietina.  All structures were assigned 
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using detailed spectroscopic methods, including 1D and 2D NMR spectroscopy and 
mass spectrometry.  In addition to the full characterisation of 5.24, this represents the 
first report of the full 2D NMR assignment for compounds 5.23-5.25.  Compounds 5.1, 
5.20 and 5.23-5.25 all displayed varying degrees of antitumour activity while 
compounds 5.1, 5.23 and 5.24 displayed antibacterial activities.  (+)-Usnic acid (5.1) 
displayed the greatest antitumour and antibacterial activities. 
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HPLC-NMR, together with subsequent off-line techniques, was used to 
chemically profile the red marine alga Plocamium mertensii.  A combined approach of 
both off-line and on-line chemical profiling was undertaken to establish the nature of 
these polyhalogenated terpenes.  This is the first application of HPLC-NMR using (on-
flow, stop-flow and time-slice experiments) to rapidly profile a marine alga, which 
resulted in the partial identification of compounds (6.7), (6.13), (6.27) and (6.37).  The 
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structure of these major compounds was unequivocally identified by off-line 
characterisation.  Only partial identification of two minor metabolites compounds (6.3) 
and (6.8) was possible as these co-occurred in a mixture with (6.7) and (6.13) 
respectively.  As a result of this investigation a number of chemical shift reassignments 
were made to compound 6.37. 
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Chemical investigation of the southern Australian marine alga Laurencia 
filiformis forma heteroclada resulted in the isolation of two new compounds, 
cycloisoallolaurinterol (7.16) and isoallolaurinterol (7.23), along with the previously 
reported sesquiterpenes filiformin (7.1), filiforminol (7.2), allolaurinterol (7.3) and 
bromolaurenisol (7.10).  All structures were secured by detailed spectroscopic analyses 
since no previous 2D NMR studies had been described for compounds 7.1, 7.2 and 7.10.  
As a result of this study, the first single X-ray diffraction study for 7.1 was secured.  
The investigation of the chemical conversion of allolaurinterol (7.3) to filiformin (7.1) 
was monitored by on-flow HPLC-NMR, which also resulted in the identification of 
7.23.  It has also been proposed that both compounds 7.16 and 7.23 are formed as 
artefacts from allolaurinterol (7.3).  HPLC-NMR was used to profile the crude extract of 
a marine organism, as well as for monitoring on-line compound chemical conversions.  
Both on-flow and stop-flow HPLC-NMR were successfully applied in the chemical 
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profiling and compound chemical conversion studies of L. filiformis forma heteroclada.  
Compounds 7.2 and 7.3 displayed antimicrobial activities.   
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Chemical investigation of the southern Australian marine alga Laurencia elata 
resulted in the isolation of two new proposed epimeric, C16 chamigrenes, 
cycloelatanene A (8.15) and cycloelatanene B (8.18), initially identified by on-flow 
HPLC-NMR, along with the previously reported sesquiterpenes (3Z)-chlorofucin (8.5), 
pacifenol (8.7) and elatenyne (8.9). All structures were secured by detailed 
spectroscopic analyses.  The structure of elatenyne (8.9) was recently revised from the 
pyrano[3,2-b]pyran to the [2,2′]-bifuranyl and efforts to establish the relative 
configuration were attempted by conducting selective 1D NOE NMR experiments. 
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Finally, the rapid chemical profiling of the antitumour active crude DCM 
extract of the marine sponge, Dactylospongia sp. was undertaken.  A combination of 
both off-line (HPLC followed by NMR and MS) and on-line (on-flow and stop-flow 
HPLC-NMR) chemical profiling approaches was adopted to establish the exact nature 
of the major constituents present in the DCM extract of this sponge.  On-flow HPLC-
NMR analysis was employed to initially identify components present in the DCM 
extract, whilst stop-flow HPLC-NMR experiments were then conducted on the major 
component present, resulting in the partial identification of the pentaprenylated p-
quinol (9.5).  Subsequent off-line reversed phase semi-preparative HPLC isolation of 
9.5 followed by detailed spectroscopic analysis using NMR and MS permitted the 
complete structure to be established.  This included the first complete carbon NMR 
chemical shift assignment of 9.5 on the basis of heteronuclear 2D NMR experiments, 
together with the first report of its antitumour activity.  This study represents one of 
the few reports describing the application of HPLC-NMR to chemically profile 
secondary metabolites from a marine organism. 
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1.1 A Brief History of Natural Products 
 
The first records of the uses of natural products are written on clay tablets in cuneiform 
from Mesopotamia (2600 B.C.).  These include oils from Cupressus sempervirens 
(Cypress) and Commiphora species (myrrh) which are used today for the treatment of 
ailments ranging from coughs, colds to inflammation (Cragg and Newman, 2005).  The 
best known Egyptian pharmaceutical record is the Ebers Papyrus (2900 B.C.) which 
documents over (plant based) 700 drugs including gargles, infusions, pills and 
ointments.  The Chinese Materia Medica (1100 B.C.) (Wu Shi Er Bing Fang, contains 52 
prescriptions), Shennong Herbal (~ 100 B.C., 365 drugs) and the Tang Herbal (659 A.D., 
850 drugs) are some examples for records of the uses of natural products (Cragg and 
Newman, 2005). 
The Greek philosopher and natural scientist, Theophrastus (~ 300 B.C.) dealt 
with medicinal herbs (Cragg and Newman, 2005).  Dioscorides, a Greek physician (100 
A.D.), recorded the collection, storage and the uses of medicinal herbs whilst Galen 
(130-200 A.D.) practiced and taught pharmacy and medicine in Rome and was well 
known for his prescriptions and formulas used in compounding drugs (‗galenicals‘) 
(Cragg and Newman, 2005).  During the Dark and Middle Ages (5th  to 12th centuries 
A.D.), the monasteries in England, Ireland, France and Germany preserved this 
Western knowledge (Cragg and Newman, 2005).  The Arabs also preserved the Greco-
Roman knowledge and expanded the uses of their own resources, together with 
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Chinese and Indian herbs unfamiliar to the Greco-Roman world (Cragg and Newman, 
2005).  It was the Arabs who were the first to privately own pharmacies (8th  century) 
and the Persian pharmacist, physician, philosopher and poet, Avicenna contributed 
much to the sciences of pharmacy and medicine through works such as the Canon 
Medicinae (Cragg and Newman, 2005). 
1.2 Natural Products (Primary and Secondary Metabolites) 
 
In order to understand the terms ‛natural product’ or ‛secondary metabolite’ one must first 
differentiate between both primary and secondary metabolism.  The synthesis and 
breakdown of carbohydrates, proteins, fats and nucleic acids which are all vital for the 
sustainability of all living organisms is known as primary metabolism with the 
compounds involved in the pathways known as ‛primary metabolites’ (Dewick, 2002). 
The process by which an organism produces compounds called ‛secondary 
metabolites’ (also referred to as natural products) are often found to be specific to an 
organism or are an expression of the individuality of a species which is defined as 
secondary metabolism (Dewick, 2002; Maplestone et al., 1992).  These natural products are 
generally not essential for the growth, development or reproduction of an organism 
and are produced either as a result of the organism adapting to its surrounding 
environment or as a defense mechanism against predators to assist in the survival of 
the organism (Colegate and Molyneux, 2008; Dewick, 2002). 
The biosynthesis of secondary metabolites is derived from primary metabolism.   
Figure 1.1 illustrates the fundamental processes of photosynthesis, glycolysis and the 
Krebs cycle to afford biosynthetic intermediates which, ultimately, results in the 
formation of natural products (Dewick, 2002).  It can be seen that although the number 
of building blocks are limited, the formation of novel secondary metabolites is infinite.  
The most important building blocks employed in the biosynthesis of secondary 
metabolites are those derived from the intermediates: acetyl coenzyme A (acetyl-CoA), 
shikimic acid, mevalonic acid and 1-deoxyxylulose-5-phosphate. They are involved in 
countless biosynthetic pathways, involving numerous different mechanisms and 
reactions (eg.  alkylation, decarboxylation, aldol, Claisen and Schiff base formation 
(Figure 1.1) (Dewick, 2002). 
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Figure 1.1. Common building blocks employed towards the synthesis of secondary 
metabolites (natural products) (Dewick, 2002). 
 
It has been postulated that secondary metabolism utilises amino acids and the 
acetate and shikimate pathways to produce ―shunt metabolites‖ which are intermediates 
that have adopted an alternate biosynthetic route, leading to the production of 
secondary metabolites (Sarker et al., 2006).  Alterations in the biosynthetic pathway 
may be due to natural causes (eg.  viruses or environmental changes) or unnatural 
causes (eg.  chemical or radiation) (Sarker et al., 2006).  It is the biosynthesis of these 
natural products, produced by an organism, which provides unique chemical 
structures possessing unusual biological activities. 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
4 | P a g e  
 
 
1.2.1 Medicinal Natural Products in Folklore  
 
As already stated, the uses of natural products as medicines have been described 
throughout history in the forms of traditional medicines, remedies, potions and oils 
and at the time many of the chemical constituents were unknown. 
The uses of medicinal plants (the dominant source of natural products), in all 
probability, is a result of man experimenting and learning, for thousands of centuries 
through palatability trials or untimely deaths, to select available foods for the treatment 
of diseases (Hicks, 1966).  One example involves the plant genus Salvia which grows 
abundantly throughout the southwestern region of the United States as well as 
northwestern Mexico.  Salvia was used by the Indian tribes of southern California as an 
aid in childbirth (Hicks, 1966).  Newborn babies, especially males, were ―cooked‖ in 
the hot salvia ashes.  It is believed that these ―cooked‖ babies have consistently grown 
to be the strongest and healthiest members of their respective tribes and are claimed to 
have been immune from all respiratory ailments for life (Hicks, 1966). 
 
1.2.1.1 Medicinal Plants 
 
The plant, Alhagi maurorum Medik (Camels thorn) (Fabaceae) oozes a sweet, 
gummy substance from the leaves and stems during hot days (Duke et al., 2008).  The 
sugary secretion (manna) is edible, consisting mostly of melizitose, sucrose and invert 
sugar.  It is documented by the Ayurvedic people that the plant aids in the treatment of 
anorexia, bronchosis, cerebrosis, constipation, dermatosis, epistaxis, fever, leprosy, 
obesity and thirst.  Israelis boil the roots and drink the extract claiming that it stops 
bloody diarrhea.  Konkani people smoke the plant with ajwan seed, black datura, and 
tobacco for the treatment of asthma, whist the Romans claimed to use the plant for 
nasal polyps (Duke et al., 2008). 
The plant Ligusticum scoticum Linnaeus (lovage) found in northern Europe and 
eastern North America was valued for diseases of cattle and sheep.  It was also eaten 
raw first thing in the morning and was believed to preserve a person from infection for 
the rest of the day (Dillenius, 1724); the root was a reputed cure for flatulence (Beith, 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
5 | P a g e  
 
 
1995; Lightfoot, 1977; Martin, 1703) and as a aphrodisiac (Beith, 1995).  In the Faeroe 
Islands it was used as a sedative (Martin, 1703; Svabo, 1959). 
Atropa belladonna Linnaeus (deadly nightshade) is found in central and southern 
Europe, Western Asia, North Africa, North America and New Zealand.  Its notoriously 
poisonous nature (three berries are sufficient to kill a child) firmly excluded it from the 
folk medicine repertory.  Hemlock (Conium maculatum) was used to some extent for 
healing purposes.  A. belladonna seemed to have been accepted as dangerous to handle 
or to experiment with (Allen and Hatfield, 2004). 
 
1.2.1.2 Medicinal Fungi 
 
The fungus Piptoporus betulinus (Bulliard ex Fries) P. Karsten, which grows on 
birches, were steamed to produce charcoal valued as an antiseptic and disinfectant 
(Swanton, 1915).  Strips of P. betulinus were cut and used for staunching bleeding and 
were also found to make very comfortable corn pads (Swanton, 1932).  Another 
example is the fungus Agaricus campestris Linnaeux ex Fries (field mushroom) found in 
the northern and southern temperate zones and the Carribean.  A. campestris, had 
reportedly been stewed in milk to soothe cancer of the throat (Hatfield, 1994). 
 
1.2.1.3 Medicinal Lichens 
 
Lichens have been used as early as the 17th and 18th centuries as dyes and were 
far more valued than oriental spices.  They have also been used as the raw materials for 
perfumes and cosmetics (16th century) and have been used in medicine from the time of 
the early Chinese and Egyptian civilisations (Purvis, 2000).  Some examples include 
Usnea dillenius ex Adanson (beard lichen) which was traditionally used for curing 
diseases of the scalp and is still sold in pharmacies as an ingredient in anti-dandruff 
shampoos (Purvis, 2000).  In Ireland it was used for treating sore eyes. The lichen U.  
subfloridana Stirton was mixed with tobacco and butter, boiled and then cooled and 
applied as a lotion (Allen and Hatfield, 2004).  Parmelia omphalodes (Linnaeus) Acharius 
(‗crottle’), abundant in the upland and rockier regions of the British Isles, was used in 
brown dyes.  In the highlands they were traditionally sprinkled on stockings at the 
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start of a journey to prevent inflammation of the feet (Cameron, 1900; MacFarlane, 
1929) and in Ireland it was used as a cure for bad sores under the chin as well as for 
burns and cuts (Allen and Hatfield, 2004). 
 
1.2.1.4 Historic Uses of Marine Organisms 
 
Historically the marine environment has few reported applications in 
traditional medicine.  The Phoenicians used the secretion of molluscs to dye woolen 
cloths and seaweed to fertilise soil.  (Cragg and Newman, 2005).  The red algae 
Chondrus crispus and Mastocarpus stellatus were sources of a beverage ‗Sobriety‘ which 
was popular as a folk cure for colds, coughs, sore throats, chest and lung ailments, 
including tuberculosis.  The algae were boiled in milk or water, strained and drunk hot 
and have also been used for kidney trouble and burns (Moloney, 1919; Vickery, 1995).  
The red alga, Porphyra umbilicalis (Linnaeus) Kützing found in the Arctic, northern 
Atlantic, Mediterranean and northern Pacific oceans claimed that three spoonfuls of the 
juice taken every morning followed by fasting for three weeks proved effective against 
cancers.  This concoction alone apparently cured breast cancer (Borlase, 1758) and has 
been described in the Aran Islands for easing indigestion (Ó hEithir, 1983).   Similarly, 
P. umbilicalis was boiled and given to cows to relieve their springtime constipation 
(Martin, 1703). 
 
1.2.2 Well Known and Historically Important Natural Products 
 
Historically, traditional medicinal practices, particularly those involving the use of 
plants, have formed the basis of most of the early medicines; followe by subsequent 
clinical, pharmacological and chemical studies (Butler, 2004). 
The most famous and well known examples include the synthesis of the anti-
inflammatory, acetylsalicyclic acid (1.2) (aspirin) derived from the natural product, 
salicin (1.1) which was isolated from the bark of the willow tree Salix alba L. 
(DerMardenerosian and Beutler, 2002).  Papaver somniferum L. (opium poppy) resulted 
in the isolation of several alkaloids including morphine (1.3) isolated in 1803, a 
commercially important plant. In 1974 P. somniferum was boiled in acetic anhydride to 
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yield diacetylmorphine (heroine) and was found to be readily converted to codeine 
(painkiller).  The earliest reported uses of poppy extract and derivatives dates back to 
the Sumerians in Mesopotamia, where the plant was used medicinally.  The Ancient 
Greeks used this extract for medicinal purposes whilst the Arabs described opium to 
be addictive (DerMardenerosian and Beutler, 2002).  Digitalis purpurea L. (foxglove) had 
been traced back to 10th century Europe but it was not until the 1700s that the active 
constituent, digitoxin (1.4) (a cardiac glycoside), was found to improve cardiac 
conduction, thereby improving the strength of cardiac contractility.  D. purpurea and its 
derivatives are important in the management of congestive heart failure and related 
cardiac disorders.  Their use continue to be strong in underdeveloped countries where 
they can be used cost effectively (DerMardenerosian and Beutler, 2002).  The anti-
malarial drug quinine (1.5), isolated from the bark of Cinchona succirubra Pav. ex 
Klotsch, had been dried, ground and used for centuries for the treatment of malaria, 
fever, indigestion, mouth and throat diseases and cancer.  Formal use of the bark to 
treat malaria was established in the mid 1800s when the British began the worldwide 
cultivation of the plant (DerMardenerosian and Beutler, 2002).  Pilocarpine (1.6) found 
in Pilocarpus jaborandi (Rutaceae) is a L-histidine-derived alkaloid which contains an 
imidazole nucleus and has been used as a clinical drug in the treatment of chronic 
open-angle glaucoma and acute angle-closure glaucoma for over 100 years.  
Pilocarpine (1.6) is also used to treat dry mouth (xerostomia), which is a side effect of 
radiation therapy for head and neck cancers and to stimulate sweat glands to measure 
the concentrations of sodium and chloride excreted in sweat (Aniszewski, 2007). 
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1.3 Fungi and Bacteria 
 
1.3.1 The Golden Age of Antibiotics 
 
Both macro and micro fungi have been part of life for humans for thousands of years.  
They were used as food (mushrooms) in preparation of alcoholic beverages (yeasts), 
medication in traditional medicine and for cultural purposes.  At present, with the 
advances in microbiology, their uses have extended to enzymes, biological control, 
antibiotics and other pharmacologically active products (Lorenzen and Anke, 1996). 
One of the first and most famous natural product discoveries derived from a 
fungus (microorganism) is that of penicillin (1.7) from the filamentous fungus, 
Penicillium notatum by Fleming in 1929 (Mann, 1994).  A countercurrent extractive 
separation technique which produced 1.7 in large yields was required for the in vivo 
experimentation that ultimately saved countless of lives and won Chain and Florey 
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(together with Fleming) the 1945 Nobel prize in Physiology and Medicine (Abraham et 
al., 1941).  This discovery led to the re-isolation and clinical studies by Chain, Florey 
and co-workers in the early 1940s and commercialisation of synthetic penicillins which 
ultimately revolutionised drug discovery research (Alder, 1970; Lax, 2004; Mann, 1999; 
Wainwright, 1990). 
After publication of the first clinical data on penicillin G (1.7), between 1942 and 
1944 there was a worldwide effort to discover new antibiotics from microorganisms 
and bioactive products from natural products (Buss and Waigh, 1995; Williams, 1999).  
Up until 1968, old methods for detecting β-lactams were still being utilised and it was 
concluded that all natural β-lactams had been discovered (Williams, 1999).  However, 
this was not the case as the introduction in the 1970s of new screening methods, the 
production of bacterial strains supersensitive to β-lactams, tests for the inhibition of β-
lactamases and specificity for sulphur-containing metabolites, resulted in the discovery 
of novel antibiotic structural classes (norcardicins, carbapenems and monobactams) 
including the isolation of the antibiotics: norcardicin (1.8), imipenem (1.9) and 
Aztreonam (1.10), respectively (Williams, 1999).   
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1.3.2 Polypore Fungi and Bacteria 
 
Polypores, many of which are bracket fungi, (as described in Chapter 2) are a large 
group of terrestrial wood-rotting fungi of the phylum Basidiomycota (basidomycetes) 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
10 | P a g e  
 
 
and Ascomycota which are a major source of pharmacologically active substances.  
There are about 25,000 species of basidiomycetes, of which about 500 are members of 
the Aphyllophorales, a group that contains the polypores (Zjawiony, 2004).  
Approximately 75% of tested polypore fungi have shown strong antimicrobial 
activities, and may constiute a viable source for the development of novel antibiotics.  
Numerous compounds from these fungi have also displayed antiviral, cytotoxic, 
antineoplastic, cardiovascular, anti-inflammatory, immune-stimulating and anticancer 
activities (Stamets, 2002; Zjawiony, 2004). 
 Fungi are microorganisms (which also include bacteria and viruses) spend at 
least part of their life cycle inside plant tissues without causing any visible sign of 
infection or disease (Gwinn et al., 1992; Tan and Zou, 2001).  They have been found to 
inhabit trees, grasses, algae and herbaceous plants and live in the intercellular spaces of 
plant stems, petioles, roots and leaves without adversely affecting the host organism 
(Petrini, 1986).  Novel bioactive secondary metabolites derived from fungal sources 
have yielded some of the most important natural products for the pharmaceutical 
industry (Cragg and Newman, 2005).  Some well known examples which are still in 
use today are described below. 
 
Antibacterial Compounds 
 
Vancomycin (1.11) is a glycopeptide antibiotic produced in cultures of Amycolatopsis 
orientalis (formerly Streptomyces orientalis) and is active against a wide range of gram-
positive organisms such as Staphylococci and Streptococci and against gram-negative 
bacteria, mycobacteria and fungi.  It is used for the treatment of severe infection and 
against susceptible organisms in patients hypersensitive to penicillin (1.7) (Butler, 
2004).  The macrolide erythromycin (1.12) from Saccharopolyspora erythraea is a valuable 
antibacterial drug, which contains a 14-membered macrocycle composed entirely of 
propionate units.  This drug has broad spectrum activity against gram-positive cocci 
and bacilli and is used for mild to moderate, upper and lower respiratory tract 
infections, sinusitis and otitis media (Butler, 2004; Dewick, 2002). 
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Antiviral Compounds 
 
To date, there seems to have been limited antiviral natural products or synthetically 
derived analogues obtained from fungi (Newman and Cragg, 2007).  Grifola frondosa 
(Dicks. Fr.) S. F.  Gray and Lentinus edodes (Berk) Sing.  display antiviral activities and 
as a result have been commercially developed (Wasser and Weis, 1999).  Two phenolic 
compounds, hispolon (1.13) and hispidin (1.14), obatined from the basidiocarps of the 
fungus Inonotus hispidus, have shown considerable antiviral activity against influenza 
viruses A and B (Awadh Ali et al., 2003).  Ganoderic acid β (1.15) isolated from the 
fruiting bodies and spores of Ganoderma lucidum displayed significant anti-HIV-1 
protease activity with an IC50 value of 20 µM (Min et al., 1998). 
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Antitumour Compounds 
 
In 2002, amrubicin hydrochloride (1.16) based on the anthracycline, doxorubicin (1.17) 
(Adriamycin) was isolated from the fungus Streptomyces peucetius.  Doxorubicin (1.17) 
is used for induction of regression of neoplastic conditions such as acute leukaemia, 
soft tissue and bone sarcomas, lung cancer, thyroid cancer and both Hodgkins and 
non-Hodgkins lymphomas (Butler, 2004; Dewick, 2002).  Torreyanic acid (1.18) was 
isolated from an endophyte from the endangered tree, Torreya taxifolia (Lee et al., 1996).  
It was tested in several cancer cell lines and found to display 5-10 times more potent 
cytotoxicity in cell lines that are sensitive to protein kinase C causing cell death by 
apoptosis, and is therefore a potential anticancer candidate (Li et al., 2003). 
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1.4 Plants 
 
1.4.1 A Reputable Source of Therapeutic Agents 
 
The chemical and biological investigation of two Australian medicinal plants are 
described in Chapters 3 and 4.  The medicinal use of plants are well documented and 
have been utilised in medicines for thousands of years. Plants have evolved and 
adapted over millions of years to withstand bacteria, insects, fungi and weather 
producing unique, structurally diverse secondary metabolites and their 
ethnopharmacological properties were used as a primary source of medicines for early 
drug discovery (Fellows and Scofield, 1995; McRae et al., 2007). 
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1.4.2 Plant-derived Natural Products 
 
According to the World Health Organization (WHO), globally 80% of people still rely 
on plant-based traditional medicines for primary health care (Farnsworth et al., 1985).  
A report showed that the uses of up to 80% of 122 plant derived drugs were related to 
their original ethnopharmacological purpose (Fabricant and Farnsworth, 2001).  The 
knowledge associated with traditional medicine (complementary or alternative herbal 
products) has promoted further investigations of medicinal plants as potential 
medicines and has led to the isolation of many compounds that have become well 
known pharmaceuticals.  Examples of plant-derived medicines and their associated 
biological properties are discussed below.   
 
Antitumour Compounds 
 
The most famous and most widely used breast cancer drug is paclitaxel (Taxol®) (1.19), 
isolated from the bark of Taxus brevifolia (Pacific Yew).  The bark was first collected by 
the United States Department of Agriculture (USDA) in 1962 as part of their 
exploratory plant screening program at the National Cancer Institute (NCI) (Cragg, 
1998).  The bark from about three mature 100-year-old trees is required to provide one 
gram of 1.19. A course of treatment may need 2 grams of the drug.  Current demand 
for 1.19 is in the region of 100–200 kg per annum (i.e. 50,000 treatments/year) and is 
now produced synthetically (Dewick, 2002).  In 1983, Phase I clinical trials (safety in 
humans) began whilst in 1985 Phase II clinical trials (efficacy) commenced.  The first of 
several FDA approvals for various uses for Taxol® was announced in 1992 (Cseke et al., 
2006). 
Taxol® (1.19) is present in limited quantities from natural sources, its synthesis 
(though challenging and expensive) has been achieved (Nicolaou et al., 1994).  Baccatin 
III (1.20) (present in much higher quantities and readily available from T.  brevifolia) 
and associated derivatives are examples of a structural analogues which can be 
efficiently transformed into 1.19 (Dewick, 2002). 
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 Other examples of antitumour compounds currently in clinical trials include 
ingenol 3-O-angelate (1.21) a derivative of the polyhydroxy diterpenoid ingenol. 3-O-
angelate (1.21) was originally isolated from Euphorbia peplus (known as ―petty spurge‖ 
in England or ―radium weed‖ in Australia) and is a potential chemotherapeutic agent 
for skin cancer (Kedei et al., 2004; Ogbourne et al., 2004).   
PG490-88 (1.22) (14-succinyl triptolide sodium salt), a semisynthetic analogue of 
triptolide is a diterpene-diepoxide isolated from Tripterygium wilfordii and has been in 
use for autoimmune and inflammatory diseases in the Peoples Republic of China 
(Fidler et al., 2003; Kiviharju et al., 2002).  Combrestatin A-4 phosphate (1.23) is a 
stilbene derived from the plant Combretum caffrum.  It acts as an anti-angiogenic agent 
causing vascular shutdowns in tumours (necrosis) and is currently in Phase II clinical 
trials (Holwell et al., 2002; Newman and Cragg, 2005). 
 
HOO
O OH
O
OH
1.21
O
O
O
O
OPO3
1.23
O
O
O
O
O
H
O
O
O
O
Na
1.22
 
 
 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
15 | P a g e  
 
 
Antiviral Compounds 
 
The Acquired Immune Deficiency Syndrome (AIDS) pandemic in the 1980s forced the 
National Cancer Institute (NCI) and other organisations to explore natural products as 
sources of potential drug candidates for the treatment of AIDS.  Over 60,000 extracts of 
plants and marine organisms were tested against lymphoblastic cells infected with 
HIV-1.  The most important result of these tests is the class of compounds known as the 
calanolides, in particular calanolide A (1.24) and calanolide B (1.25), isolated from the 
Calonphyllum species, along with prostratin (1.26) from Homalanthus nutans, have now 
progressed into clinical and preclinical development (Cox, 2002; Gustafson et al., 1992; 
Kashman et al., 1992). 
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Other Biologically Active Compounds from Plants 
 
Arteether (1.27) introduced in 2000 as Artemotil is derived from artemisinin (1.28) 
(introduced in 1987 as Artemisin) was originally isolated from the plant Artemisia 
annua and are both approved antimalarial drugs (Newman and Cragg, 2007).   The 
plant was originally used in traditional Chinese medicine as a remedy for chills and 
fevers.  Other derivatives of artemisinin (1.28) are in various stages of clinical 
development as antimalarial drugs in Europe (Cragg and Newman, 2005; Dewick, 
2002). 
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Grandisines A (1.29) and B (1.30) are two indole alkaloids which were isolated 
from the leaves of the Australian Rainforest tree, Elaeocarpus grandis.  Grandisine A 
(1.29) contains a unique tetracyclic skeleton, while Grandisine B (1.30) possesses an 
unusual combination of isoquinuclidinone and indolizidine ring systems.  Both 
grandisines exhibit binding affinity for the human δ-opioid receptor and are potential 
leads for analgesic agents (Carroll et al., 2005).  Galantamine hydrobromide (1.31) is an 
Amaryllidaceae alkaloid obtained from the plant Galanthus nivalis and has been used 
traditionally in Turkey and Bulgaria for neurological conditions and is a selective 
acetylcholinesterase inhibitor for the treatment of Alzheimers disease (Heinrich and 
Teoh, 2004; Howes et al., 2003).  Apomorphine (1.32) is a derivative of morphine (1.3) 
isolated from the poppy (P.  somniferum).  Apomorphine (1.32) is a short-acting 
dopamine D1 and D2 receptor agonist, as well as a potent dopamine agonist, used to 
treat Parkinsons disease (Deleu et al., 2004).  “Curare” is the arrow poison of the South 
American Indians and is prepared in the rain forests of the Amazon and Orinoco.  
There are some variants of curare but the principal ingredient is from the climbing 
plant, Chondrodendron tomentosum (Menispermaceae).  Tubocurarine (1.33), which is 
one of the active constituents, is used as a muscle relaxant in surgical operations, 
reducing the need for deep anaesthesia.  The limited availability of tubocurarine (1.33) 
has led to the development of a series of synthetic analogues which are now preferred 
over the natural product (Dewick, 2002). 
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1.5 Lichens 
 
1.5.1 History and Lichen Chemistry 
 
The chemical and biological investigation of three Australian lichens are described in 
Chapter 5.  Lichens are symbiotic organisms composed of a fungal (mycobiont) and an 
algal (phycobiont) association.  It has long been postulated that lichens produce 
protective natural products that serve to deter herbivores and colonisation by 
pathogens (Golojuch and Lawrey, 1988; Lawrey, 1983; Rundel, 1978).  The classical 
period of lichen chemistry is connected with two names Zopf (botanist, Germany) and 
Hesse (chemist, Germany) who both published papers on lichen constituents, many of 
which still remain uncharacterised (Huneck and Yoshimura, 1996).  The topical uses of 
lichen extracts dates back to as early as the 18th century B.C.  in Egypt (Vartia, 1973).  
Lichens biosynthesise structurally unique natural products that are rarely encountered 
in other organisms and to date there have been in excess of 800 compounds reported 
from lichens (Huneck and Yoshimura, 1996). 
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1.5.2 Natural Products from Lichens 
 
Some examples of secondary metabolites derived from lichens include phenolic 
compounds, with the most common classes being the aliphatic acids, pulvinic acid 
derivatives, depsides and depsidones, dibenzofurans, anthraquinones, 
naphthoquinones and the epidithiopiperazinediones.  Lichen secondary metabolites 
exert a wide variety of biological actions including antibiotic, antimycobacterial, 
antiviral, anti-inflammatory, analgesic, antipyretic, antiproliferative and cytotoxic 
effects and their potential pharmaceutical uses have been reviewed (Müller, 2001; 
Vartia, 1973).  A recent review in 2005 discusses lichens as a promising source of 
bioactive secondary metabolites, however there are no lichen derived secondary 
metabolites currently approved as clinical drug candidates (Boustie and Grube, 2005).   
 
Antibacterial Compounds 
 
One of the most famous and probably the most biologically active lichen natural 
product is (+)-usnic acid (1.34) isolated from Cladonia species which prevents the 
growth of Bacillus subtilis (Huneck and Yoshimura, 1996).  A study in 1907 reported the 
collection of 52 species of lichens of which 38 were active against Staphylcoccus and 
which contained (+)-usnic acid (1.34) (Vartia, 1973).  (+)-Usnic acid (1.34) is well known 
for its antimicrobial activities against Staphylcoccus aurerus, Entercoccus faecalis and 
Enterococcus faecium.  As lichens are surface attached communities that produce 
antibiotics to protect themselves from colonisation by bacteria, 1.34 can possibly see 
application in medical biofilms to prevent widespread infection (Francolini et al., 2004).  
The activity against gram-positive bacteria has prompted topical preparations of 1.34 to 
be included in toothpaste and mouthwashes (Boustie and Grube, 2005). 
 Vulpinic acid (1.35) has been known since the early 1800s when early Eskimos 
used lichens containing the acid to poison wolves (Knight and Pattenden, 1979).  In a 
study in 1995, vulpinic acid (1.35) was tested against selected aerobic and anaerobic 
microorganisms and found to display activity against Staphylcoccus and Enterococcus 
species (Lauterwein et al., 1995). 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
19 | P a g e  
 
 
1.34
O
O
O
CH3
CH3
OH
HO
OH
H3C
O
H3C
1.35
O
O
OH
O
O
CH3
 
 
Antiviral Compounds 
 
The more common anthraquinones such as emodin (1.36) have shown in vitro antiviral 
activity against human cytomegalovirus.  Furthermore, in one study, the depsidone 
virensic acid (1.37) was active against HIV by inhibiting viral integrase (Boustie and 
Grube, 2005).  The butyrolactone, protolichesterinic acid (1.38) isolated from the lichen 
Cetraria islandica is another prime example of a lichen natural product found to inhibit 
HIV-RT (Boustie and Grube, 2005). 
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Antitumour Compounds 
 
Several reports in the last decade have discussed the antitumoural properties of lichen 
natural products.  In 2002 several depsides and depsidones, in particular pannarin 
(1.39) and sphaeophorin (1.40), were tested in cell cultures of lymphocytes and were 
found to display higher cytoxic effects than colchicine. This is an alkaloid extracted 
from the plant of the genus Colchicum autumnale, which inhibits rapidly proliferating 
cells and has been used in cancer therapy) (Correche et al., 2002).  The depsidone, 
salazinic acid (1.41) was found to be the most active derivative evaluated on primary 
cultures of rat hepatocytes (Correche et al., 2004). 
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1.6 Marine Organisms 
 
1.6.1 The Marine Environment as a Source of New Drugs  
 
The ongoing battle against infections and diseases has provoked chemists to search for 
new drug candidates in new environments.  ―We are not marine organisms”, says Fenical, 
“so until about 1970, no one even thought of the ocean.  It was left as a deep secret.  It seemed 
ridiculous to me that the ocean — with such a vast habitat — had escaped anyone's notice.  But 
there are good reasons.  People fear the ocean; it has been considered a very hostile, inhospitable 
place” (Marris, 2006).   Drug companies started to realise this untapped source of 
possible drug candidates for the purposes of drug discovery.  With more than 70% of 
planet earths surface covered by ocean, the biological diversity is far higher than in 
tropical rain forests (Haefner, 2003). 
 Exploration of the marine environment and organisms (algae, sponges, 
ascidians, tunicates and bryozoans) became possible due to snorkeling (1960s), the 
introduction of SCUBA (1970s), to the use of manned submersibles (1980s) and more 
recently the use of remotely operated vehicles (ROVs) (1990s).  The progressive 
advancment in submersibles in the past 40 years of exploration of the marine 
enviornment has resulted in the isolation of thousands of structurally unique bioactive 
marine natural products Today there are several marine-derived drugs currently 
commericially available including, Ziconotide (Prialt, Elan Pharmaceuticals) a peptide 
first discovered in a tropical cone snail was approved in December, 2004 for the 
treatment of pain. In October, 2007 trabectedin (Yondelis, PharmaMar) became the first 
marine anticancer drug to be approved in the European Union (Molinski et. al., 2009).‖  
Several examples of marine-derived natural products which are currently in clincial 
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trials, commercially available or which have been submitted to clinical trials and failed, 
are described below. 
Aplidine (dehydrodidemnin B) (1.42) was isolated from the Mediterranean 
tunicate Aplidium albicans (Rinehart and Lithgow-Bertelloni, 1990; Urdiales et al., 1996).  
Aplidine (1.42) is used to treat various cancers, including melanoma, pancreatic, head 
and neck, small cell and non-small cell lung, bladder, prostate cancers, as well as non-
Hodgkin lymphoma and acute lymphoblastic leukemia (Henríquez et al., 2005). 
 Ecteinascidin 743 (ET743; Yondelis™) (1.43) was isolated in very low yields 
from the ascidian Ecteinascidia turbinata (Rinehart et al., 1990; Wright et al., 1990).  The 
quantities of ET743 (1.43) required for advanced preclinical and clinical studies was 
achieved by adopting very large-scale aquaculture of E. turbinata in open ponds, 
followed by isolation (Henríquez et al., 2005; Manzanares et al., 2001).  ET743 (1.43) is 
the first marine anticancer drug to be approved in the European Union (Molinski et. al., 
2009) for ovarian, soft tissue sarcoma, breast, endometrial, prostate, non-small cell 
lung, and pediatric cancers and is the first of a novel class of DNA-binding agents 
(Henríquez et al., 2005). 
 Spisulosine (1.44), isolated from the marine clam Spisula polynyma, exhibited 
substantial selective activity against tumour cells compared to normal cells (Alvarez-
Miranda et al., 2003).  It advanced to phase I trials against solid tumours but was 
withdrawn in late 2006 (Cuadros et al., 2000; Salcedo et al., 2003a; Salcedo et al., 2003b). 
Cryptophycin (1.45) was selected for clinical trials in the mid 1990s.  It 
advanced to phase II trials but was terminated in 2002 due to toxicity and lack of 
efficacy (Trimurtulu et al., 1994).  Similar compounds possessing the same activities 
have been isolated from the Okinawan sponge Dysidea arenaria (Kobayashi et al., 1994a; 
Kobayashi et al., 1994b). 
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1.6.2 Marine Algae 
 
Algae (macroalgae, seaweed) represents at least 30,000 species worldwide.  They 
supply oxygen to the biosphere, food for fish and man, medicine and fertilisers as well 
as being a prolific source of structurally unique secondary metabolites (Faulkner, 2002).  
The terpenoids are a class of compounds predominantly isolated from marine algae 
and have extensively been investigated in the last four decades.  Chemical 
investigations into terpenoid-type structures have led to the isolation of many classes 
including brominated oxygen heterocyclics, nitrogen heterocyclics, phenazine 
derivatives, sterols, amino acids, amines and guanidine derivatives (Bhakuni and 
Rawat, 2005).  With respect to biological activity, green, brown and red algae have been 
intensely screened for their antibacterial and antifungal activities (Baslow, 1969).   
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1.6.2.1 Biologically Active Natural Products from Marine Algae 
 
Polycavernoside-A (1.46) is a toxic glycoside isolated from the red alga Polycaverosa 
tsudai and is assumed to be responsible for seafood poisoning.  In 1991 thirteen people 
became ill and three died in Japan and it was claimed that 1.46 was responsible for 
these deaths (Paquette et al., 2000; White et al., 2001; Yotsu-Yamashita et al., 1993). 
The brown alga, Dictyota dichotoma afforded diterpenes, 4-acetoxydictylolactone 
(1.47), dictyolides A (1.48) and B (1.49) and nordictyolide (1.50) which display 
antitumour activities (Faulkner, 1988; Ishitsuka and Kusumi, 1988).  Another example 
is crenuladial (1.51), isolated from the brown alga Dilophus ligatus which displayed 
antimicrobial activity against Staphylcoccus aureus, Micrococcus luteus and Aeromonas 
hydrophyla (Faulkner, 1988; Tringali et al., 1988). 
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1.6.2.2 Marine Red Algae 
 
The chemical and biological investigation of three red marine algae are described in 
Chapters 6-9.  Red algae, in particular the genus Laurencia (Rhodophyta) are 
unsurpassed as a source of halogenated sesquiterpenes.  Chemical investigations into 
the genus Laurencia for secondary metabolites have been active since the 1970s.  The 
most commonly occuring secondary metabolites are the halogenated sesquiterpenes 
and diterpenes.  Furthermore, this genus is unique in producing C15-acetogenins, for 
example those constituents which end in an enyne such as (1.52) (San-Martin et al., 
1997).  Other examples include the class of compounds known as the chamigrenes 
which are halogenated terpenes possessing unique spiro structures such as (1.53) and 
(1.54).  There have been many chamigrenes which have been isolated to date from the 
genus Laurencia which grows in many very different geographical areas (Elsworth, 
1989; Kimura et al., 1999).   
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1.6.2.3 Agrochemicals from Red Algae 
 
 Productivity in agriculture in the last half century has been as a result of 
advances in pest control due to synthetic chemical pesticides (SCPs) (Duke et al., 1993).  
However, the search for new pesticidies has been necessary due to the significant rise 
in the resistance to current control agents.  It has been documented that between 1984 
to 1990 resistance to SCPs by species of insects and mites increased by 13% (El Sayed et 
al., 1997; Georghiou, 1990).  As a result, a significant amount of research has focused on 
the isolation of insecticidal leads from marine algae.  This has led to the isolation of 
over 40 active constituents (El Sayed et al., 1997). 
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 Some examples of natural insecticides include the isolation of 1α-(2-E-
chlorovinyl)-2α,4β,5α-trichloro-1β,5β-dimethylcyclohexane (1.55) and 1β-(2-E-
chlorovinyl)-2β,4α,5α-trichloro-1α,5β-dimethylcyclohexane (1.56) which are cyclic 
polyhalogenated monoterpenes isolated from the Chilean red alga Plocamium 
cartilagineum.  These compounds show insecticidal activity against the Aster 
leafhopper, Macrosteles pacifrons (San-Martin et al., 1991).  Other examples include 
laurepinnacin (1.57), an acetylenic cyclic ether from the red alga Laurencia pinnata 
Yamada (Fukuzawa and Masamune, 1981), and (Z)-laureatin (1.58) and related 
compounds from the red alga L. nipponica Yamada.  These have all shown to display 
strong insecticidal activity against the mosquito larva, C. pipiens pallens (Watanabe et 
al., 1989). 
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1.6.3 Sponges 
 
The chemical and biological investigation of one marine sponge is described in Chapter 
9.  Sponges (Porifera) are sessile organisms which lack a nervous, digestive and 
circulatory system.  They maintain a constant water flow through their bodies to obtain 
food, oxygen and to remove wastes.  All sponges are ‗current‘ or ‗filter‘ feeders and 
have few physical means of defense against predators.  They are considered to be the 
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first multicellular animals and have changed very little in approximately 500 million 
years. 
The first notable discovery of biologically active compounds from marine 
sources can be traced back to the reports of Bergmann on the isolation and 
identification of C-nucleosides, spongouridine (1.59) and spongothymidine (1.60) from 
the Carribean sponge, Cryptotheca crypta in the early 1950s (McConnell et al., 1994).  
These compounds were found to possess antiviral activity and the synthesis of 
structural analogues led to the development of cytosine arabinoside (Ara-C) as a 
clinical anticancer agent, together with (Ara-A) as an antiviral agent 15 years later 
(McConnell et al., 1994).  This was an important discovery since, previously, it was 
believed that for a nucleoside to possess biological activity, it had to have a 
deoxyribose or ribose sugar moiety.  These investigations led to the identification of 
(Ara-C) as a potent antileukemic agent (Newman et al., 2000). 
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1.6.3.1 Sponge-derived Natural Products Currently in Clinical Trials 
 
The class of synthetic derivatives known as the bryologs, such as compound 1.61, are 
derived from bryostatin 1 (1.62), an antineoplastic compound isolated from the 
bryozoan, Bulgula neritina (Butler, 2004; Chin et al., 2006).  Bryostatin 1 (1.62) has been 
isolated in sufficient quantities to permit more than 80 clinical trials to date, with 20 
being completed at both phase I and phase II levels.  It has displayed positive 
responses acting as a single agent with effects ranging from complete to partial 
remission (Colegate and Molyneux, 2008).   
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Halichondrin B (1.63) has been isolated from several sponges including, 
Halichondria okadai (Japan) (Uemura et al., 1985); Axinella sp. from the Western Pacific 
(Pettit et al., 1991), Phakellia carteri from the Eastern Indian Ocean (Pettit et al., 1993) and 
from Lissodendoryx sp., off the East Coast of the South Island of New Zealand (Litaudon 
et al., 1994).  Halichondrin B (1.63) has successfully been synthesised (Aicher et al., 1992) 
along with several structural analogues including Halichondrin E-7389 (1.64) which 
has been selected for further development and is currently in phase III clinical trials for 
the treatment of breast carcinoma (Chin et al., 2006). 
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1.7 Drug Discovery 
 
1.7.1 Combinatorial Chemistry versus Natural Product Chemistry 
 
After the ―Golden Age of Antibiotics‖ (see Section 1.3.1) and the worldwide motivation 
to discover new antibiotics. All major pharmaceutical companies at the time, initiated 
natural product discovery programs which focused not only on antibacterial and 
antifungal targets, but also on infectious diseases. These programs provided lead 
compounds for the treatment of cancer, microbial infections, hypercholesteremia and 
tissue rejection in organ transplantations (Baker et al., 2007; Ojima, 2008).  However, 
many of the larger pharmaceutical companies de-emphasised their NPD programs 
during the 1990s and early 2000s.  The advent of automated high throughput screening 
(HTS) increased the speed of biological testing and combinatorial chemistry began to 
be promoted as a better approach to creating ―drug-like‖ chemical compounds for 
HTS.  As a result, many of the pharmaceutical companies disposed of or sold their 
collections of screening extracts (Nussbaum et al., 2006).  The downsizing or 
termination of natural product screening programs was justified as follows: 
(Luzhetskyy et al., 2007). 
 Traditional extract-based screening leads to the re-discovery of previously 
isolated compounds; 
 Structural complexity of natural products requires total synthesis and 
derivatisation which is problematic; 
 Because of supply problems, the time required to develop a natural product 
from an extract hit to a pharmaceutical is too long; 
 Focus on combinatorial chemistry to generate huge compound libraries is 
needed to fulfill the promise of HTS technologies. 
In the past two decades ―classical natural product chemistry‖ has largely been 
replaced by molecular target based drug discovery, utilising large combinatorial 
libraries to obtain efficiently ―hits‖ (Ojima, 2008).  However, advances in technology 
and sensitive instrumentation for the rapid identification of novel bioactive natural 
products and structure elucidation continues to improve the natural product discovery 
process (Baker et al., 2007).   
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From the 1980s onwards it was thought that combinatorial chemistry will be the 
future source of numerous novel carbon skeletons and drug leads or new chemical 
entities (NCEs).  This has clearly not been the case as there has only been one de novo 
combinatorial NCE approved by the U.S Food and Drug Administration (FDA) in that 
time period.  This was the kinase inhibitor sorafendib (1.65) (approved by the FDA, 
2005) for renal carcinoma (Newman, 2008). 
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 Nevertheless, combinatorial chemistry has revolutionised the development of 
active chemical leads, resulting in the synthesis of novel structural analogues 
(Newman, 2008).  During this time combinatorial libraries consisted of hundreds to 
thousands to millions of new compounds, but during the late 1990s synthetic chemists 
realised that these libraries lacked the ―complexity‖ of the diverse array of structures 
biosynthesised by nature (Newman, 2008).  The concept of diversity-oriented synthesis 
(DOS) was adopted in which synthetic chemists would synthesise compounds that 
resembled natural products (mimics) or that are based on natural product topologies.  
These compounds are currently being tested in a large number and variety of 
biological screens in order to determine their roles(s) as leads to novel drug entities 
(Newman, 2008).   
Inspection of the rate of NCE approvals demonstrates that natural products still 
produce or are involved in ~50% of all small molecule testing between the years 2000-
2006 (Figure 1.2) (Newman and Cragg, 2007). 
The pharmaceutical industry has expended a considerable amount of resources 
to both HTS and combinatorial chemistry (Newman and Cragg, 2007).  Overall, of the 
1184 NCEs covering all diseases/countries/sources between the years 01/1981-
06/2006, 30% were found to be synthetic (Figure 1.2).  It is also illustrated that 52% 
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(total) of these compounds either are a natural product, a mimic or a chemical 
modification of an existing natural product pharmacophore. 
 
 
Figure 1.2 All new chemical entities, 01/1981-06/2006, by source (N = 1184). 
Adapted from (Newman and Cragg, 2007). 
 
1.7.2 Dereplication 
 
A drug discovery program endeavours to search for a novel bioactive natural 
product(s) which possesses some form of potent biological activity.  Nevertheless, the 
isolation of known and undesirable natural products with no chemical or 
pharmacological interest is inevitable.  The process of identifying known compounds 
responsible for the activity of an extract prior to bioassay-guided isolation is referred to 
as dereplication (Colegate and Molyneux, 2008; Sarker et al., 2006).  At present there are 
many advanced methodologies and protocols that distinguishes novel entities from 
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known natural compounds at an early stage of a drug discovery program or in a 
natural product isolation strategy (Sarker et al., 2006).   
It is important to realise that the isolation of novel natural products was far 
more frequent during the 1970s-1990s and although natural sources (eg.  plants, fungi, 
marine and microbial sources) are still regarded as inexhaustible sources for novel 
chemicals, the time, effort and cost to find new chemical entities must be considered as 
their discovery has become far more infrequent (Ramakrishna et al., 1999).   
Furthermore, even the selection of new types of organisms (terrestrial and or 
marine) tends to lead to the rediscovery of previously reported natural products as 
they are often present in more than one species and some also in several genera 
(Sashidhara and Rosaiah, 2007).  It has been estimated that it takes $US 50,000 and 3 
months of work to isolate and identify an active compound from a natural product 
source (Cordell and Shin, 1999).  Therefore, it is exceedingly important to recognise 
previously known compounds early on, not only for saving time and money, but to 
allocate resources to more profitable extracts.  It is evident that natural product 
programs require more patience and perseverance for the identification of adequate 
lead compounds than programs strictly based synthetic chemicals.  This is also 
dependent on availability of bioassay-guided fractionation, in-house screening, 
accessibility to higher field NMR and mass spectrometers, all of which are necessary to 
efficiently run such a program.  Lead compounds arising from natural product 
discovery programs are structurally unique due to their co-evolution with target sites 
in biological systems.  However, the speed at which lead compounds can be generated 
and advanced is slower than corresponding synthetic drug discovery approaches 
(Baker et al., 2007).   
With the advent of new hyphenated spectroscopy technologies such as HPLC-
MS, HPLC-NMR and HPLC-NMR-MS, further means of rapid compound 
identification and dereplication are now possible (Baker et al., 2007).   
 
Methods of Dereplication 
 
Dereplication strategies generally involve a combination of bioassay, separation 
science, spectroscopic methods, and database searching and can be regarded as 
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chemical or biological screening processes.  There a number of ways in which natural 
product programs or pharmaceutical companies approach dereplication, which is 
based upon availability of screening methods/instrumentation, time and the cost to 
identify possible ―biological leads or novel compounds‖ from a crude extract.  
Discussed below are some classical and current methods implemented in the 
dereplication process. 
 
Database Searching 
 
There are many commercially available databases which can assist in the 
dereplication process and will often reduce the time taken for structure elucidation of 
known compounds.  The Chapman and Halls Dictionary of Natural Products (DNP, 
2009);  The Dictionary of Marine Natural Products (on-line) (subset of the Dictionary of 
Natural Products) containing over 30,000 compounds (DMN, 2009);  MarinLit- The 
Marine Natural Products Database contains up to date bibliographic data on marine 
organisms with the number of references from 1,200 journals/books is ~22,000 with 
data for ~21,000 compounds (MarinLit, 2009); AntiMarin is a more recent tool, in which 
the number of methyl groups, the number of sp3-hybridised methylene or methine 
protons, alkene, acetal, ether and formyl groups can be searched (Blunt et al., 2007; 
Lang et al., 2008).  SciFinder Scholar is a research discovery tool (Chemical Abstracts 
on-line) (Scholar, 2009).  NAPRALERTTM is a database of all natural products, 
including ethnomedical information, pharmacological/biochemical information of 
extracts of organisms in vitro, in situ, in vivo, in humans (case reports, non-clinical trials) 
and clinical studies (Napralert, 2009). 
 Access to scientific databases such as the ones mentioned, is a fundamental and 
crucial step in a well governed natural product program.  Thorough and extensive 
literature searches are necessary when the following questions need to be addressed: 
o Have there been any previous literature reports on the target organism 
(terrestrial or marine?) 
o Is there potential to isolate novel compounds (geographical or seasonal 
variations?) 
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o What kind of compound classes have been isolated from the species and if not 
from the species, then the genus or family? 
o Is there incomplete or poor NMR spectroscopic data for previously 
uncharacterised natural products? 
o Are there any new biological activities for known compounds that have been 
overlooked? 
It is fundamentally important to address these questions early as one of the 
most common issues that occurs is the time consuming process of isolating, purifying 
and determining the structure of a suspected novel compound and realising that it has 
already been reported in the literature.   
  
1.7.3 Hyphenated Instrumentation “Classical versus Hyphenated (On-line) 
Approaches” 
 
Natural product extracts often contain a large number of constituents including those 
which are challenging to separate.  The combination of classical techniques such as UV, 
IR, MS and NMR spectroscopy often permits the unambiguous structure determination 
of pure compounds.  In cases where the absolute configuration cannot be determined, 
synthesis or single-crystal X-ray analysis is utilised.  As classical separation techniques 
are tedious and time consuming, the direct hyphenation of an efficient separation 
technique with powerful spectroscopic techniques can assist in the dereplication 
process (Urban and Separovic, 2005).   
Such hyphenated systems (though not in widespread use) include HPLC-FTIR 
which is useful for the detection of functional groups in major consituents of mixtures.  
HPLC-FTIR has been used by their designers but has not found wide application due 
to limitations on compatability that is, obtaining optimal separation together with 
detection conditions (Urban and Separovic, 2005). 
HPLC-MS, a standard technique allows for the separation of consituents on a 
stationary phase (e.g.  Reversed phase C18) and its molecular weight determined using 
various ionisation techniques including: Thermospray (TSP) and Atmospheric Pressure 
Chemical Ionisation (APCI) are used for moderately polar compounds (eg.  
polyphenols and terpenoids.  Continuous Flow Fast Atom Bombardment (CF-FAB) 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
34 | P a g e  
 
 
and Electrospray Ionisation (ESI) are the most common used techniques for medium to 
large polar molecules (MW > 800 Da) (Urban and Separovic, 2005).   HPLC-MS is best 
suited for polar constituents and as natural product extracts represent complex 
mixtures (hydrophillic and lipophillic constituents), optimised conditions (eg.  solvent 
compositions, stationary phases, buffers and different ionisation sources) need to be 
determined. 
FIA-NMR involves a sample which is injected as a plug into a fluid stream 
which is then swept into the NMR detector coil by the motion of liquid.  FIA-NMR uses 
the mobile phase as a hydraulic-push solvent to carry the injected sample from the 
injector port to the NMR flow cell.  After the pump stops, the spectrometer aquires the 
scout scan to determine location of solvent peaks and then acquires the solvent 
supressed spectrum.  After completion, a signal is sent to the solvent pump to flush the 
old sample from the NMR flow-cell (Urban and Separovic, 2005). 
HPLC-NMR-MS is an advanced spectrometric hyphenated technique which is 
used in the dereplication of natural product extracts (typically plant extracts).  Apart 
from its efficiency, the most important advantage of HPLC-NMR-MS is the 
unequivocal matching of the MS data to the NMR spectrum.  Furthermore, as HPLC-
NMR does not provide information about silent functional groups (eg.  hydroxyl and 
amino moieties) as a result of D2O exchange, these functionalites can be readily 
detected by MS techniques. 
 
1.7.4 High Pressure Liquid Chromatography-Nuclear Magnetic Resonace 
Spectroscopy (HPLC-NMR) 
 
Chemical and biological investigation in search of novel bioactive natural products 
involves the extraction, isolation, purification and structure elucidation (classical 
natural product isolation methododologies) which can be challenging and/or time 
consuming.  The extraction is normally the first step for both marine and terrestrial 
organisms.  The choice of the extraction solvent followed by solvent partitioning or by 
trituration can result in many problems including the formation of artefacts as 
described in Chapters 5 and 7.   
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Further, homogenisation and lyophilisation with organic solvents can affect the 
nature and relative amounts of extracted secondary metabolites present.  The 
application of HPLC-NMR to the crude extracts (NMR and UV profile from PDA 
HPLC detection) is a powerful spectroscopic tool which has advanced in recent years, 
in particular with the advent of higher field magnets, cryo-probes and capillary-NMR.  
Apart from providing a ―high-fidelity‖ snapshot of the constituents in the extract, the 
information acquired from both 1D and 2D NMR spectra may be sufficient to identify 
compound classes, therefore providing information which will allow rational decisions 
about the best method of fractionation or whether to pursue the isolation further. 
The technique and use of HPLC-NMR in natural products 
identification/characterisation is well documented in the literature but applications of 
its uses have predominately dealt only with the chemical profiling of plants (Clarkson 
et al., 2006; Cogne et al., 2005; Zschocke et al., 2005).   
The research described in this thesis includes the application of HPLC-NMR to 
chemically profile selected marine organisms.  Various modes of HPLC-NMR 
(predominantly on-flow and stop-flow modes) were used to identify suspected novel 
or known natural products ―on-line‖, along with the identification of intermediates 
and artefacts (Chapters 6-9).  This technique combines the resolving power of 
chromatography which is interfaced with the structural insight provided by NMR.  
This is the first HPLC-NMR to be installed in Victoria, Australia (School of Applied 
Sciences) and the MATNAP Research group uses this hyphenated spectroscopic 
technique to dereplicate and profile natural product extracts and fractions. 
 
1.8 Scope of Research 
 
The aim of the research conducted in this thesis was to investigate a selection of both 
terrestrial (fungi, plants and lichens) and marine organisms (marine algae and 
sponges) in an effort to isolate and identify any known and/or novel bioactive 
compound(s) from the extracts of the organisms investigated.  Both terrestrial and 
marine organisms were studied to provide a wide variety of structure classes for 
characterisation and evaluation as well as increasing the likelihood and probability of 
isolating new chemical entities.  In addition to a full biological evaluation, all known 
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and novel compounds isolated were subjected to a full 1D and 2D NMR spectroscopic 
characterisation.  In this way many natural products, which had been previously 
reported, were recognised as being poorly characterised which provided an  
opportunity to address this issue.  The selection of the particular organism for chemical 
investigation was motivated on the basis of either, 1) the crude extract displaying 
significant biological activities; 2) the presence of limited or no reports in the literature 
for a particular genus or species; 3) the application of on-line dereplication techniques 
such as HPLC-NMR to rapidly assist in the profiling of crude extracts (particularly 
those of highly studied marine organisms including Laurencia and Plocamium genera as 
well as to provide a chemical profiling strategy for suspected new and known 
compounds and the formation of novel intermediates and artefacts in situ. 
All compounds isolated from the extracts of the organisms studied were 
evaluated, with new biological activities discovered for the targeted organisms and/or 
the compounds isolated being reported (see Journal Publications Arising from this 
Thesis, pg. xiii).  All extracts were subjected to purification methodologies including 
extraction, solvent partitioning and trituration often followed by column 
chromatography and reversed phase HPLC purification resulting in the isolation and 
purification of known or novel compounds.  These constituents were elucidated 
principally by NMR spectroscopy and mass spectrometry.  Figure 1.3 illustrates the 
general techniques and methodologies implemented to isolate known or novel entities  
along with available techniques used (outlined in red). 
Where necessary and possible, confirmation (some of the natural products 
degraded before any further assessments could be carried out) of the stereochemical 
assignment was performed either by 1D selective NOE NMR experiments (for relative 
configuration assignments) or by single crystal X-ray analysis (which may result in the 
absolute configuration of the compound).  In this way the complete characterisation of 
both the known (natural products which had previously been isolated but either had 
poor, incomplete or incorrectly assigned chemical shifts) and the novel inactive or 
biologically active compound(s) was completed.  Ultimately the natural product 
isolated was evaluated for its biological activity and a conclusion made regarding 
whether the compound was solely or partly responsible for the biological activity 
initially displayed in the crude extract. 
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Figure 1.3.     Characterisation of a natural product using information obtained 
from spectroscopic techniques (Adapted from Urban and Separovic, 2005). 
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2.0 IntroductionC 
 
Pycnoporus cinnabarinus (Jacq.:Fr.) P. Karst., is a bright, red-orange, bracket fungus that 
is commonly found growing on dead wood (Lepp, 2003). It has been reported that 
Australian Aborigines used species of the fungus to treat sore mouths, oral thrush and 
sore lips (Lepp, 2003). The constituents responsible for the intense colour of the fungus 
have been previously identified as the phenoxazone alkaloid pigments, cinnabarin (2.1) 
(also known as polystictin), tramesanguin (2.2) and cinnabarinic acid (2.3) (Gripenberg, 
1951, 1963; Gripenberg et al., 1957), with the distribution of these pigments being 
dependent on species and season (Gripenberg, 1963). Phenoxazone pigments have 
previously been reported from other variants of similar fungi, including Trametes 
cinnabarina var. sanguinea (L.) Pilat (Gripenberg, 1963), T. cinnabarina Jacq. (Gripenberg, 
1951) and Coriolus sanguineus (Polystictus cinnabarinus) (Lemberg, 1952). 
To date, approaches adopted to determine the structures of 2.1-2.3 have 
included the use of infrared (IR) and raman spectroscopy, ultraviolet spectroscopy 
(UV), polarographic reductions, together with various syntheses and degradation 
studies (Cavill et al., 1961; Gripenberg et al., 1957; Gripenberg and Kivalo, 1957; Schatz 
et al., 1956). Given that the phenoxazone alkaloid pigments 2.1-2.3 are notoriously 
                                            
†
Dias DA and Urban, S. 2009. HPLC and NMR Studies of Phenoxazone Alkaloids from Pycnoporus cinnabarinus. Nat. 
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insoluble in most organic and aqueous solvents, it is not surprising that a successful 
strategy for the isolation, separation and unequivocal NMR assignment of these 
compounds has so far eluded researchers (Cavill et al., 1953; Graf et al., 2007). 
Investigations of related fungi such as that collected from La Digue Island, Seychelles, 
have afforded new phenoxazone pigments (Achenbach and Blümm, 1989). In this case 
the total crude pigment mixture was methylated with methl iodide (CH3I) in an effort 
to alter the solubility characteristics and subsequently chromatographed to yield o-
acetyl cinnabarine (2.4), 2-amino-9-formylphenoxazone-1-carbonic acid (2.5), 9-
hydroxymethyl-2-methylamino-phenoxazone-1-carbonic acid methyl ester (2.6), 
phenoxazone (2.7) and the phenoxazone ether, pycnosanguin (2.12) (Achenbach and 
Blümm, 1989). Ergosterol (2.9), 5,6-dihydroergosterol (2.10) and ergosterol peroxide 
(2.11) were also isolated from the same fungus (Achenbach and Blümm, 1989). 
 
O
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O
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4a
9a
12
9
8
6  
 
 R R1 R2 
cinnabarin (polysictin)  (2.1) CH2OH COOH NH2 
tramesanguin  (2.2) CHO COOH NH2 
cinnabarinic acid  (2.3) COOH COOH NH2 
o-acetyl cinnabarine  (2.4) CH2OAc COOH NH2 
2-amino-9-formylphenoxazone-1-carbonic acid  (2.5) CHO COOH NH2 
9-hydroxymethyl-2-methylamino-phenoxazone-1-carbonic acid 
methyl ester  (2.6) 
CH2OH COOCH3 NHCH3 
phenoxazone  (2.7) H H H 
pycnoporin  (2.8) CH(OCH3)OH COOH NH2 
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This chapter describes the chemistry and biological activity of the bright, red, 
wood-rotting fungus, P. cinnabarinus, collected from five separate geographical 
locations in Australia. The investigation of this fungus was pursued on the basis of the 
crude extract (P. cinnabarinus collected from Mentone, Victoria Australia) which 
displayed moderate antioxidant, anti-inflammatory, antitumour, antiviral and 
antifungal activities. As a result, five separate samples of P. cinnabarinus were 
evaluated for their biological activities and are detailed in Table 2.4 (page 72).  
Analytical HPLC was also employed to qualitatively and quantitatively assess 
the variability and the relative proportions of the phenoxazone alkaloid pigments 
present in the five specimens. The majority of this investigation was carried out on two 
collections of the fungus, the Mentone and Heidelberg. As a result of this investigation 
a new phenoxazone alkaloid, pycnoporin (2.8) was isolated. The strategy that enabled 
the successful isolation, purification and complete structural determination of 
compounds 2.1-2.3 and 2.8 has now been achieved.  
 
 
2.1 Collection, Extraction and Isolation 
 
Separate, geographically distinct collections of the fungus Pycnoporus cinnabarinus 
(Jacq. Fr.) P. Karst. were collected from five locations and details are presented in Table 
2.1. Sample (2002-03) was collected by Mr Donald Harney (specimen provided by Dr 
Theo Macrides) from Mentone, Victoria. Sample (2003-59) was collected by Mr Daniel 
Dias from Marysville State Forest, Victoria. Sample (2004-02) was collected by Dr 
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Sylvia Urban from Eltham, Victoria. Sample (2004-40) was collected by Mr Allan Tinker 
from the Western Flora Caravan Park, 22 km north of Eneabba (Irwin botanical 
province) in Western Australia (plant licence for scientific or other prescribed purposes 
SW008335). Finally, sample (2006-24) was collected by Mr Michael Timmers from 
Heidelberg, Victoria Australia. The fungi were identified by Prof. Ann Lawrie (RMIT 
University, Melbourne, Victoria) and represent collections made in each season. 
Voucher specimens designated the sample codes 2002-03, 2003-59, 2004-02, 2004-40 and 
2006-24, respectively are deposited at the School of Applied Sciences, (RMIT 
University. For photographs of the respective fungi specimens, see pages 75-77. 
 
Table 2.1. Details of the various collections of P. cinnabarinus undertaken. 
Sample Code Location Date 
2002-03 Mentone, Victoria, Australia 1st, August, 2002 
2003-59 Marysville State Forest, Victoria, Australia 3rd, January, 2003 
2004-02 Eltham, Victoria, Australia 14th, April, 2004 
2004-40 Eneabba, Western, Australia 6th, July, 2004 
2006-24 Heidelberg, Victoria, Australia 30th, May, 2006 
 
The Heidelberg sample, code 2006-24 (40 g) (13 g dr. wt.) was extracted by 
soxhlet extraction with acetone (500 mL). The crude extract was then decanted and 
transferred to several large vials. The extracts were reduced to approximately half their 
volume, sealed and stored in the freezer at -25°C for approximately 12 months. Several 
of these fractions were combined, filtered repeatedly through 0.45  PTFE membrane 
filters (HP045 Advantec, Japan) and subjected to semi-preparative reversed phase 
HPLC using a standard gradient method (0 - 2 min 10% CH3CN/H2O; 14 min 75% 
CH3CN/H2O and 15 - 30 min 100% CH3CN) with the addition of 0.45 M ammonium 
formate buffer to yield cinnabarin (2.1) (9.2 mg, 0.07%), tramesanguin (2.2) (4.4 mg, 
0.03%) and pycnoporin (2.8) (2.3 mg, 0.02%) (% based on the mass of the dried weight 
of the fungus) as shown in Scheme 2.1. 
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Pycnoporus cinnabarinus (2006-24) (40 g)
Soxhlet extraction (acetone) (500 mL)
Filtered,
Semi-preparative RP-HPLC
(gradient method)
(Storage, 12 months, -25°C)
cinnabarin (2.1)
(9.2 mg, 0.07 %)
tramesanguin (2.2)
(4.4 mg, 0.03 %)
pycnoporin (2.8)
(2.3 mg, 0.02 %)
 
Scheme 2.1. Extraction and isolation procedure adopted for P. cinnabarinus (2006-24). 
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 Sample code 2002-03 (30 g) (9g dr. wt.) was extracted with 100% EtOH (200 
mL) and the crude extract was decanted and concentrated under reduced pressure. The 
EtOH extract was subjected to flash silica gel column chromatography (50% stepwise 
elution from n-hexane to DCM to EtOAc and finally to MeOH). After 24-36 months of 
storage, analysis of the 100% EtOAc fraction yielded semi-pure cinnabarinic acid (2.3) 
(1.8 mg, 0.02%) (> 80% purity based on 1H NMR spectroscopy), shown below in 
Scheme 2.2. 
 
Pycnoporus cinnabar inus (2002-03) (30 g)
100% EtOH (200 mL)
cinnabarinic acid (2.3)
(1.8 mg, 0.02 %)
Flash silica column chromatography (50% stepwise elution)
Fraction 1 Fraction 12
 
  Scheme 2.2. First extraction and isolation procedure adopted for P. cinnabarinus (2002-03). 
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Sample code 2002-03 (92 g) (34 g dr. wt.) was extracted with 100% EtOH (500 
mL) and the crude extract was decanted and concentrated under reduced pressure. The 
extract was then solvent partitioned between EtOAc and H2O. Approximately half of 
the EtOAc soluble fraction was subjected to flash silica gel column chromatography 
(10% stepwise elution from n-hexane to DCM to EtOAc and finally to MeOH). The 
80:20 DCM/EtOAc silica gel column fraction yielded ergosterol peroxide (2.11) (10.3 
mg, 0.03%) (> 95% purity based on 1H NMR spectroscopy) shown below in Scheme 2.3. 
 
Pycnoporus cinnabar inus (2002-03) (92 g)
100% EtOH (500 mL) (2.2 g)
ergosterol peroxide (2.11)
(10.3 mg, 0.03 %)
Water (0.9 g)
Flash silica gel chromatography
(10% stepwise elution) (478 mg)
EtOAc (1.1g)
Fraction 38Fraction 1
 
Scheme 2.3. Second extraction and isolation procedure adopted for P. cinnabarinus (2002-03). 
 
2.1.1 Analytical HPLC Analysis of Crude Extracts 
 
For all five samples approximately 2 g of the frozen fungus was extracted 
overnight at room temperature in 100% acetone (50 mL). The crude extract was 
decanted, filtered, concentrated under reduced pressure and the extract weighed and 
transferred to a volumetric flask with acetone (10 mL). A 1.5 mL aliquot of the stock 
solution was filtered through a 0.45  PTFE membrane filter and the extract was then 
subjected to analytical HPLC using the standard gradient method (see Section 10.1.3) 
with the addition of 0.45 M ammonium formate buffer added to the water (employing 
50 L injections in each case). The relative amounts of cinnabarin (2.1), tramesanguin 
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(2.2), cinnabarinic acid (2.3) and pycnoporin (2.8) were determined on peak (λmax = 435 
nm) (Table 2.3, page 70). As a result of this quantification it was clearly evident that the 
five geographically different fungi contain varying quantities of 2.1 and 2.2 (major 
phenoxazone pigments). For example, 2.2 is the major pigment in sample 2004-02 
whereas in all other samples 2.1 and 2.2 vary in relative quantities. In all cases, 2.3 and 
2.8 are found to be present (as minor constituents) in all samples. 
 
 
2.2 Results and Discussion 
 
2.2.1 Isolation and Purification Strategies for Phenoxazone Alkaloids 
 
The Heidelberg collection of P. cinnabarinus (sample code 2006-24) was subjected to 
Soxhlet extraction with 100% acetone to give a blood-red coloured extract. It was 
established that to avoid re-solubilisation difficulties, concentration of the crude 
pigment extract under reduced pressure should be minimised. The extract was 
subsequently reduced to approximately half its volume via slow evaporation, sealed 
and stored in the freezer at -25°C for approximately 12 months while small scale 
attempts to determine an appropriate fractionation procedure for the compounds were 
undertaken. The extract was filtered repeatedly through 0.45 μ PTFE membrane filters 
and subsequently purified by reversed phase HPLC to yield cinnabarin (2.1), 
tramesanguin (2.2) and pycnoporin (2.8) for which the extraction and isolation 
procedure adapted is detailed on page 53. In addition, it was necessary to employ an 
elevated and constant NMR temperature of 40°C to record all subsequent NMR 
experiments in order to maintain maximum solubility of the phenoxazone alkaloids in 
DMSO-d6. Shown in Figure 2.1 is the semi-preparative reversed phase HPLC 
purification method, used to isolate compounds 2.1, 2.2 and 2.8. The characteristic UV 
profile (λmax ~435 nm) of 2.2 and 2.8 are also shown below illustrating that pycnoporin 
(2.8) is structurally related to 2.1. 
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    Figure 2.1. HPLC chromatograms illustrating the separation of cinnabarin (2.1), 
tramesanguin (2.2) and pycnoporin (2.8) (TOP).  
Expansion of the 2D PDA contour plot illustrating unique UV chomophores for 
the phenoxazone pigments (BOTTOM). 
 
 
cinnabarrin (2.1) tramesanguin (2.2) 
pycnoporin (2.8) 
HPLC chromatogram 
Extracted UV profile for pycnoporin (2.8) 
 (2.1) 
 (2.2) 
 (2.8) 
Extracted UV profile for tramesanguin (2.2) 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
58 | P a g e  
 
 
2.2.2 Isolation and Purification Strategies for Phenoxazone Pigments 
 
2.2.2.1 Structure Elucdation of Cinnabarin (2.1) 
 
Cinnabarin (2.1) was obtained as a red oily gum. The ESI-MS of 2.1 exhibited a 
[M+H]+ at m/z 287, consistent with the molecular formula C14H10N2O5 and 11 DBE. The 
UV profile for 2.1, extracted from the HPLC contour plot, displayed a UV maxima (λmax 
235, 266, 308, 433 and 451 nm), consistent with those previously reported for 2.1 
(Chung et al., 1978; Eggert et al., 1995; Gripenberg et al., 1957; Schatz et al., 1956). The IR 
spectrum supported the presence of hydroxy and amine moieties (3386 and 3270 cm-1), 
carbonyl groups (1676 and 1655 cm-1) and an unsaturated cyclic system (1598 and 1596 
cm-1) again similar to that previously reported for 2.1 (Cavill et al., 1953). 
 
O
N
CH2OH
O
NH2
COOH
1
11
3
10a
4a
9a
12
9
8
6  
cinnabarin (2.1) 
 
The 1H NMR spectrum of 2.1, as shown in Figure 2.3 exhibited signals due to 
one deshielded methylene δ 4.87 (2H, s, H-12), three aromatic methines at [δ 7.47 (1H, 
d, J = 7.5 Hz, H-6), 7.52 (1H, m, H-8) and 7.54 (1H, m, H-7)], one isolated aromatic 
methine at δ 6.59 (1H, s, H-4) and two exchangeable NHs at δ 9.57 (1H, brs, 2-NHa) and 
δ 8.68 (1H, brs, 2-NHb). The carboxylic acid and secondary alcohol exchangeable 
protons were not detected.  
The 13C NMR and HSQCAD NMR experiments supported the presence of one 
methylene, four methines and nine quaternary carbons. The 13C NMR spectrum 
(Figure 2.4), of 2.1 indicated the presence of signals due to a carbonyl at δ 177.9 (C-3) 
and a carboxylic moiety and δ 169.0 (C-11), together with an oxygen substituted 
methylene at δ 58.9 (C-12). The COSY NMR spectrum of 2.1 confirmed that the 
aromatic methines were adjacent to each other δ 7.47 (H-6), 7.54 (H-7) and 7.52 (H-8). 
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The HMBC spectrum showed key correlations from the methylene at δ 4.87 (H-12) to 
C-8 (123.8), C-9 (138.1) and to the quaternary carbon adjacent to the nitrogen at C-9a 
(126.9) ppm. In addition the isolated methine at δ 6.59 (H-4) showed a 3J HMBC 
correlation to C-10a (151.0) ppm and a 2J HMBC correlation to C-4a (146.2) ppm, 
confirming the presence of the oxazine ring system as shown in Figure 2.2.  
 
1
11
6
9
9a
4O
N
CH2OH
O
NH2
COOH
H
H
H H  
Figure 2.2. Selected HMBC correlations for cinnabarin (2.1). 
 
Carbon shifts were compared with model compounds previously reported in 
the literature (Bhansali and Kook, 1987; Bhansali et al., 1997; Manthey et al., 1992). This 
is the first unequivocal assignment for the structure of cinnabarin (2.1) employing 2D 
NMR spectroscopy for which the complete characterisation is detailed in Section 10.2. 
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2.2.2.2 Structure Elucidation of Tramesanguin (2.2) 
 
Tramesanguin (2.2) was isolated as a red-orange oily gum, from P. cinnabarinus 
(2006-24). The ESI-MS of 2.2 exhibited a [M+H]+ at m/z 285, consistent with the 
molecular formula C14H8N2O5 and 12 DBE. The UV profile for 2.2, extracted from the 
HPLC contour plot, displayed UV maxima (λmax ~435 nm) characteristic of the 
phenoxazone nucleus (Figure 2.1.) (Chung et al., 1978; Eggert et al., 1995; Gripenberg et 
al., 1957; Schatz et al., 1956). The IR spectrum which was similar to that of 2.1, once 
again supported the presence of hydroxy and amine groups (3420 cm-1), together with 
the presence of carbonyl groups (1690 and 1660 cm-1). The 1H NMR spectrum of 2.2 
exhibited signals due to one aldehyde moiety at δ 10.35 (1H, s, H-12), three aromatic 
methines at [δ 7.87 (1H, d, J = 7.8 Hz, H-6), 7.74 (1H, dd, J = 7.5, 7.8 Hz, H-7) and 8.00 
(1H, d, J = 7.5 Hz, H-8)], one isolated aromatic methine δ 6.65 (1H, s, H-4) and two 
exchangeable NHs at δ 9.80 (1H, brs, 2-NHa) and 8.92 (1H, brs, 2-NHb), the 
exchangeable carboxylic acid proton was not detected.  
The HSQCAD and HMBC NMR experiments supported the presence of five 
methines and nine quaternary carbons. The complete structure of tramesanguin (2.2) 
was established by 1D and 2D NMR experiments. The complete characterisation of this 
compound is detailed in Section 10.2. 
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tramesanguin  (2.2) 
 
The fungus P. cinnabarinus collected from Mentone (2002-03) afforded 
cinnabarinic acid (2.3) in which the extraction and isolation procedure is detailed on 
page 54. 
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2.2.2.3 Structure Elucidation of Cinnabarinic Acid (2.3) 
 
Cinnabarinic acid (2.3) was obtained as a semi-pure orange oily gum. The ESI-
MS of 2.3 displayed a [M+H]+ at m/z 301, consistent with the molecular formula 
C14H8N2O6 and 12 DBE. Once again, the UV profile extracted for 2.3 from the HPLC 
contour plot, displayed characteristic UV maxima consistent with the presence of a 
phenoxazone nucleus (Chung et al., 1978; Eggert et al., 1995; Gripenberg et al., 1957; 
Schatz et al., 1956). The IR spectrum suggested the presence of hydroxy and amine 
groups (3431 cm-1) together with the presence of carbonyl moieties (1715 and 1594 cm-
1). The 1H NMR spectrum of 2.3 showed the presence of signals due to three aromatic 
methines at δ 7.95 (1H, d, J = 7.8 Hz, H-8), 7.77 (1H, d, J = 8.0 Hz, H-6) and 7.61 (1H, dd, 
J = 7.8, 8.0 Hz, H-7), one isolated aromatic methine at δ 6.62 (1H, s, H-4) and two 
exchangeable NHs at δ 9.73 (1H, brs, 2-NHa) and 8.80 (1H, brs, 2-NHb), the 
exchangeable carboxylic acid protons were not detected.  
HSQCAD and HMBC NMR experiments supported the presence of four 
methines and ten quaternary carbons. A key HMBC correlation was observed from the 
methine at H-8 (δ 7.95, d, J = 7.8 Hz) to the carbon at C-12 (167.0) ppm, confirming the 
presence of a carboxylic acid (by comparison to the 13C NMR shift reported for the 
carboxylic acid obtained for 2.1 at C-10 (169.0 ppm). Combination of both 1D and 2D 
NMR experiments and mass spectrometry resulted in complete characterisation of 2.3 
as detailed in Section 10.2. 
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2.2.2.4 Structure Elucidation of Pycnoporin (2.8) 
 
The new phenoxazone pigment, pycnoporin (2.8) was obtained as a red-orange 
oily gum from sample code 2006-24. The molecular formula of 2.8 was determined as 
C15H12N2O6 based on the HR-ESI-MS m/z 317.0773 ([M+H]+, calculated for 317.0695), 
consistent with 11 DBE. The UV maxima for 2.8, once again, was interpreted as being 
characteristic and diagnostic for the presence of a phenoxazone chromophore (Chung 
et al., 1978; Eggert et al., 1995; Gripenberg et al., 1957; Schatz et al., 1956). The IR 
spectrum identified the presence of hydroxy and amine groups (3431 cm-1), together 
with the presence of a carbonyl moiety (1646 cm-1). The 1H NMR spectrum of 
pycnoporin (2.8) (Figure 2.5) exhibited signals due to one deshielded oxygenated 
methine δ 5.77 (1H, s, H-12), three aromatic methines [δ 7.57 (1H, m, H-6), 7.55 (1H, m, 
H-8) and 7.53 (1H, m, H-7), one isolated aromatic methine δ 6.61 (1H, s, H-4), one 
methoxy moiety δ 3.33 (3H, s, H-13) (identified in the HSQCAD NMR experiment, 
Figure 2.6) and two exchangeable NHs at δ 9.68 (1H, brs, 2-NHa) and δ 8.68 (1H, brs, 2-
NHb). The exchangeable hemi-acetal and carboxylic acid protons were not detected 
(Table 2.2). 
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HSQCAD (Figure 2.6) and HMBC NMR experiments supported the presence of 
five methines, one methyl and nine quaternary carbons. Key HMBC correlations were 
observed from the oxygenated methine at δ 5.77 (H-12) to the methoxy group at C-13 
(53.7) ppm and to C-9a (128.2) ppm. Furthermore, HMBC correlations from the 
methoxy group at δ 3.33 positioned the oxygenated methine at C-12 (100.9) ppm 
(Figure 2.7). Attempts to secure the relative or absolute configuration of pycnoporin 
(2.8) could not be attempted since the compound degraded shortly after HPLC 
purification. 
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Figure 2.6. HSQCAD NMR experiment illustrating 1JCH correlations for pycnoporin (2.8). 
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Figure 2.7. Key HMBC NMR correlations for pycnoporin (2.8). 
 
Table 2.2. NMR Data (500 MHz, d6-DMSO, maintained at 40°C) for pycnoporin (2.8). 
 
position 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
1  ND   
2  153.0, qC   
3  169.1, qC   
4 6.61, s 105.1, CH  C-10a, C-2, C-4a 
4a  148.0, qC   
5a  ND   
6 7.57, m 116.8, CH H-8 C-8 
7 7.53, m 124.1, CH  C-9 
8 7.55, m 129.0, CH H-6 C-9, C-9a 
9  143.0, qC   
10a  151.0, qC   
9a  128.2, qC   
11  ND   
12 5.77, s 100.9, CH  C-8, C-9a, C-13 
13 3.33, s 53.7, CH3  C-12 
2-NHa 9.68, brs    
2-NHb 8.68, brs    
11-OH ND    
12-OH ND    
aCarbon assignments based on the HSQCAD and HMBC NMR experiments 
ND = signal not detected 
 
 
2.2.2.5 Structure Elucidation of Ergosterol Peroxide (2.11) 
 
A second portion of the same fungus sample code 2002-03 afforded ergosterol 
peroxide (2.11) (10.3 mg, 0.03%) (> 95% purity based on the 1H NMR spectroscopy) in 
which the extraction and isolation procedure is detailed on page 55. Ergosterol 
peroxide (2.11) was isolated as a pale yellow oil and its spectroscopic data was found to 
be identical to that previously reported in the literature (Correa et al., 2006; Wei-Guang 
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et al., 1994; Yue et al., 2001). The unequivocal assignment of ergosterol peroxide (2.11) is 
detailed in Section 10.2. 
 
2.2.3 HPLC Profiling of P. cinnabarinus Specimens Collected from Geographically 
Distinct Australian Locations 
 
In 1963 Gripenberg reported that phenoxazone producing fungi collected from three 
worldwide, geographically distinct localities produced varying quantities of the 
naturally occurring phenoxazone pigments 2.1-2.3 (Gripenberg, 1963). This variation in 
phenoxazone composition prompted this investigation of Australian P. cinnabarinus 
variants and their localities, to determine whether location and/or seasonal variation 
would result in the production of different or similar phenoxazone pigments.  
Analytical HPLC of P. cinnabarinus specimens collected from five different 
Australian locations indicated that compounds 2.1 (tR = ~12.5 min) and 2.2 (tR = ~13.3 
min) are the main constituents present in all extracts (λmax = ~435 nm). Cinnabarinic 
acid (2.3) (tR = ~12.1 min) was found to almost co-elute with cinnabarin (2.1). Figure 2.8 
shows that analytical HPLC chromatogram of the P. cinnabarinus (2006-24) extract, 
identifying the presence of the naturally occurring phenoxazone pigments (2.1-2.3) and 
(2.8). 
Table 2.3 summarises the relative proportions (expressed as %) of 2.1-2.3 and 
2.8 present in the various specimens studied, highlighting the similarities and 
differences in pigment composition of the five separate fungi collected. It was 
immediately evident that Australian variants of P. cinnabarinus produce the new 
phenoxazone 2.8 in addition to compounds 2.1-2.3, which have already been described 
from Northern hemisphere species. Both cinnabarinic acid (2.3) and pycnoporin (2.8) 
are present as minor constituents in all five Australian specimens. 
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Figure 2.8. Analytical HPLC chromatogram of the P.cinnabarinus extract (2006-24) 
illustrating the relative ratio of the phenoxazone pigment composition. 
 
Table 2.3. Analytical HPLC profiling of crude P. cinnabarinus extracts showing the relative 
distribution of the phenoxazone pigment composition. 
*Total amount of extract obtained from a 2 g sample of the fungus 
**Amount of extract (μg), in a 50 uL injection 
Composition % calculated based on integration of the peak area (λmax = 435 nm) for compounds 1-3 and 8 
 
While it may be suspected that pycnoporin (2.8) could be an artifact that results 
from the storage and/or isolation procedure, there is sufficient evidence to suggest it 
being a natural product. The presence of pycnoporin (2.8) could always be detected by 
analytical HPLC in fresh extracts of the fungus (conducted in DCM, MeOH or acetone). 
Semipreparative HPLC isolation of compounds 2.1, 2.2 and 2.8 (from the Heidelberg 
specimen, code 2006-24) suggested that the ratio of 2.8 present in relation to 
 
Sample 
Code 
 
Fungus Sample (2g 
extract) 
 
Cinnabarin (2.1) 
 
Tramesanguin 
(2.2) 
 
Cinnabarinic 
Acid (2.3) 
 
Pycnoporin (2.8 
*(µg) **(µg) (%) (µg) (%) (µg) (%) (µg) (%) (µg) 
 
2002-03 4110 137 48.0 65.9 41.2 56.4 6.2 8.4 4.6 6.3 
2003-59 1680 56 48.5 27.2 43.0 24.1 5.6 3.1 2.9 1.6 
2004-02 3075 102 11.1 11.3 84.0 85.7 1.2 1.2 3.7 3.8 
2004-40 2460 82 42.1 34.2 53.0 43.5 1.3 1.1 3.6 3.2 
2006-24 3735 124 52.3 64.9 42.4 52.6 2.3 2.9 3.0 3.6 
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compounds 2.1 and 2.2 appeared to have increased as a result of the fungus extract 
being left to stand over a period of 12 months. Despite this, 2.8 was still isolated as the 
minor constituent in the fungus, which is consistent with the initial chemical profiling 
conducted on all crude extracts of the fungi (see Table 2.3). It is suggested that 2.8 
represents a new phenoxazone alkaloid pigment found in Australian variants of P. 
cinnabarinus. 
 
2.3 Biological Evaluation and Details of Assays 
 
3:1 MeOH/DCM extracts of all specimens of the fungi (2 g) were tested at 50 mg/mL 
and evaluated in a number of biological assays including against a P388 Murine 
Leukaemia cell line (antitumour assay), against the DNA Herpes simplex virus 1 and the 
RNA Polio virus 1 (antiviral assays) as well as against a number of bacteria and fungi 
(antimicrobial assays) at the University of Canterbury, Christchurch, New Zealand. 
Since the completion of these studies, the University of Canterbury has phased out 
both the antimicrobial and antiviral assays, which meant that compounds 2.1-2.3 and 
2.8 were unable to be evaluated. 
The antibacterial activity of cinnabarin (2.1) was reported as early as 1945 when 
Bose indicated that yellow or orange culture fluids of the fungus possessed strong 
antibiotic activity against gram-negative organisms from P. sanguineus (Bose, 1945; 
Lemberg, 1952). In 1995 it was concluded that the phenoxazone nucleus was part of a 
mechanism involved in the protection of mammalian tissue from oxidative damage 
(Eggert et al., 1995).  
Furthermore, an investigation by Smânia and co-workers resulted in optimal 
cinnabarin (2.1) production (in culture) in which this compound was tested against 
several bacteria (Smânia et al., 1997). Cinnabarin (2.1) was found to be active against 
Bacillus cereus and Leuconostoc plantarum, (inhibition of 0.0625 mg/mL) (Smânia et al., 
1998). 
Ergosterol peroxide (2.11), which had also been isolated from P. sanguineus, is 
known for its activity against Leishmania (Viannia) panamensis. Leishmaniasis is a disease 
caused by protozoan parasites that belong to the genus Leishmania and is transmitted 
by the bite of certain species of sand fly (Correa et al., 2006). 
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2.3.1 P388 Antitumour Activity 
 
As a result of the previous antibiotic activity reported for cinnabarin (2.1), extracts of P. 
cinnabarinus collected from several locations, were evaluated for further biological 
activities. It was observed that all tested extracts displayed moderate activities against 
Murine Leukaemia cells. In addition, the antitumour activities of the isolated 
phenoxazone 2.1, 2.2 and 2.8 from P. cinnabarinus (sample code 2006-24) and for 
compounds 2.3 and 2.11 from P. cinnabarinus (sample code 2002-03) are provided 
below in Table 2.4. 
 
Table 2.4. Biological evaluation of P. cinnabarinus crude extracts and compounds 2.1-2.3, 
2.8 and 2.11. 
- = not tested; ND = no activity detected; * = virus inhibition; ** = cytotoxicity observed; P388 = Murine leukaemia cell 
line; HSV = DNA Herpes simplex virus type 1; PV = RNA Polio virus type 1; BS = Bacillus subtilis; CA = Candida albicans; 
TM = Trichophyton mentagrophytes; CR = Cladosporium resinae; EC = Eschericha coli; PA = Pseudomonas aeruginosa 
 
It was observed that all tested extracts displayed moderate activities against 
murine leukemia cells (Table 2.4). Sample code 2002-03 (tested at 5.8 and 58 mg/mL) 
displayed slight antiviral activity and cytotoxicity against Herpes simplex and Polio 
viruses. Selective antifungal activity against Candida albicans (2 mm zone of inhibition) 
and against the bacterium Eschericha coli (3 mm zone of inhibition) was also observed. 
Cinnabarin (2.1) displayed the greatest antitumor activity (IC50 of 13 μM at 1 
mg/mL) followed by pycnoporin (2.8) (IC50 of 36 μM at 1 mg/mL), while compounds 
2.2 and 2.3 displayed much less activity (IC50 of > 44 μM at 1 mg/mL). Ergosterol 
peroxide (2.11), isolated from sample code 2002-03, displayed almost comparable 
antitumor activity to 2.1 (IC50 of > 20 μM at 1 mg/mL) and slight antiviral activity and 
 
Extracts 
 
Assay 
concentration 
(mg/mL) 
 
Antitumour 
assay 
Antiviral assays 
Antimicrobial assays 
(Zone of inhibition in mm) 
P388 
(IC50 in ng/mL or 
µM) 
HSV HSV 
Cyt 
PV PV 
Cyt 
BS CA TA CR EC PA 
2002-03 5.8 60,653 ND ND ND ND ND ND ND ND ND ND 
2002-03 58 30,873 * ** * ** ND 2 ND ND 3 ND 
2003-59 50 8,843 - - - - - - - - - - 
2004-02 50 10,893 - - - - - - - - - - 
2004-40 50 7,396 - - - - - - - - - - 
2006-24 - - - - - - - - - - - - 
(2.1) 1 13 - - - - - - - - - - 
 (2.2) 1 > 44 - - - - - - - - - - 
 (2.3) 1 > 44 - - - - - - - - - - 
 (2.8) 1 36 - - - - - - - - - - 
 (2.11) 1 > 20 * ** * ** - - - - - - 
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cytotoxicity against the Herpes simplex and Polio viruses. This study is the first to report 
the antitumor activity of 2.1. Cinnabarin (2.1) along with ergosterol peroxide (2.11) are 
suggested to be the bioactive constituents responsible for the antitumor activity 
observed in the crude extracts of P. cinnabarinus. 
 
2.3.2 Antioxidant Activity 
 
Sample 2002-03 was solvent partitioned between EtOAc and water and a separate 
sample of the same fungus also triturated between DCM, MeOH and water, 
respectively. Stock solutions of all five extracts (1 and 10 mg/mL) were prepared and 
individually reacted with 2,2-diphenyl-1- picrylhydrazyl (DPPH radical). In this assay, 
antioxidative constituents present in the extracts would react with the stable radical. 
The EtOAc extract, which was found to be the most active at 1 mg/mL, was re-tested at 
10 mg/mL (Table 2.5) and found to display DPPH radical scavenging activity of ~36 %. 
In addition, antioxidant activity was found to be present in both the DCM and MeOH 
extracts. No activity was detected for the corresponding water extract. As a result of 
these biological activities, further investigation and fractionation was carried out on 
this fungus, resulting in the isolation of 2.3 and 2.11. The isolated compounds could not 
be re-evaluated for any potential antioxidant activity, as access to these assays was no 
longer available at the time of their isolation. 
 
Table 2.5. Anti-oxidant activity for extracts of the Mentone collection of P. cinnabarinus 
(2002-03). 
Extract DPPH radical scavenging activity (%) 
(1 mg/mL) 
DPPH radical  
scavenging activity (%) 
(10 mg/mL) 
EtOAc 15.7 35.9 
Water 13.0 - 
*DCM 4.5 - 
*MeOH 9.5 - 
*Water - - 
- = Not tested, *trituration 
 
2.3.3 Anti-inflammatory Activity 
 
The same extracts obtained from 2002-03 (as described above for the antioxidant assay) 
were tested for anti-inflammatory activity against the 5-lipoxygenase enzyme, which is 
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responsible for the production of the LTB4 and 5- HETE products (Section 10.1.12.5) 
(see Appendix for further details). These products are responsible for the pathways 
leading to pain. The extracts were tested at 10 mg/mL and results are shown in Table 
2.6. 
 
Table 2.6. Anti-inflammatory activity for extracts of the Mentone collection of P. 
cinnabarinus (2002-03). 
Extract LTB4 
Inhibition 
(%) 
6t-12epi-LTB4  
(%) 
6t-LTB4 
(%) 
5-HETE 
Inhibition 
(%) 
EtOAc 87 100 100 88 
Water  12 82 85 18 
*DCM  70 95 100 60 
*MeOH  13 81 84 11 
*Water  4 78 83 19 
* Sequentially partitioned 
 
The EtOAc extract displayed the greatest inhibition of LTB4 and isomers. The 
DCM and MeOH extracts inhibited LTB4 and isomers, with the DCM extract being the 
most active. The results also indicated that inhibition of the 5-HETE pathway was 
primarily caused by the EtOAc (88% inhibition) and the DCM (60% inhibition) extracts. 
Once again, the DCM extract was active, with slight inhibition observed in the MeOH 
extract. No further assaying of subsequent fractions was conducted using these 
biological assays as access to the assays was no longer available. 
 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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Pycnoporus cinnabarinus  (2002-03) 
 
Kingdom:  Fungi 
Phylum:  Basidiomycota 
Class:   Basidiomycetes 
Subclass:  Agaricomycetidae 
Order:   Polyporales 
Family:  Polyporaceae 
Genus:  Pycnoporus 
Species:  cinnabarinus 
 
 Collected by Mr Donald Harney (Mentone, Victoria, Australia) 
(August, 2001) 
 
 
 
 
Pycnoporus cinnabarinus  (2003-59) 
Collected by Mr Daniel Dias (Marysville State Forest, Victoria, Australia) 
(January, 2003) 
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Pycnoporus cinnabarinus  (2004-02) 
Collected by Dr Sylvia Urban (Eltham, Victoria, Australia) 
(April, 2004) 
 
 
 
 
 
Pycnoporus cinnabarinus  (2004-40) 
Collected by Mr Allan Tinker from the Western Flora Caravan Park, 22 km north of 
Eneabba (Irwin botanical province) in Western Australia.  
(plant licence for scientific or other prescribed purposes SW008335) 
(July, 2004) 
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Pycnoporus cinnabarinus  (2006-24) 
Collected by Mr Michael Timmers (Heidelberg, Victoria, Australia) 
(May, 2006) 
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3.0 IntroductionD 
 
Haemodorum simplex is a bulbaceous perennial herb, which grows to a height of 0.2-
0.65m, producing black/brown flowers from the months of September to December 
(Paczkowska, 1994). The plant is endemic to the south-west region of Western 
Australia, growing in the region from the north of Geraldton to the south coast, east of 
Albany (Bick and Blackman, 1973). Commonly known as blood root, due to its strongly 
red-coloured bulbs, H. simplex belongs to the family, Haemodoraceae which is 
predominantly Australian (Cooke and Segal, 1955a). 
The genus Haemodorum was first investigated in 1955 with haemocorin (3.1) 
being the first phenylphenalenone (perinaphthenone) pigment reported from the plant, 
H. corymbosum Vahl (Cooke and Segal, 1955a). Haemocorin (3.1) was found to display 
antibacterial activity against Bacillus subtilis and other bacteria including Staphylococcus 
aureus (Narasimhachari et al., 1968). 
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3.1 
                                            
†
Dias DA, Goble DJ, Silva CA and Urban, S. 2009. Phenylphenalenones from the Australian Plant, Haemodorum simplex, J. 
Nat. Prod. 72: 1075-1080. 
 
Phenylphenalenones from the Australian Plant, 
Haemodorum simplex† 
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Over the last 50 years there have been several reports discussing the isolation of 
phenylphenalenones, mainly from plants such as Lachnanthes tinctoria, Wachendorfia 
paniculata and W. thyrsiflora Berm., indicating that the phenylphenalenone nucleus is 
characteristic to the family Haemodoraceae (Edwards, 1972, 1974; Edwards and Weiss, 
1974). Investigation of H. distichophyllum (Hook.), which is endemic to the 
southwestern region of Tasmania, afforded the dark red pigment haemodorin (3.2) 
(Bick and Blackman, 1973). By the early 1970s twenty naturally occurring phenalenones 
had been reported from both fungi and higher plants (Thomas, 1973). Chemical 
analyses extended to other plants in the family, including the roots of L. tinctoria, which 
afforded, compound 3.3 (Cooke, 1970), along with several naturally occurring phenolic 
precursors (Opitz et al., 2002).  
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                                                    3.2                                                           3.3 
 
Investigation of the phenylphenalenones present in the flowers of L. tinctoria 
resulted in the isolation of 3.4 which was converted into compound 3.5 using ethereal 
diazomethane (Bazan and Edwards, 1976; Cooke, 1970; Cooke and Segal, 1955b).  
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It was not until the early 1990s that investigation of Dilatris vicosa Bergius, 
endemic to South Africa, resulted in the isolation of the new phenylphenalenone 
glycoside dilatrin (3.6), which was confirmed by 1D and 2D NMR (COSY and NOESY) 
experiments (Dora et al., 1993). 
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                                                                      3.6 
 
In determining the position of the sugar moiety in 3.6, methylation was carried 
out which resulted in a single monomethyl ether 3.7, suggesting that the hexose was 
located at C-1 (Dora et al., 1993). Hydrolysis of 3.7 afforded xiphidone (3.8) (Edwards 
and Weiss, 1974), previously isolated from the plant Xiphidium caeruleum (Cooke and 
Dagley, 1979; Dora et al., 1993; Opitz et al., 2002). A minor phenylphenalenone 
glycoside, lachnanthoside aglycone 1-glucoside (3.9) was also isolated from the plant 
D. vicosa which was dimethylated to afford 3.7, demonstrating that the new compound 
was the C-1 glycoside of (3.9) (Dora et al., 1993). 
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3.9 
 
This chapter describes the chemistry and biological activity of the medicinal 
plant, Haemodorum simplex from Western Australia. The crude extract of the bulbs and 
aerial components of the plant showed varying antibacterial, antifungal and antiviral 
activities, whilst only the crude extract of the bulbs of the plant displayed potent 
antitumour activity. On the basis of these biological activities, subsequent chemical 
investigation was only carried out only on the bulbs of the plant. The isolation and 
structure determination of three new phenylphenalenones, haemodorone (3.10), 
haemodorol (3.11) and haemodorose (3.12) and the first report for the complete 2D 
NMR characterisation for compound 3.5, dilatrin (3.6) and xiphidone (3.8), which 
subsequently resulted in a number of chemical shift reassignments for dilatrin (3.6) is 
now documented. 
 
                       
O
O
O
O
OHCH3
         
O
O
O
O
OHCH3
HO
 
                                             3.10                                                                  3.11 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
84 | P a g e  
 
 
O
OCH3
O
OHO
HO
OH
O
OH
 
3.12 
 
3.1 Collection, Extraction and Isolation 
 
The plant identified as Haemodorum simplex (Haemodoraceae), was collected by Mr 
Allan Tinker on the 20th of January, 2005, from the Western Flora Caravan Park, 22 km 
north of Eneabba (Irwin botanical province) in Western Australia (plant licence for 
scientific or other prescribed purposes SW008335). The plant material was physically 
separated into its aerial and bulbaceous components respectively. Voucher specimens 
with the designated codes 2005-01a (bulbaceous roots) and 2005-01b (aerial parts) are 
deposited at the School of Applied Sciences, RMIT University. Photographs of the 
plant specimen Haemodorum simplex, are shown on page 107. 
The bulbaceous part of the plant (22 g) (7g dr. wt ) was extracted with 3:1 
MeOH/DCM (400 mL) and the crude extract decanted and concentrated under 
reduced pressure and sequentially partitioned into DCM then MeOH soluble extracts. 
The bulbs were then re-extracted with MeOH (100%) and this extract was combined 
with the previous MeOH extract. The combined MeOH extract was then fractionated 
using flash C18 VLC (10% stepwise elution from H2O to MeOH and finally to DCM). 
All fractions were analysed using a reversed phase HPLC method (standard HPLC 
gradient, as described in Section 10.1.3) and on this basis, the 40:60 (fraction 7) and 
50:50 H2O/MeOH (fraction 8) column fractions were combined and subjected to semi-
preparative reversed phase HPLC using the following gradient method (0 - 12 mins 
30% CH3CN/H2O and 13 - 30 mins 100% CH3CN) to yield dilatrin (3.6) (12.2 mg, 
0.15%) and the novel phenylphenalenones, haemodorone (3.10) (1.4 mg, 0.02%), 
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haemodorol (3.11) (2.7 mg, 0.03%) and haemodorose (3.12) (13.1 mg, 0.16%) (% based 
on the mass of the dried weight of the plant) as shown is Scheme 3.1.  
The DCM extract was fractionated using flash silica gel column 
chromatography (20% stepwise elution from n-hexane to 100% DCM to 100% EtOAc 
and finally to 100% MeOH). All fractions were analysed by normal phase analytical 
HPLC using a gradient method consisting of (0 - 20 mins 65% n-hexane/EtOAc, 20.01 -
30 mins 30% n-hexane/EtOAc and 30.01 - 40 mins 100% EtOAc). The 100% n-hexane 
silica gel column fraction was subjected to reversed phase HPLC (85% CH3CN/H2O) 
which afforded compounds 3.5 (3.3 mg, 0.04%) and xiphidone (3.8) (2.0 mg, 0.03%) (% 
based on the mass of the dried weight of the plant) as shown is Scheme 3.1. 
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3.2 Results and Discussion 
 
Once the plant was physically separated into its bulbaceous and aerial components, 2 g 
of each was extracted with 3:1 MeOH/DCM. Following the results obtained from the 
bioassay of these extracts (Section 3.3), only the bulbaceous extract was bulk extracted 
and further fractionated. Final purification was achieved by semi-preparative reversed 
phase HPLC to yield compounds 3.6, 3.10, 3.11 and 3.12. The extraction and isolation 
scheme is shown in Scheme 3.1.  
The DCM extract of the bulbs was fractionated by silica gel vacuum liquid 
chromatography. The 100% n-hexane fraction was then subjected to reversed phase 
HPLC to yield compounds 3.5 and 3.8. The extraction and isolation scheme is shown in 
Scheme 3.1. 
 
3.2.1 Structure Elucidation of Compound 3.5 
 
Compound 3.5 was first isolated by Cooke in 1955 and subsequently prepared 
by Bazan in 1976. Only 1H NMR data of 3.5 had been reported (Bazan and Edwards, 
1976; Cooke and Segal, 1955b). In the current study of 3.5 was established by 1D and 
2D NMR experiments, resulting in the first complete unequivocal assignment of this 
compound along with the first report of compound 3.5 occurring as a natural product, 
detailed in Section 10.3. 
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3.2.2 Structure Elucidation of Dilatrin (3.6) 
 
As a result of the re-isolation of dilatrin (3.6), additional chemical shift 
assignments are reported for the sugar moiety for this compound by comparison of 
carbon chemical shifts to the phenylphenalenone nucleus (Hölscher et al., 2006; 
Hölscher and Schneider, 2000; Opitz et al., 2002; Otálvaro et al., 2007). The NMR data of 
3.6, which had been previously reported in d6-acetone and d6-DMSO (the latter solvent 
used for the assignment of the sugar moiety protons) were compared to the literature 
NMR (Dora et al., 1993). It was immediately evident that several of the carbon chemical 
shifts and their multiplicities were not consistent with reported data of dilatrin (3.6) 
(Dora et al., 1993; Opitz et al., 2002). This resulted in the reassignment of a number of 
the chemical shifts of 3.6. The reassignments were supported by the results obtained 
from the 2D NMR experiments, shown in Figures 3.1 and 3.2. The 1H NMR data of 3.6 
recorded in d6-acetone is detailed in Section 10.3. 
These reassignments include the previously assigned methine at δ 7.14,  
148.63 (C-2) which has now been reassigned to a quaternary carbon bearing a hydroxy 
substituent at 148.1 (C-2). Position C-3 was previously assigned as a quaternary carbon 
115.27, (C-3) however HSQCAD NMR experiments confirmed the 1JCH connectivity 
and multiplicity of this carbon to be a methine δ  7.62, 124.1 (C-3). The carbon bearing 
the pendant sugar moiety was formerly assigned as 149.15 (C-1) which has now been 
reassigned to be 140.4 (C-1) on the basis of gHMBC NMR correlations. Other chemical 
shifts reassignments made include the following: the methine previously assigned at δ 
7.57, 121.68 (C-4) has now been reassigned to δ 7.23, 114.3 (C-4), the carbon at 141.88 
(C-6a) is now reassigned to 130.7 (C-6a) and positions C-9a and C-9b which were 
incorrectly reported as 126.64 and 129.7 ppm, respectively. These have now been 
reassigned on the basis of HMBC NMR experiments and comparison to carbon 
chemical shifts reported for the phenylphenalenone nucleus to be 127.8 and 120.7 ppm, 
respectively (Hölscher et al., 2006; Hölscher and Schneider, 2000; Opitz et al., 2002; 
Otálvaro et al., 2007). Furthermore, gHSQCAD NMR experiments confirmed direct 1JCH 
connectivity for δ 2.20, 73.8 (C-2‖) and δ 2.72, 70.4 (C-4‖). These chemical shifts were 
previously either incorrectly assigned or not assigned at all (Dora et al., 1993) (Figures 
3.1 and 3.2). 
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Figure 3.1. Incorrect 1H and 13C NMR assignment for dilatrin (3.6) (Dora et al., 1993). 
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Figure 3.2. Correct 1H and 13C NMR assignment for dilatrin (3.6). 
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3.2.3 Structure Elucidation of Xiphidone (3.8) 
 
Xiphidone (3.8) had been previously reported from the roots of L. tinctoria 
(Edwards and Weiss, 1974) as well as from the neotropical plant Xiphidium caeruleum 
Aubl. (Cremona and Edwards, 1974). Once again, only the 1H NMR of 3.8 had been 
reported (Cremona and Edwards, 1974). Detailed spectroscopic analyses (1D and 2D 
NMR experiments) confirmed the structure of 3.8, resulting in its first complete 
unequivocal assignment detailed in Section 10.3. 
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3.2.4 Structure Elucidation of Haemodorone (3.10) 
 
The novel phenylphenalenone, haemodorone (3.10) was isolated as a yellow oil. 
HRESI-MS established the molecular formula as C19H12O5 (319.0610 [M-H]- calculated 
for C19H11O5, 319.0685), possessing fourteen DBEs. The IR spectrum supported the 
presence of a hydroxy group (3430 cm-1) and carbonyl moieties at (1769 and 1725 cm-1). 
The UV profile extracted for 3.10 from the HPLC contour plot, displayed UV maxima 
(λmax 218, 259, 327, 344 and 393 nm) that were similar to those previously reported for 
3.3, thereby suggesting a phenylphenalenone anhydride nucleus (Opitz et al., 2002).  
Analysis of the NMR spectra (recorded in d6-DMSO) (Figures 3.3 and 3.4, 
respectively) indicated the presence of a methoxy group (δ 3.25, s, 3H; 59.9 (C-10), three 
aromatic methines [δ 8.22, s, 1H; 124.8, (C-4), δ 7.53, d, J = 7.5 Hz, 1H; 130.4 (C-8) and δ 
8.34, d, J = 7.5 Hz; 129.2 (C-9)] as well as a phenyl moiety [δ 7.44, m 2H; 127.2 (C-2‘, C-
6‘); δ 7.37, m, 3H; 128.2 (C-3‘, C-4‘, C-5‘)] (Table 3.1). 
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Table 3.1. NMR Data (500 MHz, d6-DMSO) for haemodorone (3.10). 
 
O
O
O
O
OH
1
3a6a
8
1'
9b
5 '
10
CH3
 
 
 
position 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
1 - 161.0, qC   
2 - -   
3 - 160.4, qC   
3a - 114.4, qC   
4 8.22, s 124.8, CH  C-3, C- 5, C- 6, C- 3a, C-9b 
5 - 149.0, qC   
6 - 148.6, qC   
6a - 118.3, qC   
7 - 144.9, qC   
8 7.53, d, (7.5) 130.4, CH H-9 C-6a, C-9a, C-1‘ 
9 8.34, d, (7.5) 129.2, CH H-8 C-1, C-7, C-9b 
9a - 125.5, qC   
9b - 127.1, qC   
10 3.25, s 59.9, CH3  C-6 
1‘ - 142.2, qC   
2‘, 6‘ 7.44, m 127.2, CH  C-2‘, C-6‘ 
3‘, 4‘, 5‘ 7.37, m 128.2, CH  C-7, C-2‘, C-6‘, C-3‘, C-4‘, C-5‘ 
5-OH 10.60, bs -  C-5 
a Carbon assignments based on DEPT and  HSQCAD experiments 
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The 13C NMR and HSQCAD NMR experiments supported the presence of one 
methyl and eight methine carbons (three being equivalent). Ten quaternary carbons 
were identified on the basis of HMBC correlations (Figure 3.5). A combination of the 
COSY and HMBC NMR experiments as well as comparison to the literature NMR data 
for the structurally related compound 3.3, readily confirmed the presence of a 
phenylphenalenone anhydride (Opitz et al., 2002). Linking of the phenylphenalenone 
nucleus to the phenyl ring was achieved through the observation of a HMBC 
correlation from the olefinic methine at δ 7.53 to the quaternary carbon at 142.2 (C-1‘) 
ppm. The aromatic methine at δ 8.34, which was coupled to H-8, showed a HMBC 
correlation to the ester carbon at 161.0 (C-1) ppm.  
 
 
 
 
 
Figure 3.5. Expansion of the HMBC NMR spectrum for haemodorone (3.10)  
illustrating HMBC correlations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Expansion of the HMBC NMR spectrum for haemodorone (3.10)  
illustrating HMBC correlations. 
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In comparing the NMR data between 3.10 and the structurally related 
compound 3.3 (recorded in d6-acetone), it was immediately evident that the data was 
not identical (Figure 3.6) (the 1H NMR data for 3.10 is detailed in Section 10.3). In 
particular, the methoxy resonance (δ 3.29 in d6-acetone) in 3.10, is shifted upfield by 
0.82 ppm compared to the closely related analogue 3.3 (δ 4.11 in d6-acetone) which is 
attributable to the shielding effect of the aromatic ring (Opitz et al., 2002). This allowed 
the methoxy moiety to be positioned at position 6 in 3.10, adjacent to the aromatic ring 
(Bazan and Edwards, 1976; Cooke, 1970; Dora et al., 1993; Opitz et al., 2002). 
 
O
O
O
HO
OCH3
4.11, s
57.7
H
H
H
7.52, d, J = 7.3 Hz
130.4
8.44, d, J = 7.3 Hz
131.8
8.32, s
119.6
1
3a6a
8
1'
9b
5'
6
5
  
 
    
O
O
O
O
OH
1
3a6a
8
1'
9b
5'
10
CH3
3.29, s
59.9
H
H
H7.53, d, J = 7.5 Hz
130.4
8.34, d, J = 7.5 Hz
129.2
8.22, s
124.86
5
 
Figure 3.6. 1H and 13C NMR data for compound 3.3 (500 MHz, d6-acetone) (TOP) and 
1H and 13C NMR data for haemodorone (3.10) (500 MHz, d6-acetone) 
(BOTTOM). 
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3.2.5 Structure Elucidation of Haemodorol (3.11) 
 
The novel phenylphenalenone, haemodorol (3.11) was also isolated as a yellow 
oil (85% purity based on the intergration of the 1H NMR spectrum), for which HR-ESI-
MS established the molecular formula as C19H12O6 (335.0558 [M-H]- calculated for 
C19H11O6, 335.0556), possessing fourteen DBEs. As in the case of 3.10, the IR spectrum 
supported the presence of hydroxy groups (3369 cm-1) and carbonyl moieties (1761 and 
1729 cm-1) and the UV maxima suggested the presence of a phenylphenalenone 
anhydride nucleus (Opitz et al., 2002).  
Analysis of the 1H NMR spectra (Figure 3.7) indicated that the only difference 
between compounds 3.10 and 3.11 was the absence of two ortho substituted aromatic 
methines [δ 7.20, d, J = 8.5 Hz; 130.5 (C-2‘, C-6‘) and δ 6.82, d, J = 8.5 Hz; 114.8 (C-3‘, C-
5‘)] indicating that the pendant aromatic ring was 1,4-disubstituted in 3.11, as 
supported by HMBC and COSY correlations (Table 3.2). HSQCAD NMR experiments 
indicated the presence of one o-methyl and seven methine carbons (two of these being 
equivalent) (Figure 3.8), while eleven quaternary carbons were identified from the 
HMBC experiment (Table 3.2).  
 
O
O
O
O
OH
1
3a6a
8
1'
9b
5'
10
CH3
HO
 
      haemodorol (3.11) 
 
Linking of the 1,4-disubstituted phenyl moiety to the phenylphenalenone 
anhydride nucleus was possible due to the observation of a HMBC correlation from the 
aromatic methine at δ 7.51 to the quaternary carbon at 133.2 (C-1‘). Once again the 
shielded nature of the methoxy moiety in haemodorol (3.11) at δ 3.26 supported its 
placement nearest to the aromatic ring at position C-6 (Bazan and Edwards, 1976; 
Cooke, 1970; Dora et al., 1993; Opitz et al., 2002). 
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Figure 3.8. HSQCAD NMR spectrum for haemodorol (3.11) illustrating 1JCH correlations. 
 
 
 
 
 
 
125.3, CH, C-4 
130.0, CH, C-9 
114.8, CH, C-3’, C-5’ 
130.5, CH, H-2’, H-6’ 
131.3, CH, C-8 
60.8, CH3, C-10 
H-3’, H-5’ 
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
 
H-3’, H-5’ 
H-2’, H-6’ 
H-10 
H-8 
H-4 
H-9 
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Table 3.2. NMR Data (500 MHz, d6-DMSO) for haemodorol (3.11). 
 
HO
O
O
O
O
OH
1
3a6a
8
1'
9b
5 '
10
CH3
 
 
 
position 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
1 - 161.8, qC   
2 - -   
3 - 161.4, qC   
3a - 115.0, qC   
4 8.20, s 125.3, CH  C-3, C-3a, C-5, C-6, C-9b 
5 - 157.0, qC   
6 - 149.5, qC   
6a - 118.5, qC   
7 - 145.9, qC   
8 7.51, d, (7.5) 131.3, CH H-9 C-1‘, C-6a, C-9, C-9a 
9 8.31, d, (7.5) 130.0, CH H-8 C-1, C-7, C-9b 
9a - 126.3, qC   
9b - 127.4, qC   
10 3.26, s 60.8, CH3  C-6 
1‘ - 133.2, qC   
2‘, 6‘ 7.20, d, (8.5) 130.5, CH H-3‘, H-5‘ C-2‘, C-4‘, C-6‘, C-7 
4‘ - 157.1, qC   
3‘, 5‘ 6.82, d, (8.5) 114.8, CH H-2‘, H-6‘ C-1‘, C-3‘, C-4‘, C-5‘ 
4‘-OH 9.60, bs -  C-3‘, C-4‘, C-5‘ 
6-OH 10.54, bs -   
aCarbon assignments based on HSQCAD and HMBC experiments 
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3.2.6 Structure Elucidation of Haemodorose (3.12) 
 
Haemodorose (3.12) was isolated as a yellow oil for which HR-ESI-MS 
established the molecular formula as C25H24O9 (469.1496 [M+H]+, calculated for 
C25H26O9, 469.1493) and (491.1313 [M+Na]+, calculated for C25H24O9Na, 491.1313), 
possessing fourteen DBEs. The IR spectrum supported the presence of hydroxy groups 
(3421 cm-1) and a carbonyl moiety (1711 cm-1). The extracted UV spectrum of 3.12, 
displayed similar UV maxima to the known phenylphenalenone glycoside dilatrin (3.6) 
(Dora et al., 1993). Analysis of the 1H NMR spectra (Figure 3.9) revealed chemical shifts 
indicative of a methoxy group (δ 3.90, s, 3H; 56.8 (C-10), three aromatic methines [δ 
7.59, s, 1H; 112.4 (C-4), δ  7.33, d, J = 7.3 Hz, 1H; 130.2 (C-8) and δ 8.10, d, J = 7.3 Hz, 1H; 
125.7 (C-9), as well as a monosubstituted phenyl moiety δ 7.29, m, 5H; 125.9 (C-2‘- C-6‘) 
and a deshielded oxymethylene δ 5.83, bs, 2H; 68.9 (C-3) together with chemical shifts 
consistent with the presence of a sugar moiety [δ 4.78, 101.4, (C-1‖); δ 1.84, 72.5, (C-2‖); 
δ 2.95, 76.0 (C-3‖), δ 2.76, 69.2 (C-4‖); δ 2.74, 76.5 (C-5‖); δ 3.37 and 3.20, 60.6 (C-6); δ 
4.38 (2‖-OH); δ 4.75 (3‖-OH) and δ 4.04 (6‖-OH).  
The doublet at δ 4.78 with a coupling constant of 7.5 Hz indicated the β-
configuration of the anomeric proton, and vicinal coupling constants indicated that all 
protons are axial, supportive of glucose as the sugar residue. Due to the shielding effect 
of the phenyl ring, the sugar resonances appear at unusually high field since the sugar 
attached to the phenalenone ring lies within the shielding cone of the phenyl 
substitutent (Dora et al., 1993; Opitz et al., 2002). Similar high-field shifts in glucosides 
have been observed for such protons in the antibiotic moenomycin A and 
benzoxazinone-N-glucosides (Pauli et al., 2000; Henning et al., 1998; Sticker et al., 2001). 
DEPT and HSQCAD NMR experiments (Figure 3.10) supported the presence of 
one methyl, thirteen methines (four of these being equivalent), two methylene carbons 
and nine quaternary carbons identified from the HMBC experiment (Table 3.3). The 
UV maxima, together with comparison of the NMR data reported for the closely 
related compound dilatrin (3.6), readily established the presence of a 
phenylphenalenone glycoside skeleton for 3.12 (Dora et al., 1993).  
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Table 3.3. NMR Data (500 MHz, d6-DMSO) for haemodorose (3.12). 
 
O
OCH3
O
OHO
HO
OH
O
OH
1'
5'
1"
3"
5"
9b
8
10
1
3a6a
 
 
 
pos 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
1 - 164.6, qC   
2 - -   
3 5.83, bs 68.9, CH2 H-4 C-1, C-3a, C-4, C-5, C-6, C-9b  
3a - 125.0, qC   
4 7.59, s 112.4, CH H-3 C-3, C-3a, C-5, C-6 
5 - 149.9, qC   
6 - 139.3, qC   
6a - 130.1, qC   
7 - 144.6, qC   
8 7.33, d, (7.3) 130.2, CH H-9 C-7, C-9a, C-9b, C-1‘ 
9 8.10, d, (7.3) 125.7, CH H-8 C-1, C-7, C-9a  
9a - 125.5, qC   
9b - 119.1, qC   
10 3.90, s 56.8, CH3  C-5 
1‘ - 145.4, qC   
2‘, 3‘, 4‘, 
5‘, 6‘ 
7.29, m 125.9, CH   
1‖ 4.78, d, (7.5) 101.4, CH H-2‖ C-6 
2‖ 1.84, ddd, (4.5, 7.5, 12.5) 72.5, CH H-1‖, 2‖-OH, H-3‖ C-1‖, C-3‖  
3‖ 2.95, dd, (4.0, 8.5) 76.0, CH H-2‖, H-4‖, 3‖-OH  
4‖ 2.76, m 69.2, CH H-3‖, H-5‖ C-3‖, C-5‖ 
5‖ 2.74, m 76.5, CH   
6‖a 3.37, m 60.6, CH2   
6‖b 3.20, m 60.6, CH2 6‖-OH C-5‖ 
2‖-OH 4.38, d, (4.5) - H-2‖ C-1‖, C-2‖, C-3‖  
3‖-OH 4.75, d, (4.5) - H-3‖ C-3‖ 
4‖-OH ND -   
6‖-OH 4.04, t, (5.5) - H-6‖b C-5‖, C-6‖ 
aCarbon assignments based on HSQCAD and DEPT experiments 
ND = signal was not detected. 
 
Acid hydrolysis of haemodorose (3.12) indicated the presence of a β-D-
glucopyranose moiety via TLC comparison to authentic standards in addition to its 
positive optical rotation (Cichewicz et al., 2002). A combination of HMBC and COSY 
correlations established the presence of a phenyl moiety. Linking of the phenyl group 
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to the phenylphenalenone glycoside nucleus was achieved on the basis of a HMBC 
correlation observed from δ 7.33 (H-8) to the quaternary carbon at 145.4 (C-1‘) ppm. 
Additional correlations include a COSY correlation from the aromatic methine at δ 8.10 
to H-8 (COSY) and a HMBC correlation from H-9 to the ester carbon at 164.6 (C-1). The 
oxymethylene at δ 5.83 (H-3) showed HMBC correlations to a quaternary carbon at 
164.6 (C-1), confirming the presence of a lactone, as well as to the C-4 aromatic methine 
112.4 (C-1) ppm. The deshielded nature of the methoxy moiety in 3.12 (δ 3.90) allowed 
for the positioning of the methoxy and sugar substituents (Dora et al., 1993). This, 
together with HMBC correlations, confirmed the presence of the methoxy substituent 
at C-5, adjacent to the glucosidic linkage with the pendant aromatic moiety attached at 
149.9 (C-6) ppm. Acid hydrolysis, optical rotation, NMR and MS data supported the 
presence of a β-D-glucopyranose residue. The NMR data for the β-D-glucopyranose 
moiety was also compared directly with that of the β-D-glucopyranose that occurs in 
dilatrin (3.6) and found to be in agreement (Dora et al., 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
103 | P a g e  
 
 
 
 
0
.5
0
.5
1
.0
1
.0
1
.5
1
.5
2
.0
2
.0
2
.5
2
.5
3
.0
3
.0
3
.5
3
.5
4
.0
4
.0
4
.5
4
.5
5
.0
5
.0
5
.5
5
.5
6
.0
6
.0
6
.5
6
.5
7
.0
7
.0
7
.5
7
.5
8
.0
8
.0
8
.5
8
.5
9
.0
9
.0  
F
ig
u
re
 3
.9
.
1
H
 N
M
R
 (
5
0
0
 M
H
z
, d
6
-D
M
S
O
) 
o
f 
h
a
em
o
d
o
ro
se
(3
.1
2
).
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
104 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
ig
u
re
 3
.1
0
.
D
E
P
T
1
3
5
 (
C
H
3
‘s
 a
n
d
 C
H
‘s
 u
p
, 
C
H
2
‘s
 d
o
w
n
) 
fo
r 
h
a
em
o
d
o
ro
se
(3
.1
2
) 
(T
O
P
)
D
E
P
T
9
0
 (
C
H
‘s
 u
p
) 
fo
r 
h
a
em
o
d
o
ro
se
(3
.1
2
) 
(B
O
T
T
O
M
).
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
105 | P a g e  
 
 
3.3 Biological Evaluation and Details of Assays 
 
 To date, compounds containing the phenylphenalenone nucleus have been 
isolated from the family Haemodoroceae, predominately from Haemodorum, Wachendorfia, 
Anigozanthos, Dilatris, Lachnanthes and Xiphidium genera. This nucleus is regarded as a 
characteristic chemotaxonomic marker (Opitz et al., 2002). The phenylphenalenones 
have also been reported from the families Strelitziaceae, Pontederiaceae and Musaceae, for 
which the species, Haemodorum is restricted to the south-west region of Western 
Australia (Hölscher et al., 2006; Holscher and Schneider, 2000; Opitz et al., 2002; 
Otálvaro et al., 2007). Phenylphenalenones have shown to function as phytoalexins 
(antibiotics) which are produced in plants and act as toxins to the attacking organism. 
They are able to cause damage to the cell wall, disrupt metabolism or prevent 
reproduction of the pathogen and are often targeted to specific predators for example, 
a plant that has anti-insect phytoalexins may not have the ability to repel a fungal 
attack (Borges and Fernandez-Falcon, 2003). Isolation of these compounds from fungal 
species has also been reported, where it was noted that they are produced through a 
polyketide biogenesis (Thomas, 1973). In plants, the phenylphenalenones have been 
shown to be biosynthesised from phenylpropanoid units derived from the shikimate 
biogenesis (Thomas, 1973). Extracts of the bulbs from several species from the genus, 
Haemodorum have been reportedly used by the Aborigines, including medicinal uses as 
a purgative, applied externally for snake bites, and also as a dyeing agent for the 
colouring of strings, ropes and baskets (Li et al., 2003; Reid and Betts, 1979; Webb, 
1969). In a recent study of the secondary metabolites occurring in a marine-derived 
fungus, two novel phenalenones, sculezonone A (3.13) and sculezonone B (3.14), were 
reported, along with their inhibitory activity towards DNA polymerase (Perpelescu et 
al., 2002). 
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The bulbs and aerial parts of the plant were first physically separated. Crude 
extracts (2 g extracted with 40 mL 3:1 MeOH/DCM) were generated and evaluated (at 
50 mg/mL) in a number of biological assays including against a P388 Murine 
Leukaemia cell line (antitumour assay), against Herpes simplex and Polio viruses 
(antiviral assays) as well as against a number of bacteria and fungi (antimicrobial 
assays) at the University of Canterbury, Christchurch, New Zealand. Potent 
antitumour activity was observed for the crude extracts of the bulbs (IC50 <4,875 
ng/mL), but only moderate antitumour activity was observed for the crude extract of 
the aerial parts (IC50 104,717 ng/mL).  
In addition, both extracts displayed antiviral activity against the Herpes simplex 
and the Polio viruses. Moderate antifungal activity was detected for the bulbs and 
aerial components of the plant against Trichophyton mentagrophytes, whilst antibacterial 
activity was detected for both the bulbs and aerial parts of the plant against Bacillus 
subtilis. For both crude extracts no activity was observed against Eschericha coli, 
Pseudomonas aeruginosa, Candida albicans or Cladosporium resinae. Compounds 3.5, 3.6, 
3.8 and 3.10-3.12 displayed moderate antitumour activities (IC50 of > 26-39 µM when 
tested at 1 mg/mL). It is suggested that the principle bioactive secondary metabolite(s) 
are yet to be identified, however, any efforts to secure these will require a recollection 
of the plant material which is not foreseen for any time in the near future.  
Since the completion of these studies, the University of Canterbury has phased 
out both the antimicrobial and antiviral assays, which precluded compounds 3.5, 3.6, 
3.8 and 3.10-3.12 from being subsequently evaluated in these assays.  
 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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O[op[ iop[ i op[op[  
 
 
Haemodorum simplex  (2005-01a) (aerial parts shown only) 
 
Kingdom:  Plantae 
Division:  Magnoliophyta 
Class:   Liliopsida 
Order:   Commelinales 
Family:  Haemodoraceae 
Genus:  Haemodorum 
Species:  simplex 
 
 Collected by Mr Allan Tinker from the Western Flora Caravan Park, 22 km north of 
Eneabba (Irwin botanical province) in Western Australia.  
(plant licence for scientific or other prescribed purposes SW008335) 
 (January, 2005) 
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4.0 IntroductionE 
 
Dianella callicarpa (Liliaceae) is an evergreen perennial herb growing to approximately 
190 cm in height and 1.5 m in diameter at the base. It has wide, flat, green leaves, 
fibrous yellow roots and blue-violet flowers and produces small blue fruits (Carr and 
Horsfall, 1995). The genus Dianella is commonly known as the "swamp flax-lily" and is 
predominantly endemic to Victoria, with possible occurrences of the species also 
reported from the southwest regions of South Australia (Carr and Horsfall, 1995; 
Palombo and Semple, 2001; Semple et al., 2001; Semple et al., 1998). One of the earliest 
reports on the chemistry of Dianella species was the isolation of dianellin (4.1) obtained 
from the alcoholic extracts of the roots of D. caerulea, as well as the corresponding 
aglycone derivative dianellidin (4.2) (also known as musizin and nepodin) (Murakami 
and Matsushima, 1961) obtained from the roots of D. laevis (Batterham et al., 1961). 
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†
Dias DA, Silva CA and Urban, S. 2009. Naphthalene Aglycones and Glycosides from the Australian Medicinal Plant, 
Dianella callicarpa, Planta. Med. 75: 1-6. 
 
Naphthalene Aglycones and Glycosides from the 
Australian Medicinal Plant, Dianella callicarpa† 
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Subsequent studies have included the chemical investigation of the roots of 
both D. revoluta and Stypandra grandis which have afforded dianellinone (4.3) and 
stypandrone (4.4), respectively (Cooke and Sparrow, 1965).  
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In 1971 Cooke reported the isolation of the pigment, trianellinone (4.5) from the 
benzene extracts of D. revoluta (Cooke and Down, 1970c). In the same year Cooke 
isolated an optically active flavan, (-)-4'-hydroxy-7-methoxy-8-methylflavan (4.6) from 
the benzene extracts of D. revoluta, whereby the structure and absolute configuration 
were deduced by NMR spectroscopy (Cooke and Down, 1970a, b). 
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In addition, the proposed oxidative biosynthetic pathway, which produces 
various naphthols such as naphtholquinone and binaphthol species from the primary 
precursor such as dianellidin (4.2), was confirmed by the discovery of stypandrol (4.7), 
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isolated from both D. revoluta and S. imbricata indicating that these compounds are also 
found in the family Noctuoidea (Byrne et al., 1987). Stypandrol (4.7) has been shown to 
induce toxicosis in goats and sheep, with observations such as weakness and paralysis 
of the hind limbs which progresses to prostration and/or death (Colegate et al., 1985). 
In 1987 the isolation of the closely related compound imbricatonol (4.8) was reported 
by the same group from both S. imbricata and D. revoluta, but unlike stypandrol (4.7), 
this compound did not display any toxicity against laboratory mice (Byrne et al., 1987). 
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This chapter describes the chemistry and biological activity of a Australian 
medicinal plant. Separate crude extracts of the stems/leaves as well as the roots of 
Dianella callicarpa (Liliaceae) were evaluated in several bioassays (Section 4.3). It was 
established that only the crude extract of the roots displayed significant antimicrobial 
and antiviral activities. Consequently, chemical and biological investigations were only 
carried out on the crude extract of the roots of D. callicarpa. This resulted in the 
isolation of the new naphthalene glycoside dianellose (4.10) as well as the known 
naphthalene aglycone or glycoside derivatives, dianellin (4.1) and stellalderol (4.9), 
together with the identification of dianellidin (4.2), dianellinone (4.3) and 5-
hydroxydianellin (4.11). While the chemistry of the genus Dianella has been previously 
studied, this thesis describes the first chemical and biological evaluation of the 
callicarpa species. The isolation of naphthalene glycosides appears to be generally 
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absent from other studies carried out on the genus Dianella. With the exception of 
dianellin (4.1) (Cichewicz et al., 2002; Murakami and Matsushima, 1961), no other 
naphthalene glycosides have been reported from species of Dianella to date. 
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4.1 Collection, Extraction and Isolation 
 
Two plant specimens labelled as Dianella longifolia were purchased from the Victorian 
Indigenous Nurseries Co-Operative located on Yarra Bend Road in Fairfield, 
Melbourne, Australia on the 20th of January and 18th of February, 2005. Both samples 
had been propagated from a parent plant picked from Diamond Creek in Eltham 
Victoria on the 7th of April, 2004. To confirm the species of Dianella purchased, samples 
of both plant specimens were provided to Mr Geoffrey Carr (Director & Senior Botanist 
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at Ecology Australia and Australian expert in Dianella taxonomy) for identification 
(sample vouchers of the two plants were lodged with Ecology Australia).  
The specimens were subsequently reclassified as Dianella callicarpa G.W. Carr & P.F. 
Horsfall, Muelleria 8:366 (1995) (Liliaceae). The plant specimens were then physically 
separated into the roots (voucher code 2005-02a) and the leaves/stems (voucher code 
2005-02b) with voucher specimens also being deposited at the School of Applied 
Sciences, RMIT University. Subsequent chemical and biological investigations deal 
predominantly with extracts originating from the roots of D. callicarpa (voucher code 
2005-02a). Photographs of the plant specimen Dianella callicarpa, are shown on page 
134. 
A sample of the D. callicarpa roots (~15 g dr. wt.) was cleaned by removing the 
majority of the attached soil material. In the first extraction procedure ~27 g of root 
material was extracted with 3:1 MeOH/DCM (600 mL) and the crude extract (1.3 g) 
stored at 4C. The extract was filtered under gravity, concentrated under reduced 
pressure and then sequentially solvent partitioned into DCM (125 mL, 68.5 mg, 0.46%) 
then MeOH (125 mL, 1.23 g, 8.2%) soluble fractions, respectively (% based on the mass 
of the dried weight of the plant). 
The MeOH extract (0.8 g) was then subjected to C18 (VLC) using a 10% stepwise 
elution from 100% H2O to 100% MeOH and finally to 100% DCM. Analysis of the 40% 
MeOH/H2O fraction by 1H NMR spectroscopy, analytical HPLC as well as by ESI-MS 
indicated that it contained a mixture of the known compounds, stellalderol (4.9) (~70% 
purity) and 5-hydroxydianellin (4.11) (~5% purity) (42 mg, 0.28%). The 60% 
MeOH/H2O fraction contained a mixture of compounds [(dianellin (4.1) and the novel 
naphthalene glycoside, dianellose (4.10)] present in a 1:1 ratio, based on 1H NMR 
integration) (72 mg, 0.48%).  
These individual fractions were then evaluated for their antimicrobial and 
antiviral properties (Section 4.3) and then subsequently combined for further 
purification using semi-preparative reversed phase HPLC using the standard HPLC 
gradient (Section 10.1.3), resulting in three separate fractions being collected. The first 
fraction contained semi-pure stellalderol (4.9) (~90% purity, based on 1H NMR 
spectroscopy) (5.4 mg, 0.04%). The second fraction contained a mixture of compounds 
4.1 and 4.10 (16.4 mg, 0.11%) and was subsequently subjected to further reversed phase 
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HPLC purification using an isocratic HPLC method (25% CH3CN/H2O), with two 
subsequent fractions collected. The first fraction contained, once again, a mixture of 
dianellin (4.1) and dianellose (4.10) (in a ratio of 1:1, based on the integration of the 1H 
NMR spectrum) (7.3 mg, 0.05%) and the second fraction was identified as dianellose 
(4.10) (>95% purity based on 1H NMR spectroscopy and analytical HPLC) (8.8 mg, 
0.06%) shown below in Scheme 4.1. 
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Dianel lica call icarpa (roots) (27 g)
3:1 (MeOH:DCM) (600 mL) (1.3 g)
DCM (125 mL) MeOH (125 mL)
(68.5 mg)
stellalderol (4.9) (~70% purity) and
5-hydroxydianellin (4.11) (~5% purity)
(42 mg, 0.28%)
C18 Vacuum Liquid Chromatography (0.8 g)
(10% stepwise elution)
(H2O-MeOH-DCM)
(1.23 g)
Fraction 1 Fraction 22
dianellin (4.1) and dianellose (4.10)
(1:1 mixture)
(72 mg, 0.48%)
Semi-Preparative RP-HPLC
(standard HPLC gradient)
stellalderol (4.9) (~90% purity)
(5.4 mg, 0.04%)
Fraction 2 Fraction 3
dianellin (4.1) and dianellose (4.10)
(16.4 mg, 0.11%)
Semi-Preparative RP-HPLC
(25% CH3CN/H2O)
dianellin (4.1) and dianellose (4.10)
(1:1 mixture)
(7.3 mg, 0.05%)
dianellose (4.10) (>95% purity)
(8.8 mg, 0.06%)
 
 
Scheme 4.1. Initial extraction and isolation procedure adopted for D. callicarpa (roots). 
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A second extraction procedure was carried out for the D. callicarpa roots (~13 g 
dr. wt.) whereby the plant material was immersed in liquid N2, and then ground to a 
fine powder with a mortar and pestle. The ground roots were then subjected to a 
sequential solvent extraction procedure by solubilisation and 30 mins of ultrasonication 
using the solvents n-hexane (400 mL, 0.14 g), DCM (400 mL, 0.45 g), EtOAc (500 mL, 
0.12 g) and finally MeOH (1.5 L, 2.1 g). The n-hexane extract (134 mg) was 
subsequently fractionated using flash silica gel chromatography adopting a 20% 
stepwise elution from 100% n-hexane to 100% DCM and finally to 100% MeOH, 
generating fourteen fractions. The 40% DCM/n-hexane fraction contained dianellidin 
(4.2) (~70% purity, based on 1H NMR spectroscopy and analytical HPLC) (6.8 mg, 
0.05%).  
The DCM extract (447 mg) was subjected to diol flash chromatography using a 
20% stepwise elution from 100% n-hexane to 100% DCM and finally to 100% MeOH 
generating twenty-two fractions. All fractions were analysed by normal phase 
analytical HPLC (35% EtOAc/n-hexane). Fractions four, seven and eight were 
combined and subsequently subjected to normal phase semi-preparative HPLC (35% 
EtOAc/n-hexane) which afforded semi-pure dianellinone (4.3) (~90% purity, based on 
1H NMR spectroscopy) (11.1 mg, 0.09%) (% based on the mass of the dried weight of 
the plant) as shown in Scheme 4.2. 
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4.2 Results and Discussion 
 
D. callicarpa was initially extracted with 3:1 MeOH/DCM and then sequentially solvent 
partitioned into DCM then MeOH soluble fractions. The MeOH extract was subjected 
to reversed phase VLC and fractions subsequently analysed using both 1H NMR 
spectroscopy and analytical HPLC. The 40% MeOH/H2O afforded a mixture of the 
known compounds, stellalderol (4.9) and 5-hydroxydianellin (4.11) shown in Scheme 
4.1. The presence of these compounds was confirmed by ESI-MS (Cichewicz et al., 
2002). This fraction was subsequently combined with the 60% MeOH/H2O fraction, 
which contained other naphthalene glycosides, and subjected to reversed phase HPLC, 
resulting in the isolation of stellalderol (4.9) and a mixture of naphthalene glycosides in 
which the semi-preparative HPLC chromatogram is shown in Figure 4.1. The presence 
of 5-hydroxydianellin (4.11) was not detected by ESI-MS in this fraction after 
purification. 
 
 
 
Figure 4.1. HPLC chromatogram and 2D PDA contour plot illustrating the elution of  
stellalderol (4.9) and a mixture of naphthalene glycosides (4.1) and (4.10). 
 
 
 
Stelladerol (4.9) 
On-line 2D PDA contour plot 
Mixture of dianellin (4.1) and dianellose (4.10) 
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4.2.1 Structure Elucidation of Stelladerol (4.9) and 5-hydroxydianellin (4.11) 
 
Compound 4.9 was confirmed on the basis of 1D and 2D NMR experiments and 
mass spectrometry, with the sugar moieties confirmed by acid hydrolysis, followed by 
TLC comparisons to authentic standards as well as comparison of the 1D and 2D NMR 
data to that previously reported in the literature. The unequivocal assignment for 
stellalderol (4.9) is detailed in Section 10.4 (Cichewicz and Nair, 2002).  
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            stellalderol (4.9) 
 
The second fraction collected (see Scheme 4.1), containing compounds 4.1 and 
4.10, was subjected to further reversed phase HPLC purification (25% CH3CN/H2O) to 
yield a 1:1 fraction of compounds 4.1 and 4.10 as well as dianellose (4.10) as shown in 
Figure 4.2. Although the semi-prep HPLC chromatogram of the extract showed almost 
baseline-resolved separation of the two peaks labelled dianellin (4.1) and dianellose 
(4.10), 1H NMR analysis of the purified fraction showed that the first fraction 
contained, dianellin (4.1) which was contaminated with 4.10 whereas, the second 
fraction contained dianellose (4.10). 
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Figure 4.2. HPLC chromatogram illustrating the elution of a mixture of dianellin (4.1) and 
dianellose (4.10) and dianellose (4.10) (TOP). Expansion of the 2D PDA contour plot illustrating 
the structurally related constituents (BOTTOM) 
 
 
4.2.2 Structure Elucidation of Dianellin (4.1) 
 
The unequivocal assignment of dianellin (4.1) was difficult due to the overlap of 
chemical shifts due to compounds 4.1 and 4.10. However, on the basis of the 13C NMR 
spectrum acquired on the mixture, the carbon chemical shifts due to 4.1 could be 
dianellose (4.10) 
 
 Mixture of dianellin (4.1) and dianellose (4.10) 
 
On-line 2D PDA contour plot Mixture of dianellin (4.1) and dianellose (4.10) 
Mixture of dianellin (4.1) and dianellose (4.10) 
dianellose (4.10) 
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compared to those previously reported for this compound once the carbon signals due 
to 4.10 were subtracted (Figure 4.3). In addition, supporting COSY, HSQCAD and 
HMBC NMR information, together with the confirmation obtained by both ESI-MS and 
acid hydrolysis (via direct comparison to authentic sugar standards) established the 
presence of dianellin (4.1) in this fraction. The complete NMR assignment for dianellin 
(4.1) is detailed in Section 10.4 
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4.2.3 Structure Elucidation of Dianellose (4.10) 
 
The HR-ESI-MS of dianellose (4.10) displayed a m/z at 509.1666 [M-H]- (calcd 
for C24H29O12 m/z 509.1665), consistent a molecular formula of C24H30O12 and 10 DBE. 
The 13C NMR spectrum of 4.10 showed 24 discrete signals and the DEPT and HSQCAD 
NMR experiments indicated the presence of two methyls, two methylenes, thirteen 
methines and seven quaternary carbons (Table 4.1).  
 
H3C
O
H3C
OH O
O
O
O
HO
OH
OH
HO
OH
OH
 
                                                      dianellose (4.10) 
 
The IR spectrum displayed absorptions at 3400 and 1686 cm-1 indicative of 
hydroxy and carbonyl moieties respectively. The 1H NMR (Figure 4.4) and gCOSY 
NMR experiments identified the presence of four deshielded aromatic methines at δ 
7.44 (1H, m, H-5), 7.42 (1H, m, H-6), 7.41 (1H, m, H-7) and δ 7.19 (1H, s, H-4) 
designated as Fragment A in Figure 4.5. The presence of an aromatic methyl at δ 2.24 
(3H, s, H-13), 19.3 ppm and an acetyl methyl at δ 2.51 (3H, s, H-12), 32.2 ppm were 
supported by 1H, 13C and HSQCAD NMR experiments. Examination of the COSY 
NMR identified that the isolated aromatic proton at δ 7.19 (1H, s, H-4) was adjacent 
and displayed weak coupling to the aromatic methyl at δ 2.24 (3H, s, H-13) which was 
confirmed by a 3J HMBC correlation to the carbon chemical shift at 19.3 (C-13) ppm 
(Figure 4.5). 
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Key HMBC correlations were observed from the acetyl methyl at δ 2.51 which 
showed a 3J HMBC correlation to the carbon at 125.4 (C-2) ppm and from the aromatic 
methyl at δ 2.24 to 125.4 (C-2) (Figure 4.5). The 13C NMR shift at 150.4 (C-1) ppm was 
indicative of a carbon bearing a hydroxy group at δ 9.55 (1H, brs, 1-OH), and was 
found to be identical to the carbon shift previously reported for dianellin (4.1) (δ 150.2, 
qC, C-1, within 2 ppm) (Cichewicz et al., 2002). Most importantly, the aromatic methine 
at δ 7.41 (1H, m, H-7) showed a 2J HMBC correlation to the carbon at 154.4 (C-8) ppm, 
confirming the presence of an 8-O-linkage, designated as Fragment B (Figure 4.5). The 
aglycone portion of 4.10 was directly compared to the 1H and 13C NMR chemical shifts 
reported for 4.1 (Cichewicz et al., 2002). 
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Figure 4.5. COSY and HMBC correlations resulting in partial fragments A and B, used to 
determine the aglycone moiety in dianellose (4.10). 
 
Compounds 4.1 and 4.10 only differ with respect to their disaccharide residues. 
with 4.1 containing a D-β–glucopyranose and D-β-rhamnopyranose sugar moieties, 
whilst dianellose (4.10) was found to contain a D-β-xylopyranose and a D-β- 
glucopyranose sugar moiety (Cichewicz et al., 2002). The remaining 1H and 13C NMR 
features were consistent with D-β-xylopyranose and D-β-glucopyranose residues. 
Structure elucidation of the sugar moieties were determined by a combination of the 
COSY and HMBC NMR experiments shown in Figure 4.6.  
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Figure 4.6. Expansion of the COSY NMR spectrum for dianellose (4.10) illustrating 
COSY correlations used to determine sugar moieties. 
 
A three-bond correlation was observed from the anomeric proton at δ 5.01 (1H, 
d, J = 8.5 Hz, C-1‘) to the carbon 154.4 (C-8) ppm. A 1→6 linkage was confirmed 
between the β-D-xylopyranose and β-D-glucopyranose residues on the basis of a 
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HMBC correlation from both methylene signals at δ 4.02 (1H, d, J = 11.0 Hz, H-6′a) and 
δ 3.59 (1H, m, H-6′b) to the carbon at 104.2 (C-1‖) ppm (Figure 4.7). 
This was reciprocated by a correlation from the proton at δ 4.23 (1H, d, J = 8.0 
Hz, H-1‖) to the carbon at 68.5 (C-6‘) ppm. The β-D-xylopyranose residue was 
confirmed on the basis of the methylene 1H signals at δ 3.67 (1H, dd, J = 5.5, 11.5 Hz, H-
5″a) showing HMBC correlations to the carbons at 104.2 (C-1‖), 76.2 (C-3‖) and 69.7 (C-
4‖) ppm (Figure 4.7).  
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Figure 4.7. Key HMBC NMR correlations for dianellose (4.10) (methylene and methine signals 
not shown for clarity). 
 
 
Both the 1H and 13C NMR shifts for the glycosidic residues, together with the 
acid hydrolysis products (Section 10.1.9) of dianellose (4.10) (which were compared by 
TLC to authentic sugar standards) established the presence of a β-D-glucopyranose and 
β-D-xylopyranose sugar moieties (Cichewicz et al., 2002; Cichewicz and Nair, 2002). 
The complete structure of 4.10 was determined by detailed spectroscopic analyses 
involving examination of both 1D and 2D NMR experiments, mass spectromeyr and 
comparison of the spectroscopic data to those of dianellin (4.1) abd stellalderol (4.9) as 
well as confirmation of the sugar residues by acid hydrolysis.  Further spectroscopic 
assignments which support the structure of dianellose (4.10) is detailed in Section 10.4. 
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Table 4.1. NMR Data (500 MHz, d6-DMSO) for dianellose (4.10). 
H3C
O
H3C
OH O
O
O
O
HO
OH
OH
HO
OH
OH
1
3
4
6
8
10
11
12
13
1'
3'
6'
1''
3''
 
 
 
position 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
1  150.4, qC   
2  125.4, qC   
3  132.9, qC   
4 7.19 (s) 119.6, CH H-5, H-13 C-2, C-5, C-9, C-10, C-13 
5 7.44 (m) 122.4, CH H-4, H-6 C-7, C-8 (w), C-9, C-10 
6 7.42 (m) 128.1, CH H-5 C-5, C-8, C-10, 
7 7.41 (m) 111.3, CH   
8  154.4, qC   
9  113.2, qC   
10  135.9, qC   
11  204.9, qC   
12 2.51 (s) 32.2, CH3  C-2, C-11 
13 2.24 (s) 19.3, CH3 H-4 C-2, C-3, C-4 
1′ 5.01 (d, 8.5) 102.7, CH H-2′ C-8 
2′ 3.37 (m) 73.4, CH H-1′, H-3′  
3′ 3.08 (m) 76.6, CH 3′-OH, H-2′ C-2′, C-4′ 
4′ 3.18 (m) 70.0, CH 4′-OH C-3′, C-5′, C-6′ 
5′ 3.33 (m) 76.7, CH   
6a 
6b 
4.02 (d, 11.0) 
3.59 (m) 
68.5, CH2 6b 
6a 
C-1, C-4′ 
C-1, C-5′ 
1 4.23 (d, 8.0) 104.2, CH H-2 C-5, C-6 
2 3.00 (m) 73.5, CH H-1, 2-OH C-1, C-3, C-4 
3 3.62 (m) 76.2, CH  C-1 
4 3.27 (m) 69.7, CH 5a, 4-OH C-3 
5a 
5b 
2.97 (m) 
3.67 (dd, 5.5, 11.5) 
65.8, CH2 
 
5b, H-4 
5a 
C-1, C-3, C-4 
C-1, C-3, C-4 
1-OH 9.55 (brs)    
2′-OH 5.87 (brs)    
3′-OH 5.02 (d, 5.0)  H-3′ C-2′, C-3′, C-4′ 
4′-OH 5.27 (d, 6.0)  H-4′ C-3′/C-5′, C-4′ 
2-OH 5.08 (d, 4.5)  H-2 C-1, C-2, C-3 
3-OH 5.29 (d, 4.5)  4-OH (w) C-2 
4-OH 4.96 (d, 5.0)  H-4, 3-OH (w) C-3,C-4, C-5 
aCarbon assignments based on the HSQCAD NMR experiment 
w = weak correlation 
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4.2.4 Structure Elucidation of Dianellidin (4.2) and Dianellinone (4.3) 
 
In an attempt to identify the nature of the non-polar constituents, a second 
extraction of D. callicarpa was carried out. The extraction and isolation procedure is 
described on page 118. The 40% DCM/n-hexane fraction afforded the known semi-
pure compound, dianellidin (4.2) (Scheme 4.2) (Batterham et al., 1961). The ESI-MS 
displayed a m/z 215 [M-H]-, consistent with a molecular formula of C13H12O3 and 8 
DBE. The 1H NMR data of 4.2 was found to be identical to that previously reported 
(Colegate et al., 1985; Rizzacasa and Sargent, 1988).  
 
1
3
5
7 CH3
O
CH3
OHOH
 
  dianellidin (4.2) 
 
The DCM extract was subjected to diol flash chromatography and subsequent 
fractions were analysed by normal phase HPLC which afforded the semi-pure 
naphthaquinone dimer, dianellinone (4.3) for which the extraction and isolation 
procedure is described on page 118. Comparison of the extracted UV profile (λmax at 
254 and 429 nm) obtained from the HPLC PDA data (35% EtOAc/n-hexane), were 
consistent with literature values reported for dianellinone 4.3 (Cooke and Sparrow, 
1965). The 1H NMR data of dianellinone 4.3 was found to be identical to that 
previously reported and is detailed in Section 10.4 (Colegate et al., 1987). 
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dianellinone (4.3)    
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4.3 Biological Evaluation and Details of Assays 
 
There have been several accounts of the medicinal uses of Dianella species to 
treat colds by the Aborigines, whereby an extract of the roots of the plant was prepared 
by soaking the crushed roots in either cold or boiling water (Clarke, 1987). One of the 
first reports detailing the biological activity of Dianella species appeared in 1948 which 
indicated that four separate Dianella species caused death to livestock after ingestion of 
the foliage or roots (Webb, 1948). A study of the antiviral activities of the Aboriginal 
medicines found that an ethanolic extract of Dianella longifolia var. grandis roots 
(Liliaceae) displayed potent activity against polio virus type 1 at a non-cytotoxic 
concentration of 52 μg/mL (Semple et al., 1998). In terms of biological activity, 
stypandrone (4.4) has been shown to cause methemoglobinemia in poisoned animals, 
thereby reducing the oxygen-carrying capacity of blood as well as promoting the 
conversion of haemoglobin to methaemoglobin in vitro, which contributes to the death 
of affected animals (Colegate et al., 1987).  
In a later study, the same authors isolated and identified one of the antiviral 
constituents as the anthraquinone, chrysophanic acid (4.12) (Semple et al., 2001). 
Stellalderol (4.9) first isolated from the edible daylily (Hemerocallis) flowers exhibited 
strong antioxidant activity (94.6 ± 1.4% inhibition) compared to the commercial 
synthetic antioxidants tert-butylhydroquinone (TBHQ), butylated hydroxyanisole 
(BHA) and butylated hydroxytoluene (BHT), (81.8± 1.2%, 80.0 ± 1.0% and 86.4 ± 1.3%, 
respectively) (Cichewicz and Nair, 2002). 
 
O
O
CH3
OHOH
 
chrysophanic acid (4.12) 
 
In this investigation the root and stem/leaves extracts of D. callicarpa were 
evaluated at 50 mg/mL in a number of biological assays including against a P388 
Murine Leukaemia cell line (antitumour assay), against the DNA Herpes simplex virus 1 
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and the RNA Polio virus 1 (antiviral assays) as well as against a number of bacteria and 
fungi (antimicrobial assays). 
Insignificant antitumour activity was observed for the crude extracts of both the 
roots and stem/leaves of D. callicarpa (IC50 >625,000 ng/mL), but both extracts 
displayed some antiviral activity against the Herpes simplex and the Polio viruses (Table 
4.2). In addition extracts of the roots displayed antimicrobial activity against Bacillus 
subtilis, Candida albicans, Trichophyton mentagrophytes and Cladosporium resinae but not 
against Eschericha coli or Pseudomonas aeruginosa. The crude extract of the stems/leaves 
did not display any antimicrobial activity.  
A summary of the biological activities for compounds and mixtures isolated is 
provided in Table 4.2. Dianellidin (4.2) inhibited the growth of Bacillus subtilis and 
Trichophyton mentagrophytes, as well as, displaying slight virus inhibition together with 
cytotoxicity against both viruses. The antiviral activity for the roots of D. callicarpa is 
consistent with previous studies conducted on the closely related Dianella species 
(Jassim and Naji, 2003; Semple et al., 2001; Semple et al., 1998).  
The antifungal activity is also consistent with previous studies carried out on 
dianellidin (4.2), a secondary metabolite isolated from Dianella spp (Choi et al., 2004). 
Dianellose (4.10) could not be evaluated separately for its antimicrobial or antiviral 
activities, as these assays had been phased out before 4.10 was isolated. This is also the 
first report of the antitumour activities of dianellin (4.1) and/or dianellose (4.10), (as 
these two compounds were present in a 1:1 mixture with 4.10), stelladerol (4.9) and 
dianellose (4.10), which displayed moderate antitumour activities (IC50 of >24-25 µM 
when tested at 1 mg/mL). Fractions containing dianellidin (4.2) and dianellinone (4.3) 
were not evaluated for their antitumour activities. 
 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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Dianella callicarpa (TOP) Roots  (2005-02a)  (LEFT) 
    Leaves (2005-02b) (RIGHT) 
 
Kingdom:  Plantae 
Division:  Magnoliophyta 
Class:   Liliopsida 
Order:   Asparagales 
Family:  Noctuoidea 
Genus:  Dianella 
Species:  callicarpa 
 
 Purchased by C. Silva from the Indigenous Nurseries Co-Operative located on Yarra 
Bend Road in Fairfield, Melbourne, Australia 
 (January, 2005) 
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5.0 IntroductionF 
 
Lichens are composed of a fungal (mycobiont) and an algal (phycobiont) association 
living together in a symbiotic relationship. It has long been suggested that lichens may 
produce protective secondary metabolites that serve to deter herbivores and 
colonisation by pathogens (Golojuch and Lawrey, 1988; Lawrey, 1983; Rundel, 1978). 
The topical use of lichen extracts occurred as early as the 18th century B.C. in Egypt 
(Vartia, 1973). They form characteristic secondary metabolites that are rarely 
encountered in other organisms and to date there has been in excess of 800 compounds 
reported from lichens (Huneck and Yoshimura, 1996). Typical secondary metabolites 
from lichens include phenolic compounds with the most common classes being the 
aliphatic acids, pulvinic acid derivatives, depsides, depsidones, dibenzofurans, 
anthraquinones, naphthoquinones and the epidithiopiperazinediones. Lichen 
metabolites exert a wide variety of biological actions including antibiotic, 
antimycobacterial, antiviral, antiinflammatory, analgesic, antipyretic, antiproliferative 
and cytotoxic effects and their potential pharmaceutical use has been reviewed (Muller, 
2001; Vartia, 1973). A recent review discussing lichens as a promising source of 
bioactive secondary metabolites has been reviewed by Boustie and Grube, 2005. 
                                            
†
 Dias D, White JM and Urban S. 2007. Pinastric acid revisited: A complete NMR and X-ray structure assignment. Nat. 
Prod. Res. 21: 368-378. 
Dias DA and Urban, S. 2009. Chemical Constituents of the Lichen, Candelaria concolor: A Complete NMR and Chemical 
Degradative Investigation. Nat. Prod. Res. 23: 925-939. 
Dias DA and Urban S. 2009.  Phytochemical Investigation of the Australian Lichens Ramalina glaucescens and Xanthoria 
parietina. Nat. Prod. Communs. 7: 959-964. 
Phytochemical and NMR Studies of  
Australian Lichens† 
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Numerous lichens contain yellow or orange coloured pigments typified by the 
dibenzofuran derivative, usnic acid (5.1), which has been extensively studied for its 
pharmacological properties (Boustie and Grube, 2005; Cocchietto et al., 2002; Francolini 
et al., 2004; Ingόlfsdόttir, 2002; Lauterwein et al., 1995; Muller, 2001). Other pigments 
are attributed to pulvinic acid (5.2) and derivatives (also referred to as the lichen acids 
and the 4-ylidenetetronic acid derivatives) such as vulpinic (5.3) and pinastric acid (5.4) 
(Chawla et al., 1979).  
 
         
O
COCH3
HO
H3C
OH
H3C
O
COCH3
OH
           
O
O
OHHO O
 
                      (+)-usnic acid (5.1)                         pulvinic acid (5.2) 
 
             
O O
OHH3CO O
          
O
O
OHH3CO O
OCH3
 
                        vulpinic acid (5.3)                       pinastric acid (5.4) 
 
The common structural feature of these latter compounds is an unsaturated, 
hydroxylated γ-lactone substituted by a hydroxycarbonylalkylidene moiety. Over the 
years many pulvinic acid derivatives have been reported including leprapinic acid 
(5.5), isopinastric acid (5.6) and pulvinic dilactone (5.7) (Agarwal and Seshadri, 1964; 
Grover and Seshadri, 1958; Mittal and Seshadri, 1955; Mosbach, 1967).  
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                   leprapinic acid (5.5)                       isopinastric acid (5.6) 
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O
O
O
O  
pulvinic dilactone (5.7) 
 
All known natural pulvinic acids show variations that include either 
hydroxylation or methoxylation of the aryl rings e.g. atromentic acid (5.8), xercomic 
acid (5.9), variegatic acid (5.10) and gomphidic acid (5.11) or lactonisations involving 
the carboxy function as in the case for calycin (5.12) (Ǻkermark, 1961; Beaumont et al., 
1968; Singh and Anchel, 1971; Steglich et al., 1969).  
 
  
O
O
OHHO O
HO
OH
       
O
OH
O
OHO OH
OH
HO
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                variegatic acid (5.10)                              gomphidic acid (5.11) 
 
O
HO
O
O
O
 
                                                      calycin (5.12)        
 
Pinastric acid methyl esters and amide derivatives including pulvinamide (5.13) 
are other examples (Maas, 1970). Cochliodinone (5.14) is the only example of a natural 
pulvinic acid derivative containing a heterocyclic ring (Jerram et al., 1975). In addition 
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there are structurally related compounds that bear two pulvinic chains (Gill and Lally, 
1985).  
O
O
OHH2N O
 
pulvinamide (5.13) 
 
O
O
O
ON
H
H
N
 
              cochliodinone (5.14) 
 
The pulvinic acid derivatives are biosynthetically derived from a shikimic acid 
pathway and it has been documented that the algal component of the organism 
apparently plays no direct part in the biosynthesis (Mosbach, 1969). Vulpinic acid (5.3) 
has been known since 1831 when early Eskimos used lichens containing the acid to 
poison wolves and this contributed to the trivial name for this compound (Knight and 
Pattenden, 1979a; b). Vulpinic acid (5.3) has reportedly displayed antibiotic activity, 
anti-inflammatory properties, inhibition of influenza (RNA) viruses as well as 
hypotensive, analgesic, antispasmodic and neuromuscular junction blocking properties 
(Appa Rao and Prabhakar, 1988; Foden et al., 1975; Nadir et al., 1992). In the 1970s the 
Smith Kline Corp. filed several patents for the antiarthritic properties displayed by 
derivatives of pulvinic acid (5.2) and vulpinic acid (5.3) (Foden et al., 1972; Sutton et al., 
1974). Synthetic chemists have been particularly attracted to synthesise the pulvinic 
acid derivatives due to the fact that they constitute a group of biologically active 
pigments (Ahmed and Langer, 2005; Desage-El Murr et al., 2006; Edwards and Gill, 
1973; Gedge et al., 1986; Heurtaux et al., 2005; Knight and Pattenden, 1976; Pattenden et 
al., 1991a; Pattenden et al., 1991b; Ramage and Griffiths, 1984; Weinstock et al., 1979). 
Progressive developments in separation and purification strategies as well as 
advances in the sensitivity of instrumentation have resulted in the ability to rapidly 
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isolate and identify lichen constituents (Culberson and Culberson, 2001). In the 1900s, 
pioneers in lichen natural products chemistry used microcrystal tests, ultraviolet 
spectroscopy and paper chromatography to identify lichen metabolites. In the 1960s 
more use was made of techniques such as infra-red spectroscopy, circular dichroism 
and sensitive techniques such as mass spectrometry for compound identification. It 
was the late 1980s which saw improvements in chromatographic techniques including 
High Pressure Liquid Chromatography, Gas Chromatography, together with advances 
in spectroscopic techniques such as Nuclear Magnetic Resonance spectroscopy, single-
crystal X-ray analyses as well as the improvement in the sensitivity of mass 
spectrometry techniques, coupled with synthetic techniques to confirm the absolute 
configuration of structures (Culberson and Culberson, 2001). These improvements 
have ultimately enabled rapid isolation and structure elucidation.  
One of the more powerful spectroscopic techniques in the identification of 
organic compounds is NMR spectroscopy and presently advances in probe technology, 
such as cryo-probes, higher field strength magnets as well as the development of 
superior 2D NMR experiments have provided new opportunities to fully characterise 
lichen constituents. This is particularly important for lichen metabolites which had 
previously only been partially assigned as less compound is now required for complete 
structural assignment. 
This chapter describes the chemistry and biological activity of four Australian 
lichens. Chrysothrix xanthina, Candelaria concolor, Ramalina glaucescens and the co-
occurring lichen, Xanthoria parietina.  
The crude extract of C. xanthina demonstrated moderate antitumour activity as 
well as antiviral and antimicrobial activities. The pulvinic acid derivatives have 
historically presented significant structural challenges and as a consequence pinastric 
acid (5.4), reported from a number of lichens, and closely related pulvinic acid 
derivatives, have appeared in many reports including isolation strategies, chemical 
degradation studies and synthetic studies. The X-ray structure and full structural 
characterisation involving 2D NMR spectroscopy for pinastric acid (5.4), along with the 
first report of the X-ray structure for pinastric acid (5.4) is now documented. The 
importance of the detailed spectroscopic characterisation becomes evident when it is 
realised that previous NMR characterisation for the pulvinic acid derivatives has been 
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very much restricted to 1D NMR studies. Furthermore, the potential of GCxGC has 
been applied to rapidly profile the crude extract of C. xanthina. This resulted in the 
identification of the novel derivative, monotrimethyl pinastric acid (5.32). 
Also described is the isolation of pulvinic dilactone (5.7), pulvinic acid (5.2) 
[prepared from (5.7)], vulpinic acid (5.3), calycin (5.12), atranorin (5.20), 5-
chloroatranorin (5.21) as well as the first reported isolation of 5,5′-dichloroatranorin 
(5.22) from the yellow lichen Candelaria concolor (Dickson) B. Stein. To date, reports on 
the lichen C. concolor have been restricted to biomonitoring studies (Loppi and Frati, 
2006; Pišút and Pišút, 2006; Purvis, 2000; Ruisi et al., 2005). The crude extract of C. 
concolor demonstrated significant antibacterial activity. In addition the first complete 
structural characterisation involving the use of 2D NMR spectroscopy for several 
previously isolated compounds including 5.2, 5.3, 5.7, 5.12 and 5.20-5.22 and the 
importance of the selection of the extraction solvent, as well as the chemical 
degradation of 5.20 and the application of GCxGC to profile the lichen extract has been 
reported. 
Finally, the structure elucidation of the novel metabolite, 5-chlorosekikaic acid 
(5.23) [(formed from the spontaneous reaction of sekikaic acid (5.24) with CDCl3 in situ] 
has been isolated for the first time. (+)-Usnic acid (5.1) and atranorin (5.20) were also 
identified from the lichen, R. glaucescens along with parietin (5.25) from the co-
occurring lichen, X. parietina. The crude extract of R. glaucescens demonstrated 
significant antimicrobial activity and to date there has been no reports on the chemistry 
of this species of lichen. However, lichen constituents have previously been reported 
from other species from the genus Ramalina. In the late 1940s investigation of the lichen 
R. tayloriana  resulted in the isolation of usnic acid (5.1), sekikaic acid (5.24) and D(+)-
arabitol (5.26) (Seshadri and Subramanian, 1949).  
This thesis describes the first complete structural characterisations involving the 
use of 2D NMR spectroscopy for several previously isolated compounds including 
5.23, 5.24 and 5.25 along with the biological activities of compounds 5.1, 5.24 and 5.23 
and 5.25. 
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5.1 Chrysothrix xanthina (Vain.) Kalb. 
 
5.1.1 Collection, Extraction and Isolation 
 
The bright yellow lichen was collected on the 29th of August, 2004 and on the 13th of 
February, 2005 from Watsons Creek Reserve (off-Eltham-Yarra Glen Road), Kangaroo 
Ground, Victoria, Australia, growing on the bark of a Eucalypt. A small (2 x 2 cm) 
sample of the lichen was sent to Emeritus Prof John A. Elix (Australian National 
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University, Canberra, ACT, Australia) for identification and HPLC profiling. A 
voucher specimen designated the code 2004-46 for the lichen, Chrysothrix xanthina 
(Vain.) Kalb., is deposited at the School of Applied Sciences, RMIT University. 
Photographs of the lichen Chrysothix xanthina is shown on page 194. 
 In the purification of compounds the lichen was subjected to two different 
extraction protocols. Firstly the lichen which present on the bark (7 g) was extracted 
with 3:1 MeOH/DCM (1000 mL). The crude extract was decanted and concentrated 
under reduced pressure and then triturated into DCM, MeOH and H2O soluble 
extracts. The DCM extract was then sequentially solvent partitioned with n-hexane 
followed by DCM. Half of the hexane soluble fraction was subjected to a flash silica 
column (20% stepwise elution from n-hexane to DCM to EtOAc and finally to MeOH) 
followed by size exclusion chromatography (Sephadex LH-20 using 100% MeOH) to 
yield semi-pure pinastric acid (5.4) (4.5 mg, 0.06%) (% based on the mass of the dried 
weight of the bark) as shown in Scheme 5.1.‖ 
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Chrysothrix xanthina (7 g)
3:1 (MeOH:DCM) (1000 mL)
DCM MeOH
(102 mg)
Water
Flash Silica column chromatography (20% stepwise elution)
Fraction 6 Fraction 8
Sephadex LH-20 (MeOH 100%)
semi-pure pinastric acid (5.4)
(4.5 mg, 0.06 %)
(245 mg) (35 mg)
n-hexane DCM
(75 mg) (25 mg)
(35 mg)
Fraction 1 Fraction 28
 
 
Scheme 5.1. Initial extraction and isolation procedure adopted for C. xanthina. 
 
 
 
 
 
 
 
 
 
 
 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
146 | P a g e  
 
 
 In a second purification, the lichen present on the bark (50 g) was extracted 
with 3:1 MeOH/DCM (1000 mL). The crude extract (3 g) was decanted and 
concentrated under reduced pressure  and subjected to flash silica chromatography 
using a 50% stepwise elution from n-hexane to DCM and finally to MeOH followed by 
size-exclusion chromatography (Sephadex LH-20, 100% MeOH). Final purification of 
pinastric acid (5.4) was achieved using reversed-phase HPLC using isocratic conditions 
(80% CH3CN/H2O with detection at λmax 254 and 425 nm) to afford pinastric acid (5.4) 
(19.3 mg , 0.04%) (% based on the mass of the dried weight of the bark) as shown in 
Scheme 5.2. 
 
Chrysothrix xanthina (50 g)
3:1 (MeOH:DCM) (1000 mL)
Flash Silica column chromatography (50% stepwise elution)
Fraction 4
Sephadex LH-20 (MeOH 100%)
Semi-Preparative RP-HPLC
(80% CH3CN/H2O)
semi-pure pinastric acid (5.4)
(19.3 mg, 0.04 %)
Fraction 1 Fraction 14
(3 g)
Fraction 8
Fraction 4Fraction 1 Fraction 8
 
 
Scheme 5.2. Extraction and isolation procedure adopted for C. xanthina  
              (Second Extraction). 
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5.1.2 Crystallography 
 
Intensity data were collected with a Bruker SMART Apex CCD detector using Mo-Kα 
radiation (graphite crystal monochromator l = 0.71073). Data were reduced using the 
program SAINT and corrected for absorption where appropriate (SADABS) (Siemens, 
1999).  The structure was solved by Prof. J. White (Bio21, The University of Melbourne, 
Victoria, Australia) by direct methods and fourier synthesis using the SHELX 
(Sheldrick, 1998) suite of programs as implemented with the WINGX (Farrugia, 1999) 
software and the data deposited at the Cambridge Crystallographic Data Centre, 
CCDC 617750 (Section 10.1.8). 
 
5.1.3 Results and Discussion 
 
The bright yellow lichen was extracted with MeOH/DCM and initially separated by 
flash silica chromatography, followed by size-exclusion chromatography (LH-20). Final 
purification was achieved using reversed-phase HPLC to yield pinastric acid (5.4) 
isolated as stable, yellow translucent needles.  
Pinastric acid (5.4) was isolated as stable, yellow translucent needles for which 
HR-ESI-MS displayed a m/z at 351.0867 [M-H]-calculated for C20H15O6 m/z 351.0869) 
and m/z 353.1024 [M+H]+ calculated for C20H17O6, 353.1025 consistent with 13 DBE. The 
13C NMR spectrum of 5.4 showed 16 signals (two methyls, five methines (four 
representing equivalent pairs) and nine quaternary carbon peaks as indicated by 
gHSQC NMR experiment. The IR spectrum of 5.4 had absorptions at (3385 and 3436 
cm-1) and (1775 and 1772 cm-1) suggestive of hydroxy and carbonyl groups, 
respectively. 
Analysis of the 1H NMR spectrum (Figure 5.1) together with the COSY NMR of 
(5.4) suggested the presence of a 1,4-disubstituted aromatic ring [δ 8.14, dd, J = 2.0, 9.0 
Hz (H-2‖/H-6‖) and 6.96, dd, J = 2.0, 9.0 Hz (H-3‖/H-5‖)] and a monosubstituted 
aromatic ring [δ 7.41, ddd, J = 2.0, 8.0, 10.0 Hz (H-3‘/H-5‘); 7.40, dddd, J = 1.5, 2.0, 10.0, 
10.0 Hz (H-4‘) and 7.27 (ddd, J = 1.5, 2.0, 8.0 Hz (H-2‘/H-6‘)]. 1H and 13C NMR spectra 
(Figures 5.1 and 5.2) also supported the presence of two methoxy groups [δ 3.84, s, 55.2 
ppm and 3.87, s, 54.3 ppm.  
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HMBC correlations were observed from the aromatic methine at δ 8.14 (H-
2‖/H-6‖) to 105.2 (C-5) ppm, δ 7.27 (H-2‘/H-6‘) to 115.2 (C-2) ppm as well from the 
methyl ester moiety δ 3.87, 54.3 (OCH3) to 171.6 (C-1) ppm] (Figure 5.3 and Table 5.1). 
 
O
O
OH
OCH3
H3CO O
1
3
5
6
4''
1''
1'
4'
 
Figure 5.3. Important HMBC correlations of pinastric acid (5.4). 
                      (Proton signals not shown for clarity) 
 
Although pinastric acid (5.4) was first reported over 50 years ago the NMR data 
for 5.4 was only obtained once a formal synthesis had been completed (Ahmed and 
Langer, 2005; Knight and Pattenden, 1976; Pattenden et al., 1991a; Pattenden et al., 
1991b). Whilst the 1H NMR data was assigned (although not unequivocally) the 13C 
NMR signals were not assigned other than via their multiplicities. Presented in Table 
5.1 is the complete 1D and 2D assignment of the NMR resonances of pinastric acid (5.4) 
which is also detailed in Section 10.5. 
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Table 5.1. 1H (500 MHz) and 13C (125 MHz) NMR assignment of (5.4) in CDCl3. 
 
O
O
OH
OCH3
H3CO O
1
3
5
6
4''
1''
1'
4'  
 
 
Pos 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY  
 
gHMBC 
 
1 
 
- 
 
171.6, qC 
 
- 
 
- 
2 - 115.2, qC - - 
3 - 154.9*, qC - - 
4 - 158.6*, qC - - 
5 - 105.2, qC - - 
6 - 166.1*, qC - - 
1‘ - 132.1, qC - - 
2‘, 6‘ 7.27, ddd, (1.5, 2.0, 8.0) 129.9, CH H-3‘/H-5‘ C-2, C-2‘/C-6‘, C-3‘/C-5‘, C-4‘,  
3‘, 5‘ 7.41, ddd, (2.0, 8.0,10.0) 128.5, CH H-2‘/H-6‘ C-1‘, C-3‘/C-5‘, C-4‘, C-2‘/C-6‘  
4‘ 7.40, dddd, (1.5, 2.0, 10.0, 10.0) 128.1, CH - C-2‘/C-6‘, C-3‘/C-5‘ 
1‖ - 121.6, qC - - 
2‖, 6‖ 8.14, dd, (2.0, 9.0) 129.3, CH H-3‘‘/H-5‘‘ C-5, C-2‘‘/C-6‘‘, C-4‘‘  
3‖, 5‖ 6.96, dd, (2.0, 9.0) 113.9, CH H-2‘‘/H-6‘‘ C-1‘‘, C-3‘‘/C-5‘‘  
4‖ - 159.5, qC - - 
1-OCH3 3.87, s 54.3, CH3 - C-1 
4-OH ND - - - 
4‖-OCH3 3.84, s 55.2, CH3 - C-4‘‘ 
     
*Signals may be interchanged 
aCarbon assignments based on HSQCAD, DEPT and HMBC NMR experiments 
ND: indicates signal was not detected 
 
Prior to the structural elucidation of pinastric acid (5.4) there have been reports 
on the 2D NMR characterisation studies of pulvinic acid derivatives (Duncan et al., 
2003; Kirmiziguel et al., 2003; Toyota et al., 2004; Van der Sar et al., 2005; Winner et al., 
2004).  
Pinastric acid (5.4) was crystallised as yellow translucent needles (Figures 5.4) 
and was subjected to a single X-ray analysis carried out by Prof. J. White (Bio21, The 
University of Melbourne, Victoria, Australia). Figure 5.5 depicts a thermal ellipsoid 
plot (ORTEP diagram), depicting 20% ellipsoids. The intramolecular hydrogen bond 
which is evident in the structure is characterised by the geometrical parameters; O-2-H 
= 0.91 Å, O-2…O-3 distance 2.513 Å, H-1…H-3 1.61 Å, and O-2-H…O-3 angle 169.6º.  
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This is the first report of the X-ray structure of pinastric acid 5.4 and is 
important in confirming the central lactone ring fragment. NMR experiments alone 
could not unequivocally assign this unit in particular (positions C-3, C-4 and C-6) due 
to interchangeable carbon signals (positions C-4 and C-6) and due to the inability to 
observe any HMBC correlations into this central ring (other than H-2‖/H-6‖ to C-5) 
(Table 5.1).  
To date there have only been X-ray structures reported for vulpinic acid (5.3), 
pulvinic acid methyl ester and a polymorph of vulpinic acid, a chlorinated pulvinic 
acid derivative (5.15) and a sesquiterpene pulvinic acid derivative (5.16) (Brassy et al., 
1985; Duncan et al., 2003; Van der Sar et al., 2005). 
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                                5.15                                                                                  5.16  
 
 
Figure 5.4. Photomicrograph illustrating yellow, translucent needles of pinastric acid (5.4). 
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Figure 5.5. ORTEP diagram of pinastric acid (5.4). 
 
5.1.4 Biological Evaluation and Details of Assays 
 
The antiviral and antibacterial properties of 5.4 are consistent with previous 
findings for pulvinic acid derivatives (Muller, 2001). Closely related analogues 
including 4,4‘-dimethoxyvulpinic acid (5.17), 3,3‘-dibromo-4,4‘-dimethoxyvulpinic acid 
(5.18) and acetyl 4,4‘-dimethoxyvulpiate (5.19) exhibit antitubercular activity against 
M. tuberculosis whilst 3,3‘-dibromo-4,4‘-dimethoxyvulpinic acid (5.18) and acetyl 4,4‘-
dimethoxyvulpiate (5.19) show cytotoxicity towards the lung cancer cell line NCI-H187 
with IC50s of 13.4 and 5.7 µg/mL, respectively (Kanokmedhakul et al., 2003). 
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      4,4‘-dimethoxyvulpinic acid (5.17)   3,3‘-dibromo-4,4‘-dimethoxyvulpinic acid (5.18) 
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Extracts of the lichen were evaluated in a number of biological assays including 
against a P388 Murine Leukaemia cell line (antitumour assay), against Herpes simplex 
and Polio viruses (antiviral assays) as well as against a number of bacteria and fungi 
(antimicrobial assays) at the University of Canterbury, Christchurch, New Zealand.  
No activity was observed against Eschericha coli, Pseudomonas aeruginosa, Candida 
albicans or Cladosporium resinae. Moderate antitumour activity was observed for the 
lichen extract (11,040 ng/mL tested at 10 mg/mL) and the lichen/bark extract (43,438 
ng/mL tested at 50 mg/mL). In addition the lichen extract displayed antiviral activities 
against the Herpes simplex virus and the Polio virus as well as antimicrobial activity with 
zones of inhibition detected against Bacillus subtilis and Trichophyton mentagrophytes. It 
was on the basis of these activities that the lichen was selected for investigation. 
Pinastric acid (5.4) was found to be moderately active against the P388 murine 
leukaemia cell line with an IC50 of 7,044 ng/mL. It was observed that 5.4 inhibited the 
growth of Bacillus subtilis and Trichophyton mentagrophytes with inhibition zones (radius 
of inhibition outside the 6 mm diameter application disc) of 4 and 2 mm zones, 
respectively. At a concentration of 30 µg/mL the standard compound chloramphenicol 
had an inhibition zone of 12 mm against B. subtilis whilst 100 mg of nysatin had an 
inhibition zone of 6 mm against T. mentagrophytes. Pinastric acid (5.4) was tested 
against the DNA Herpes simplex virus and the RNA Polio virus. 
 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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5.1.5 Application of Comprehensive Two-Dimensional Gas Chromatography 
(GCxGC) to Profile Constituents of the Lichen Chrysothrix xanthina 
 
Comprehensive two-dimensional gas chromatography (GC×GC) is a technique which 
arose in the 1990s and has undergone significant development since (Kueh et al., 
2003a). In GCxGC, the first column (D1) usually consists of a non-polar column, 
typically at a normal capillary length with the separation of constituents based on their 
boiling points. The second column (D2) is a fast elution column, typically short in 
length with a narrow-bore internal diameter and thin film phase employing a more 
polar stationary phase. The primary aim of GCxGC is to resolve closely eluting peaks 
of similar boiling points, but of differing polarity (Kueh et al., 2003a). Optimal 
separation is based on the two columns being ―orthogonal‖ to each other in order to 
resolve closely or overlapping chromatographic peaks.  
The successful implementation of GCxGC has only become possible due to the 
innovations in the construction of an appropriate modulator. There have been many 
modulators introduced, but the three most commonly employed which provide mass 
conservation are the sweeper modulator (Phillips et al., 1999), the longitudinally 
modulated cryogenic modulator (LMCS) (Kinghorn et al., 2000) and the cryo-jet 
modulator (Beens et al., 2001; Ledford Jr. and Billesbach, 2000). The objective of the 
modulator is to provide complete sample transfer from the first to the second column, 
or alternatively to provide only a small subsample from the first column effluent. The 
latter systems generally employ valve sampling methods in contrast to the former 
setup providing complete transfer of the solute (i.e. conservation in mass transfer) 
(Figure 5.6). 
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Figure 5.6. GCxGC system showing the modulator M located between the first and second 
columns (D1 and D2). In this case a moving cryogenic modulator is used, and 
the expanded regions show the cryotrap in its trapping (t) and release (r) 
positions (Kueh et al., 2003a). 
 
GCxGC has proven to be advantageous over conventional gas chromatography 
(1D GC) in terms of achieving greatly increased peak capacity (separation power), 
enhanced S/N ratio and it also offers unique structured chromatograms when 
structurally related classes of substances (analogues, congeners, isomers) are analysed. 
This technique has been successfully applied in many areas of analysis, including 
petrochemicals (Adahchour et al., 2004; Von Mühlen et al., 2006) essential oils (Junge et 
al., 2007; Shellie et al., 2001), foods (Khummueng et al., 2006; Wang et al., 2006) 
environmental samples (Marriott et al., 2003) (Focant et al., 2004; Van De Weghe et al., 
2006) as well as in forensic applications (Kueh et al., 2003b).  
The application of GCxGC to profile natural product extracts and enriched 
fractions can aid the rapid identification of secondary metabolites from both terrestrial 
and marine sources, without the need for off-line isolation. The purpose of this study 
was to evaluate the feasibility and success of the GCxGC technique as a means to 
dereplicate natural product extracts in future research applications. In this way it was 
decided that simple natural product extracts would be used to test the methodology. It 
is recognised that the majority of natural product crude extracts are complex mixtures 
and that preliminary extraction and clean up steps are necessary. 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
157 | P a g e  
 
 
5.1.5.1  Results and Discussion 
 
A 1 mg/mL stock solution of the crude lichen extract, Chrysothrix xanthina, was 
prepared by extraction with 3:1 (MeOH:DCM). This was carried out in order to 
determine the complexity of the lichen extract and to identify the presence of low-level 
constituents present in the C. xanthina, which were not able to be identified by HPLC 
and NMR. 
The extract of C. xanthina was derivatised using MSTFA (Section 10.1.7) to 
ensure that it would be suitable for both GC-MS (Section 10.1.5) and GCxGC-FID 
(Section 10.1.6) analyses. GC-MS displayed a major peak at tR = 13.01 min (C23H24O6Si, 
[M]+ = 424 m/z), indicating the presence of monotrimethylsilyl pinastric acid (5.32) 
(Figure 5.7). 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
158 | P a g e  
 
 
 
 
Figure 5.7  GC-MS trace of the silylated extract of C. xanthina identifying 
monotrimethylsilyl pinastric acid (5.32) as the major constituent. 
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The application of GCxGC-FID was carried out on the crude extract of C. 
xanthina (see Section 10.1.6) to observe other silyated constituents present that were 
unable to be resolved by GC-MS. The contour at ~tR = 21 min was identified as a 
common plasticiser, bis(2-ethylhexyl)phthalate (5.33) (m/z = 391). The contour at ~tR = 
22.2 min was identified as the derivative of the major constituent in the crude extract of 
C. xanthina (Figure 5.8). 
 
 
Figure 5.8. GCxGC contour plot identifying the presence of (5.32) as the major constituent 
present in the crude lichen extract. 
 
As GCxGC is ideal for far complicated mixtures containing hundreds to 
thousands of constituents, the application of GCxGC with respect to other terrestrial 
(e.g. plants) and marine organisms (e.g. marine algae) may have future application for 
the rapid identification and chemical profiling of natural product extracts, which may 
greatly assist in the dereplication process. However, the choice of derivatising agent 
may be problematic as natural product crude extracts can contain many different 
structural classes. A knowledge on the organism (i.e. previously reported isolated 
compounds) may help in selecting an appropriate derivatising agent.  
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5.2 Candelaria concolor (Dickson) B. Stein 
 
5.2.1 Collection, Extraction and Isolation 
 
The yellow lichen was collected on the 19th of August, 2007 near Merlynston Railway 
Station, Victoria, Australia. The lichen and bark were chiselled off a Eucalyptus tree 
and a small (2 x 2 cm) sample sent to Emeritus Prof. John A. Elix (Australian National 
University, Canberra, ACT, Australia) for taxonomic identification and analytical 
HPLC profiling of the crude extract of the lichen. A voucher specimen designated the 
code 2007-04 is deposited at the School of Applied Sciences, RMIT University. A 
photograph of the lichen, C. concolor is shown on page 195. 
In the initial extraction procedure, C. concolor, the lichen, together with the bark (170 g) 
was extracted with 3:1 MeOH/DCM (750 mL). The crude extract was decanted and 
concentrated under reduced pressure. Approximately half of the crude extract was 
subjected to a flash silica column (50% stepwise elution from petroleum spirits to DCM  
and finally to EtOAc) with the third fraction yielding vulpinic acid (5.3) (7.2 mg, 
0.004%). In addition, the known compound, calycin (5.12) (present in the fourth 
fraction), was identified in a mixture with 5.3. This mixture was subjected to further 
flash silica chromatography using 100% EtOAc as the eluent affording calycin (5.12) 
(1.5 mg 0.0008% based on the mass of the lichen and bark extracted, shown in Scheme 
5.3). 
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Natural Product Studies of Terrestrial and Marine Organisms 
 
 
161 | P a g e  
 
 
Candelar ia concolor (170 g)
3:1 (MeOH:DCM) (750 mL)
Flash Silica column chromatography (50% stepwise elution) (510 mg)
Fraction 3
vulpinic acid (5.3)
(7.2 mg, 0.004 %)
Fraction 1 Fraction 16Fraction 4
mixture of calycin (5.12) and (5.3)
Flash Silica column chromatography (EtOAc) (100%)
calycin (5.12)
(1.5 mg, 0.0008 %)
 
 
Scheme 5.3. First extraction and isolation procedure adopted for C. concolor. 
 
In a effort to purify compounds 5.3 and 5.12 by semi-preparative reversed 
phase HPLC, the 3:1 MeOH/DCM crude extract was sequentially partitioned using 
DCM followed by MeOH. The MeOH partition was then subjected to reversed-phase 
HPLC using isocratic conditions (100% CH3CN with detection at λmax 215 and 254 nm) 
which afforded atranorin (5.20) as a pale yellow oil (1.1 mg, 0.006 %, based on the mass 
of the lichen and bark extracted, shown in Scheme 5.4). It was noted that atranorin 
(5.20) rapidly converted to 5.21 and finally to a stable pale yellow oil, 5.22 over a period 
of 1-2 days in CDCl3 in situ as shown in Figure 5.9. 
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 R R1 
atranorin  (5.20)                        H H 
5-chloroatranorin (5.21)          Cl H 
5,5′-dichloroatranorin (5.22)  Cl Cl 
 
Candelar ia concolor (170 g)
3:1 (MeOH:DCM) (750 mL)
(480 mg)
Fraction 3
Semi-Preparative RP-HPLC
(100% CH3CN)
DCM
(160 mg) (285 mg)
Fraction 1 Fraction 6Fraction 4
atranorin (5.20)
(1.1 mg, 0.006 %)
MeOH
 
 
Scheme 5.4. Extraction and isolation procedure adopted for C. concolor to isolate 5.20  
(Second Extraction).  
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Figure 5.9. Chemical conversion of 5.20 to 5.21 and then finally to 5.22 in CDCl3 in situ 
(mild conditions). 
 
In a second extraction of the lichen (Scheme 5.5), C. concolor together with the 
bark (55 g) was extracted with 100% DCM (50 mL). The crude extract was decanted 
and concentrated under reduced pressure. The entire extract was then subjected to 
flash silica chromatography using 100% EtOAc as the eluent, to afford pulvinic 
dilactone (5.7) (201.3 mg, 0.4%, based on the mass of the lichen and bark extracted).   In 
this instance, the purity of 5.7 was assessed on the basis of the 1H NMR analysis and is 
shown in Scheme 5.5. 
The chemical conversion of 5.7 to 5.2 was demonstrated by heating 5.7 (75 mg) 
in 80% aqueous acetone (100 mL) for 15 minutes, resulting in 5.2 (>95% purity as 
assessed by 1H NMR) (65.2 mg, 82% yield) (Figure 5.10). 
O
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Candelaria concolor (55 g)
(100% DCM) (50 mL)
Fraction 1
(89 mg)
Flash Silica column chromatography (EtOAc) (100%) (325 mg)
Pulvinic dilactone (5.7)
(201.3 mg, 0.4 %)
Fraction 2
 
 
Scheme 5.5.  Extraction and isolation procedure adopted for C. concolor to isolate 
pulvinic dilactone (5.7). 
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Figure 5.10. Chemical conversion of 5.7 to 5.3 and 5.12 using MeOH as the extraction 
solvent and preparation of 5.2 from 5.7, highlighting the importance of the 
extraction solvent. 
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5.2.2 Results and Discussion 
 
5.2.2.1 Isolation of Vulpinic acid (5.3) and Calycin (5.12) 
 
The yellow lichen was extracted with 3:1 MeOH/DCM and then separated by flash 
silica chromatography to yield vulpinic acid (5.3). The structure of 5.3 had previously 
been confirmed by partial synthesis with the total synthesis achieved in the 1950s 
(Frank et al., 1950; Moore et al., 1969; Pattenden et al., 1991a; Ramage and Griffiths, 
1984). There have been several reports of the single crystal X-ray structure of 5.3, 
previously isolated from the lichen Letharia vulpina (L.) Hue, with the first crystal 
structure being reported in 1985 (Brassy et al., 1985). Vulpinic Acid (5.3) and its crystal 
structure have also been reported from the New Zealand liverwort, T. tenellus, for 
which 5.3 was the major constituent (Toyota et al., 2004). In 2003 the isolation of 5.3 and 
a polymorph from P. ravenelii was also described (Duncan et al., 2003).  There have 
been a number of attempts to unambiguously assign the NMR data for 5.3, but owing 
to the number of quaternary carbons present in this molecule, the unequivocal 
assignment of these resonances has been difficult, as they are often not even observed. 
To date there have not been any reports of the complete 1D and 2D NMR assignment 
of 5.3 (Heurtaux et al., 2005; König and Wright, 1999; Pattenden et al., 1991a). This 
prompted an attempt to obtain a complete unequivocal NMR assignment of all proton 
and carbon chemical shifts on the basis of 2D NMR connectivity experiments for all 
compounds isolated from C. concolor. 
The complete structure of 5.3 was determined by detailed spectroscopic 
analyses involving both 1D and 2D NMR experiments and mass spectrometry. The 
ESI-MS displayed a m/z 321 [M-H]-, consistent with a molecular formula of C19H14O5 
and 13 DBE.  
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The 13C NMR spectrum of 5.3 showed 15 discrete signals and this combined 
with DEPT and HSQCAD experiments supported the presence of one methyl, six 
methines and eight quaternary carbons. The IR spectrum of 5.3 displayed absorptions 
at 3426 and 1774 cm-1, indicative of hydroxy and ester carbonyl moieties. The 
molecular formula together with the observation of only 15 distinct carbon signals in 
the 13C NMR spectrum, immediately suggested elements of symmetry in parts of 5.3 
with four pairs of equivalent aromatic methines observed (based on the intesity of the 
13C NMR signals). Analysis of the 1H NMR and the gCOSY NMR spectra of 5.3 
suggested the presence of two isolated mono-substituted aromatic rings the first at [δ 
7.27, dd, J = 2.0, 8.0 Hz (H-2/H-6); 7.34, dd, J = 7.0, 7.5 Hz (H-3/H-5) and 7.44, m (H-4)] 
and the second at [δ 8.13, dd, J = 1.5, 8.5 Hz (H-2‘/H-6‘); 7.41, m (H-3‘/H-5‘) and 7.42, 
m (H-4‘)]. The presence of a methyl ester [δ 3.89, s, 54.4 ppm] was supported by 1H, 13C 
and HSQCAD NMR experiments and a HMBC correlation to δ 171.7 (C-12) which 
confirmed that the methoxy was attached to a carbonyl moiety.  
Important HMBC correlations were observed from aryl protons on both 
aromatic rings, which ultimately allowed for the placement of the two 
monosubstituted aromatic rings. In particular the second mono-substituted aromatic 
ring showed an important correlation to δ 105.1 (C-10), thereby confirming the position 
of this ring, relative to the central lactone ring moiety. Owing to the number of 
quaternary carbons in the central hydroxyfuranone core and the lack of any HMBC 
correlations to these carbons due to their remoteness from the aromatic protons, the 
remaining quaternary carbons at δ 165.9 (C-11), 160.2 (C-9) and 154.8 (C-8) were 
assigned on the basis of a direct comparison to the carbon shifts previously assigned 
for pinastric acid (5.4) as shown below in Figure 5.11. The unequivocal assignment of 
5.3 is detailed in Section 10.5 (Dias et al., 2007). 
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                        vulpinic acid (5.3)                        pinastric acid (5.4) 
 
Figure 5.11. 13C NMR assignment of the central hydroxy furanone of 5.3 based on 5.4. 
 
Analysis of another fraction resulting from the same flash silica column 
fractionation step yielded a mixture of vulpinic acid (5.3) and calycin (5.12). This 
mixture was further purified by additional silica gel chromatography and resulted in 
the isolation of (5.12) as an orange oil. Calycin (5.12) had been previously isolated in 
1890 as a deep red compound from the lichen L. candelaris Shaer (Ǻkermark, 1961; 
Hesse, 1880). Compounds 5.3 and 5.12 were also isolated from the lichen L. clorina Stein 
(Grover and Seshadri, 1959; Zöpf, 1895). The structure of 5.12 had initially been 
reported as 2-hydroxypulvic dilactone (5.27). In the 1960s the synthesis of 5.12 was 
achieved, for which the correct structure was supported by infra-red and ultraviolet 
spectroscopy (Ǻkermark, 1961; Kǖhler et al.). 
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                      2-hydroxypulvic dilactone (5.27)                                  calycin (5.12) 
                               (Incorrect structure)                                         (Correct structure) 
 
The structure of calycin (5.12) was confirmed using 1D and 2D NMR 
spectroscopy as well as by mass spectrometry. The ESI-MS displayed a m/z 305 [M-H]-, 
which suggested a molecular formula of C18H10O5 and 14 DBE.  The 13C NMR spectrum 
of 5.12 contained 15 signals (nine methines, including two representing a pair of 
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equivalent methines) and eight quaternary carbons, as supported by a gHSQCAD 
NMR experiment. The IR spectrum of 5.12 showed absorptions at 3401 and 1804 cm-1, 
suggestive of hydroxy and carbonyl moieties. The 1H NMR and gCOSY NMR 
identified the presence of two isolated spin systems. These included a monosubstituted 
aromatic ring [δ 8.19, d, J = 7.5 Hz (H-2‘/H-6‘); 7.47, m (H-3‘/H-5‘); 7.39, t, J = 7.5 Hz 
(H-4‘)] and a di-substituted aromatic ring [δ 7.98, d, J = 7.5 Hz (H-3); 7.45, m (H-5); 7.32, 
dd, J = 7.5, 8.0 Hz (H-4) and 7.23 d, J = 8.0 Hz (H-6)].  
A key HMBC correlation was observed from δ 7.98 (H-3) to the carbon at δ 
107.0 (C-8) which unequivocally positioned the benzofuranone moiety adjacent to the 
hydroxyfuranone core, whilst another HMBC correlation positioned the other mono-
substituted aromatic ring δ 8.19 (H-2‘/H-6‘) to the carbon at δ 105.9 (C-11) as shown 
below in Figure 5.12. Positions C-10 and C-12 were assigned on the basis of 
comparisons to carbon shifts previously assigned to 5.4 (Dias et al., 2007). The 
unequivocal assignment of 5.12 is detailed in Section 10.5. 
 
          
O
HO
O
O
O
10
12
1'
4'
1
7
4
6
H
H
H
H
H
H
H
H
H
Selected HMBC correlations
105.9
160.0
152.8
165.4
(5.12)
   
1
3
5
6
2''
4''
5''
1''
1'
3'
4'
6'
O
O
OH
OCH3H3CO O
158.6
154.9
166.1
105.2
(5.4)
 
Figure 5.12. Selected HMBC correlations for calycin (5.12) and selected 13C chemical shifts 
comparison to pinastric acid (5.4). 
 
5.2.2.2 Identification of Atranorin (5.20), 5-chloroatranorin (5.21) and the Isolation of  
5,5’-dichloroatranorin (5.22) 
 
In an effort to separate 5.3 and 5.12 by HPLC, the 3:1 MeOH/DCM crude extract was 
sequentially partitioned using DCM followed by MeOH. The MeOH partition was then 
subjected to semi-preparative reversed-phase HPLC, which resulted in the isolation of 
the known compound, atranorin (5.20). Surprisingly 5.3 and 5.12 were not detected in 
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the MeOH partition by analytical HPLC. However, 5.3 and 5.12 were detected in the 
DCM partition, as confirmed by analytical HPLC. Atranorin (5.20) was first isolated in 
1898 and reported to be always accompanied by 5.3 in the lichen L. vulpina (Hesse and 
Prakt, 1898; Solberg and Remedios, 1978). In addition, this β-orcinol depside (5.20) has 
been described as being a significant taxonomic marker for various species of lichens 
that possess ecological and biological properties (Elix, 1993; Elix et al., 1982; Rundel, 
1978). It was not until 1999 that the re-isolation together with the complete 1D and 2D 
NMR for 5.20 was described (Huneck and Yoshimura, 1996; König and Wright, 1999). 
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atranorin (5.20) 
 
In the present isolation of atranorin (5.20) the structure was confirmed on the 
basis of 1D and 2D NMR experiments and mass spectrometry. The ESI-MS showed a 
m/z 373 [M-H]-, consistent with a molecular formula of C19H18O8 and 11 DBE. The 1H 
NMR, gHSQCAD and gHMBC NMR spectra supported the assignments of 5.20 
previously reported in the literature (König and Wright, 1999). The structural 
assignment of atranorin (5.20) is detailed in Section 10.5 
Following the NMR data acqusition of 5.20 it was observed that changes 
occurred in the 1H NMR spectrum (in particular, the disappearance of the 1H chemical 
shift at δ 6.41, s (H-5) after approximately 16 hours. Clearly a chemical conversion was 
occurring and this was monitored by the acquisition of 1D and 2D NMR experiments 
as well as ESI-MS. The NMR data acquired, together with the supporting ESI-MS data 
identified the presence of a m/z 407 [M-H]- (molecular formula of C19H17ClO8 and 11 
DBE) which confirmed the presence of the known depside, 5-chloroatranorin (5.21).  
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                5-chloroatranorin (5.21)               5,5'-dichloroatranorin (5.22) 
 
Due to the conversion of 5.21 to 5.22, during NMR data acquisition only a 
HSQCAD NMR experiment could be acquired for 5.21 within the time it took for it to 
further convert to 5.22. This permitted the observation of four methyls [δ 2.86, s (H-9); 
2.09, s (H-8‘); 2.54, s (H-9‘) and 3.99, s (H-10‘)] and one deshielded methine δ 6.52, s (H-
5‘). The methine proton at (C-5) was absent as it had now been replaced by a chlorine 
substituent, as confirmed by the isotopic ratio (3:1) observed in the ESI-MS. The 
identification of 5-chloroatranorin (5.21) dates back as early as the 1930s (St. Pfau, 
1933). It was not until 1964 that the halogenation of 5.20 was reported, together with 
the chlorination of lecanoric acid (5.28) to 5-chlorolecanoric acid (5.29) suggesting that 
the source of chlorine was indeed as a result of the the spectroscopic analyses carried 
out in CDCl3 (Neelakantan et al., 1964; Neelakantan et al., 1962). 
 
O
O
CH3HO
OH
CH3 O
OH
OH
R
 
lecanoric acid                   R = H (5.28) 
5-chlorolecanoric acid      R = Cl (5.29) 
 
Following the  NMR data acquisition of 5-chloroatranorin (5.21) (approximately 
14 hours), it was observed that the 1H NMR spectrum of 5.21 showed the 
disappearance of the chemical shift at δ 6.52, s (H-5‘) and that all other observed signals 
which had been evident for 5.21 were now slightly shifted downfield (Figures 5.13 and 
5.14) 
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Analysis of the 1H NMR, gHSQCAD and gHMBC NMR data of 5.22 identified 
the presence of 17 carbons [(one methine, four methyls and twelve quaternary carbons 
(two were not detected)]. The IR spectrum of 5.22 once again showed absorptions at 
3401 and 1735 cm-1, suggestive of hydroxy and carbonyl moieties. The ESI-MS 
displayed a m/z 441 [M-H]-, consistent with a molecular formula of C19H16Cl2O8 and 11 
DBE.   
Key HMBC correlations were observed from the methyl group at δ 2.65 (H-9‘) 
to the carbon bearing the chlorine substituent at δ 118.4 (C-5‘). This enabled the 
position of the chlorine substituent to be deduced as being adjacent to the bridging 
ester at (C-4‘).  The methyl group at δ 2.13 (H-8‘) also showed key HMBC correlations 
to δ 148.8 (C-4‘), 159.6 (C-2‘) and to 119.1 (C-3‘). Furthermore the methyl group at δ 2.92 
(H-9) exhibited a 3J HMBC correlation to the carbon containing the second chlorine at 
115.6 (C-5) ppm. The hydroxy group at δ 12.22 (2-OH) displayed a 2J bond HMBC 
correlation to 166.7 (C-2) ppm and allowed the carbon δ 109.1 (C-3) ppm bearing the 
aldehyde substituent to be positioned. Finally, the methyl ester at δ 4.01 (H-10‘) 
showed a 3J HMBC correlation to the ester carbonyl at δ 171.2 (C-7‘). These key HMBC 
correlations and similar 1H and 13C chemical shifts observed for 5.20 and 5.21 
supported the structure of the depside, 5,5′-dichloroatranorin (5.22) (see Table 5.2 and 
Figure 5.15). 
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Figure 5.15. Key HMBC correlations for 5.22. 
 
The first report of 5.22 appeared in 1964 where the halogenation of depsides 
was described (Neelakantan et al., 1964). This study reported the halogenation of 5.20 
to 5.21 and then 5.21 to 5.22, using Cl2 (2 moles). Methanolysis by Neelakantan et. al. of 
5.22 produced two fission products, 5-chlorohaematommate (5.30) and methyl-5-
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chloro-β-orcinol carboxylate (5.31) which were then used to deduce the structure of the 
chlorinated depside. At the time 5,5′-dichloroatranorin (5.22) had not been isolated or 
fully characterised. This represents the first isolation of 5.22 along with its detailed 
chemical characterisation. 
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Table 5.2. 1H (500 MHz) and 13C (125 MHz) NMR data of 5.22 in CDCl3. 
 
O
O
H
O
CH3HO
OH
CH3
CH3 O
O
OH
CH3
Cl
Cl
13
5
7
1'
3'
9'
9
8'
10'
8
 
 
Position 
 
δH (J in Hz) 
 
δca, mult 
 
gHMBC and CIGAR 
 
 
1 
 
- 
 
103.6, qC 
 
- 
2 - 166.7, qC - 
3 - 109.1, qC - 
4 - ND - 
5 - 115.6, qC - 
6 - 149.1, qC - 
7 - ND - 
8 10.38, s 193.9, CH - 
9 2.92, s 21.5, CH3 C-1, C-5, C-6 
1′ - 111.9, qC - 
2′ - 159.6, qC - 
3′ - 119.1, qC - 
4′ - 148.8, qC - 
5′ - 118.4, qC - 
6′ - 136.6, qC - 
7′ - 171.2, qC - 
8′ 2.13, s 10.5, CH3 C-2′, C-3′, C-4′ 
9′ 2.65, s 19.8, CH3 C-1′, C-5′, C-6′ 
10′ 4.01, s 53.1, CH3 C-7′ 
2-OH 12.22, s - C-1, C-2, C-3 
2′-OH 11.52, s - C-1′, C-2′ 
4-OH ND - - 
    
*Signals may be interchanged 
aCarbon assignments based on HSQCAD and DEPT experiments 
ND: indicates signal was not detected 
 
5.2.2.3 Isolation of Pulvinic Dilactone (5.7) and the Conversion to Pulvinic Acid (5.2) 
 
The identification of 5.7 was previously reported in 1883 (Spiegel, 1883) while the 
hydrolysis (aqueous methanolic soluton) of 5.7 to 5.2 had been reported in the late 
1950s (Frank et al., 1950). It was anticipated by HPLC profiling that 5.3 and 5.12 may 
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have been formed as hydrolysis products resulting from the initial extraction step. In 
an effort to confirm this, a separate extraction of C. concolor was carried out using DCM 
alone as the extraction solvent, resulting in almost 95% pure (on the basis of 1H NMR 
spectrum) known compound, pulvinic dilactone (5.7). From this result it appears that 
in terms of the chemical profiling of lichens, selection of the extraction solvent is crucial 
in correctly determining the true lichen constituents present and should be ideally 
performed using a selection of solvents. 
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pulvinic dilactone (5.7) 
 
Pulvinic dilactone (5.7) was isolated as yellow-green oil. The ESI-MS showed 
the presence of m/z 291 [M+H]+, consistent with a molecular formula of C18H10O4 and 
14 DBE. The 13C NMR spectrum of 5.7 contained 7 discrete signals, [(δ 128.2 (C-5/C-
5‘/C-9/C-9‘), 129.2 (C-6/C-8‘/C-6/C-8‘), 130.1 (C-7/C-7‘), 126.4 (C-4/C-4‘), 101.4 (C-
2/C-2‘), 165.7 (C-3/C-3‘) and 157.1 (C-1/C-1‘) (4:4:2:2:2:2:2)]. The gHSQCAD NMR 
experiment supported a symmetrical structure for 5.7 in which ten methines and eight 
quaternary carbons were identified. 1H NMR and gCOSY NMR experiments identified 
the presence of two ortho coupled aromatic methines δ 8.04, d, J = 8.0 Hz (H-5/H-5‘/H-
9/H-9‘) and δ 7.50, dd, J = 7.0, 7.5 Hz (H-6/H-6‘/H-8/H-8‘) in which both signals 
showed a COSY correlation to an aromatic methine at δ 7.44, dd, J = 7.0, 6.5 Hz (H-
7/H-7‘). The only key HMBC correlation was that observed from the protons at δ 8.04, 
H-5/H-5‘/H-9/H-9‘) to δ 101.4 (C-2/C-2‘) which enabled the positioning of these 
aromatic protons as being adjacent to the furanone. Positions C-1, C-1‘ and C-3, 
consistent with vinyl ester carbons, were assigned on the basis of carbon chemical shift 
previously assigned for compounds 5.3, 5.4 and 5.12. 
The conversion of 5.7 to 5.2 was carried out and it appears that the complete 1H 
and 13C NMR assignments of 5.2 has not been previously documented. The first report 
of pulvinic acid (5.2) dates back to 1894 (Volhard, 1894) and includes the conversion of 
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5.7 to 5.2 by acid hydrolysis (Frank et al., 1950). The synthesis of 5.2 was carried out in 
CDCl3, in an NMR tube where a solution of permethylated pulvinic acid, treated with 
iodotrimethylsilane, and sealed under N2 was heated to 55°C (Pattenden et al., 1991a). 
After 3 days the reaction mixture was hydrolysed in MeOH to afford 5.2 which was 
characterised by 1H and 13C NMR (Pattenden et al., 1991a). 
In the present study pulvinic dilactone (5.7) was heated with aqueous acetone 
for 15 minutes, resulting in the isolation of 5.2 (in >95% purity based on 1H NMR 
spectroscopy) in which the conversion is shown in Figure 5.10. The structure of 5.2 was 
confirmed by 1D and 2D NMR experiments as well as mass spectrometry and the 
structure found to be similar to 5.4.  
 
O
O
OHHO O
 
pulvinic acid (5.2) 
 
The negative mode ESI-MS showed the presence of a m/z 307 [M-H]- (molecular 
formula of C18H12O5 and 13 DBE). The IR spectrum of 5.2 displayed absorptions at 3307 
(broad) and 1611 cm-1, suggestive of carboxylic and ester carbonyl moieties. The 1H 
NMR spectrum, together with the gCOSY NMR identified the presence of two isolated 
mono-substituted aromatic rings [δ 7.33, m (H-4); 7.29, m (H-3/H-5) and 7.19, d, J = 7.0 
Hz (H-2/H-6)] and [δ 8.14, d, J = 7.0 Hz (H-2‘/H-6‘); 7.30, m (H-3‘/H-5‘) and 7.12, dd, J 
= 7.0, 7.5 Hz (H-4‘)].  
Diagnostic HMBC correlations were observed from aryl protons on both rings δ 
8.14 (H-2‘/H-6‘) to δ 95.7 (C-10) and δ 7.19 (H-2/H-6) to δ 118.3 (C-7), which enabled 
them to be positioned accordingly. As HMBC correlations were not observed for the 
exchangeable protons, the remaining quaternary carbon shifts were assigned by 
comparison to those previously assigned in 5.4, 5.3 and 5.12 (Dias et al., 2007). The 
unequivocal assignment of pulvinic acid (5.2) is detailed in Section 10.5. 
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5.2.3 Biological Evaluation and Details of Assays 
 
The antibacterial activity of lichen acids has been reported as early as the 1940s where 
it was demonstrated that compounds 5.3 and 5.20 displayed antibiotic activity against 
gram-positive bacteria (Krogg, 1955). Around the same time it was concluded that 5.7 
displayed inotropic effects in the same order of concentration as that of the cardiac 
glycosides, ouabain and digitoxin (Giarman, 1949). In 1991 it was demonstrated that 5.3 
inhibited the growth of B. subtilis (MIC of 15.8 µg/mL) (Nadir et al., 1992). Other 
reported activities for 5.3 include anti-inflammatory, inhibition of influenza RNA 
viruses, analgesic, local anaesthetic activity and toxicity effects (Appa Rao and 
Prabhakar, 1988; Foden et al., 1975; Rashan et al., 1990). In another study 5.3 displayed 
activity against the fungus U. violacea, M. microspora and E. repens and the bacteria B. 
megaterium, whereas 5.20 displayed activity only against E. repens (König and Wright, 
1999). 
Extracts of C. concolor (Dickson) B. Stein were evaluated against a P388 Murine 
Leukaemia cell line (antitumour assay) as well as against a number of bacteria and 
fungi (antimicrobial assays) at the University of Canterbury, Christchurch, New 
Zealand. Only moderate antitumour activity was observed for the crude C. concolor 
extract (IC50 31,776 ng/mL at 10 mg/mL). The C. concolor extract displayed significant 
antibacterial activity against Bacillus subtilis. No activity was observed against 
Eschericha coli, Pseudomonas aeruginosa, Candida albicans, Trichophyton mentagrophytes or 
Cladosporium resinae. 
Compounds 5.2, 5.3, 5.7, 5.12 and 5.22 were all found to display insignificant 
activity against the P388 murine leukaemia cell line (> IC50 12,500 ng/mL when tested 
at 1 mg/mL). Pulvinic dilactone (5.7) moderately inhibited the growth of Bacillus 
subtilis while compounds 5.2, 5.3, 5.12 and 5.22 showed slight inhibition against Bacillus 
subtilis. Compounds 5.20 and 5.21 were unable to be tested due to their instability and 
conversion to 5.22.  
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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5.2.4 Application of Comprehensive Two-Dimensional Gas Chromatography 
(GCxGC) to Profile the Constituents of the Lichen, Candelaria concolor 
 
5.2.4.1 Results and Discussion 
 
GCxGC was carried out on the crude extract of the lichen, Candelaria concolor. Once 
again, a 1 mg/mL stock solution of the crude extract of this (extracted with 3:1 
DCM:MeOH) was subjected to both GC-MS and GCxGC analyses.  
The C. concolor extract was derivatised with MSTFA (Section 10.1.7) (using the 
same procedure previously described for C. xanthina) to ensure sufficient volatility for 
both GC-MS (Section 10.1.5) and GCxGC-FID (Section 10.1.6) analyses. The GC-MS 
trace immediately identified a major peak at tR = 8.90 min (C22H22O5Si, [M]+ = 394 m/z), 
supporting the identification of monotrimethylsilyl vulpinic acid (5.34) (Figure 5.16), a 
new silylated derivative of vulpinic acid (5.3), along with some degradation of this 
product at tR = ~9-12 min. The common plasticiser 5.33 was also identified. The crude 
extract, C. concolor was extracted using 3:1 DCM:MeOH and it was anticipated that the 
derivatised analogues of both 5.3 and 5.12 would be identified. The choice of extraction 
solvent has been previously described in Section 5.2.2.3). 
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Figure 5.16. GC-MS trace of the silylated extract of C. concolor identifying 
monotrimethylsilyl vulpinic acid (5.34) as the major constituent. 
 
The silylated lichen extract, C. concolor was subjected to GCxGC-FID analysis 
(Section 10.1.6) to determine whether there were unresolved constituents present 
which were not able to be resolved utilising 1D GC. Monotrimethylsilyl vulpinic acid 
O
O
O
O OCH3Si
 
monotrimethylsilyl vulpinic acid (5.34) 
Slight degradation of (5.34) 
bis(2-ethylhexyl)phthalate  (5.33) 
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(5.34) (contour at ~tR = 17.1 min) was found to be the major constituent present, as well 
as evidence for its slight degradation (contour between ~tR = 17.5-25.0 min) (Figure 
5.17). The 2D GCxGC plot identified the presence of several unknown constituents, 
which were unable to be identified. 
 
 
Figure 5.17. GCxGC contour plot identifying the presence of 5.34 as the major constituent 
present in the crude extract of the lichen C. concolor 
 
The GCxGC analysis of the lichen extract C. concolor was simplistic in nature as 
for the lichen extract C. xanthina (see Section 5.1.5). Prior knowledge of the lichen and 
class of compounds assisted in the choice of a suitable derivatising agent for GC-MS 
and GCxGC chemical profiling. Obvious limitations include the analysis of complex 
natural product extracts with more than one compound class present, as more than one 
derivatising agent would be required to obtain a true representation of a natural 
product extract.  
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5.3 Ramalina glaucescens Kremp. and Xanthoria parietina (L.) 
 
5.3.1 Collection, Extraction and Isolation 
 
The green lichen Ramalina glaucescens Kremp, accompanied by the bright orange lichen, 
Xanthoria parietina (L.) Th. Fr. were collected on the 8th of September, 2006 from 
Trentham, Victoria, Australia. The lichens were collected by chiselling pieces off tree 
branches and then physically separating the two lichen samples.  Small (2 x 2 cm) 
samples of each lichen were sent to Emeritus Prof John A. Elix (Australian National 
University, Canberra, ACT, Australia) for identification and HPLC profiling.  Voucher 
specimens were designated the codes 2006-33 and 2006-32 for the lichens R. glaucescens 
and X. parietina, respectively and are deposited at the School of Applied Sciences, 
RMIT University. Photographs of the lichens are shown on page 196. 
Following the physical separation of R. glaucescens from X. parietina the sample 
of R. glaucescens (20 g) (7g dr. wt.) was extracted with 100% DCM (200 mL). The crude 
extract (86 mg) was then decanted and concentrated under reduced pressure, filtered 
through a 0.45 µ filter and subjected to normal phase semi-preparative HPLC using an 
optimised gradient method consisting of 0 mins 20% EtOAc/n-hexane; 10 mins 20% 
EtOAc/n-hexane; 11 mins 100% EtOAc and 20 mins 100% EtOAc affording, (+)-usnic 
acid (5.1) (17.4 mg, 0.22 %), a mixture of sekikaic acid (5.24) and 5-chlorosekikaic acid 
(5.23) (5.4 mg, 0.07 %) (as confirmed by 1H NMR), atranorin (5.20) (2.8 mg, 0.04 %) and 
parietin (5.25) (7.8 mg, 0.01 %). Inadvertently a small portion of X. parietina had also 
been extracted in the process, resulting in the isolation of 5.25. All percentages are 
based on the mass of the dried weight of both lichens as shown in Scheme 5.6. 
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Ramalina glaucesens accompanied with
Xanthor ia parietina (20 g)
(100% DCM) (200 mL) (86 mg)
Filtered (0.45 µ)
Semi preparative NP-HPLC
(gradient method)
(+)-usnic acid (5.1)
(17.4 mg, 0.22 %)
mixture of sekikaic acid (5.24) and
5-chlorosekikaic acid (5.23)
(5.4 mg, 0.07%)
atranorin (5.20)
(2.8 mg, 0.04 %)
parietin (5.25)
(7.8 mg, 0.01 %)
  
 
Scheme 5.6. Extraction and isolation procedure adopted for R. glaucescens with X. parietina. 
 
 
5.3.2 Results and Discussion 
 
5.3.2.1 Isolation of Lichen Constituents from Ramalina glaucescens and Xanthoria 
parietina 
 
The green coloured lichen, R. glaucescens, was extracted with DCM, filtered through a 
0.45 µ filter and subjected to normal phase HPLC to yield the known compounds 5.1, 
5.20, 5.24, 5.25 and the novel chlorinated analogue 5.23. 
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                               sekikaic acid                 R = H (5.24)                   parietin (5.25) 
                               5-chlorosekikaic acid   R = Cl (5.23) 
 
The major constituent isolated from R. glaucescens was the dibenzofuran, (+)-
usnic acid (5.1). This compound has been extensively studied and is well known for its 
medicinal and commercial applications (Ingόlfsdόttir, 2002). Usnic acid (5.1) was first 
isolated in 1844 and is widely distributed in species of Cladonia (Cladoniaceae), Usnea 
(Usneaceae), Lecanora (Lecanoraceae), Ramalina (Ramalinaceae) and other lichen genera 
(Ingόlfsdόttir, 2002).  
 
O
COCH3
HO
H3C
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H3C
O
COCH3
OH
 
(+)-usnic acid (5.1) 
 
Cladonia species were used in the treatment of pulmonary tuberculosis (Vartia, 
1973). Extracts of U. barbata have been used as a source of 5.1 in modern-day cosmetic 
and pharmaceutical preparations (Vartia, 1973). R. thrausta was used in Finland for 
treating wounds, athletes foot, treatment of a sore throat and tooth ache (Vartia, 1973). 
(+)-Usnic acid (5.1) has widespread biological activity including antibacterial, antiviral, 
antiproliferative, antiinflammatory, analgesic and antipyretic activities (Cocchietto et 
al., 2002; Ingόlfsdόttir, 2002; Lauterwein et al., 1995). In this current study (+)-usnic acid 
(5.1) was isolated as a pale yellow oil and the structure confirmed by 1D and 2D NMR 
spectroscopy and mass spectrometry. The ESI-MS showed the presence of a distinct ion 
at m/z 343 [M-H]-, consistent with a molecular formula of C18H16O7 and 11 degrees of 
unsaturation. Analysis of the 13C NMR spectrum of 5.1 showed that it contained 18 
signals (one methine, four methyls and thirteen quaternary carbons) as supported by 
the HSQCAD NMR experiment. The 1H NMR, COSY, HMBC and optical rotation are 
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consistent with the structure of 5.1 and were found to be identical in all respects to data 
previously reported (König and Wright, 1999). The unequivocal asssignment of (+)-
usnic acid (5.1) is detailed in Section 10.5. 
The most polar fraction was isolated as viscous, unstable brown oil. 1D and 2D 
NMR analyses identified this fraction to contain a mixture of sekikaic acid (5.24) and a 
chlorinated derivative, confirmed by ESI-MS. Sekikaic acid (5.24) was first isolated 
from the lichen R. dilacerata, a Chinese drug known as ‗Shi-hoa‘ (Asahina and 
Nonomura, 1933; Kurokawa and Jinzenji, 1965; Nakao and Yakugaku, 1923; Seshadri 
and Subramanian, 1949). Sekikaic acid (5.24) is an orcinol derived depside which is 
restricted to the family Ramalina (Culberson, 1965). The ESI-MS showed the presence of 
a m/z 417 [M-H]-, consistent with a molecular formula of C22H26O8 and 10 DBE. Sekikaic 
acid (5.24) was fully characterised the data found to be identical to that previously 
reported (Sundholm and Huneck, 1981). 
Prior to this study there had been no report for the complete chemical shift 
assignment for 5.24. The structural assignment of sekikaic acid (5.24) is detailed in 
Section 10.5. 
During the characterisation of 5.24, it was found that over a oeriod of time 
degradation of the sample occurred resulting in a mixture of 5.23 and 5.24. Eventually 
the chemical transformation of 5.23 to 5.24 was complete, allowing for the 
characterisation of 5.23 (Figure 5.18). 
During NMR data acquisition of sekikaic acid (5.24) (ca. 16 hours later), analysis 
of the 1H NMR identified the presence of the novel compound 5-chlorosekikaic acid 
(5.23). ESI-MS identified the presence of an additional ion, m/z 34 units greater than 
that of 5.24, consistent with the replacement of one of the protons in 5.24 with a 
chlorine substituent (Figure 5.19). 
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The structure of 5.23 was determined by a combination of 1D and 2D NMR 
experiments. The HR-ESI-MS displayed a m/z 451.1166 [M-H]-, consistent with a 
molecular formula of C22H25ClO8 and 10 DBE. In addition the isotopic ratio for the m/z 
451:453 (3:1) ions was consistent for the presence of a chlorine. The 13C NMR spectrum 
of 5.23 contained 22 signals (four methyls, four methylenes, two methines and twelve 
quaternary carbons as supported by a gHSQCAD NMR experiment.  
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                                                  5-chlorosekikaic acid (5.23) 
 
The IR spectrum of 5.23 displayed absorptions at 3435 and 1651 cm-1, 
supportive of hydroxy and carbonyl moieties. Analysis of the 1H, 13C and COSY NMR 
spectra of 5.23 identified the presence of two propyl units [δ 0.99, t, J = 7.0 Hz (H-3‖); 
1.73, m (H-2‖) and 3.21, t, J = 6.0 Hz (H-1‖)] and [δ 1.01, t, J = 7.0 Hz (H-3‘‖); 1.65, m (H-
2‘‖) and 2.96, t, J = 8.5 Hz (H-1‘‖)]; two methoxy groups δ 3.93, s (H-8) and δ 3.91, s (H-
10) and two isolated aromatic methines [δ 6.46, s (H-5‘) and δ 6.48, s (H-3)]. 
Key HMBC correlations were observed from the methylene at [δ 2.96, t, J = 8.5 
Hz (H-1‘‖)] to δ 106.3 (C-5′) allowing one of the propyl moieties to be positioned. 
Further correlations were observed from the aromatic methine at δ 6.46, s (H-5‘) to the 
carbon bearing the carboxylic moiety at δ 104.7 (C-1‘) and to the quaternary carbon at δ 
124.7 (C-3‘). The methylene at δ 3.21, t, J = 6.0 Hz (H-1‖), belonging to the second 
propyl substituent, showed key HMBC correlations to the carbon bearing the chlorine 
substituent at δ 115.6 (C-5) and to the carbon bearing the bridging ester at δ 106.1 (C-1), 
thereby positioning this propyl fragment. The isolated aromatic methine at δ 6.48, s (H-
3) showed HMBC correlations to the carbon bearing the chlorine group at δ 115.6 (C-5) 
as well as to the carbon bearing the hydroxy moiety at δ 162.4 (C-2) (Table 5.3 and 
Figure 5.20). The observed difference between compounds 5.23 and 5.24 was the 
presence of the carbon bearing the chlorine substituent at δ 115.6 (C-5) in 5.23, which 
replaced the methine at δ 6.38, s (H-5) in 5.24. Confirmation for the chemical shifts for 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
189 | P a g e  
 
 
the aromatic ring bearing the chlorine were also based on comparisons to closely 
relateed compounds reported from Thelomma mammosum (Huneck et al., 1980). 
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Figure 5.20. Key HMBC NMR correlations for compounds 5.23 (R = Cl) and 5.24 (R = H). 
(Proton signals not shown for clarity) 
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Table 5.3. 1H (500 MHz) and 13C (125 MHz) NMR data of 5-chlorosekikaic acid (5.23) in 
CDCl3. 
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aCarbon assignments based on HSQCAD and DEPT experiments 
ND: indicates signal was not detected 
 
A study conducted several decades ago described that in the biogenesis of 
chlorodepsidones, a depside may undergo halogenation and that the halogenated 
derivative can then undergo ring closure by the elimination of a hydrogen halide 
 
Position 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY  
 
gHMBC 
 
 
1 
 
- 
 
106.1, qC 
 
- 
 
- 
2 - 162.4, qC - - 
3 6.48, s 98.6, CH - C-1, C-2, C-5 
4 - 156.6, qC - - 
5 - 115.6, qC - - 
6 - 144.8, qC - - 
7 - 167.9, qc - - 
8 3.93, s 56.0, CH3 - C-4′ 
9 - 174.1, qc - - 
10 3.91, s 56.4, CH3 - C-4 
1′ - 104.7, qC - - 
2′ - 156.0, qC - - 
3′ - 124.7, qC - - 
4′ - 159.8, qC - - 
5′ 6.46, s 106.3, CH - C-1′, C-3′, C-1″′ 
6′ - 147.2, qC - - 
1″ 3.21, t (6.0) 34.4, CH2 H-2″ C-1, C-5, C-6, C-2″, C-3″ 
2″ 1.73, m 22.9,  CH2 H-1″, H-3″ C-1″, C-3″ 
3″ 0.99, t (7.0) 14.5,  CH3 H-2″ C-1″, C-2″  
1″′ 2.96, t (8.5) 39.1,  CH2 H-2″′ C-5′, C-6′, C-2″′, C-3″′ 
2″′ 1.65, m 25.3,  CH2 H-1″′, H-3″′ C-1″′, C-2″′ 
3″′ 1.01, t (7.0) 14.7,  CH3 H-2″′ C-1′, C-2′, C-3′ 
2-OH 10.69, brs - - C-1, C-2, C-3 
2′-OH 11.69, brs - - C-1′, C-2′, C-3′ 
9-OH ND - - - 
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(Neelakantan et al., 1964). It was not until 1964 that the halogenation of 6 and the first 
systematic study on the halogenation of lichen depsides was reported (Neelakantan et 
al., 1964).  
Compounds 5.23 and 5.24 were isolated by normal phase semi-preparative 
HPLC as a 1:1 mixture. After approximately 16 hours of acquisition, the 1H NMR 
spectrum had changed and indicated the presence of 5.23 as the major compound, with 
5.24 only being present in small quantities (~3 %, based on the 1H NMR integration).  It 
is speculated that 5.23 could be an artifact of the isolation procedure resulting from the 
extraction of the lichen with CH2Cl2 followed by subsequent analysis in CDCl3. This 
transformation occurs in situ in an NMR tube, which could occur via the electrophilic 
substitution of chlorine that replaces the activated methine at C-5 and is catalyzed by 
the presence of acidic CDCl3. However, the observation of 5.23 in the crude extract as 
well as the fraction prior to HPLC purification, leading to the isolation of a 1:1 mixture 
of compounds 5.23 and 5.24, still leaves the possibility for 5.23 to be a natural product. 
One of the fractions obtained during this investigation contained atranorin 
(5.20), which was also isolated from the lichen C. concolor as an unstable colourless oil. 
The 1H NMR, gHSQCAD and gHMBC supported the structure of 5.20, which was 
identical to that previously reported (Section 10.5) (König and Wright, 1999). 
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atranorin (5.20) 
 
Parietin (also known as physcion) (5.25) was first isolated in the early 1900s 
from the lichen Teloschistes flavicans (Zöpf, 1905) and its single crystal X-ray diffraction 
structure was reported in 1991 (Ulickŷ et al., 1991). Though, the 1D NMR data for this 
anthraquinone has been reported, the complete structural assignment based on 2D 
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NMR experiments have not been documented (Bachmann et al., 1979; Edwards et al., 
2003).  
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parietin (5.25) 
 
Parietin (5.25) was isolated from the contaminating lichen, X. parietina (L.) Th. 
Fr., in which the lichen was also present in the extract of R. glaucescens, despite efforts 
to separate it prior to extraction. The ESI-MS displayed a m/z 283 [M-H]-, which is 
consistent with a molecular formula of C16H12O5 and 11 degrees of unsaturation. The 
13C NMR data of 5.25 contained 16 signals (four methines, two methyls and ten 
quaternary carbons) as indicated by the gHSQCAD NMR experiment. The IR spectrum 
of 5.25 showed absorptions at 3425 (broad), and 1631 cm-1, indicative of hydroxy and 
carbonyl moieties. Important HMBC NMR correlations observed included those that 
supported the placement of the aromatic methyl group δ 2.45, s (H-15) adjacent to both 
methines at δ 7.08, s (H-2) and δ 7.62, s (H-4). The meta-coupled methine at δ 7.36, d (H-
8) showed a 3J HMBC correlation to the ketone moiety at δ 182.0 (C-6). Key HMBC 
correlations from the other meta-coupled methine at δ 6.68, s (H-10) included those to 
the hydroxy bearing carbon at δ 165.2 (C-11) together with carbons δ 166.5 (C-9) and δ 
110.2 (C-12). Additional diagnostic HMBC correlations were observed from the 
hydroxy group at δ 12.11, s (1-OH) to the ring junction carbon at δ 113.6 (C-14) and to 
the aromatic carbon at δ 124.5 (C-2). 
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Figure 5.21. Key HMBC correlations for parietin (5.25). 
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5.3.3 Biological Evaluation and Details of Assays 
 
Extracts of R. glaucescens and X. parietina were evaluated in a number of biological 
assays at 50 mg/mL including against a P388 Murine Leukaemia cell line (antitumour 
assay), as well as against a number of bacteria and fungi (antimicrobial assays) at the 
University of Canterbury, Christchurch, New Zealand. For R. glaucescens, moderate 
antitumour activity was observed for the crude extract (IC50 of 16,652 ng/mL). The R. 
glaucescens extract also displayed significant antimicrobial activity with zones of 
inhibition detected against Bacillus subtilis, Trichophyton mentagrophytes and 
Cladosporium resinae. No activity was detected for Eschericha coli, Pseudomonas aeruginosa 
and Candida albicans. For the crude extract X. parietina, much less antitumour activity 
was observed (IC50 of 26,101 ng/mL). In addition the X. parietina extract displayed only 
slight antimicrobial activity, with marginal zones of inhibition detected against B. 
subtilis, T. mentagrophytes and C. resinae. During the course of these studies the 
University of Canterbury phased out the antimicrobial assays.  
(+)-Usnic acid (5.1) displayed significant activity against the P388 murine 
leukaemia cell line (IC50 of 15 µM, when tested at 1 mg/mL) as well as significant 
antibacterial activity against Bacillus subtilis (10 mm zone of inhibition at 30 µg 
compared to 12 mm for the standard compound chloroamphenicol). (+)-Usnic acid 
(5.1) showed no antimicrobial activity against Trichophyton mentagrophytes and 
Cladosporium resinae. Sekikaic acid (5.24) could only be tested as a mixture of 5.23 and 
5.24 and was found to display moderate activity against the P388 murine leukaemia 
cell line (IC50 >28-30 µM, when tested at 1 mg/mL) as well as moderate antibacterial 
activity (5 mm zone of inhibition) against Bacillus subtilis but no activity against 
Trichophyton mentagrophytes and Cladosporium resinae. Atranorin (5.20) had previously 
been isolated from the lichen C. concolor and rapidly degraded, precluding any 
biological testing. 5-chlorosekikaic acid (5.23) and parietin (5.25) displayed some 
antitumour activity (IC50 >28 and >44 µM respectively, when tested at 1 mg/mL). 
During the course of this investigation the antimicrobial assays were phased out at the 
University of Canterbury which precluded any further evaluation of compounds 5.23 
and 5.25.  
Further details on the biological assays are detailed in Section 10.1.12 and the Appendix.
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Chrysothrix xanthina (2004-46) 
    
 
Domain: Eukaryota 
Kingdom:  Fungi 
Sub kingdom: Dikarya 
Phylum:  Ascomycota 
Class:   Ascomycetes 
Order:   Arthoniales 
Family:  Chrysothricaceae 
Genus:  Chrysothrix 
Species:  xanthina 
 
 Collected by Dr Sylvia Urban from Watsons Creek Reserve (off-Eltham-Yarra Glen 
Road), Kangaroo Ground, Victoria, Australia, growing on the bark of a Eucalypt. 
 (August, 2004) 
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Candelaria concolor (2007-04) 
    
 
Domain: Eukaryota 
Kingdom:  Fungi 
Sub kingdom: Dikarya 
Phylum:  Ascomycota 
Subphylum: Pezizomycotina 
Class:   Ascomycetes 
Subclass: Lecanoromycetidae 
Order:   Lecornorales 
Family:  Candelariaceae 
Genus:  Candelaria 
Species:  concolor 
 
 Collected by Mr Alick Dias from Merlynston Railway Station, Victoria,  
Australia off a Eucalyptus tree 
 (August, 2007) 
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Ramalina glaucesens (2006-33) (green) Xanthoria parietina (2006-32) (orange) 
    
 
Domain: Eukaryota   Domain: Eukaryota 
Kingdom:  Fungi    Kingdom:  Fungi 
Sub kingdom: Dikarya   Sub kingdom: Dikarya 
Phylum:  Ascomycota   Phylum:  Ascomycota 
Subphylum: Pezizomycotina  Subphylum: Pezizomycotina 
Class:   Ascomycetes   Class:   Ascomycetes 
Subclass: Lecanoromycetidae  Subclass: Lecanoromycetidae 
Order:   Lecornorales   Order:   Teloschisales 
Family:  Ramalinaceae   Family:  Teloschistaceae 
Genus:  Ramalina   Genus:  Xanthoria 
Species:  glaucesens    Species:  parietina 
 
Collected by Mr Daniel Dias and Miss Lisa Hodgson from Trentham,  
Victoria, Australia. 
 (September, 2006) 
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6.0 IntroductionG 
 
High Pressure Liquid Chromatography (HPLC) coupled with Nuclear Magnetic 
Resonance (NMR) spectroscopy (HPLC-NMR) is a hyphenated spectroscopic 
technique, which has taken time to become accepted as a robust analytical tool.  First 
developed in 1978, it was considered more of an academic curiosity for the first 10-15 
years.  It was not until 1997 that HPLC-NMR began to find wider use in natural 
products analysis (Urban and Separovic, 2005; Urban, 2006).  HPLC-NMR studies of 
natural products have included the characterisation of individual components in crude 
or partially purified extracts and have demonstrated the full power of the hyphenated 
technique in eliminating the need to isolate individual components from a crude 
extract for subsequent NMR experiments.  One of the first applications of the profiling 
of natural product extracts by HPLC-NMR was the characterisation of the 
sesquiterpene lactones in Zaluzania grayana by on-flow and stop-flow HPLC-NMR 
experiments (Spring et al., 1995).  To date the identification of a wide range of plant 
natural products has been achieved using HPLC-NMR (Urban and Separovic, 2005; 
Urban, 2006).   Most of these studies have described the identification of known 
members of these structure classes by HPLC-NMR, but the technique has also been 
used to determine the structures of new analogues of known compounds.  HPLC-NMR 
                                            
†
Dias DA and Urban, S. 2008. Phytochemical Analysis of the Southern Australian Marine Alga, Plocamium mertensii 
using HPLC-NMR. Phytochem. Anal. 19: 453-470. 
Phytochemical Analysis of the Southern Australian 
Marine Alga, Plocamium mertensii  
Using HPLC-NMR† 
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applications have dealt mainly with the characterisation of plant-derived mixtures 
(Clarkson et al., 2006), while applications to secondary metabolites of micro-organisms 
(Abel et al., 1999; Kleinwachter et al., 2000) or marine natural products (Hostettmann et 
al., 1998; Bobzin et al., 2000; Sandvoss et al., 2000, 2001) are still relatively uncommon.  
Publications to date have focused mainly on the characterisation and identification of 
small molecules up to a molecular weight of about m/z 700, but HPLC-NMR has also 
been successfully applied to identify saponins of a molecular weight up to m/z 1400 
and to characterise larger biomolecules such as glycosphingolipids (Backer et al., 1999; 
Sandvoss et al., 2000, 2001). 
The advantages of HPLC-NMR include the ability to separate components 
within a sample in situ.  For components that are unstable to light, air, time or the 
environment, it is the preferred NMR technique for the potential on-line structure 
identification of natural products.  As the number of applications of the use of HPLC-
NMR to profile marine natural product extracts has been limited to a few studies it was 
decided that this robust analytical technique would be used to profile a crude extract of 
the marine alga Plocamium mertensii. 
Red algae belonging to the genus Plocamium are a well-established source of 
polyhalogenated monoterpenes with many of the secondary metabolites described 
isolated during the 1970-1980s (Mynderse et al., 1975a; Crews et al., 1978; Stierle et al., 
1979; Naylor et al., 1982).  Most of the halogenated monoterpenes have been identified 
from P. cartilagineum which is the most cosmopolitan of the Plocamium species, with 
collections ranging along the Pacific coasts of North America, Australia, New Zealand, 
the Mediterranean, the Isle of Wight (Bembridge, British Coast) and the inhospitable 
Janus Island of Antarctica.  (Mynderse et al., 1967; Kazlauskas et al., 1976; Higgs et al., 
1977; Blunt et al., 1978; Stierle et al., 1979; Naylor et al., 1982).  It is well documented that 
the Plocamiaceae family produces a range of acyclic and cyclic monoterpenes, typically 
composed of a ten carbon unit, varying in the degree of bromine and chlorine 
incorporation (Figure 6.1) (Fenical et al., 1979).   
Cyclic monoterpenes have frequently proven to be a structural elucidation 
challenge with the main difficulties being associated with the determination of the 
halogen substitution and regiochemistry as well as the relative and absolute 
configuration.  
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Figure 6.1.         General acyclic (A) and cyclic (B-D) monoterpenes  
                belonging to the family Plocamiaceae. 
 
The first report of a cyclic monoterpene skeleton from a marine algae was in 
1974 with the isolation of violacene (6.1) from the extracts of P. violaceum (Mynderse et 
al., 1974).  This was followed closely in 1975 by the isolation of plocamene B (6.2), 
which possesses a nonisoprenoid monoterpene skeleton (rearranged isoprene units). 
Plocamene B (6.2) displayed moderate toxicity to laboratory test fish, from a less 
common variation of P. violaceum (Crews et al., 1975).  A separate investigation of P. 
violaceum, resulted in the isolation of violacene-2 (Higgs et al., 1977) (also known as 
plocamene-C) (6.3) (Crews et al., 1978) whose structure was secured by a single crystal 
X-ray diffraction analysis but was found to have decomposed during acquisition 
(Mynderse et al., 1975b).    
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The first structural reassignment of a cyclic monoterpene was reported in 1978 
for violacene (6.1) (Van Engen et al., 1978).  A single-crystal X-ray diffraction study 
confirmed that the correct structure of violacene (6.1) is actually 6.4 and the revised 
structure is consistent with the reversed assignments at positions C-5 and C-10 for 
which the carbon chemical shift of the methylene chloride (CH2Cl) appears ca. 10 ppm 
further downfield compared to the carbon shift of the methylene bromide (CH2Br) 
(Van Engen et al., 1978).   In 1977 an additional five cyclic monoterpenes 6.5-6.9 were 
reported from P. cartilagineum for which the stereochemical assignments were based on 
the absolute configuration previously reported for 6.3 (Higgs et al., 1977).  At the time it 
was postulated that a modification in the stereochemistry at positions C-1 or C-5 would 
cause a considerable difference in the carbon chemical shifts due to the methyl groups 
and the axial protons (Higgs et al., 1977; Norton et al., 1977a, b).   
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A collection of P. cartilagineum resulted in the isolation of several linear 
monoterpenes as well as the minor cyclic monoterpene 6.10, which were not fully 
characterised at the time (Higgs et al., 1977).  In 1977 a number of investigations were 
carried out on several species of Plocamium including P. mertensii which yielded the 
new bromotrichloro terpene, mertensene (6.11) [structure class (C) in Figure 6.1] 
(Norton et al., 1977a).   
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Analysis of an Australian collection of P. cartilagineum resulted in the isolation 
of two cyclic monoterpenes 6.12 and 6.13 whose structures and relative configurations 
were established by spectroscopic techniques including 1H-1H coupling constants and 
13C-spin-lattice relaxation times (Norton et al., 1977a).  An additional two cyclic 
monoterpenes 6.14 and 6.15 were isolated from P. cartilagineum in 1978 and their 
absolute configuration secured by a combination of spectroscopic and single X-ray 
diffraction studies.  However, it was noted that during acquisition 6.14 displayed 
considerable degradation (González et al., 1978).  Compound 6.15 was tested for 
cytostatic and antibacterial activities and displayed inhibitory activity (ID50 1-10 
µg/mL) (González et al., 1978, 1980).   
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Investigation of P. violaceum, collected from Monterey Bay California resulted in 
the isolation of two additional cyclic monoterpenes, plocamene D (6.16) and plocamene 
D’ (6.17) for which the latter only differed to the former by the replacement of a 
chlorine with a bromine substituent (Crews et al., 1978).  The halogen bearing carbon 
was shielded by ca. 9 ppm in 6.17 relative to 6.16 (Crews et al., 1978).  The absolute 
configurations of 6.16 and 6.17 were confirmed by chemical interconversions including 
hydrogenation and reductive dehalogenation of 6.4 and comparison of 13C NMR shifts 
to the literature (Crews et al., 1978).   
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A separate analysis of P. violaceum collected from Pigeon Point, California 
afforded plocamene E (6.18) (Crews et al., 1978).  By the early 1980s a significant 
number of cyclic monoterpenes had been isolated and the opportunity of isolating new 
variations of the cyclic compounds appeared to be restricted to the isolation of isomers.  
An analysis of P. cartilagineum collected from Antarctica led to the isolation of a new 
stereoisomer 6.19 almost identical to 6.16 only differing at position C-6 (Stierle et al., 
1979).   
The comprehensive characterisation of the cyclic monoterpenes 6.20 and 6.21 
was described, including the confirmation of relative and absolute configurations by 
Stierle et al. in 1979.    The extract of P. cartilagineum was previously tested against the 
fungus Cladosporium cucumerinum and found to display moderate antifungal activity 
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(Stierle et al., 1979). In 1979 it was proposed that, in general, polyhalogenated 
compounds were produced to discourage invertebrate predators and to act as a 
defence mechanism against parasitic microflora (Fenical, 1979). 
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In addition the cyclic monoterpenes 6.11, 6.12, 6.13 and 6.16 caused ataxia and 
prevented pentylenetetrazole-induced convulsions in mice (ED50= 100-300 mg/kg); 
produced a non-specific block in isolated muscle preparations and inhibited rat liver 
mitochondrial respiration (Taylor et al., 1981).   Plocamadiene A (6.9) displayed spastic 
paresis up to several days after a single high dose above 100 mg/kg when 
administered to mice (González et al., 1982).  Central nervous system depressant drugs, 
including trihexyphenidyl hydrochloride, meprobamate and chloropromazine were 
ineffective in antagonising the spasticity induced by 6.9 (Taylor et al., 1981).   A study 
conducted in 1982 demonstrated the antibacterial and cytostatic activities of 6.5, 6.6, 6.9 
and 6.15 (González et al., 1982).  In 1984 an unclassified Plocamium species collected off 
the Western Australian coast, led to the isolation of the cyclic monoterpene 6.22 and 
also a revision to the structure of mertensene to 6.24 (Capon et al., 1984).  Both 6.22 and 
mertensene 6.24 were characterised by spectroscopic techniques as well as by single X-
ray crystallographic studies which defined their absolute configurations (Capon et al., 
1984).   
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As already mentioned the assignment of the halogen regiochemistry has proved 
to be troublesome in cyclic monoterpenes and has often resulted in the incorrect 
assignment of regio-chemical positions, despite convincing and evidential NMR data.  
Spectroscopic approaches for determining halogen regiochemistry as well as some 
cases of employing single X-ray crystallography analyses have all contributed to 
incorrect assignments.  A case in point is the structure of mertensene for which a total 
of five structures have been reported to date.  These included mertensene reported as 
6.11 (Norton et al., 1977a), 6.25 (Crews et al., 1978), 6.24 (Capon et al., 1984), 6.26 (Crews 
et al., 1984) and finally 6.27 (Coll et al., 1988).  Alternative strategies reported include, 
13C (or 1H) T1 measurements, but ambiguities were noted with this method and 
lanthanide-induced shift methods were also utilised (Van Engen et al., 1978; Crews et 
al., 1984).  Another approach adopted relied on substituent additivity parameters and 
model compound 13C NMR shift data to predict halogen regiochemistry resulting in 
plausible correlations between calculated and experimental values (Crews et al., 1984).  
This approach was utilised to determine the structure of epi-plocamene D (6.23) 
isolated from P. violaceum (Crews et al., 1984).  The methodology was also implemented 
in the structural revision of two previously isolated compounds, mertensene (6.11) and 
compound 6.12 which were subsequently revised to 6.26 and 6.28, respectively (Crews 
et al., 1984).  Despite the report of the absolute configuration by single-crystal X-ray 
analysis the structural confirmation of mertensene has underwent a significant amount 
of revision as outlined above.   
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Reinvestigation of the alga, P. coccineum Lyngb. collected intertidally from the 
north-west coast of Spain as well as by dredging at Ria de Arosa, Spain, led to the 
isolation of several previously reported cyclic monoterpenes, along with the isolation 
of a new cyclic monoterpene coccinene (6.29) (Castedo et al., 1984).  Following the 
investigation on P. coccineum, the opportunity to fully characterise these compounds 
was possible with the advent of the latest NMR techniques including 2D NMR and 
Nuclear Overhauser Enhancement Difference Spectroscopy (NOEDS).  This resulted in 
the reassignment of coccinene (6.29) to 6.30 as well as 6.15 to 6.31, which has the 
epimeric configuration at position C-2 (Sardina et al., 1985).   
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Indeed, 1D NOEDS and 2D NOESY/ROESY NMR studies have now become 
the standard techniques adopted in the determination of relative configuration.  The 
previously reported structure for 6.15, identified by single X-ray diffraction studies, 
underwent considerable degradation and most probably was the origin of the incorrect 
assignment of this compound.  A collection of P. hamatum J. Agardh afforded two new 
cyclic monoterpenes 6.32 and 6.33. The structure of 6.32 was confirmed by both NMR 
and single X-ray crystallography studies and was found to display insecticidal activity 
(Watanabe et al., 1989).   
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The previously reported cyclic compounds, mertensene (6.27) and violacene 
(6.4) were completely characterised by 2D NMR in 1988 (Coll et al., 1988).  In 1989 the 
isolation of telfairine (6.34) was described from P. telfairiae (Watanabe et al., 1989).   
Telfairine (6.34) and its relative configuration was elucidated by NOEDS and by 
comparison with the absolute configuration of 6.32 (Watanabe et al., 1989).    
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                                                         telfairine (6.34) 
     
P. cartilagineum, collected from the Chilean coast, yielded four new cyclic 
monoterpenes 6.35-6.38 all sharing similar 1H NMR spectra and all being isobaric 
(C10H14Cl4).  These isomers were characterised on the basis of coupling constants and 
comparison of 13C NMR data to that found in the literature (San-Martín et al., 1991).    
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Compound 6.36 is the C-1 isomer of a cyclic monoterpene 6.39 reported 
simultaneously by two groups and given the names gelidene isolated from Gelidium 
sesquipedale (Aazizi et al., 1989) and Aplysiaterpenoid A from Aplysia kurodai (Watanabe 
et al., 1990; Sakata et al., 1991). 
In 1998 a new epoxymonoterpene (6.40) was isolated from P. cartilagineum and 
the halogen regiochemistry was assigned by comparison of its 13C NMR data with both 
model compounds and NOE studies.  This was the first report of a naturally occurring 
alicyclic polyhalogenated epoxymonoterpene (Abreu et al., 1988).  Structural revisions 
continue to arise for this structure class as exemplified by the recent absolute 
configuration determination of compound 6.7 by a single X-ray analysis study (König 
et al., 1999).  The stereochemistry was established to be as depicted in compound 6.41 
which was opposite to that indicated by earlier workers (Higgs et al., 1977; Stierle et al., 
1979).   
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This chapter describes the chemistry and biological activity of a Southern 
Australian collection of the marine alga Plocamium mertensii from Port Phillip Bay 
Victoria, Australia.  The crude extract of this specimen demonstrated some moderate 
antitumour activity as well as slight antifungal activity.  These activities together with 
the fact that the genus Plocamium is known to be a rich source of polyhalogenated 
terpenes prompted the investigation of this alga using a combination of on-line 
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hyphenated spectroscopic approaches (HPLC-NMR) as well as conventional off-line 
isolation approaches.  The first application of HPLC-NMR to rapidly profile a marine 
alga resulted in the partial identification of four polyhalogenated monoterpenes 6.7, 
6.13, 6.27 and 6.37.  The structures of these major compounds were unequivocally 
identified by off-line characterisation.  Only partial identification of two minor 
metabolites 6.3 and 6.8 was possible as these co-occurred in a mixture with compounds 
6.7 and 6.13, respectively.   
This is one of the few reports describing the application of HPLC-NMR to 
rapidly profile or dereplicate a marine organism and the only application of HPLC-
NMR to profile the chemistry of a marine alga.  Carbon chemical shift revisions for 
compound 6.37 have also been documented. 
 
6.1      HPLC-NMR Operation 
 
The types of data acquisitions used in HPLC-NMR include on-flow and stop-flow 
techniques (see Scheme 6.1).  On-flow HPLC-NMR measurements are mainly restricted 
to the direct measurement of the main constituents of a crude extract often where the 
HPLC injection has been overloaded.  Wolfender and co-workers have indicated that 
typically 1-5 mg of crude plant extracts needs to be injected on-column (Wolfender et 
al., 2003).  
However, the detection limits can be improved by performing the analysis at 
low-flow rates or by running time slice experiments over a whole chromatogram where 
the flow is stopped at defined time intervals.  Both modes of operation enable a higher 
number of transients per increment to be recorded and, thereby, a significantly better 
S/N ratio.   
Stop-flow mode is more sensitive and allows for the acquisition of 2D NMR 
experiments (eg.  COSY, HSQCAD and HMBC).  The stop-flow mode can be employed 
so that samples may be analysed directly as they elute from the column, one 
chromatographic peak at a time.  Stop-flow acquisition is a simpler mode but the 
repeated stop/go disturbances of the HPLC gives rise to peak diffusion during long-
lasting experiments as well as memory effects if a large peak precedes a small peak 
(Scheme 6.1). 
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The data acquisition techniques include ―Time-slicing‖, involving a series of 
stops during the elution of the chromatographic peak of interest (Elipe et al., 2003).  The 
―Loop collection‖ method allows chromatographic peaks of interest to be collected into 
loops of tubing (off-line) and then eluting the intact fractions into the NMR flow probe 
one at a time as needed (Keifer et al., 2000).  A variation of this technique is to trap the 
eluted peaks onto another chromatographic column to allow concentration of the 
solute and then re-elute with another solvent into the flow probe as a more 
concentrated sample (Keifer et al., 2000).   
 
6.1.1 HPLC-NMR Resolution, Sensitivity and Limits of Detection  
 
Since NMR is a low sensitivity technique, analytical columns are often overloaded 
when a sample is injected and this will affect the chromatographic resolution and 
separation.  Another factor that can affect chromatographic performance is the use of 
deuterated solvents, where in many cases analytes show chromatographic peak 
broadening and occasionally different retention times from protonated solvents.  
Further chromatographic development is then required in order to obtain reasonable 
resolution.  Typically HPLC-NMR operates with the use of protonated solvents such as 
CH3CN in combination with D2O which involves solvent suppression of both the 
residual CH3CN and HDO resonances by WET (Water Enhanced through T1 Effects) 
solvent suppression techniques. 
The limits of detection in 2002 for a MW 500 at a 1H observation frequency of 
600 MHz was reported to be ~ 100 ng in stop-flow and loop-storage mode, (Figure 6.2) 
(Croasmun et al., 1994).   
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
219 | P a g e  
 
 
0
0.5
1
1.5
2
2.5
1985 1987 1990 1992 1994 2002
Year
Mass 
(g)
 
Figure 6.2.    Amount of sample able to be measured successfully using HPLC-NMR. 
(Adapted frum Urban and Separovic, 2005) 
 
Although on-flow modes use NMR as the real-time detector, sensitivity and 
resolution are limited by the short residence time of the analytes at 0.5-1.5 mL/min, 
and typically > 10 µg per analyte is needed for quality results at the 1H observation 
frequency of 500 MHz (Albert, 2002).   
Typical stop-flow detection limits at the 1H observation frequency of 600 MHz 
using micro coil probes and capillary systems are in the 5 ng range but these require an 
overnight acquisition, with high concentrations of analyte required in the 1.5 L NMR-
active probe volume (Albert, 2002).   
The limitations that exist with HPLC-NMR include its sensitivity or limit of 
detection (requires HPLC overloading which affects separation); the fact that not all the 
information by conventional measurement in standard deuterated NMR solvents can 
be obtained (eg.  the use of solvent suppression can lead to the suppression of signals 
of the analyte that reside under or adjacent to the solvent peaks); and that the chemical 
shifts recorded in a reversed-phase solvent will differ from those reported in standard 
deuterated NMR solvents which can be a drawback if precise comparisons with 
literature data need to be made as in the case of identification of previously reported 
natural products (dereplication).  Despite these limitations, the technique is impressive 
for providing on-line information in crude natural product extract analyses.  This 
technique alone will not always provide sufficient spectroscopic information for a 
complete identification of natural products and other techniques are needed for 
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providing complementary information.  Ideally, the integration of a hyphenated 
technique in a single set-up (eg.  HPLC-NMR-MS) with centralised acquisition of the 
spectroscopic data would permit the complete spectroscopic characterisation of the 
different metabolites in a single analysis.   
 
6.2 Collection, Extraction and Isolation 
 
The marine alga, identified as P. mertensii, was collected on the 30th of April, 2004 from 
Port Phillip Bay (off Queenscliff), Victoria, Australia via SCUBA from a depth of 2-3 m.  
The alga was identified by Roderick Watson (Victorian Marine Sciences Consortium, 
Queenscliff, Victoria, Australia) and Dr Gerald Kraft (Honorary Principal Fellow), 
Faculty of Science, School of Botany, University of Melbourne, Australia.  A voucher 
specimen designated the code 2004-13 is deposited at the School of Applied Sciences, 
RMIT University.  The alga was growing in association with the sea grass Amphibolis 
antarctica.  Prior to extraction the alga was separated from the sea grass.  A photograph 
of the alga P. mertensii is shown on page 237. 
A frozen sample of P. mertensii (150 g, 17 g dr. wt.) was extracted with 3:1 
MeOH/DCM (800 mL).  The crude extract (7 g) was decanted, concentrated under 
reduced pressure and then sequentially partitioned into DCM (5.6 g) and MeOH (1.3 g) 
soluble extracts.  Approximately (2 g) of the DCM soluble fraction was subjected to a 
flash silica column (50% stepwise elution from petroleum spirits to DCM to EtOAc and 
finally to MeOH), resulting in five fractions.  Several of these fractions were combined 
on the basis of their similar 1H NMR spectra.  Final purification of the compounds was 
achieved using semi-preparative reversed-phase HPLC using isocratic conditions (80% 
CH3CN/H2O with detection at λmax 254 and 235 nm) to afford 6.27 (16.3 mg, 0.11%), 
6.37 (16.4 mg, 0.09%), semi-pure 6.7 (26.2 mg, 0.17%) and 6.13 (37.8 mg, 0.22%) which 
were found to contain small traces of the minor secondary metabolites 6.3 and 6.8, 
respectively. (% based on the mass of the dried weight of the marine alga as shown in 
Scheme 6.1). The cyclic monoterpenes were characterised and compared to the 
literature and the unequivocal assignment is detailed in Section 10.6. 
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Scheme 6.1.  Extraction procedure showing conventional isolation and HPLC-NMR profiling 
resulting in the identification of compounds 6.3, 6.7, 6.8, 6.13, 6.27 and 6.37. 
 
6.3 Results and Discussion 
6.3.1 On-line Secondary Metabolite Profiling of P. mertensii Using On-flow 
HPLC-NMR Analysis 
 
P. mertensii was extracted with 3:1 MeOH/DCM and subsequently partitioned into 
DCM followed by MeOH soluble partitions, respectively.  1H NMR and analytical 
HPLC analysis of these two partitions identified polyhalogenated terpenes, which are 
so reminiscent of this genus of alga, to be confirmed.  It was decided that a combined 
approach of both off-line and on-line chemical profiling would be undertaken in an 
effort to establish the nature of these polyhalogenated terpenes.  Typically 
polyhalogenated terpenes are non-polar and would be predominately present in the 
DCM partition but their presence was also detected in the MeOH partition.  The 1H 
NMR spectra of the crude DCM and MeOH partitions indicated that the MeOH 
partition was less complex and for this reason a decision was made to use the MeOH 
partition to profile the secondary metabolites present by HPLC-NMR and to then cross 
check these metabolites with those present in the DCM fraction.  In fact the DCM 
partition would later be investigated by off-line conventional approaches to confirm 
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the identity of some of the minor polyhalogenated terpenes detected in the MeOH 
partition.  
Once an off-line HPLC method for the effective separation of the MeOH 
partition was established (preferably it is desirable to use an isocratic HPLC method if 
possible to maintain consistent lock levels), HPLC-NMR profiling of the MeOH 
partition was achieved in a number of modes including on-flow, stop-flow and time-
slicing experiments (See Scheme 6.2 and Figures 6.3 to 6.5). 
Scheme 6.2 illustrates the principles of on-flow HPLC-NMR analysis whereby 
the sample is injected into the HPLC, the peaks detected by a Photo-Diode Array 
(PDA) detector which then enter the NMR flow-cell and finally exit the NMR which 
can either be sent to waste or collected via a fraction collector.  On-flow HPLC-NMR 
involves continuous monitoring of the chromatographic peaks as they elute from the 
HPLC column and pass the NMR flow cell by acquiring a series of NMR scans during 
the elution period.  Typically scans are acquired every 20 s and the final analysis can be 
displayed as a 2D plot of the retention time versus WET1D acquired.  This mode of 
operation is best suited to the analysis of major compounds and requires overloading 
of the analytical column. 
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Scheme 6.2. HPLC-NMR operation (continuous monitoring and stop flow mode). 
 
On-flow HPLC-NMR analysis of the MeOH partition clearly established the 
presence of four structurally related polyhalogenated terpenes (see Figure 6.3), which 
could be partially identified. 
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6.3.2 On-line Secondary Metabolite Profiling of P. mertensii Using Stop-flow 
HPLC-NMR Analysis 
 
Scheme 6.2 also illustrates the principles of stop-flow HPLC-NMR analysis whereby 
the sample is once again injected into the HPLC and the peaks detected by a PDA 
detector.  However, as the name suggests stop-flow HPLC-NMR involves stopping the 
HPLC pump as a selected peak of interest enters the NMR flow cell.  A pre-determined 
calibration delay is necessary to ensure the peak of interest is indeed resident in the 
NMR flow cell.  The compound of interest can be held in the NMR flow cell for an 
indefinite period resulting in a greater enhancement in sensitivity.  This mode of 
operation extends HPLC-NMR to the analysis of minor metabolites due to the greater 
sensitivity in the WET1D spectra that can be obtained, as well as the possibility to 
acquire some 2D NMR information.  Once analysis is completed on the desired peak of 
interest the HPLC pump is restarted and the chromatography resumes and peaks will 
exit the NMR which can either be sent to waste or collected via a fraction collector.   
One of the major compounds 6.27 observed in the on-flow HPLC-NMR 
experiment (Figure 6.4) could be identified from a further stop-flow HPLC-NMR 
experiment which allowed for a longer 1H NMR acquisition on this single compound 
while trapped in the NMR flow-cell, thus leading to an increase in S/N.  Figure 6.4 
illustrates a comparison of the increase in sensitivity that was achieved between the on-
flow and stop-flow HPLC-NMR analyses of compound 6.27. 
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Figure 6.4. 1H NMR spectra extracted from on-flow (top spectrum) and  
stop-flow HPLC-NMR (500 MHz, 80% CH3CN/D2O) experiments for (6.27) (bottom spectrum). 
 
Finally a time-slice HPLC-NMR experiment (Figures 6.5 and 6.6) allowed for 
resolution of the two closely eluting polyhalogenated terpenes 6.27 and 6.37 eluting 
between 10.0 and 11.0 mins.  The time-slice HPLC-NMR experiment clearly illustrates 
the 1H NMR of the first metabolite 6.27 at ~10.3 min, a mixture of two compounds at 
~10.5 min and 10.6 min and then finally the 1H NMR of the second unresolved 
compound as a pure entity at ~10.8 min.  This application illustrates the importance 
and powerful nature of HPLC-NMR in that it can be used to effectively resolve two 
closely eluting but unresolved secondary metabolites “on the fly” by simply 
accumulating a series of NMR scans across the peak(s).  For unstable secondary 
metabolites it is unquestionably the analysis of choice. 
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Figure 6.5. Time-slice HPLC-NMR analysis showing online 2D-contour plot, HPLC 
chromatogram, selective UV profile at any given point in the HPLC run and the series of  
stops during acquisition. 
 
There are numerous polyhalogenated terpenes reported from Plocamium spp. in 
the literature and based on the HPLC-NMR profiling work conducted additional 
polyhalogenated terpenes could be detected, however, their low concentration 
precluded any further identification by this means.  In addition, spectral differences 
were noted for the major polyhalogenated terpenes identified from the HPLC-NMR 
profiling work when compared to the literature data.  These differences, such as some 
slight chemical shift differences (due to the CH3CN/D2O mixture compared to 
deuterated solvents such as CDCl3 for NMR data reported in the literature) and analyte 
signal suppression due to the nearby D2O and CH3CN solvent suppressions, were 
anticipated.  However, the combination of both on-flow and stop-flow experiments 
resulted in the partial identification of fragments, including the (E)-double bond 
geometry (determined by coupling constants), the number of methyl groups present 
(provided that these were not coincidentally suppressed during solvent suppression), 
and the degree of methylene and methine incorporation with the aid of thorough 
literature searches and a knowledge of the organism.  The decision to undertake 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
228 | P a g e  
additional off-line conventional isolation work was primarily motivated by the 
presence of the minor polyhalogenated terpene analogues for which any definitive 
structural elucidation could not be achieved by HPLC-NMR due to their low 
concentration.    
Unequivocal proof of the structures was achieved by combining the on-line 
HPLC-NMR analysis results with conventional off-line analyses such as GC-MS to 
establish the molecular weight and halogen content of each secondary metabolite.  
Whilst 13C NMR is informative in terms of determining bromine versus chlorine 
substitution (Crews et al., 1984), 1H NMR is not and so off-line 2D NMR experiments 
were also conducted to establish the nature of the substitution pattern for the bromine 
and chlorine halogens in compounds 6.7, 6.13, 6.27 and 6.37.  In HPLC-NMR the 
necessary 13C NMR information is only readily available through HSQCAD and 
HMBC experiments (obtainable via the stop-flow HPLC-NMR method).  However, due 
to the collapse in chromatography that would result in obtaining the information for 
these compounds through stop-flow HPLC-NMR (eg. restarting the HPLC pump after 
8 h) it was deemed that off-line approaches would be more useful.  Hyphenated 
spectroscopic methods such as HPLC-NMR are very useful for chemical profiling of 
crude or enriched fractions but often must be combined with conventional off-line 
approaches especially in the case of novel secondary metabolite identification.   
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Figure 6.6. Time-slice HPLC-NMR analysis showing the resolution of  
             mertensene (6.27) and compound 6.37. 
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6.3.3 Off-line (Conventional Isolation and Structure Determination) Secondary 
Metabolite Confirmation of P. mertensii 
 
The red alga P. mertensii was extracted with 3:1 MeOH/DCM and partitioned 
sequentially between DCM followed by MeOH, detailed in Scheme 6.1.  Analytical 
HPLC comparison of the DCM and MeOH fractions confirmed the presence of similar 
secondary metabolites.  The MeOH partition was profiled as outlined earlier by HPLC-
NMR and identified the presence of compounds 6.7, 6.13, 6.27 and 6.37.  The DCM 
partition was investigated by a conventional isolation procedure involving silica flash 
chromatography.  Final purification was achieved using reversed phase HPLC to 
afford 6.27, 6.37, 6.7 and 6.13.  The unequivocal assignment of these known compounds 
is detailed in Section 10.6. 
Further analysis of the 1H NMR spectra of 6.7 and 6.13 identified the presence 
of the minor compounds 6.3 and 6.8, respectively.  All compounds were identified by 
comparison of the NMR and GC-MS data to that previously described.  Other than 
compound 6.7 the molecular ion was not observed for all other compounds.  Typically 
the highest ion mass observed was due to a facile loss of a halogen but in all cases the 
MS fragment ions showed the halogen isotopic pattern.  Structure assignments were 
made on the basis of NMR (obtained from both the extracted 1H NMR spectra from the 
HPLC-NMR as well as by conventional 1D and 2D NMR analyses) for all compounds 
except the two minor compounds 6.3 and 6.8 for which only partial NMR data was 
obtained.  The relative configuration for all but the two minor compounds 6.3 and 6.8 
was confirmed by performing either selective 1D Nuclear Overhauser Enhancement 
(NOE) irradiation experiments or via a ROESY NMR experiment and on the basis of 
the 1H-1H coupling constants. 
Compounds 6.3 and 6.8 were found to co-occur in a mixture with 6.7 and 6.13, 
respectively as minor compounds.  This allowed for only the partial characterisation of 
these compounds by 1H NMR and limited 2D NMR data (COSY and partial HSQCAD).  
The structure and relative stereochemistry of compounds 6.3 and 6.8 were tentatively 
assigned on the basis of a comparison to the literature (Mynderse et al., 1975b; Higgs et 
al., 1977; Sardina et al., 1986).  The absolute stereochemistry of compound 6.3 had 
previously been solved by a single-crystal x-ray study (Mynderse et al., 1975b).  The 
relative stereochemistry of compound 6.8 was determined by close analysis of the 1H 
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NMR and corresponding coupling constants along with comparison of the 13C shifts 
with known compounds to deduce the positioning of halogen substituents.  
Furthermore, the chemical assignments of compound 6.8 were confirmed by chemical 
reactions (Higgs et al., 1977).   These minor compounds were not detected in the HPLC-
NMR profiling methods used. The structural assignment of compounds 6.3 and 6.8 are 
detailed in Section 10.6. 
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 Compound 6.7 was characterised and the data found to be identical to that 
previously reported including, the relative configuration which was confirmed on the 
basis of the 1H-1H coupling constants and a ROESY NMR experiment (Higgs et al., 
1977; Stierle et al., 1979).  Recently, the absolute configuration of this compound was 
determined on the basis of a single X-ray analysis study (König et al., 1999) and 
structure found to be similar to compound 6.41 which is opposite to that indicated by 
earlier workers (Higgs et al., 1977; Stierle et al., 1979).  However, absolute configuration 
determination for polyhalogenated monoterpenes needs to be exercised with caution 
as there have been many instances where degradation has occurred during data 
acquisition resulting in an incorrect assignment (Mynderse et al., 1975b, González et al., 
1978, Sardina et al., 1985).  The 1H NMR spectrum extracted from the on-flow HPLC-
NMR analysis is given in Figure 6.3 and was of reasonable sensitivity to rapidly 
suggest a halogenated monoterpene containing a diagnostic halogenated methylene. 
The structural assignment of compounds 6.7 is detailed in Section 10.6 
 
Cl
ClBr
Cl
1
3
7
9 10
Br
 
   6.7 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
232 | P a g e  
Compound 6.13 was characterised and the data found to be identical to that 
previously reported including the relative configuration which was confirmed on the 
basis of the 1H-1H coupling constants and single irraditation NOE experiments (Higgs 
et al., 1977; Norton et al., 1977a; González et al., 1978; Sardina et al, 1986; Abreu et al., 
1996; Wessels et al., 2000).  The 1H NMR spectrum extracted from the on-flow HPLC-
NMR analysis is given in Figure 6.3. The structural assignment of compound 6.8 and 
6.13 are detailed in Section 10.6. 
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As already discussed the structure of mertensene has undergone a number of 
revisions.  Originally the halogens at positions C-2 and C-4 were incorrectly assigned 
(Norton et al., 1977a) and revised by Crews and Capon in the same year (Capon et al., 
1984; Crews et al., 1984).  The relative configuration of mertensene (6.27) was confirmed 
in 1988 and was related to the single-crystal X-ray determination of 6.32 which 
confirmed their close relationship (Coll et al., 1988).   
Mertensene 6.27 was characterised and the data found to be identical to that 
previously reported including the relative configuration which was confirmed on the 
basis of the observed coupling constants and selective 1D NOE experiments (Norton et 
al., 1977a; Capon et al., 1984; Crews et al., 1984; Coll et al., 1988).  In addition carbon 
chemical shifts and NMR prediction data (ACD Labs) supported the two methyls at 
positions C-1 and C-5 as being equatorial (δ 26.1 and 20.0 ppm) in accordance with the 
latest structure proposed for mertensene (6.27) (Coll et al., 1988).   
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The extracted 1H NMR spectrum of 6.27 obtained from on-line HPLC-NMR was 
comparable to the off-line, conventional 1H NMR recorded in CDCl3 (Figure 6.7) with a 
slight difference in chemical shift due to solvent composition.  The WET1D spectrum 
acquired utilising both on-flow and stop-flow HPLC-NMR analyses was sufficient to 
provide enough information to deduce partial fragments of mertensene (6.27) 
including two methyls, the position C-3 and C-6 methylenes, two olefinic methines 
with trans or (E) coupling and two deshielded methines (positions C-2 and C-4) 
(Figures 6.3 and 6.4). The structural assignment of mertensene (6.27) is detailed in 
Section 10.6. 
 
 
Figure 6.7.  Stop-flow HPLC-NMR (80% CH3CN/D2O) (top spectrum) and conventional  
1H NMR (500 MHz, CDCl3) (bottom spectrum) of mertensene (6.27). 
 
The resolution and sensitivity of the 1H NMR spectra that can be extracted from 
HPLC-NMR analyses is affected when compounds co-elute.  This fact was 
demonstrated in the 1H NMR extracted from the on-flow HPLC-NMR analysis of 
compound 6.37, which closely eluted after compound 6.27 (Figure 6.3).  In order to 
extract 1H NMR spectra for closely eluting compounds the use of time-slice stop-flow 
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HPLC-NMR is advantageous (Figure 6.6) which shows the enhanced resolution and 
sensitivity achieved for compounds 6.27 and 6.37.   
Compound 6.37 was characterised by 1D and 2D NMR and GC-MS.  On the 
basis of direct 1JCH correlations observed in the gHSQCAD spectrum of 6.37 a number 
of chemical shift reassignments to the carbons at positions C-2 (δ 62.0 now revised to 
66.2 ppm), C-3 (δ 44.9 now revised to 37.4 ppm), C-4 (δ 65.7 now revised to 62.4 ppm), 
and C-6 (δ 37.3 now revised to 44.8 ppm) were evident when compared to the data 
reported in 1991 (San-Martín et al., 1991).  The structural assignment of compound 6.37 
is 6.8 detailed in Section 10.6. 
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These carbon chemical shift revisions were supported by correlations observed 
both in the gHSQCAD and CIGAR NMR experiments.  All other data was found to be 
identical to that previously reported including the relative configuration which was 
confirmed on the basis of 1H-1H coupling constants, the carbon chemical shifts of the 
methyl resonances (δ 26.0 and 33.1 ppm supporting an equatorial and axial 
configuration) and a ROESY NMR experiment (San-Martín et al., 1991).  The axial 
chlorine at C-2 and the equatorial chlorine at position C-4 were supported by the 
coupling constants of the protons at these positions.  In terms of the relative 
configuration, determination of the polyhalogenated monoterpenes, the striking 
feature in the 1H NMR spectra is that there is an obvious coupling difference between 
axial-axial and axial-equatorial coupled protons.  For instance in compounds 6.3, 6.7, 
6.13 and 6.27 axial coupled protons are observed as being well resolved with dd or ddd 
multiplicities whereas for compounds 6.8 and 6.37 an axial-equatorial disposition is 
apparent in which one proton appears as a dd whilst the other is a brs. 
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6.4 Future Application of HPLC-NMR 
 
The use of HPLC-NMR to rapidly profile or dereplicate (Section 1.7.2) natural product 
extracts (or mass-limited samples) seems cemented with recent advances in the 
miniaturisation of NMR instrumentation and the hyphenation to a variety of capillary-
scale analytical separation techniques (Urban and Separovic, 2005; Urban, 2006).  The 
number of publications utilising HPLC-NMR as well as HPLC-NMR-MS 
methodologies has been steadily increasing in the last decade and its implementation is 
only expected to grow with continuing improvements to the methodology (Urban and 
Separovic, 2005).  Additional future hyphenations have also been proposed involving 
the use of other detectors (Urban and Separovic, 2005). 
 
6.5 Biological Evaluation and Details of Assays 
 
Of the halogenated metabolites compounds isolated during this study several 
including 6.7, 6.13, mertensene (6.27) and 6.37 have been previously evaluated for a 
range of biological activities (González et al., 1982; San-Martín et al., 1991; König et al., 
1999; Wessels et al., 2000; Argandona et al., 2002; DeInes et al., 2004).  Evaluation of the 
insecticide/acaricide and fungicide activity of compounds 6.27 and 6.37 showed that 
both compounds displayed insecticidal activity with growth inhibitory activity against 
some insects (San-Martín et al., 1991).  Evaluation of the antifungal, antibacterial and 
antialgal activities of compounds 6.7 and 6.27 indicated 6.27 to be inactive in all three 
assays whilst 6.7 was found to possess potent antialgal activity towards Chlorella fusca 
as well as being moderately antitubercular and cytotoxic (König et al., 1999).  Both 
compounds 6.7 and 6.27 were also tested for HIV-1 reverse transcriptase inhibition and 
both were found to be inactive (König et al., 1999).  The antifeedant effects of 
compounds 6.7, 6.27 and 6.37 was evaluated in tests against several divergent insect 
species and all were found to be toxic to at least one species (Argandona et al., 2002).  
Compounds 6.27 and 6.37 also showed some selective toxicity and all three compounds 
did not show phytotoxic effects (Argandona et al., 2002).  Compounds 6.7, 6.27 and 6.37 
were also evaluated for their cytotoxicity against various tumour cell lines.  The 
Minimum Inhibitory Concentration (MIC) values ranged between 39 to >312 M and 
only compounds 6.7 and 6.27 showed some selectivity against the various tumour cell 
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lines (DeInes et al., 2004).  Compounds 6.7 and 6.13 were evaluated for antimicrobial, 
algacidal, nematicidal, antiplasmodial and antitrypanosomal activities as well as 
inhibition of reverse transcriptase of the human immunodeficiency virus type 1 (HIV-
1-RT), cytotoxic properties and lethalities in the brine shrimp assay (Wessels et al., 
2000).  It was concluded that compounds 6.7 and 6.13 exhibited activity in the brine 
shrimp assay whilst 6.7 displayed moderated antimicrobial activity and was strongly 
algacidal (Wessels et al., 2000).  Finally compound 6.13 displayed cytostatic activity 
with an ID50 of 1 µg/mL as well as antimicrobial activities against B. sphaericus, S. 
aureus, P. aeruginosa and Proteus S.P.  (González et al., 1982).   
In this study the crude extract of P. mertensii displayed moderate antitumour 
activity (254448 ng/mL at 50 mg/mL), as well as some cytotoxicity against the Herpes 
simplex virus and slight antifungal activity against Trichophyton mentagrophytes (1 mm 
zone of inhibition).  These findings are consistent with previous biological activities 
reported, particularly the antimicrobial activity.  The crude extract of P. mertensii 
showed no activity when tested against Bacillus subtilis, Eschericha coli, Pseudomonas 
aeruginosa, Candida albicans or Cladosporium resinae.  On the basis of the antitumour 
activity displayed by the crude extract, P. mertensii was selected for a chemical and 
biological investigation. 
The monoterpenes 6.3, 6.7, 6.8, 6.13, 6.27 and 6.37 isolated in this study were 
found to be inactive against the P388 murine leukaemia cell line at a concentration of 1 
mg/mL (IC50 >12500 ng/mL) and were not evaluated for their antimicrobial 
properties.  The percentage of compounds 6.3 and 6.8 present in a mixture with 6.7 and 
6.13 respectively, was estimated by 1H NMR integration.  To account for the moderate 
antitumour activity observed in the crude extract the monoterpenes could be re-
assayed at a much higher concentration. 
 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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Plocamium mertensii (2004-13) 
    
 
Kingdom:  Plantae 
Phylum:  Rhodophyta 
Class:   Florideophyceae 
Order:   Plocamiales 
Family:  Pyraloidea 
Genus:  Plocamium 
Species:  mertensii 
 
 Collected by Mr Roderick Watson from Port Phillip Bay (off Queenscliff), Victoria, 
Australia via SCUBA from a depth of 2-3 m  
(April, 2004) 
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7.0 Introduction 
 
Red algae belonging to the genus Laurencia (Ceramiales, Rhodomelaceae) are a prolific 
source of secondary metabolites, predominantly producing sesquiterpenes, diterpenes, 
triterpenes, C15 acetogenins and acetylenes (Erickson, 1983).  Laurencia is a common 
genus occurring along southern Australian coasts, with numerous species having been 
credited to this region (König and Wright, 1997a).  There are three known forms of 
Laurencia filiformis including: forma filiformis based on the type which is generally a 
sheltered-water plant, epiphytic on seagrass; forma heterocladaa, based on L. heteroclada, 
a rough-water reef form; and a large, deeper-water form described as forma dendritica 
(Saito and Womersley, 1974).  These three forms have also been found to be 
chemotaxonomically distinct (Capon et al., 1988; Saito and Womersley, 1974).  In 
addition there are forms of Laurencia which are between species and related to other 
species including, Laurencia arbuscula Sonder and Laurencia tasmanica Hooker and 
Harvey (Capon et al., 1988; Saito and Womersley, 1974).  In terms of secondary 
metabolite chemistry, it is well known that L. filiformis forma heteroclada contains 
sesquiterpenes based on the laurane skeleton.  However, there have been reported 
species of Laurencia collected in Australia, which produce chamigrene type 
                                            
†
 Dias DA, White JM and Urban, S.  2009. Laurencia filiformis: Phytochemical Profiling by Conventional and HPLC-NMR 
Approaches, Nat. Prod. Comm., 4: 157-172. 
aLaurencia filiformis forma heteroclada is also known as Laurencia filiformis heteroclada Harvey (AlgaeBase database). 
 
Laurencia filiformis: Phytochemical Profiling by    
Conventional and HPLC-NMR Approaches† 
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sesquiterpenes (Capon et al., 1988).  By the mid 1970s, the occurrence of laurane related 
derivatives had been well documented (Irie et al., 1969b; Irie et al., 1966; Irie et al., 1967; 
Irie et al., 1969c; Irie et al., 1965; Suzuki et al., 1969).  Many of these compounds were 
found to be present in the sea hare Aplysia sp. and the source of the Aplysia 
sesquiterpenes was almost certainly as a result of the Laurencia red algae on which 
Aplysia species are known to graze (Stallard and Faulkner, 1974a, b).  In 1976 the 
isolation of four new laurane-related sesquiterpenes filiformin (7.1), filiforminol (7.2), 
allolaurinterol (7.3), dihydrolaurene (7.4), together with compound 7.5 were reported 
from a southern Australian L. filiformis forma heteroclada specimen (Kazlauskas et al., 
1976), whilst in 1977, a new selinane sesquiterpene heterocladol (7.6) was isolated from 
L.  filiformis (Kazlauskas et al., 1977).   
 
     O
Br
          O
Br
CH2OH
     OH
Br
 
                 filiformin (7.1)                     filiforminol (7.2)                  allolaurinterol (7.3) 
 
                                
H
Cl
Br
HO  
            dihydrolaurene (7.4)                           7.5                             heterocladol (7.6) 
 
In 1981, aplystatin (7.7) and 6-hydroxyaplystatin (7.8) were isolated and 
identified in the extracts of L. filiformis (Capon et al., 1981).  These compounds had been 
previously isolated from the sea hare Aplysia angasi (Petit et al., 1977).   
 
            H H
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                     aplystatin (7.7)                      6-hydroxyaplystatin (7.8) 
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In 1988 chemical investigations resulted in the re-isolation of several 
sesquiterpene classes including selinanes, lauranes and aplystatins and enabled the 
differences in sesquiterpenes between related species of L. filiformis to be reported 
(Capon et al., 1988).  A sample of L. filiformis forma heteroclada collected from Hamelin 
Bay (ca.  50 km south of Perth, Australia) afforded only 7.3, whereas samples from 
Lancelin and Cottesloe Beach (Perth, Australia) yielded 7.3 as well as laurenisol (7.9), 
previously isolated from L. nipponica Yamada (Irie et al., 1969a) and bromolaurenisol 
(7.10) (Capon et al., 1988; Sims et al., 1978).  A sample from Shoalwater Bay (ca. 50  km 
south of Perth, Australia) afforded 7.9, 7.10 and isolaurinterol (7.11), previously 
isolated from L. nipponica Yamada (Irie et al., 1970), together with 7.1 and (-)α-
bromocuparene (7.12), previously reported from L. glandulifera  (Suzuki et al., 1975).   
           OH
H
Br           
Br
OH
H
Br
1
4
8
6
1'4'
  
                      laurenisol (7.9)                     bromolaurenisol (7.10) 
 
         OH
Br
H3C
              
Br
H  
                  isolaurinterol (7.11)                (-)α-bromocuparene (7.12) 
 
In 2002 the chemical relationships between, Aplysia parvula and L. filiformis were 
investigated, resulting in several compounds being isolated from both organisms 
including, 5-acetoxy-2,10-dibromo-3-chloro-7,8-epoxy-α-chamigrene (7.13), together 
with deoxyprepacifenol (7.14) and 2,10-dibromo-3-chloro-7-chamigrene (7.15) 
(Jongaramruong et al., 2002). 
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  5-acetoxy-2,10-dibromo-3-      deoxyprepacifenol (7.14)               2,10-dibromo- 
        chloro-7,8-epoxy-                                                                               3-chloro- 
      α-chamigrene (7.13)                                                                     7-chamigrene (7.15) 
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This chapter describes the chemistry and biological activity of the marine alga 
L. filiformis forma heteroclada.  The crude extract of this organism demonstrated 
moderate antiviral and antimicrobial activities from which compounds 7.1-7.3, 7.10 and 
7.16 were isolated.  As a result of this chemical and biological investigation, two new 
compounds, cycloisoallolaurinterol (7.16) and isoallolaurinterol (7.23) were identified, 
the first single X-ray diffraction study was conducted on 7.1, unequivocally confirming 
its absolute configuration, and the first full 2D NMR characterisation for compounds 
7.1-7.3 and 7.10 has now been documented.  This study permitted the successful 
application of HPLC-NMR to profile extracts of the L. filiformis forma heteroclada 
specimen.  In particular on-flow HPLC-NMR was employed to monitor secondary 
metabolite chemical conversions in situ. 
 
               
O
Br
H3C
H
               
Br
H3C OH  
                         cycloisoallolaurinterol (7.16)            isoallolaurinterol (7.23) 
 
7.1 Collection, Extraction and Isolation 
 
An intertidal collection of the red alga Laurencia filiformis forma heteroclada was carried 
out on the 3rd of January, 2003 from St. Pauls Beach, Sorrento, Victoria, Australia.  The 
alga was identified by Dr Gerald Kraft (Honorary Principal Fellow), Faculty of Science, 
School of Botany, University of Melbourne, Australia.  A voucher specimen designated 
the code 2003-04 is deposited at the School of Applied, RMIT University.  A 
photograph of the alga, L. filiformis is shown on page 267. 
The purification of L. filiformis forma heteroclada extract was undertaken on 
separate occasions.  The initial study involved extraction of the frozen sample of L. 
filiformis (119 g) (25 g dr. wt.) with 3:1 MeOH:DCM (500 mL).  The crude extract was 
decanted and concentrated under reduced pressure and then triturated into DCM, 
MeOH and H2O soluble extracts.  Approximately (270 mg) of the DCM soluble fraction 
was subjected to flash silica column chromatography (20% stepwise elution from 
petroleum spirits to DCM to EtOAc and finally to MeOH).  This fractionation step 
resulted in the generation of twenty-seven fractions, which were left to stand at 4°C for 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
247 | P a g e  
a period of 48 months.  After this period of time several fractions were combined on 
the basis of 1H NMR analyses.  Final purification of compounds 7.1-7.3, 7.10 and 7.16 
was achieved by reversed phase HPLC using isocratic conditions (85% CH3CN/H2O 
with detection at λmax 215 and 254 nm) to afford filiformin (7.1) (18.0 mg, 0.07%), 
filiforminol (7.2) (18.0 mg, 0.07%), allolaurinterol (7.3) (20.3 mg, 0.08%), 
bromolaurenisol (7.10) (3.8 mg, 0.01%) and the novel compound, 
cycloisoallolaurinterol (7.16) (6.4 mg, 0.02%) (% based on the mass of the dried weight of 
the marine alga as shown in Scheme 7.1). 
 
Laurencia f i lif ormis (119 g)
3:1 (MeOH:DCM) (500 mL)
DCM MeOHHPLC-NMR Analysis
(On-flow and Stop-flow)
Experiments
(270 mg)
filiformin (7.1)
(18.0 mg, 0.07 %)
Water
Flash Silica column chromatography (20% stepwise elution)
Fraction 1 Fraction 27
(2.26 g) (2.09 g)
Fraction 6 Fraction 15
(151 mg)
Combined of the basis of 1H NMR analysis
(4°C , 48 months)
Semi-Preparative RP-HPLC
(85% CH3CN/H2O)
filiforminol (7.2)
(18.0 mg, 0.07 %)
allolaurinterol (7.3)
(20.3 mg, 0.08 %)
bromolaurenisol (7.10)
(3.8 mg, 0.01 %)
cycloisoallolaurinterol (7.16)
(6.4 mg, 0.02 %)
 
 Scheme 7.1. Extraction and isolation procedure adopted for L. filiformis 
 
In an effort to re-isolate 7.16 a second extraction of the frozen sample of L. 
filiformis forma heteroclada (75 g) was undertaken with 3:1 MeOH:DCM (500 mL).  The 
crude extract was decanted and concentrated under reduced pressure and then 
trituated into DCM, MeOH and H2O soluble extracts.  The DCM fraction was 
immediately used to carry out on-flow and stop-flow HPLC-NMR experiments for 
phytochemical profiling of the alga as well as to monitor on-line degradation and 
chemical transformations.  The HPLC-NMR analysis was performed using the 
conditions described in Section 10.1.4. 
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A small extraction of the frozen alga (2 g) was also carried out with 3:1 
MeOH:DCM to permit analysis of the freshly extracted sample by GC-MS.  Following 
this analysis 0.7% TFA was added to the same extract and the sample re-analysed by 
GC-MS and the results of the two analyses which is detailed in Section 7.2.5. 
 
7.1.1 Crystallography 
 
Crystal data for filiformin (7.1): C15H19BrO, M = 295.21, T = 130.0(2) K, λ = 0.71069, 
orthorhombic, space group P212121 a = 6.7821(7), b = 12.2648(13), c =16.2244(17) Å, V = 
1349.6(2) Å3, Z = 4, Dc = 1.453 mg M-3 µ(Mo-Kα) 3.028 mm-1, F(000) = 608, crystal size 
0.45 x 0.4 x 0.4 mm.  4868 reflections measured, 2279 independent reflections (Rint = 
0.016) the final R was 0.0211 [I > 2σ(I)] and wR(F2) was 0.0917 (all data), absolute 
structure parameter = 0.01(1).  Crystallographic data for 7.1 has been deposited at the 
Cambridge Crystallographic Data Centre (CDDC 656114) 12 Union Road, Cambridge, 
CB2 1EZ, UK (www.ccdc.cam.ac.uk/data_request/cif).  For further details see Section 
10.1.8. 
 
7.2 Results and Discussion 
 
7.2.1 Profiling Methodology 
 
In the chemical screening of crude natural product extracts for dereplication, two main 
approaches have been adopted.  They are the use of conventional off-line techniques 
such as HPLC, MS and NMR or, alternatively, by the use of on-line hyphenated 
approaches such as HPLC-MS, HPLC-NMR and HPLC-NMR-MS.  The obvious 
advantage of the on-line hyphenated approach is the great potential to speed up the 
dereplication process (Dias and Urban, 2008; Hostettmann and Wolfender, 2000; 
Urban, 2006; Urban and Separovic, 2005).  In this study the application of both off-line 
conventional and on-line hyphenated (HPLC-NMR) approaches were adopted to 
investigate the constituents of the red alga L. filiformis forma heteroclada.  In the 
application of HPLC-NMR, two main modes of operation were employed.  These 
included the on-flow HPLC-NMR mode to provide a rapid overview of the 
constituents present in the crude extract and selected fractions, together with the stop-
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flow HPLC-NMR mode to provide greater sensitivity and further structural insight.  
On-flow HPLC-NMR is far less sensitive than stop-flow HPLC-NMR, but the 
application of both modes in this study illustrates that important structural information 
can quickly be obtained from both types of analyses.  In particular it was only the 
application of HPLC-NMR in this study that enabled the new compound 
isoallolaurinterol (7.23) to be detected.   This study represents one of only a few 
applications where HPLC-NMR has been used to successfully profile the crude extract 
of a marine organism, as well as for monitoring in situ compound chemical conversions 
(Bobzin et al., 2000; Dias and Urban, 2008). 
 
7.2.2 Extraction and Isolation of Secondary Metabolites from L. filiformis forma 
heteroclada by HPLC and NMR (Off-line Conventional Phytochemical 
Profiling) 
 
L. filiformis forma heteroclada was initially extracted in 2004 with 3:1 MeOH:DCM and 
then triturated into DCM, MeOH and H2O soluble fractions, respectively.  The DCM 
fraction was subjected to flash silica chromatography and only selected fractions 
analysed by 1H NMR spectroscopy.  At this stage no further investigations were 
carried out and fractions were left to stand for approximately 48 months before being 
re-analysed.  After this period selected fractions were combined on the basis of 
similarities in their 1H NMR spectra and final purification was achieved using reversed 
phase HPLC to afford compounds 7.1-7.3, 7.10 and 7.16.  Despite cycloisoallolaurinterol 
(7.16) being stored at 4C, sample degradation was observed to begin ca. 7-10 days 
after purification. 
Cycloisoallolaurinterol (7.16) was isolated as an unstable colourless oil which 
rapidly degraded.  A molecular formula C15H17BrO (seven DBEs) was deduced from a 
combination of HR-EI-MS and NMR experiments.  The isotopic ratio [M]+:[M+2]+ 
supported the presence of one bromine and EIMS analysis also showed the presence of 
intense ions at 277/279, again in a 1:1 ratio, suggesting the loss of a methyl moiety.   
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cycloisoallolaurinterol (7.16) 
 
Analysis of the 1H and 13C NMR data (Table 7.1) indicated the presence of two 
isolated aromatic methines at δ 6.63 (1H, s, H-10) and δ 7.20 (1H, s, H-7), with a para-
relationship.  Also evident was the presence of a deshielded methine [δ 5.18 (1H, d, J = 
2.0 Hz, H-2), C-2 (99.2 ppm)], adjacent and consistent with a phenolic ether (Yamamura 
and Hirata, 1963).  The presence of an olefinic methine moiety [δ 5.46 (1H, d, J = 2.0 Hz, 
H-3), C-3 (122.3 ppm)] adjacent to an olefinic methyl δ 1.70 (3H, d, J = 1.0 Hz, H-12), 
was supported by a COSY correlation.  Remaining features included the presence of a 
slightly deshielded methine at δ 2.52 (1H, q, J = 7.0 Hz, H-5) and two methyl groups at 
δ 0.93 (3H, d, J = 7.0 Hz, H-13) and 1.42 (3H, s, H-14) (Figure 7.1).  
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Confirmation for the relative disposition and ortho relationship of the bromine 
and aromatic methyl substituent at δ 2.31 (3H, s, H-15) relative to each other, was 
supported from direct comparison to the NMR data reported for aplysin (7.17) and 
from carbon chemical shift predictions (Yamamura and Hirata, 1963).   
HMBC correlations enabled the remaining degrees of unsaturation to be 
identified as being due to two rings with key correlations between H-2 (δ 5.18, d, J = 2.0 
Hz) and H-7 (δ 7.20, s) to C-11 (158.8) and H-14 (δ 1.42, s) to C-2 (99.2) and C-6 (132.2), 
respectively.  A combination of HMBC and COSY NMR correlations permitted the 
three rings to be assembled, supporting the structure of 7.16 (Table 7.1).   
 
Table 7.1.  NMR data for cycloisoallolaurinterol (7.16) in CDCl3. 
O
Br
H3C
H
1
3
6
915
12
13
14H
H
 
 
Pos. 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
 
1D NOE 
 
1  55.8, qC    
2 5.18, bd, (2.0) 99.2, CH H-3, H-12 C-4, C-11, C-14(w) H-3, H-14 
3 5.46, d, (2.0) 122.3, CH H-2, H-5(w), H-12 C-1, C-2, C-5, C-12 H-2, H-12 
4  151.4, qC    
5 2.52, q, (7.0) 53.6, CH H-3, H-12(w), H-13 C-1, C-3, C-4, C-6(w), C-13, C-14 H-12, H-13, H-14 
6  132.2, qC    
7 7.20, s 129.1, CH H-15 C-1, C-8, C-9, C-11 H-13, H-14 
8  114.3, qC    
9  137.6, qC    
10 6.63, s 112.3, CH H-15(w) C-6, C-8, C-11, C-15 H-15 
11  158.8, qC    
12 1.70, d, (1.0)  15.4, CH3 H-2, H-3, H-5 C-3, C-4, C-5 H-3, H-13 
13 0.93, d, (7.0) 16.2, CH3 H-5 C-1, C-4(w), C-5 H-5, H-7, H-12, H-14 
14 1.42, s 26.7, CH3  C-1, C-2(w), C-5, C-6(w) H-2, H-5, H-7  
15 2.31, s 23.3, CH3 H-7(w), H-10 C-9, C-10 H-10 
a Carbon assignments based on HSQCAD and DEPT experiments 
w = indicates a weak correlation 
 
This resulted in two possible structures (A and B) being proposed for 7.16.  
Selective 1D NOE NMR experiments and molecular modeling were used to calculate 
distances of protons to protons in space (typically less than 3Å) to confirm the correct 
relative structure (Figure 7.2).  The 1D NOE NMR enhancements, which conclusively 
established the position of the double bond in the cyclopentene moiety, were observed 
from H-7 (δ 7.20, s) to the H-13 methyl (δ 0.93, d, J = 7.0 Hz) and the H-14 methyl (δ 
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1.42, s) as well as from the H-5 methine (δ 2.52, q, J = 7.0 Hz) to the H-13 methyl (δ 0.93, 
d, J = 7.0 Hz) and the H-14 methyl (δ 1.42, s) (Figure 7.2). 
 
Figure 7.2. Important NOE enhancements that distinguished the correct structure (A) from 
(B) for cycloisoallolaurinterol (7.16).  (- - - - - - - represents NOE enhancements) 
 
These NOE enhancements definitively identified the correct relative structure 
of 7.16 as structure A with the olefinic bond at the C-3 and C-4 positions rather than 
structure B (position C-4 and C-5) as these would be too distant in space to be observed 
in structure B (Figure 7.2).  The relative configuration proposed for 7.16 is consistent 
with the relative configuration reported for aplysin (7.17) at positions C-1 and C-2 
(Yamamura and Hirata, 1963).  No further confirmation of the relative or absolute 
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configuration of 7.16 could be achieved since the compound degraded.  Efforts to 
secure more of 7.16 from freshly extracted L. filiformis forma heteroclada were 
unsuccessful. 
For the previously reported compounds 7.1, 7.2, and 7.10 it was ascertained that 
the NMR data reported in the literature was incomplete.  In particular 1H and 13C 
NMR chemical shifts were not fully assigned and 2D NMR assignments were absent.  
As such, 2D NMR experiments (COSY, HSQCAD and HMBC) were recorded to permit 
the complete and unambiguous assignment of these compounds for the first time.   
Filiformin (7.1) was isolated as a colourless oil and characterised by both 1D 
and 2D NMR and found to be identical to that previously reported (Capon et al., 1988; 
Kazlauskas et al., 1976) from L. filiformis.  The unique oxabicyclo[3.2.1]octane had been 
previously synthesised (Goldsmith et al., 1980; Laronze et al., 1989; Laronze et al., 1991) 
and the total synthesis for (-)-filiformin has been achieved (Nemoto et al., 1994; Nemoto 
et al., 1995a; Nemoto et al., 1995b).  The unequivocal assignment of filiformin (7.1) is 
detailed in Section 10.7. 
O
Br
 
    filiformin (7.1) 
 
A single crystal of filiformin (7.1) was also obtained, which permitted the first 
single crystal X-ray diffraction study of 7.1 to be carried out.  A thermal ellipsoid plot 
of 7.1 depicting 20% ellipsoids showing the absolute configuration determined by X-
ray analysis is given in Figure 7.3 (Section 10.1.8). 
  
Figure 7.3.  Single crystal X-ray structure (ORTEP) of filformin (7.1). 
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Filiforminol (7.2) was isolated as pale, yellow oil.  It was completely 
characterised by 1D and 2D NMR and found to be identical to that reported from L. 
filiformis (Kazlauskas et al., 1976), including the relative configuration which was 
confirmed on the basis of 1H-1H coupling constants.  Filiforminol (7.2) has also been 
previously isolated from the CHCl3 extracts of the red alga Hypnea pannosa J. Ag. 
(Karachi, Pakistan) (Afaq-Husain et al., 1991).  The total synthesis of 7.2 was achieved 
in 1998 (Yoo et al., 1998).  The complete unequivocal assignment of filiforminol (7.2) is 
detailed in Section 10.7. 
O
Br
CH2OH
 
filiforminol (7.2) 
 
Allolaurinterol (7.3) was isolated as a yellow oil as the major constituent from L. 
filiformis forma heteroclada.  Both the 1H and 13C NMR data was identical to that 
previously reported (Kazlauskas et al., 1976).  Allolaurinterol (7.3) has also been 
isolated from other algae including L. subopposita (Wratten and Faulkner, 1977), L. 
majuscula (Masuda et al., 2002), L. obtusa (König and Wright, 1997b) and the sea hare 
Aplysia dactylomela (Appleton et al., 2001) as well as having been synthesised (Gewali 
and Ronald, 1982).  The unequivocal assignment of allolaurinterol (7.3) is detailed in 
Section 10.7. 
OH
Br
 
allolaurinterol (7.3) 
 
Bromolaurenisol (7.10) was isolated as an unstable pale yellow oil which 
degraded within 3-5 days after purification.  Rapid characterisation was undertaken 
and the NMR data of 7.10 was found to be identical to that previously reported from L. 
filiformis forma heteroclada and from L. microcladia (Kladi et al., 2005).  Bromolaurenisol 
(7.10) has also been isolated from the crude extracts of L. pacifica obtained from Avalon 
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Harbor, Catalina Island, California (Crews and Selover, 1986).  The unequivocal 
assignment of bromolaurenisol (7.10) is detailed in Section 10.7. 
 
Br
OH
H
Br  
     bromolaurenisol (7.10) 
 
7.2.3 Secondary Metabolite Analysis of L. filiformis forma heteroclada by On-flow 
and Stop-flow HPLC-NMR (On-line Phytochemical Profiling) 
 
In an effort to re-isolate more of 7.16 a fresh extraction L. filiformis forma heteroclada was 
carried out in exactly the same manner as the initial 3:1 MeOH:DCM extraction 
procedure as outlined in Section 7.1.  HPLC-NMR was then used to rapidly profile the 
range of secondary metabolites in the DCM extract to quickly confirm the presence of 
the brominated sesquiterpenes, which are so characteristic of this genus.  However, on 
the basis of off-line analytical HPLC and on-line HPLC-NMR studies conducted, the 
presence of 7.16 could not be detected in this freshly extracted sample of the marine 
alga.   
Once a suitable off-line HPLC separation method was developed, the DCM 
fraction was profiled using both on-flow and stop-flow HPLC-NMR methodologies 
whereby analyses of the major constituents were carried out (Figure 7.4).  On-flow 
HPLC-NMR analysis of the DCM extract established the presence of a major 
metabolite, for which stop-flow HPLC-NMR experiments (WET1D and WET COSY 
NMR) were also obtained and resulted in the partial structure elucidation of this 
metabolite (Figure 7.4). 
Acquisition of WET1D and WET COSY NMR experiments (Figure 7.4) 
permitted a number of key structural features to be ascertained without the need for 
any off-line isolation or purification.  Close analysis of the WET1D identified the 
presence of two aromatic methine singlets (δ 7.14, s and 6.68, s) and two olefinic 
methines (δ 4.81, m and 4.92, m) that were coupled to each other (WET COSY), as well 
as a deshielded methine δ 2.93, q, J = 7.0 Hz which was coupled to the methyl moiety at 
δ 0.59, d, J = 8.0 Hz. This HPLC-NMR data was found to be consistent with 
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allolaurinterol (7.3).  Analysis of the UV 2D contour plot obtained from the HPLC-
NMR analysis identified the presence of additional low-level secondary metabolites.   
Compounds 7.1-7.3, 7.10 and 7.16 were found to be present either in low 
concentrations or not at all, even though the same extraction procedure was carried out 
as that conducted in the initial extraction and isolation of these compounds (Section 
7.1). 
 
 
Figure 7.4 [A] WET COSY and expansions (Stop-flow HPLC-NMR), 30 minutes acquisition;  
[B] Extracted WET1D 1H NMR of the major component (Stop-flow LC-NMR), 20 minutes 
acquisition; [C] 2D-HPLC-NMR contour plot illustrating 7.3 as the major metabolite (On-flow 
HPLC-NMR). 
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7.2.4 Chemical Transformation Studies of L. filiformis forma heteroclada as 
Monitored by On-flow and Stop-flow HPLC-NMR 
 
In the second attempt to re-isolate 7.16, HPLC-NMR of the DCM fraction was carried 
out, but the presence of compounds 7.1 or 7.16  was not observed (Figure 7.4).  This 
finding is consistent with the possibility that some of these compounds undergo 
interconversion over time, since compounds 7.1-7.3, 7.10 and 7.16 were isolated from 
the DCM extracts of the same L. filiformis forma heteroclada specimen after 48 months of 
storage.   
The most structurally similar compound to 7.16 is aplysin (7.17), for which the 
isolation was first reported over 40 years ago (Yamamura and Hirata, 1963).   
 
O
Br
H3C  
aplysin (7.17) 
 
There have been several reports which discuss whether the host Aplysia sp.  or 
the alga itself is the producer of these natural products (Irie et al., 1965).  The rapid 
degradation/chemical transformation and instability of these natural products is well 
documented with many of the laurane derivatives undergoing rapid degradation 
leading to the isolation of artefacts.  The spontaneous acid catalysed cyclisation of 
laurane derivatives is also well documented.  The intramolecular acid-catalysed 
cyclisation of 7.18 to 7.17 and 7.19 to 7.20 upon addition of acid has also been 
demonstrated (Irie et al., 1969a; Irie et al., 1969b; Irie et al., 1969c).  Despite the fact that 
these compounds have been reported as natural products (Suzuki et al., 1969), they also 
have clearly been shown to occur as artefacts.  Other examples include the conversion 
of 7.11 to 7.17 (Irie et al., 1970) and 7.21 to 7.22 (Blunt et al., 1984) (Figure 7.5).   
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OH
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OH
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OH
Br
H
OH3C
isoaplysin (7.22)
Br
TFA
 
 
Figure 7.5. Acid-catalysed chemical transformations of laurane type natural products. 
 
Since HPLC-NMR is particularly suited to the in situ analysis of unstable 
secondary metabolites, the L. filiformis forma heteroclada specimen in this study was 
analysed by HPLC-NMR using the same HPLC methodology that was used to isolate 
compounds 7.1-7.3, 7.10 and 7.16 by off-line conventional methods.  This was 
undertaken in an effort to detect the presence of 7.1 and 7.16 and to ascertain whether 
these compounds are natural products or possible artefacts.  On-line HPLC-NMR 
analysis of the extract identified the presence of 7.3 and trace levels of compounds 7.2 
and 7.10.  However, compounds 7.1 and 7.16 were not present.  This supported the 
theory that 7.1 and 7.16 could possibly be artefacts formed after several months of 
storage in various solvents such as CDCl3 (acidic conditions) as well as in the presence 
of oxygen.   
Following sample recovery after the initial 1H NMR analyses were conducted, 
the fractions were left to stand in a combination of DCM and CDCl3 in the fridge for a 
period of 48 months.  Rapid chemical transformations have been previously reported 
by Kazlauskas, who originally isolated compounds 7.1-7.3 in 1976 and suggested that 
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7.3 spontaneously converted to 7.1 over a number of weeks.  Kazlauskas conducted 
experiments whereby 0.1% d1-TFA/D2O was added directly to the NMR tube and the 
conversion monitored (Kazlauskas et al., 1976).   
HPLC-NMR was used to monitor any possible side reactions or chemical 
interconversion products of any other secondary metabolites present in the DCM 
fraction.  In this way the conversion of 7.3 was monitored directly using on-flow 
HPLC-NMR as well as by GC-MS by firstly injecting a portion of the DCM fraction 
without the addition of TFA and then by re-injecting the DCM fraction after the 
addition of 0.7% TFA.  This was carried out to establish the differences in the 
metabolites present before and after the presence of TFA in order to monitor any 
chemical transformations.   
It was evident in both the 2D-UV contour plot of the HPLC-NMR trace and the 
extracted 1H NMRs obtained from the 2D WET1D HPLC-NMR plots, that there were 
several side reactions occurring simultaneously, along with the conversion of 7.3 to 7.1.  
A compound later identified to be isoallolaurinterol (7.23) was observed to elute at a tR 
= 12.1 minutes (85% CH3CN/D2O) in the HPLC-NMR experiment compared to a tR = 
of 15.3 minutes observed for cycloisolaurinterol (7.16) (85% CH3CN/H2O by off-line 
HPLC).  This novel secondary metabolite displayed 1H NMR resonances similar to 
compounds 7.3 and 7.16 (Figure 7.6). 
 
 
 
 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
261 | P a g e  
 
Figure 7.6. [A] Extracted WET1D 1H NMR of 7.1 after 90% conversion from 7.3 (Stop-flow 
LC-NMR), 20 minutes acquisition; [B] 2D HPLC-NMR contour plot illustrating the conversion 
of 7.3 to 7.1 after the addition of TFA (On-flow HPLC-NMR); [C] Extracted WET1D 1H NMR of 
isoallolaurinterol (7.23) and assigned COSY correlations, (Stop-flow HPLC-NMR). 
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Stop-flow HPLC-NMR experiments allowed for longer acquisition times to be 
obtained for this unknown compound (WET COSY).  Analysis of the WET1D data 
(Figure 7.6) identified the presence of isolated aromatic methines δ 6.68 (1H, s, H-10) 
and δ 7.13 (1H, s, H-7) with a para-relationship, as well as a broad olefinic methine at δ 
5.21 (1H, brs, H-3) which was adjacent to a methylene moiety at δ 2.79 (1H, d, J = 14.0 
Hz, H-2ª) and 2.03, H-2b, (suppressed but oberved in the WET COSY spectrum) and an 
olefinic methyl δ 1.66 (3H, s, H-12, partly suppressed).  Remaining features included an 
isolated methyl group at δ 1.20 (3H, s, H-14) and the presence of a methine at δ 2.56 
(1H, q, J = 7.5 Hz, H-5), which showed COSY correlations to the methyl group at δ 0.56 
(3H, d, J = 7.5 Hz, H-13).  The substitution of the bromine and aromatic methyl at δ 2.20 
(3H, s, H-15) was supported from direct comparison to the NMR data reported for 
aplysin (7.17) and found to be the same as that in 7.16 (Yamamura and Hirata, 1963).  
On the basis of the WET1D, the observed COSY NMR correlations, the Advanced 
Chemistry Development ACD/Labs Software for 1H NMR predictions and comparison 
to model compounds in the literature (Afaq-Husain et al., 1991; Izac and Sims, 1979) the 
structure of this minor, unstable isoallolaurinterol (7.23) is proposed. The structural 
assignment of isoallolaurinterol (7.23) is detailed in Section 10.7 
In order to obtain NMR data for isoallolaurinterol (7.23) two separate stop-flow 
HPLC-NMR experiments were necessary.  Each of the stop-flow WET1D 1H NMR and 
WET COSY experiments were separately acquired for a period of approximately 20 
mins.  After this period of time it was observed that 7.23 had completely decomposed.  
After a period of 30 mins the DCM fraction containing 0.7% TFA, was re-injected and 
the HPLC-NMR analysis showed that 7.3 had completely converted to 7.1 and that 7.23 
was no longer present.  These observations support the previous report that 7.1 is an 
artefact formed by the acid-catalysed cyclisation of 7.3 to the cyclic ether 7.1 
(Kazlauskas et al., 1976).   
Cycloisoallolaurinterol (7.16) could not be detected in the DCM fraction either 
before or after the addition of TFA by off-line conventional analytical HPLC, or by on-
line HPLC-NMR in a freshly extracted sample of L. filiformis forma heteroclada.  It is 
believed that compound 7.16 may have formed over the extended 48 month period as a 
result of the acid-catalysed isomerisation of allolaurinterol (7.3) leading to the 
formation of isoallolaurinterol (7.23).  A subsequent oxidative cyclisation process 
resulted in the formation of cycloisoallolaurinterol (7.16) (Figure 7.7).  The fraction 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
263 | P a g e  
resulting in the isolation of 7.16 was stored under mildly acidic conditions in a range of 
solvents including CDCl3. 
 
O
Br
H3C
H
OH
Br
H3C OH
Br
H3C
7.3 7.23
acid-catalysed
isomerisation
oxidation
7.16  
 
Figure 7.7. Proposed acid-catalysed isomerisation of allaurinterol (7.3) to isoallolaurinterol              
(7.23) followed by oxidation to cycloisoallolaurinterol (7.16). 
 
Whilst 7.16 appears to be stable when present in a crude mixture, once isolation 
and separation was undertaken the pure compound rapidly degraded.  
Isoallolaurinterol (7.23) could not be further characterised, as it was unstable, 
decomposing in a period of approximately 20 mins, as observed during HPLC-NMR 
acquisition experiments.   Efforts to detect 7.16 in the DCM fraction (as a product 
brought about by the addition of TFA) by HPLC-NMR was unsuccessful.  The addition 
of TFA to the DCM fraction only resulted in the detection of the unstable compound 
7.23 in the vicinity of where 7.16 is known to elute (from the off-line conventional 
HPLC analysis).   
The identification of isoallolaurinterol (7.23) in the on-flow and stop-flow 
HPLC-NMR analyses is proposed to be a precursor to the formation of 
cycloisoallolaurinterol (7.16) via an oxidative acid-catalysed process (Figure 7.7).  The 
presence of 7.16 could only be detected in the crude extract fraction containing various 
solvents including CDCl3 (mildly acidic conditions) that were left to stand over a 
period of 48 months.  In this time period fractions were left to stand which resulted in 
the formation and isolation of 7.16.  This was not the case when the crude extract was 
freshly extracted followed by the immediate addition of 0.7% TFA (extremely acidic 
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conditions) for the HPLC-NMR studies.  The considerable time period, the presence of 
oxygen, as well as the acidity suggested to be crucial factors for the formation of 7.16. 
One final possibility for the origin of 7.16 is that it could be derived from a 
symbiotic relationship with another organism/bacteria associated with the alga.  It is 
possible that this association was not present in the remaining half of the specimen, 
which was extracted much later.  This symbiosis is not an uncommon occurrence in 
marine organisms (Stallard and Faulkner, 1974a, b).  This still leaves the remote 
possibility open that 7.16 could either be a natural product or an artefact, although the 
later possibility is favoured. 
 
7.2.5 GC-MS Studies of L. filiformis forma heteroclada 
 
In an effort to detect the presence of the sesquiterpenes present in the crude extract of 
L. filiformis forma heteroclada before and after the addition of TFA, a small extraction of 
the alga was carried out.  This was primarily undertaken to determine if the presence 
of 7.16 is promoted by acid.  Approximately 2 g of the frozen alga was extracted with 
3:1 MeOH:DCM and analysed by GC-MS.  Analysis of the GC-MS spectrum identified 
the presence of allolaurinterol (7.3) as the major constituent of the extract which is 
consistent with 7.3 being the major component of the extract as established previously 
by on-flow HPLC-NMR.  In addition to compound 7.2, 7.3 and 7.10 were also detected 
in the GC-MS spectrum of the crude extract.  Since filiformin (7.1) forms from 
allolaurinterol (7.3), it too was detected in the GC-MS, but only at a relatively lower 
concentration compared to the other components.  After this initial analysis, 0.7% TFA 
was added to the same crude extract in an effort to determine if the formation of 7.16 is 
brought about by the addition of the acid and to further prove that 7.1 is an artefact 
formed over time.  Analysis of the GC-MS spectrum of the acidified crude extract could 
now identify the presence of compound 7.1 as the major component of the extract, 
thereby confirming it to be an artefact formed from the addition of the acid.  In 
addition, low levels of 7.3 and 7.10 were also observed.  No traces of compound 7.2 
could be detected.  Furthermore, the presence of a very low level peak exhibiting a 
molecular ion consistent with isoallolaurinterol (7.23) could now be seen in the GC-MS 
spectrum.  It is suggested that the addition of TFA results in the formation of the 
unstable intermediate 7.23 (at a very low relative concentration) and that at this high 
acid concentration it is too unstable to be detected.  It is proposed that 
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cycloisoallolaurinterol (7.16) was formed over an extended period of time (48 months) 
in a weakly acidic environment (CDCl3 in DCM as opposed to 0.7% TFA) as well as in 
the presence of oxygen.  This variation in acid strength could explain why 7.23 was 
only detected as an extremely minor peak in the GC-MS spectrum. 
 
7.3 Biological Evaluation and Details of Assays 
 
Extracts of L. filiformis forma heteroclada were evaluated in a number of biological assays 
including against a P388 Murine Leukaemia cell line (antitumour assay), against Herpes 
simplex and Polio viruses (antiviral assays) as well as against a number of bacteria and 
fungi (antimicrobial assays) at the University of Canterbury, Christchurch, New 
Zealand.  Insignificant antitumour activity was observed for the crude extract (IC50 of 
168,632 ng/mL when tested at 50 mg/mL).  In addition the L. filiformis forma heteroclada 
extract displayed antiviral activities against the Herpes simplex virus and the Polio virus 
as well as moderate antimicrobial activity with zones of inhibition detected against 
Bacillus subtilis and Trichophyton mentagrophytes.  No inhibition against Eschericha coli, 
Pseudomonas aeruginosa, Candida albicans or Cladosporium resinae was detected. 
Compounds that were further evaluated for their biological activity were 7.1-7.3 
and 7.10.  These four compounds displayed IC50s ranging from >34-43 µM when tested 
at 1 mg/mL against the P388 murine leukaemia cell line (Table 7.2).  In the time it took 
for these bioassays to be carried out compounds 7.2 and 7.10 had degraded.   
Filiformin (7.1) has been previously reported to inhibit oxygen uptake in 
isolated rat liver mitochondria at a concentration of 150 µM (Bedir et al., 2000).  In 
another  study (Vairappan et al., 2004), 7.3 displayed activity against various gram 
positive bacteria including potent bactericidal activity against methicillin-resistant 
Staphylococcus aureus at a concentration of 2  MIC value (6.25 µg/mL).   
Allolaurinterol (7.3) also displayed activity against VCM-susceptible 
Enterococcus faecium (Vairappan et al., 2004).  In a separate study 7.1 showed moderate 
P388 activity and BSC-1 cytotoxicity, along with antimicrobial activity against Bacillus 
subtilis, Trichophyton mentagrophytes and Candida albicans (Appleton et al., 2001).  
Allolaurinterol (7.3), isolated from Laurencia obtusa, displayed activity against 
Mycobacterium tuberculosis (16 µg/mL) (König et al., 2000), along with moderate 
antifungal and antibacterial activity, as well as antialgal activity towards the bacterium 
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Bacillus megaterium and the fungus Ustilago violacea (König and Wright, 1997b).  
Bromolaurenisol (7.10) has been previously reported to display anticancer activity with 
an IC50 of 26.5 µM (NSCHPLCN6 cell line) (Kladi et al., 2005). 
In completing the biological evaluation of the compounds isolated in this study 
it was found that 7.2 and 7.3 showed slight inhibition of the growth of Bacillus subtilis 
and moderate inhibition of Trichophyton mentagrophytes while filiformin (7.1) did not 
inhibit the growth of either Bacillus subtilis or Trichophyton mentagrophytes.  The 
antimicrobial properties of compounds 7.2 and 7.3 are consistent with previous 
findings for laurane derivatives (Sims et al., 1975).  In the time it took to completely 
characterise 7.16, the compound had completely degraded thereby precluding any 
biological testing from being carried out.   
Compounds 7.1 and 7.2 displayed moderate antimicrobial activity while 7.3 
showed only antifungal activity.  Compounds 7.1-7.3 and 7.10 displayed IC50s in the 
range >34-43 µM in the P388 antitumour assay (Table 7.2). 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
 
Table 7.2 Antitumour activity of sesquiterpenes 7.1-7.3 and 7.10. 
Compound IC50  
(µM) 
Filiformin (7.1) >43 
Filiforminol (7.2) >40 
Allolaurinterol (7.3) >43 
Bromolaurenisol (7.10) >34 
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Laurencia filiformis (2003-04) 
    
 
Domain: Eukaryota 
Kingdom:  Plantae 
Subkingdom: Biliphyta 
Phylum:  Rhodophyta 
Subphylum: Macrorhodophytina 
Class:   Florideophyceae 
Order:   Ceramiales 
Family:  Rhodomelaceae 
Genus:  Laurencia 
Species:  filiformis 
 
 Collected by Dr Sylvia Urban and Dr Rick Tinker from St.  Pauls Beach, Sorrento, 
Victoria, Australia (hand intertidal) 
(March, 2003) 
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8.0 IntroductionH 
 
As already detailed in Chapter 7, the genus Laurencia has yielded a myriad of  
halogenated sesquiterpenes. The search for bioactive natural products from this genus 
of red algae has been an active area of research since the 1970s (Sims and Fenical, 1972). 
Examples of secondary metabolites from this genus include C15 acetogenins, such as 
laurendecumenyne A (8.1) (Nai-Yun et al., 2007) and pannosallene (8.2), the latter 
contains a bromoallene group (Suzuki et al., 1996).  
 
                         
O
Br
OHOO
             
H
H
H
H
H
H
Br HH3C
C
Br
H
 
                                laurendecumenyne A (8.1)                      pannosallene (8.2)  
 
Other examples include the class of compounds known as the chamigrenes, 
many of which are halogenated secondary metabolites containing a unique spiro centre 
and/or a cyclohexane moiety such as ma‘ilione (8.3) (Francisco and Erickson, 2001) and 
the sesquiterpene bromo diether 8.4 (Kikuchi et al., 1985).  
                                            
†
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                         ma‘ilinone (8.3)                                         8.4 
 
The genus Laurencia occurs throughout the world and continues to provide new 
and unique bioactive natural products (Vairappan et al., 2001). In terms of its biological 
activity, it is well documented that in a marine ecosystem, marine algae are directly 
exposed and are susceptible to ambient micro-organisms (bacteria, fungi and viruses) 
(Vairappan et al., 2001). In Japan, diseases caused by marine bacteria such as 
Pseudoalteromonas have been found to appear in kelp. The selective occurrence of these 
infections and the ability of marine algae to be resistant to such diseases has prompted 
the exploration for the possible existence of inherently available antibacterial defence 
mechanisms (Vairappan et al., 2001). 
This chapter describes the chemical constituents and associated biological 
activities present in the red alga, Laurencia elata collected from St. Pauls Beach, 
Sorrento, Victoria, Australia as well as the chemical profiling of the crude extract by 
HPLC-NMR. The crude extract of Laurencia elata displayed slight antitumour activity 
along with selective antifungal and antiviral activities (Section 8.3). As a result of the 
on-line HPLC-NMR profiling conducted, the off-line isolation and purification of two 
new epimeric C16 chamigrenes, cycloelatanene A (8.15) and cycloelatanene B (8.18) was 
achieved. These proposed structures for compounds (8.15) and (8.18) represent a new 
carbon skeleton. This investigation also resulted in the isolation of the previously 
described compounds, (3Z)-chlorofucin (8.5), pacifenol (8.7) and elatenyne (8.9). The 
structure of elatenyne was only recently revised and in this re-isolation an effort to 
address the relative configuration was attempted by selective 1D NOE NMR 
experiments. 
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8.1 Collection, Extraction and Isolation 
 
The marine red alga Laurencia elata was collected intertidally on the 3rd January, 2003 
from St. Pauls Beach, Sorrento, Victoria, Australia.  The alga was identified by Dr 
Gerald Kraft (Honorary Principal Fellow), School of Botany, University of Melbourne, 
Australia. A voucher specimen designated, the code 2003-05 is deposited at the School 
of Applied Sciences, RMIT University. A photograph of the alga is shown on page 304. 
For the HPLC-NMR chemical profiling of the alga, a frozen sample of L. elata 
was diced and extracted with DCM (50 mL) overnight. The extract was decanted and 
concentrated under reduced pressure, re-solubilised with CH3CN (100%) and filtered 
through a 0.45 m PTFE membrane (HP045 Advantec, Japan). For the on-flow HPLC-
NMR experiments 50 µL (1,333 µg of the extract) was injected and monitored at λmax 
215 and 254 nm, using an isocratic run (75% CH3CN/D2O). Further HPLC-NMR details 
are described in Section 10.1.4. 
For the off-line purification, the alga (30 g) (8g dr. wt.) was extracted with 3:1 
MeOH/DCM (800 mL) and the crude extract was decanted and concentrated under 
reduced pressure and triturated into DCM, MeOH and water-soluble extracts.  The 
DCM extract was fractionated using flash silica column chromatography (20% stepwise 
elution from n-hexane to DCM to EtOAc and finally to MeOH).  Several silica column 
fractions were combined on the basis of 1H NMR and subjected to reversed phase 
HPLC (75% CH3CN/H2O) to yield (3Z)-chlorofucin (8.5), (12.3 mg, 0.15%), pacifenol 
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(8.7) (7.8 mg, 0.09%), elatenyne (8.9) (14.2 mg, 0.18%), cycloelatanene A (8.15) (3.4 mg, 
0.04%) and cycloelatanene B (8.18) (2.3 mg, 0.03%) (% based on the mass of the dried 
weight of the marine alga as shown in Scheme 8.1). 
 
 
Laurencia elata (30 g)
3:1 (MeOH:DCM) (800 mL)
DCM MeOH
HPLC-NMR Analysis
(On-flow Experiments)
(340 mg)
(3Z)-chlorofucin (8.5)
(12.3 mg, 0.15 %)
Water
Flash Silica column chromatography (20% stepwise elution)
Fraction 1 Fraction 22
(1.85 g) (1.98 g)
Fraction 8 Fraction 15
(45 mg)
Combined on the basis of 1H NMR analysis
Semi-Preparative RP-HPLC
(75% CH3CN/H2O)
pacifenol (8.7)
(7.8 mg, 0.09 %)
elatenyne (8.9)
(14.2 mg, 0.18 %)
cycloelatanene A (8.15)
(3.4 mg, 0.04 %)
cycloelatanene B (8.18)
(2.3 mg, 0.03 %)  
Scheme 8.1. Extraction and isolation procedure adopted for Laurencia elata. 
 
8.2 Results and Discussion 
 
8.2.1 On-flow HPLC-NMR Analysis of the Crude Extract of Laurencia elata. 
 
Extraction of Laurencia elata was carried out using 100% DCM. HPLC-NMR was then 
used to rapidly profile the range of secondary metabolites present in the crude extract 
to identify the possible presence of novel constituents.  The on-flow HPLC-NMR 
analysis of the Laurencia elata crude extract resulted in a WET1D 1H NMR spectrum 
which identified the presence of constituents deemed to be of interest (Figure 8.1). 
Analysis of the extracted WET1D 1H NMR immediately suggested terpenoid type 
structures, which are typical of this genus. In this way, a combined approach using 
both off-line (HPLC isolation) and on-line (HPLC-NMR) chemical profiling was 
utilised to establish the nature of the principal components in the crude extract. 
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8.2.2 Off-line Isolation of Secondary Metabolites from Laurencia elata 
 
8.2.2.1 Isolation of (3Z)-chlorofucin (8.5) and Pacifenol (8.7) 
 
For the off-line HPLC purification study, the marine alga Laurencia elata was 
extracted with 3:1 MeOH/DCM and then triturated into DCM, MeOH and water 
soluble fractions.  The DCM extract was subsequently fractionated by silica flash 
chromatography and several fractions combined on the basis of their 1H NMR spectra. 
Final purification was achieved using reversed phase HPLC to yield compounds 8.5, 
8.7, 8.9, 8.15 and 8.18. 
The previously reported compound, (3Z)-chlorofucin (8.5) was isolated as a 
unstable yellow oil. The positive mode ESI-MS displayed a m/z 369 [M+Na]+, which 
suggested a molecular formula of C15H20BrClO2. The structure of 8.5 was confirmed on 
the basis of detailed spectroscopic analyses (1D and 2D NMR) and was found to have 
almost identical spectroscopic data to the corresponding (E)-isomer, previously 
isolated from the marine algae, L. snyderae Dawson (Howard et al., 1980), L. pannosa 
(Suzuki et al., 1996) and also from a Malaysian species of Laurencia (Vairappan et al., 
2008). Analysis of the 1H (Figure 8.3) and 13C NMR data immediately identified 8.5 to 
differ with respect to the double bond geometry at position C-3. Comparison of the 
coupling constants for the double bond geometry of (3Z)-chlorofucin (8.5), [δ 5.55 (1H, 
dt, J = 2.5, 11.0 Hz, H-3 and δ 6.03 (1H, ddd, J = 7.5, 8.0, 10.5 Hz, H-4)] to the model 
compound, (3Z)-venustinene (8.6) [δ 5.55 (1H, brd, J =11.0 Hz, H-3 and δ 6.00 (1H, ddd, 
J = 7.0, 11.0, 11.0 Hz, H-4)] (Suzuki et al., 1983) immediately identified 8.5 to be the (Z)-
isomer (Figure 8.2). The unequivocal assignment of 8.5 is detailed in Section 10.8 
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H H
H
5.55, dt, J = 2.5, 10.5 Hz6.03, ddd, J = 7.5, 8.0, 10.5 Hz       
(3Z)-chlorofucin (8.5) 
 
       
O
Cl
H
H
H
4
3
1
5.55, brd, J = 11.0 Hz
6.03, ddd, J = 7.0, 11.0, 11.0 Hz
 
(3Z)-venustinene (8.6) 
 
Figure 8.2. Comparison of the 1H NMR shifts of 8.5 versus 8.6 highlighting similiarity with 
respect to the double bond geometry at (C-3 to C-4).
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The known compound, pacifenol (8.7) was isolated as stable colourless needles. 
The ESI-MS showed a peak at m/z 464 [M+Cl]-, consistent with a molecular formula of 
C15H21Br2Cl2O2. The 1H (Figure 8.4), 13C NMR spectra, 2D NMR experiments and mass 
spectrum confirmed the structure as 8.7. In addition, the NMR data for pacifenol (8.7) 
was found to be identical to that previously reported in the literature (Section 10.8) 
(Argandoña et al., 1993; Kaiser et al., 2001). Pacifenol (8.7) is a sesquiterpene which 
contains a spiro[5.5]undecane skeleton and was first isolated from the red alga, L. 
pacifica and characterised by a single-crystal X-ray analysis (Sims et al., 1971). Pacifenol 
(8.7) has been reported from a number of marine organisms including: L. nidifica 
(Kimura et al., 1999; Waraszkiewicz and Erickson, 1974),  L. nipponica Yamada (Suzuki, 
1980), L. claviformis (Argandoña et al., 1993), L. majuscula (Caccamese et al., 1986) and 
from the Brazilian mollusc,  Aplysia dactilomela (Kaiser et al., 2001).  
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8.2.2.2  Isolation of Elatenyne 
 
Elatenyne was isolated as a unstable colourless oil. The EI-MS identified the 
presence of fragments at m/z 329, 327, 325 (1:2:1) isotopic ratio which supported the 
presence of two bromine atoms and represented [M+-C5H5]. Though the molecular ion 
was not observed, EI-MS fragmentation was found to be almost identical to that 
previously reported, (Hall and Reiss, 1986). The 1H and 13C NMR spectra (in CDCl3) 
are presented in Figure 8.5 (including expansions illustrating complex second order 
multiplets between δ 3.90–4.30 ppm) and Figure 8.6, respectively. On the basis of the 
1H and 13C NMR data together with the HSQCAD and DEPT experiments, the 
presence of one methyl, four methylenes, nine methines and one quaternary carbon 
could be confirmed. However, the alkyne methine at 82.8 (C-1) ppm was not observed 
in the DEPT 90 spectrum until the coupling constant parameter was changed from the 
default (J = 120 Hz) to that typical for sp carbons at (J = 210 Hz). A combination of 
COSY and HMBC NMR experiments supported the initial structure assigned as "RMIT 
elatenyne‡" detailed in Tables 8.1 and 8.2 (recorded in CDCl3 and C6D6, respectively). 
C6D6 was used a NMR solvent in an effort to resolves 1H NMR signals between δ 3.96-
4.22 and to obtain coupling that was unable to be determined using CDCl3. C6D6 is a 
well known deuterated solvent often used to resolve 1H and 13C NMR signals which 
are overlapped. 
1H, 13C NMR and additional COSY, HSQCAD and HMBC data acquired for 
this compound supported the structure and was found to be identical to that 
previously reported by Hall and Reiss. 
 
 
                                                              
 
 
 
 
 
                                            
‡denoted as RMIT elatenyne temporarily to distinguish it from synthetic pseudo-elatenyne (8.9) (Sheldrake et al., 2005) 
and elatenyne (8.8) first isolated by (Hall and Reiss, 1986). 
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Table 8.1. NMR Spectroscopic Data (500 MHz, CDCl3) for "RMIT elatenyne". 
 
O
OBr
Br
H3C
H
H
9
10
11
8
 
 
Pos. 
 
δca, mult 
 
 
δH (J in Hz) 
 
 
gCOSY 
 
 
gHMBC 
 
 
 
Selective 
1D NOE 
 
1 82.8c, CH 3.14, dd, (0.5, 2.5) H-3 C-3, C-4 H-3 
2 80.1, qC     
3 111.6, CH 5.60, ddt, (1.0, 2.5, 11.0) H-1, H-4  C-1, C-2, C-4, C-5 H-1, H-4  
4 140.1, CH 6.05, ddt, (1.0, 7.5, 11.0) H-3, H-5a, H-5b C-2, C-3, C-5, C-6  H-3, H-6, H-7, H-5a, H-5b 
5a 34.9, CH2 2.57, m H-4, H-5b, H-6 C-3, C-4, C-6, C-7 H-4, H-6, H-7 
5b  2.66, m H-4, H-5a, H-6 C-3, C-4, C-6, C-7 H-3, H-4, H-6, H-7  
6 86.8, CH 4.22, dd, (5.5, 11.5) H-5a, H-5b, H-7  C-4, C-7, C-8, C-9  H-4, H-5a, H-5b, H-7, H- 8 
7 48.9, CH 4.05, dt, (5.5, 7.0) H-6, H-8  C-5, C-9 H-4, H-5a, H-5b, H-6, H-8  
8 39.1, CH2 b2.33, m H-7, H-9  C-6, C-7, C-9, C-10 H7 
9 80.3, CH b4.15, ddd, (5.5, 7.0 12.0) H-8 C-10, C-11 H-8/H-11 
10 79.5, CH b4.15, ddd, (5.5, 7.0 12.0) H-11 C-8/ C-11, C-9, C-13  H-8/ H-11 
11 39.2, CH2 b2.33, m H-10, H-12, H-13 C-9, C-10, C-12, C-13 H-12, H-13 
12 49.3, CH 3.96, m H-11 C-10, C-11, C-14 H-11, H-14, H-15 
13 89.1, CH 4.00, dd, (5.0, 7.5) H-14a, H-14b C-12, C-15 H-11, H-14a, H-14b, H-15 
14a 27.1, CH2 1.50, ddq, (7.5, 7.5, 14.0) H-13, H-14b, H-15 C-12, C-13, C-15 H12, H-13, H-14b, H-15 
14b  1.66, ddq, (5.0, 7.5, 14.0) H-13, H-14a, H-15 C-12, C-13, C-15 H-12, H-14a, H-13, H-15 
15 10.5, CH3 0.98, t, (7.5) H-14a, H-14b C-13, C-14 H-12, H-13, H-14a, H-14b 
aCarbon assignments based on HSQCAD and DEPT experiments 
bsignals may be interchanged 
cObserved in the DEPT90 (J = 210 Hz) 
 
Table 8.2. NMR Spectroscopic Data (500 MHz, C6D6) for "RMIT elatenyne"  
 
 
Pos. 
 
δca, mult 
 
δH (J in Hz) 
 
 
gCOSY 
 
 
gHMBC 
 
1 82.9 c, CH 2.77, d, (1.8) - C-3, C-4 
2 80.2, qC - - - 
3 111.2, CH 5.36, dd, (1.8, 11.0) H-4 C-1, C-4, C-5a 
4 140.1, CH 5.72, dt, (7.5, 11.0) H-3, H-5a, H-5b C-3, C-5a, C-6, C-2 
5a 34.7, CH2 2.41, ddd, (7.5, 7.5 14.5) H-4, H-6 C-3, C-4, C-7, C-6 
5b  2.49, ddd, (6.5, 6.5, 14.5) H-4, H-6 C-3, C-4, C-6, C-7 
6 86.5, CH 4.06, dd, (5.5, 12.0) H-5a, H-5b C-4, C-7, C-9 
7 49.2, CH 3.53, dt, (5.0, 7.5) H-8a C-10, C-14, C-8/C-11 
8a 39.1b, CH2 1.91, ddd, (7.5, 7.5, 14.0) H-7, H-10, H-12 C-7, C-10, C-13 
8b     
9 80.1b, CH 3.86, t, (5.5) H-8, H-11 C-8/C-11 
10 79.5b, CH 3.86, t, (5.5) H-8, H-11 C-12, C-8a/C-13 
11 39.3b, CH2 2.03, m H-10 C-10, C-12, C-13 
12 48.9, CH 3.66, dt, (5.0, 7.5) H-8 C-12 
13 88.6, CH 3.89, dd, (5.0, 7.5) H-14 C-12, C-15 
14a 26.8, CH2 1.23, ddq, (7.5, 7.5, 14.0) H-13 C-12, C-13, C-15 
14b  1.37, ddq, (5.0, 7.5, 14.0) H-15 C-7, C-13, C-15 
15 10.1, CH3 0.81, t, (7.5) H-14b C-13, C-14 
aCarbon assignments based on HSQCAD and DEPT experiments 
bsignals may be interchanged 
cObserved in the DEPT90 (J = 210 Hz) 
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Elatenyne was first isolated from L. elata in 1986 and the structure of 8.8 was 
proposed on the basis of 1H, 13C NMR spectroscopic analyses as well as the synthesis 
of various derivatives to establish the relative configuration (on and off resonance 
decoupling, double resonance and lanthanide shift experiments (Hall and Reiss, 1986). 
Attempts to secure the absolute configuration by a single-crystal X-ray analysis and the 
synthesis of crystalline derivatives were unsuccessful (Hall and Reiss, 1986). The 
structure of elatenyne has also been documented from L. majuscula (Wright et al., 1993) 
and L. decumbens (Nai-Yun et al., 2007) for which the spectroscopic data for 8.8 was 
compared to that previously reported by Hall and Reiss. 
 
O
OBr
Br
H3C
H
H
9
10
11
8
 
elatenyne (8.8) (Hall and Reiss) 
(Also synthesised by Burton and co-workers and named pseudo-elatenyne) 
 
In 2005, Burton and colleagues synthesised the proposed structure of elatenyne 
(8.8) using well known, unambiguous synthetic protocols (Sheldrake et al., 2005). The 
1H and 13C NMR data (recorded in both CDCl3 and C6D6) was found to be different to 
that reported in this thesis as well as that previously documented by Hall and Reiss. 
Burton and co-workers adopted the name pseudo-elatenyne for their newly synthesised 
compound but clearly the structure of elatenyne as proposed by Hall and Reiss in 1986 
was incorrect. In the interests of clarity, this thesis will refer to the synthetic compound 
prepared by Burton and co-workers as pseudo-elatenyne (8.8). 
A comparison of the 13C NMR data for RMIT elatenyne versus synthetic pseudo-
elatenyne (8.8) is shown in Table 8.3 for which the most striking features of difference 
are highlighted. 
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Table 8.3. 13C NMR spectroscopic data comparison of RMIT elatenyne to synthetic 
pseudo-elatenyne recorded in C6D6. 
Pos. δc, mult 
RMIT elatenyne 
 
δca, mult 
pseudo-
elatenyne 
 (Burton) 
Δδc 
(RMIT elatenyne) vs 
(Burton) 
 
δH, mult 
(RMIT elatenyne) 
δH, mult 
pseudo-elatenyne 
(Burton) 
1 82.9d, CH 82.7 0.2 2.77 2.08-2.88a 
2 80.2, qC 80.4 0.2 - - 
3 111.2, CH 110.6 0.6 5.36 5.47 
4 140.1, CH 141.3 1.2 5.72 6.04 
5a 34.7, CH2 36.7 2.0 2.41 3.08, 2.78-2.88a 
5b    2.49  
6 86.5, CH 78.7 7.8 4.06 2.78-2.88a 
7 49.2, CH 46.4 2.8 3.53 3.58b 
8a 39.1b, CH2 37.4 1.7 1.91 2.38, 1.54-1.67c 
8b      
9 80.1, CH 71.4 8.7 3.86 2.08-2.88a 
10 79.5, CH 71.2 8.3 3.86 2.08-2.88a 
11 39.3 b, CH2 37.3 2.0 2.03 2.38, 1.54-1.67c 
12 48.9, CH 46.4 2.5 3.66 3.56b 
13 88.6, CH 80.9 7.7 3.89 2.52 
14a 26.8, CH2 28.7 1.9 1.23 1.95 
14b    1.37 1.54-2.67c 
15 10.1, CH3 9.7 0.4 0.81, 0.88 
a part of 5H multiplet 
b,c assignments are interchangeable between pairs of signals 
dObserved in the DEPT90 when J = 210 Hz 
 
Comparison of Burton and co-workers spectroscopic data of pseudo-elatenyne 
(8.8) to RMIT elatenyne clearly identified several discrepancies (Table 8.3 and Figure 
8.7). The major inconsistencies included the carbon chemical shifts at 78.7 (C-6) ppm 
compared to 86.5 (C-6) ppm; 80.1 (C-9) ppm compared to 71.4 (C-9) ppm; 79.5 (C-10) 
ppm compared to 71.2 (C-10) ppm and 88.6 (C-13) ppm compared to 80.9 (C-13) ppm. 
These differences were also apparent for the 1H chemical shifts for the corresponding 
carbons (Figure 8.7). 
 
O
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H3C
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10 6
13
86.5 (78.7) C = 7.8 ppm
80.1 (71.4) C = 8.7 ppm
88.6 (80.9) C = 7.7 ppm
79.5 (71.2) C = 8.3 ppm  
 
Figure 8.7. Selected 13C chemical shifts comparing RMIT elatenyne to synthetic 
pseudo-elatenyne (8.8) (in brackets) illustrating δΔC (ppm). 
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Burton proposed that the correct structure of elatenyne is most likely the 2,2′-
bifuranyl (8.9) which is the (Z)-isomer of the known compound, lauroxolane (8.10) 
(also known as lauroxane and L. majuscula-enyne), a C15-halogenated ether first 
isolated from the red alga L. majuscula (In Kyu et al., 1989).  
A recent report by Smith and co-workers describes the use of GIAO (Gauge-
including atomic orbitals) 13C NMR calculations to predict four four possible 
diasteroisomers were concluded to be (8.9, 8.11, 8.12 and 8.13) (Smith et al., 2008). 
Comparison of the calculated carbon chemical shifts with that reported for elatenyne 
resulted in the claim that 8.9 is the most likely candidate.  The 1D and 2D NMR data 
described in this thesis (in particular the HMBC connectivity) for RMIT elatenyne (8.8) 
is consistent with the NMR data for the structurally related compound, lauroxolane 
(8.10). 
 
    
O
OBr
Br
H3C
H
H
9
10
11
8
           
O
O
H Br
Br
H3C
H
 
     pseudo-elatenyne (8.8)                               elatenyne (Likely candidate) (8.9) 
  (Burton and co-workers)                             
                               
             
O
O
Br
Br
       O
O
H Br
Br
H3C
H
 
                            lauroxolane (8.10)                                                    8.11 
                          (L. majuscula-enyne) 
 
            O
O
H Br
Br
H3C
H
              
O
O
H Br
Br
H3C
H
 
                            8.12                                                                8.13 
 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
290 | P a g e  
Differentiation between pyrano[3,2-b]pyranyl compounds such as RMIT 
elatenyne (8.8) and 2,2′-bifuranyls such as lauroxolane (8.10) presents a particular 
challenge in NMR spectroscopy. Although the structures of the pyrano[3,2-b]pyran, 8.8 
(Hall and Reiss) and the bifuranyl 8.9 are different, it is hardly surprising that 8.8 was 
initially mistakenly attributed to elatenyne. In particular, HMBC experiments, which 
are usually the mainstay for establishing connectivity through heteroatoms, are unable 
to distinguish between the two classes (Figure 8.8) since the proton and carbon 
connectivities are essentially the same. The absolute configuration of pseudo-elatenyne 
(8.9) remains with regio and stereo synthesis or single-crystal X-ray crystallography 
(Sheldrake et al., 2006). 
Burton and co-workers proposed that 13C NMR chemical shifts of the central 
oxygen-bearing carbon atoms fall into two groups: for the pyrano[3,2-b]pyran, the 13C 
NMR chemical shift of the C-9 and C-10 display δ < 76 ppm, whereas in 2,2′-bifuranyls, 
C-9 and C-10 display δ > 76 ppm (Figure 8.8) (Sheldrake et al., 2006).  
 
O
O
O
O
H
H
H
H
9109
10
 < 76 ppm  > 76 ppm
pyrano[3,2-b]pyran 2,2'-bifuranyl  
Figure 8.8. Comparison of the carbon chemical shifts at positions C-9 and C-10  
in pyrano[3,2-b]pyran and 2,2′-bifuranyls carbon skeletons. 
 
In this particular case, the marked difference in carbon chemical shifts for RMIT 
elatenyne (8.8) [(from this point forward the structure of elatenyne has been adopted as 
RMIT elatenyne (8.9), as proposed by Burton and co-workers)] prompted the use of 
more ―traditional‖ methods – in particular the use of carbon chemical shift differences 
to distinguish five and six-membered rings.  
RMIT elatenyne (8.9) was compared to the 13C NMR data (Z)-dactylomelyne 
(8.14) in which carbon chemical shift differences are shown in Table 8.4. It is evident 
that RMIT elatenyne (8.9) and (Z)-dactylomelyne (8.14) show large discrepancies with 
respect to the 13C NMR chemical data. The major inconsistencies include the carbon 
chemical shifts at 78.8 (C-6) ppm compared to 86.8 (C-6) ppm; 70.6 (C-9) ppm 
compared to 80.3 (C-9) ppm; 75.8 (C-10) ppm compared to 79.5 (C-10) ppm and 83.1 (C-
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13) ppm compared to 89.1 (C-13) ppm (Figure 8.9). If elatenyne did exist as a 
pyrano[3,2-b]pyran as in the case for (Z)-dactylomelyne (8.14), the carbon shifts in 
particular at positions C-9 and C-10 would be expected at δ < 76 ppm and this does not 
support the previous incorrect structure of 8.8 (Table 8.4 and Figure 8.9). 
 
Table 8.4. NMR Spectroscopic data comparison of RMIT elatenyne (8.9) versus (Z) 
dactylomelyne (8.14) (CDCl3 for comparison). 
 
 
Position 
 
δca, mult 
RMIT  
elatenyne 
 
δC 
(8.14) 
 
 
Δ in δc 
(RMIT elatenyne vs 8.14) 
1 82.8, CH 80.5 2.3 
2 80.1, qC 82.9 2.8 
3 111.6, CH 111.1 0.5 
4 140.1, CH 141.1 1.0 
5a 34.9, CH2 36.6 1.7 
5b    
6 86.8, CH 78.8 8.0 
7 48.9, CH 54.6 5.7 
8a 39.1, CH2 34.9 4.2 
8b    
9 80.3, CH 70.6 9.7 
10 79.5, CH 75.8 3.7 
11a 39.2, CH2 41.7 2.5 
11b    
12 49.3, CH 48.1 1.2 
13 89.1, CH 83.1 6.0 
14a 27.1, CH2 26.7 0.4 
14b    
15 10.5, CH3 8.9 1.6 
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13
78.8 (86.8) C = 8.0 ppm
75.8 (79.5) C = 3.7 ppm
83.1 (89.1) C = 6.0 ppm
70.6 (80.3) C = 9.7 ppm
(Z)-dactylomelyne (8.14)
 
Figure 8.9. Selected 13C chemical shifts comparing (Z)-dactylomelyne (8.14) to 
RMIT elatenyne (8.9) (in brackets) illustrating δΔC (ppm). 
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The 13C NMR data for RMIT elatenyne (8.9) was compared to the 13C NMR 
data previously reported for the 2,2′-bifuranyl, lauroxolane (8.10) for which carbon 
chemical shift differences are shown in Table 8.5. It was evident that RMIT elatenyne 
(8.9) and lauroxolane (8.10) did not shown large discrepancies with respect to their 13C 
NMR chemical data, thereby supporting the claim that elatenyne exists as a 2,2′-
bifuranyl as in the case for lauroxolane (8.10). This claim is made on the basis of carbon 
chemical shifts, in particular at positions C-9 and C-10 are δ > 76 ppm which as stated 
earlier, are attributed to a 2,2'-bifuranyl system (Table 8.5 and Figure 8.10). 
 
Table 8.5. NMR Spectroscopic data comparison of proposed elatenyne (8.9) to lauroxolane 
(8.10) (L. majuscula-enyne) (C6D6). 
 
 
 
Pos. 
 
δca 
RMIT 
Elatenyne 
(8.9) 
 
δH 
RMIT 
Elatenyne 
(8.9) 
 
δH 
Lauroxolane (8.10) 
 
δca 
(Lauroxolane (8.10) 
 
Δ in δc 
RMIT 
Elatenyne vs 
Lauroxolane 
 
Δ in δH 
RMIT 
Elatenyne vs 
Lauroxolane 
1 82.9c, CH 2.77 2.54 77.3 5.6 0.23 
2 80.2, qC - - 82.1 1.9 - 
3 111.2, CH 5.36 5.35 112.2 1 0.01 
4 140.1, CH 5.72 6.11 140.8 0.7 0.39 
5a 34.7, CH2 2.41 1.99 36.6 1.9 0.42 
5b  2.49 1.83   0.66 
6 86.5, CH 4.06 3.86 85.9 0.6 0.20 
7 49.2, CH 3.53 3.44 48.3 0.9 0.09 
8a 39.1b, CH2 1.91 1.94 38.8 0.3 0.03 
8b   1.84   0.07 
9 80.1, CH 3.86 3.79 79.4 0.7 0.07 
10 79.5, CH 3.86, 3.75 79.9 0.4 0.11 
11a 39.3 b, CH2 2.03 1.98 39.2 0.1 0.05 
11b   1.80   0.23 
12 48.9, CH 3.66 3.48 49.1 0.2 0.18 
13 88.6, CH 3.89 3.88 88.6 0 0.01 
14a 26.8, CH2 1.23 1.21 26.8 0 0.02 
14b  1.37 1.37   0.00 
15 10.1, CH3 0.81 0.8 10.1 0 0.01 
aCarbon assignments based on HSQCAD and DEPT experiments 
bsignals may be interchanged 
cObserved in the DEPT90 when J = 210 Hz 
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13
O
O
Br
Br
85.9 (86.5) C = 0.6 ppm
79.4 (80.1) C = 0.7 ppm
79.9 (79.5) C = 0.4 ppm
88.6 (88.6) C = 0.0 ppm
 
Figure 8.10. Selected 13C chemical shifts comparing lauroxolane (8.10) to RMIT 
elatenyne (in brackets) illustrating δΔC (ppm). 
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Ring carbons bound to oxygen in known fused pyran compounds (8.14) all 
display markedly lower chemical shifts than the corresponding carbons in known 
bifuranyl such as 8.10. 
1D NOE studies were carried out on RMIT elatenyne (8.9) in CDCl3 (Table 8.1) 
and the spectroscopic data was compared to the four possible stereoisomers proposed 
by Smith and co-workers (8.9, 8.11-8.13). Compounds 8.11 and 8.12 were noted as 
possible candidates for the proposed structures of elatenyne on the basis of the 1D 
NOE enhancements expected for these alternate structures. Key NOE enhancements 
from δ 3.96 (1H, dt, J = 5.5, 6.0 Hz, H-12) to δ 4.15 (1H, ddd, J = 5.5, 7.0, 12.0 Hz, H-9) 
was not observed in the single irradiation NOE experiments carried out. Furthermore 
the methines at δ 4.22 (1H, dt, J = 5.3, 6.0 Hz, H-6) and δ 4.05 (1H, dt, J = 5.5, 7.0 Hz, H-
7) which are on opposite faces and are adjacent to each other did not show any NOE 
enhacements and on the basis of this, 8.11 and 8.12 were ruled out. However, selective 
1D NOE studies to confirm the relative configuration for compounds 8.9 and 8.13  
could not be achieved due to the overlap of proton chemical shifts contributing to 
second order splitting. Since 1H and 13C NMR shifts at positions C-8 to C-11 could not 
be unequivocally assigned by NMR spectroscopy in CDCl3, single irradiation NOE 
experiments were inconclusive. Difficulties  when irradiating protons at these positions 
inadvertedly resulted in the irradation of nearby 1H NMR chemical shifts. Attempts to 
secure the absolute configuration by single-crystal X-ray crystallography were 
unsuccessful as crystals of elatenyne could not be obtained due to the instability of the 
compound. 
Further investigation into the structure of elatenyne is required. This involves 
further studies of the relative configuration of elatenyne to be established by carrying 
out ROESY, NOESY and Selective 1D NOE NMR experiments in C6D6 as signals in this 
solvent appear to be slightly  more resolved  compared to the overlapping proton 
signals recorded in CDCl3; or an attempt to solve the absolute configuration by single-
crystal X-ray crystallography would be ideal. 
 
8.2.2.3  Isolation of Cycloelatanene A (8.15) and Cycloelatanene B (8.18) 
Cycloelatanene A (8.15) was isolated as an colourless oil for which high resolution ESI-
MS established the molecular formula as C16H24BrClNaO2 (385.0541 [M+Na]+, calcd for 
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C16H24BrClNaO2, 385.0546) [M+Na]+ possessing four degrees of unsaturation. An 
optical rotation of [α]D23 - 80° was observed for (8.15). Analysis of the 1H (Figure 8.11), 
13C NMR and HSQCAD NMR experiments indicated the presence of one methoxy 
moiety δ 3.63, s, 3H; 60.3 (C-13); four methyls [δ 1.29, s, 3H; 30.1 (C-12), 1.14, s, 3H; 22.7 
(C-15), 1.13, s, 3H; 29.2 (C-14) and (δ 1.62, s, 3H; 28.1 (C-16) ppm], three methylenes [(δ 
2.21, ddd, J = 4.0, 7.5, 12.0 Hz; 1.68, d, J = 12.5 Hz, 2H; 33.4 (C-7), 1.98, m; 1.54, ddd, J = 
7.0, 12.5, 19.5 Hz, 2H; 31.6 (C-11); 1.83, dd, J = 7.0, 13.5 Hz; 2.94, ddd, J = 8.0, 13.0, 20.0 
Hz, 2H; 37.5 (C-10)], three methines [(δ 6.21, d, J = 6.0 Hz, 1H; 128.2 (C-3), δ 3.67, dd, J = 
6.0, 0.5 Hz, 1H; 82.4 (C-4), 4.30, dd, J = 7.5, 1.0 Hz, 1H; 84.3 (C-8) and five quaternary 
carbons [45.4 (C-1), 139.1 C-12), 85.7 (C-5), 48.8 (C-6) and 74.7 (C-9) ppm] (see Table 8.6 
and Figure 8.12). 
A
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16
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Figure 8.12. Structural fragments of cycloelatanene A (8.15). 
A combination of the COSY and HMBC NMR experiments confirmed fragment 
A to be similar to that present in laureacetal-B (8.18) (Suzuki and Kurosawa, 1979). The 
two geminal methyl groups, δ 1.14 and δ 1.13 both showed 3J HMBC correlation to the 
each other and to the brominated olefinic moiety at 139.1 (C-2) ppm. Similarly the 
olefinic methine at δ 6.21, d, J = 6.0 Hz showed 3J  HMBC correlations δ C 45.4 (C-1) and 
to 85.7 (C-5) ppm. COSY correlations confirmed the placement of the methine at δ 3.67, 
dd, J = 6.0, 0.5 Hz which showed a 3J HMBC correlation to the oxygenated methyl 
group at 30.1 (C-12) ppm, to the adjacent methoxy moiety at 60.3 (C-13) ppm and to the 
spiro carbon at 48.8 (C-6) ppm. Furthermore, the coupling constant for δ 3.67 is 
consistent with that previously reported for laureacetal-B (8.16) (δ 6.60, d, J = 7.0 Hz) 
(Suzuki and Kurosawa, 1979). The 1H and 13C NMR assignment of fragment A was 
found to be similar to previously reported chamigrenes in the literature (Kimura et al., 
1999; Kurata et al., 1983a; Suzuki et al., 1985).  
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Laureacetal B (8.16) 
 
Fragment B was found to be similar to that present in laurencial (8.17) (Kurata 
et al., 1983b). An oxygenated methine at δ 4.30, dd, J = 1.0, 7.5 Hz showed 3J HMBC 
correlation to the spiro centre at 48.8 (C-6) ppm and a 2J HMBC correlation to 74.7 (C-9) 
ppm. This 13C chemical shift is consistent with an attached chlorine and a methyl 
group at δ 1.62 as observed in many of the previously isolated chamigrenes at this 
position (Kaiser et al., 2001; Kurata et al., 1983b; Sims et al., 1971). Furthermore, the 
coupling constant for δ 4.30 is consistent with that previously reported for laurencial 
(8.16) (δ 4.11, d, J = 6.0 Hz) (Kurata et al., 1983b).  
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O H
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15
 
Laurencial (8.17) 
 
Connectivity of Fragments A and B were deduced by key HMBC correlations, 
in particular from the δ 4.30 to the 85.7 (C-5) ppm, accounting for the final double bond 
equivalent and from the methylenes at δ 1.98, m and 1.54, ddd, J = 7.0, 12.5, 19.5 Hz to 
85.7 (C-5) ppm, the spiro centre at 48.8 (C-6) ppm and to adjacent methylenes at 37.5 (C-
10) and 33.4 (C-7) ppm (Figure 8.13). 
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Figure 8.13.  Key HMBC correlations of cycloelatanene A (8.15). 
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Table 8.6. NMR spectroscopic data (500 MHz, CDCl3) for cycloelatanene A (8.15). 
 
Br
O
CH3
CH3
H3C
CH3
Cl
H3C
O
1
3
5 106
8
H
H
14
16
12
13
 
 
 
Pos 
 
δH (J in Hz) 
 
 
δca, mult 
 
gCOSY 
 
 
gHMBC 
 
 
1D NOE 
1 - 45.4, qC - - - 
2 - 139.1, qC - - - 
3 6.21, d, J = 6.0 Hz 128.2, CH H-4 C-1, C-2, C-5 H-4, H-14 
4 3.67, dd, 
J =  6.0, 0.5 Hz 
82.4, CH H-3 C-2, C-3, C-5, C-6, 
C-12, C-13 
 
5 - 85.7, qC - - - 
6 - 48.8, qC - - - 
7a 2.21, ddd, 
J =  4.0, 7.5, 12.0 Hz 
33.4, CH2 H-8, H-11, H-7b 
 
C-6, C-8, C-9, C-11 
 
H-7b, H-8, H-12, H-15 
7b 1.68, d, J =  12.5 Hz  H-7a C-8, C-9, C-11a H-7a, H-8, H-14 
8 4.30, dd, J = 7.5, 1.0 Hz 84.3, CH H-7a C-5, C-6, C-9, C-10 H-7a, H-7b, H-12, H-13, 
H-15,  
9 - 74.7, qC - - - 
10a 1.83, dd, J =  7.0, 13.5 Hz 37.5, CH2 H-10b, H-11b C-6, C-8, C-9, C-11a,  
C-16 
H-10b 
10b 2.94, ddd, 
J =  8.0, 13.0, 20.0 Hz 
 H-10a, H-11a C-9, C-11, C-16 H-13, H-10ª, H-11a 
11a 1.98, m 31.6, CH2 H-7a, H-10b, H-11b 
 
C-6, C-7, C-9, C-10a 
 
H-11b, H-15 
 
11b 1.54, ddd, 
J =  7.0, 12.5, 19.5 Hz 
 H-10a, H-10b, H-11a, 
H-16(w) 
C-5, C-6, C-7a, C-10a H-11a, H-14  
12 1.29, s 30.1, CH3 - C-4, C-5, C-6 - 
13 3.63, s 60.3, CH3  C-4 H-3, H-10b, H-12 
14 1.13, s 29.2, CH3 - C-2, C-15 H-13 
15 1.14, s 22.7, CH3 - C-2, C-14 H-12 
16 1.62, s 28.1, CH3 H-11b(w) C-8, C-9, C-10a H-8, H-10a 
aCarbon assignments based on HSQCAD and DEPT experiments 
w = weak correlation  
 
The relative configuration for cycloelatanene A (8.15) was proposed on the basis 
of selective 1D NOE NMR experiments and coupling constants reported for model 
compounds in the literature (described above). Key ID NOE enhancements were 
observed from the methyl group at δ 1.29 to one of the geminal methyls at δ 1.14. The 
deshielded methine at δ 4.30 showed a NOE enhancements to the methyl at δ 1.14 and 
to the deshielded methyl at δ 1.29. The methoxy group at δ 3.63 showed a NOE 
enhancement to the methyl at δ 1.29, positioning all these groups on the same face as 
shown below in Figure 8.12. A 3D model (MM2, energy minimised) of cycloelatanene 
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A (8.15) was constructed to illustrate these NOE enhancements and the confirmation in 
space (Figures 8.14 and 8.15).  
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Figure 8.14 Key 1D NOE enhancements of cycloelatanene A (8.15). 
 
Figure 8.15.  Key 1D NOE enhancements of cycloelatanene A (8.15), 
(MM2 Energy minimised) 
                          - - - - - - - : distance measured in Å. 
 
Cycloelatanene B (8.18) was immediately recognised to be a stereoisomer of 
cycloelatanene A (8.15) on the basis of the similarity of the IR, UV, 1H (Figure 8.16) and 
13C NMR spectra (Table 8.7).  Cycloelatanene B (8.18) was isolated as a colourless oil 
and HR-EI-MS confirmed that 8.18 possessed a molecular formula as C16H24BrClO2 
(364.0633 [M]+, calcd for C16H24BrClO2, 364.0628) possessing four degrees of 
unsaturation.  The IR and UV spectra of cycloelatanene B (8.18) was found to be 
identical to (8.15).  Analysis of the 1H NMR, 13C NMR and HSQCAD NMR 
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experiments indicated the presence of one methoxy moiety δ 3.53, s, 3H; 58.2 (C-13) 
four methyls [δ 1.27, s, 3H; 22.7 (C-12), 1.18, s, 3H; 22.6 (C-15), δ 1.09, s, 3H; 28.6 (C-14) 
and 1.60, s, 3H; 26.9 (C-16)], three methylenes [δ 2.22, ddd, J = 4.0, 7.5, 12.0 Hz; 1.68, d, J 
= 12.0 Hz, 2H; 32.5 (C-7), δ 1.70, m; 1.56, m, 2H; 30.4 (C-11); δ 2.58, ddd, J = 7.0, 14.0, 
20.0 Hz; 1.95, dd, J = 6.0, 11.0 Hz, 2H; 38.2 (C-10)], three methines [δ 5.98, d, J = 1.6 Hz, 
1H; 131.0 (C-3), δ 4.17, d, J = 1.6 Hz, 1H; 80.3 (C-4), δ 4.29, brd, J = 7.5 Hz, 1H; 84.5 (C-
8)] and five quaternary carbons [δ 45.1 (C-1), 135.2 (C-12), δ 86.8 (C-5), 50.1 (C-6) and 
72.7 (C-9) ppm (Table 8.7).  
Analysis of the 1H NMR spectrum of cycloelatanene B (8.18) (Figure 8.16) 
identified slight changes in both chemical shifts and coupling constants. The methine at 
δ 4.17 in cycloelatanene B (8.18) displayed a coupling constant of J = 1.5 Hz whereas in 
cycloelatanene A (8.15) the corresponding chemical shift at δ 3.67 had a coupling 
constant of J = 6.0, 0.5 Hz. This chemical shift and coupling difference observed was 
consistent with that observed in the previously isolated compound, 8-epi-laureacetal B 
(8.19) as δ 3.91, d, J = 1.5 Hz (Figure 8.17) (Suzuki and Kurosawa, 1979). 8-epi-
laureacetal B (8.19) is incorrectly reported as 8-epi-laureacetal, since this compound is 
epimeric at C-7. 
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Figure 8.17.  Arrow denotes epimeric configuration at C-7 for 8-epi-laureacetal B (8.19). 
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Table 8.7. NMR Spectroscopic Data (500 MHz, CDCl3) for cycloelatanene B (8.18). 
 
Br
O
CH3
CH3
H3C
CH3
Cl
H3C
O
1
3
5 106
8
H
H
14
16
12
13
 
 
 
Pos. 
 
δH (J in Hz) 
 
 
δca, mult 
 
gCOSY 
 
 
gHMBC 
 
 
1D NOE 
1 - 45.1, qC - - - 
2 - 135.2, qC - - - 
3 5.98, d, J = 1.6 Hz 131.0, CH H-4 C-1, C-2, C-5 H-4, H-12, H-13 
4 4.17, d, J = 1.6 Hz 80.3, CH H-3 C-2, C-3, C-5, C-13 H-3, H-10a, H-7a, H-13, 
5 - 86.8, qC - - - 
6 - 50.1, qC - - - 
7a 1.68, d, J = 12.0 Hz 32.5, CH2 H-7b C-5, C-6, C-9, C-11 H-4, H-7b, H-14,  
7b 2.22, ddd, J = 4.0, 7.5, 12.0 
Hz 
 H-8, H-7a C-5, C-6, C-9, C-11 H-7a, H-8, H-12, H-15 
8 4.29, brd, J = 7.5 Hz 84.5, CH H-7b C-5, C-9, C-10 H-7a, H-7b, H-12, H-16 
9 - 72.7, qC - - - 
10a 2.58, ddd,  
J = 7.0, 14.0, 20.0 Hz 
38.2, CH2 H-10b, H-11b, 
H-11a, H-16 
C-9, C-11, C-16 H-4, H-10b, H-13 
10b 1.95, dd, J = 6.0, 11.0 Hz  H-10a, H-11a C-6, C-8, C-9, C-11, 
C-16 
H-10a, H-11a, H-11b 
11a 1.56, m  30.4, CH2 H-10a, H-10b C-5, C-6, C-7, C-10 H-14, H-11b, H-10a,  
H-10b 
11b 1.70, m  H-10a - H-10a, H-7b, H-10b 
12 1.27, s 22.7, CH3 - C-5, C-4, C-6 H-3, H-7b, H-13, H-15 
13 3.53, s 58.2, CH3 - C-4 H-3, H-4, H-12 
14 1.09, s 28.6, CH3 - C-1, C-2, C-6, C-15 H-11a, H-11b 
15 1.18, s 22.6, CH3 - C-6, C-1, C-2, C-14 H-7b, H-11b 
16 1.60, s 26.9, CH3 - C-8, C-9, C-10 H-8, H-10b 
aCarbon assignments based on HSQCAD and DEPT experiments 
 
Analysis of the 1H NMR spectra of both compounds concluded that 8.15 and 
8.18 were diastereoisomers. The largest differences in chemical shifts in the 1H NMR 
spectra of both (8.15) and (8.18) was for the methine at δ 4.17, d, J = 1.5 Hz, H-4 
compared to δ 3.67, dd, J = 6.0, 0.5 Hz. A change was also observed for the adjacent 
methyl group at  δ 1.27, s, H-12; 22.7 ppm in (8.18) compared to δ 1.29, s, H-12; 30.1 
ppm (8.15). This confirms that the largest chemical shift differences between these two 
proposed compounds effected positions C-4 and the methyl group at C-5. Therefore, it 
is suggested that cycloelatanene B (8.18) is epimeric at C-4 as all other 1H NMR 
chemical shifts (including coupling constants) and 13C NMR shifts did not greatly 
differ.  
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The relative configuration of cycloelatanene B (8.18) was confirmed by single 
irradiation NOE experiments with selective irradiations shown in Figure 8.18. These 
key NOE enhancements confirmed that cycloelatanene A (8.15) and cycloelatanene B 
(8.18) are epimeric at C-4, along with comparison of the coupling constants to model 
compounds previously reported in the literature and the fact that the carbon at C-4 and 
the methoxy group at C-12, displayed the greatest 1H and 13C chemical shifts, 
supported the structures of the novel C16 epimeric compounds 8.15 and 8.18. 
 
Br
O
CH3
CH3
H3C
CH3
Cl
H3C
O
H
H
H
H
H
H
H
H4.1 7, d
5.98, d
3. 53, s
1.1 8, s
1. 09, s
1.70 , m
1.56 , m
1. 95, d d
2.58 , dd d
2.22 , d dd
1.68 , d
1.27 , s
4 .29, brd
1 .60, s
H
 
Figure 8.18.  Key 1D NOE enhancements of cycloelatanene B (8.18). 
 
A combination of both the 1D and 2D NMR data supports the structural 
assignment of these two novel metabolites. Though there were minor discrepancies 
with respect to the 1D NOE data for both cycloelatanene A (8.15) and cycloelatanene B 
(8.18) the relative configurations for both compounds has been proposed and the 
relative configuration at other chiral centres cannot be dismissed. 
 
8.3 Biological Evaluation and Details of Assays 
 
Extracts of the alga were evaluated (tested at 50 mg/mL) in a number of biological 
assays including against a P388 Murine Leukaemia cell line (antitumor assay), against 
Herpes simplex and Polio viruses (antiviral assays) as well as against a number of 
bacteria and fungi (antimicrobial assays) at the University of Canterbury, Christchurch, 
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New Zealand. Insignificant antitumor activity was observed for the alga extract 
(168632 ng/mL at 50 mg/mL). In addition the extract displayed cytotoxic activity 
against the Herpes simplex and the Polio virus as well as moderate antimicrobial activity 
(a 1 mm zone of inhibition was detected against Trichophyton mentagrophytes). No 
activity was observed for the extract against Eschericha coli, Pseudomonas aeruginosa, 
Candida albicans, Bacillus subtilis or Cladosporium resinae.  
Compounds (8.5, 8.7, 8.9, 8.15, 8.18) displayed no appreciable antitumor activity 
(IC50 of >12500 ng/mL when tested at 1 mg/mL). Recently the antimicrobial and 
antiviral assays conducted at the University of Canterbury were phased out which 
meant that no antiviral assessment of the isolated compounds could be carried out. 
Further details on the biological assays are detailed in Section 10.1.12 and the 
Appendix. 
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Laurencia elata  (2003-05) 
    
 
Domain: Eukaryota 
Kingdom:  Plantae 
Subkingdom: Biliphyta 
Phylum:  Rhodophyta 
Subphylum: Macrorhodophytina 
Class:   Florideophyceae 
Order:   Ceramiales 
Family:  Rhodomelaceae 
Genus:  Laurencia 
Species:  filiformis 
 
 Collected by Dr Sylvia Urban and Dr Rick Tinker from St. Pauls Beach, Sorrento, 
Victoria, Australia (hand intertidal) 
(March, 2003) 
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9.0 Introduction 
 
Natural products continue to be a major source of drug leads, providing, in general, 
superior structural diversity than that of counterparts arising from combinatorial 
chemistry approaches (Harvey, 2000).  Complex mixtures, such as natural product 
extracts, represent a major challenge in drug discovery and development, often 
resulting in the re-isolation of known secondary metabolites (Yang, 2006).  The process 
known as dereplication involves chemically profiling a complex mixture in an effort to 
circumvent any major isolation processes and is a critical step that is necessary in a 
drug discovery program in order to rapidly differentiate known and nuisance 
compounds from potential new chemical entities.  The process can also provide 
valuable information about pre-fractionation strategies which could be used to direct 
off-line isolation work (Lambert et al., 2005).  The hyphenated spectroscopic technique 
known as HPLC-NMR is a versatile analytical tool, which has demonstrated great 
promise for the analysis of complex mixtures (Urban and Separovic, 2005).  To date 
HPLC-NMR has been mainly applied to the analysis of plant secondary metabolites 
(Clarkson et al., 2006; Cogne et al., 2005; Zschocke et al., 2005) with only a few instances 
of its application to the analysis of secondary metabolites from a marine organism 
being described (Bobzin et al., 2000; Dias and Urban, 2008).  The types of data 
acquisitions used in HPLC-NMR include on-flow and stop flow techniques.  On-flow 
HPLC-NMR measurements are mainly restricted to the direct measurement of the 
                                            
†
Dias DA and Urban, S. 2009. Application of HPLC-NMR for the Rapid Chemical Profiling of a Southern Australian 
Sponge, Dactylospongia sp. J. Sep. Sci. 32: 542-548. 
Application of HPLC-NMR for the  
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main constituents of a crude extract where the HPLC injection has often been 
deliberately overloaded.  Limits of detection can be improved by performing the 
analysis at low flow rates or by running time slice experiments over a whole 
chromatogram where the flow is stopped at defined time intervals.  Stop-flow mode is 
more sensitive since it enables longer acquisition times. This allows reasonable spectra 
for minor compounds and even 2D NMR experiments for major compounds. The stop-
flow mode can be employed so that samples may be analysed directly as they elute 
from the column, one chromatographic peak at a time.  Stop-flow acquisition is a 
simpler mode but the repeated stop/go disturbances of the HPLC gives rise to peak 
diffusion during long-lasting experiments as well as memory effects if a large peak 
precedes a small peak. 
Chemical investigations of marine sponges belonging to the genus 
Dactylospongia have resulted in a number of structural classes and various biological 
activities being reported.  Some examples include the isolation of several 
diastereoisomeric sesquiterpene cyclopentenones such as dactylospongenone A (9.1), 
which was deduced by spectroscopic techniques including X-ray crystallography 
(Kushlan et al., 1989).  In 1994 a new species of a Southern pacific sponge Dactylospongia 
sp.  afforded two new isomeric sesterterpene lactones including (9.2) (Lal et al., 1994). 
 
      
H3CO
O
OH
COOCH3
H
   
O
O
H
OO
H
OAc
 
    dactylospongenone A (9.1)                                          9.2 
 
 One of the most active compounds isolated from the genus Dactylospongia, 
which was collected off the coast of the Vanuatu islands, was dactylolide (9.3) which 
displayed cytotoxic activity against the L1210 and SK-OV-3 tumour cell lines (63% and 
40% inhibition respectively at 3.2 g/mL) (Cutignano et al., 2001).  Due to the unique 
structure of 9.3, together with its reported potent antitumour activity, a total synthesis 
was undertaken and the relative and absolute configuration assignments achieved 
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(Hoye and Hu, 2003; Louis et al., 2006; Smith III and Safonov, 2002).  Only recently, an 
investigation of the sponge, Dactylospongia sp., collected near Moolloolaba in south 
eastern Queensland, afforded the novel cyclopropyl-substituted sesquiterpene 
quinone, dactylospongiaquinone (9.4), for which the structure was determined by 
extensive 1D and 2D NMR, NOESY experiments and molecular modeling (Jankama et 
al., 2007).  The extract of this sponge displayed cytotoxic and antimicrobial activities 
(Jankama et al., 2007).   
 
    
O
H H
O
O
O
H
            
H OH
O
O
OCH3
 
               (+)-dactylolide (9.3)                           dactylospongiaquinone (9.4) 
 
This chapter reports the chemistry and biological activity of the Southern 
Australian marine sponge, Dactylospongia sp., collected from Gunnamatta Beach, 
Victoria, Australia.  The crude extract demonstrated moderate antiviral and 
antitumour activities together with slight antimicrobial activities (Section 9.3), which 
prompted an investigation of the chemical constituents. Both on-flow and stop-flow 
HPLC-NMR analyses of the DCM crude extract followed by subsequent off-line 
isolation, resulted in the identification of the pentaprenylated p-quinol, 9.5.  This 
chapter reports one of the few applications of HPLC-NMR analysis to rapidly profile 
the extract of a marine sponge, together with the first complete structural 
characterisation of 9.5 involving 2D NMR spectroscopy and for the first time, the 
moderate antitumour activity observed for 9.5. 
OH
OHCH3CH3CH3CH3
H3C
CH3
1 1'
3
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20
25 21
7
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3' 5'
 
          The pentaprenylated p-quinol, 9.5  
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9.1. Collection, Extraction and Isolation 
 
9.1.1 Sponge Material 
 
The Dactylospongia sp. sponge specimen was collected by SCUBA at a depth of 8-15 
meters from Gunnamatta Beach (Lat 38° 23.59′S Long 144 47.03′E), Victoria, Australia 
on the 26th of November, 2004 and identified as Dactylospongia sp. A voucher specimen 
designated the code SU-2004-48 has been deposited at the Museum of Victoria. A 
photograph of the sponge Dactylospongia sp. is shown on page 321. 
 
9.1.2 Preparation of the Extract of Dactylospongia sp. for HPLC-NMR Analysis 
 
A frozen sample of Dactylospongia sp. was diced and extracted with DCM (50 mL) by 
soaking overnight.  This extract was then decanted and concentrated under reduced 
pressure, re-solubilised with CH3CN (100%) and filtered through 0.45  PTFE 
membrane filters (HP045 Advantec, Japan).  For both the on-flow and stop-flow HPLC-
NMR experiments 50 µL (553 µg of extract) of the DCM extract was injected and 
monitored at λmax 210 and 254 nm component (Scheme 9.1).  The HPLC-NMR analysis 
was performed using the conditions described in Section 10.1.4. 
 
9.1.3 Off-line Isolation of the pentaprenylated p-quinol (9.5)  
from Dactylospongia sp. 
 
In an effort to gain further information about the complete structure of 9.5, a second 
extraction of the sponge was performed.  Dactylospongia sp. (43 g) (21 g dr. wt.) was 
extracted with 3:1 MeOH:DCM (500 mL).  This crude extract was decanted and 
concentrated under reduced pressure before partitioning into DCM (300 mL) and 
MeOH (300 mL) soluble fractions, respectively and stored at 4C.  Analytical HPLC of 
the DCM crude extract confirmed that this fraction contained the major compound 9.5, 
tentatively identified by HPLC-NMR.  Approximately half of the DCM crude extract 
(720 mg) was filtered through 0.45 µ PTFE membrane filters and a portion of the dark 
green extract was immediately subjected to semi-preparative reversed phase HPLC 
(100% CH3CN) to yield pentaprenylated p-quinol (9.5) (> 95% purity) (85 mg, 0.4 %) as 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
312 | P a g e  
the major component. (% based on the mass of the dried weight of the marine sponge as 
shown in Scheme 9.1).  
Dactylospongia (43 g)
3:1 (MeOH:DCM) (500 mL)
DCM (300 mL) MeOH (300 mL)
Reversed phase
Analytical HPLC
HPLC-NMR Analysis
(On-flow and Stop-flow)
(dark green)
(720 mg)
Semi-Preparative RP-HPLC
(CH3CN) (100%)
the pentaprenylated p-quinol, 9.5
(85 mg, 0.4 %)
 
Scheme 9.1. Extraction and isolation procedure adopted for Dactylospongia sp. 
 
9.2 Results and Discussion 
 
A fresh extraction of Dactylospongia sp. was carried out using 100% DCM as the 
extraction solvent.  Once an off-line HPLC method for the effective separation of the 
DCM crude extract was established, HPLC-NMR profiling of the extract was achieved 
using both on-flow and stop-flow modes.  Initial on-flow HPLC-NMR analysis of the 
DCM crude extract resulted in a WET1D (1H NMR) spectrum with poor S/N for the 
major component.  The DCM crude extract was re-injected and then manually stopped 
(using the stop-flow HPLC-NMR mode), which permitted for longer acquisition times 
(typically 20 minutes), resulting in a greatly improved S/N WET1D spectrum for the 
major component (Figures 9.1B and 9.1C).  Analysis of the stop-flow HPLC-NMR 
WET1D spectrum immediately identified the presence of an hydroquinone moiety [δ 
6.54, d, J = 8.5 Hz (H-6´); 6.47, d, J = 3.0 Hz (H-3´) and 6.39, dd, J = 3.0, 8.5 Hz (H-5´)] 
together with olefinic methines [δ 5.23, t, J = 7.5 Hz (H-2); 5.05, m (H-6/H-10/H-14/H-
18)] and olefinic methyl moieties, [δ 1.64, s (H-21); 1.60, s (H-20) and 1.52, s (H-22/H-
23/H-24/H-25)] characteristic of a linear terpene (Section 10.9).   Several other signals, 
which were either fully or partially suppressed, as a result of the solvent WET1D 
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suppression of both the CH3CN and HDO resonances, could not be unequivocally 
identified.  In this way pentaprenylated p-quinol (9.5) could only be tenatively 
identified as the major component in the DCM crude extract (Figure 9.1).   
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Hyphenated spectroscopic methods such as HPLC-NMR are very useful for the 
chemical profiling of crude or enriched fractions, but often must be combined with 
conventional off-line approaches, especially in the case of novel secondary metabolite 
identification.  The limitations of HPLC-NMR include the sensitivity or limit of detection (i.e. 
requires HPLC overloading which affects separation); the fact that not all the information 
acquired by conventional measurement in standard deuterated NMR solvents can be 
obtained (i.e. the use of solvent suppression often leads to the suppression of analyte signals 
that reside under or adjacent to the solvent peaks); and that the chemical shifts recorded in 
the reversed phase solvents (i.e.  CH3CN/D2O) often differ from those reported in standard 
deuterated NMR solvents.  This can be a drawback if precise comparisons with literature 
data are necessary (Dias and Urban, 2008; Urban and Separovic, 2005).  The off-line isolation 
of 9.5 by reversed phase HPLC was deemed necessary for two reasons.  Firstly the major 
component in the DCM crude extract was only partially identified from HPLC-NMR studies 
due to the incomplete observation of signals resulting from solvent suppression.  Secondly, 
since the 3:1 MeOH/DCM crude extract displayed moderate antitumour activity, isolation of 
9.5 was necessary to obtain sufficient quantities to permit biological testing.  In this way, a 
combined approach using both off-line (HPLC isolation) and on-line (HPLC-NMR) chemical 
profiling was necessary to establish the nature of the principal components in the DCM 
crude extract.   
For the off-line HPLC purification study, the sponge sample was extracted with 3:1 
MeOH:DCM and then sequentially partitioned between DCM and MeOH soluble fractions, 
respectively.  A combination of both 1H NMR and analytical HPLC analysis of the crude 
DCM extract confirmed the presence of 9.5 as the major component previously identified 
using HPLC-NMR.  The MeOH crude extract was analysed using a combination of both 
analytical HPLC and 1H NMR experiments.  Since 1H NMR of the MeOH crude extract did 
not reveal any signals reminiscent of the terpenoid type structures or other signals of interest, 
only the DCM crude extract was subjected for further analysis to avoid possible sample 
degradation, the DCM crude extract was immediately filtered and subjected to semi-
preparative reversed phase HPLC, which resulted in the isolation of 9.5.  Analytical HPLC 
indicated that this was the major component present in the DCM crude extract apart from 
some minor polar constituents. 
The structure of 9.5 was confirmed by 1D and 2D NMR spectroscopy (Table 9.1) as 
well as by mass spectrometry.  The ESI-MS showed the presence of m/z 449 [M-H]-, 
consistent with a molecular formula C31H46O2 and nine degrees of unsaturation.  The 13C 
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NMR spectrum of 9.5 indicated the presence of 31 carbons [eight methines, nine methylenes, 
six methyls and eight quaternary carbons] as supported by a HSQCAD NMR experiment.  
The IR spectrum of 9.5 showed absorptions at 3392 and 1659 cm-1, which were consistent 
with the presence of hydroxy and olefinic moieties.  The 1H NMR and gCOSY NMR spectra 
(acquired in CDCl3) identified the presence of a 1,2,5-trisubstituted aromatic ring [δ 6.60, d, J 
= 2.5 Hz (H-3´); 6.57, dd, J = 2.5, 8.5 Hz (H-5´) and 6.68, d, J = 8.5 Hz (H-6´)]; five olefinic 
methines [δ 5.30, t, J = 7.0 Hz (H-2); 5.10, t, J = 7.0 Hz (H-6/H-10/H-14/H-18)]; eight 
methylenes [four with proton signals at δ 2.06, m, 4H and 1.98, m, 4H (H-4/H-8/H-12/H-
16)]; and four with proton signals at [δ 2.13, m, 4H and 2.08, m, 4H (H-5/H-9/H-13/H-17)]; 
one characteristic benzylic methylene [δ 3.30, d, J = 7.0 Hz (H-1)]; and six olefinic methyls [δ 
1.76, s (H-21); 1.60, s (H-22/H-23/H-24/H-25) and δ 1.68, s (H-20)] (Section 10.9). 
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Table 9.1. NMR Data (500 MHz, CDCl3) for the pentaprenylated p-quinol, 9.5. 
 
OH
OHCH3CH3CH3CH3
H3C
CH3
1 1'
3
513
18
20
25 21
7
10
3' 5'
 
 
 
position 
 
δH (J in Hz) 
 
δca, mult 
 
gCOSY 
 
gHMBC 
 
1 3.30, d, (7.0) 29.7, CH2 H-2, H-21(w) C-2, C-3, C-1‘, C-2‘, C-3‘ 
2 5.30, t, (7.0) 121.2, CH H-1, H-21(w) C-1, C-2, C-4, C-21 
3 - 135.0, qC - - 
4 
1.98, m 
2.06, m 
39.7, CH2 H-6 (w) 
H-6 (w) 
C-2, C-3, C-5, C-6,  
- 
5 
2.13, m 
2.08, m 
26.8, CH2 H-6  
H-6 
C-3, C-4, C-6, C-7  
- 
6 5.10, t, (7.0) 124.2, CH H-5, H-22 C-4, C-5, C-8, C-22 
7 - 135.6, qC - - 
8 
1.98, m 
2.06, m 
39.7, CH2 H-6 (w), H-10 (w) 
H-6 (w), H-10 (w) 
C-6, C-7, C-9, C-10 
9 
2.13, m 
2.08, m 
26.7, CH2 H-10 
H-10 
C-7, C-8, C-10, C-11 
10 5.10, t, (7.0) 124.3, CH H-9, H-23 C-8, C-9, C-12, C-23 
11 - 134.9, qC - - 
12 
1.98, m  
2.06, m 
39.6, CH2 H-10 (w), H-14 (w) 
H-10 (w), H-14 (w) 
C-10, C-11, C-14, C-23 
- 
13 
2.13, m 
2.08, m 
26.6, CH2 H-14 
H-14 
C-11, C-12, C-14, C-15  
14 5.10, t, (7.0) 124.4, CH H-13, H-24 C-12, C-16, C-24 
15 - 138.7, qC - - 
16 
1.98, m 
2.06, m 
39.6, CH2 H-14 (w), H-18 (w) 
H-14 (w), H-18 (w) 
C-14, C-15, C-17, C-18, C-24 
- 
17 
2.13, m 
2.08, m 
26.4, CH2 H-18 
H-18 
C-15, C-16, C-18, C-19 
18 5.10, t, (7.0) 123.6, CH H-17, H-20 (w), H-25 (w) C-16, C-20, C-25 
19 - 131.3, C - - 
20 1.68, s 25.7, CH3 H-18 (w) C-18, C-19, C-25 
21 1.76, s 16.2 , CH3 H-1 (w), H-2 (w) C-2, C-4 
22 1.60, s 16.1, CH3 H-6 (w) C-6, C-7, C-8 
23 1.60, s 16.0, CH3 H-10 (w) C-10, C-11, C-12 
24 1.60, s 15.9, CH3 H-14 (w) C-14, C-15, C-16 
25 1.60, s 17.7, CH3 H-18 (w) C-18, C-19, C-20 
1‘ - 149.3, qC - - 
2‘ - 128.2, qC - - 
3‘ 6.60, d, (2.5) 116.6, CH - C-1, C-1‘, C-4‘, C-5‘ 
4‘ - 148.2, qC - - 
5‘ 6.57, dd, (2.5, 8.5) 113.7, CH H-6‘ C-1‘, C-4‘, C-6‘ 
6‘ 6.68, d, (8.5) 116.5, CH H-5‘ C-1‘, C-2‘, C-4‘ 
     
aCarbon assignments based on HSQCAD and DEPT experiments 
w = indicates a weak correlation 
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The HMBC NMR experiment permitted complete assignment of 9.5 (Table 9.1).  
Vicinal coupling from δ 6.60 (H-3´) to the carbon signal at δ 29.7 (C-1) unequivocally 
positioned the aromatic methine ortho to the benzylic methylene moiety, whilst correlations 
observed from the benzylic methlyene signal at δ 3.30 (H-1) to the carbon signals at δ 128.2 
(C-2´), 116.6 (C-3´) and to the carbon bearing the hydroxy substituent at δ 149.3 (C-1´) 
(representative of 2J, 3J and 3J couplings, respectively) attached the linear terpene unit to the 
hydroquinone moiety.  A key HMBC correlation was observed from the methylene proton 
signals at δ 2.13, 2.08 (H-17) to the olefinic carbon signals at δ 123.6 (C-18) and 131.3 (C-19) (2J 
and 3J couplings respectively), ultimately positioning the terminal trisubstituted double 
bond.  Furthermore, HMBC correlations from the terminal olefinic methyl signals at δ 1.68, s, 
(H-20) to the carbons signals at δ 131.3 (C-19), 123.6 (C-18) and 17.7 (C-25) (2J, 3J and 3J 
couplings) and from the terminal methyl signal at δ 1.60, s (H-25) to the carbon signals at δ 
131.3 (C-19), 123.6 (C-18) and 25.7 (C-20) (2J, 3J and 3J couplings respectively) also supported 
the structure of 9.5 (Table 9.1 and Figure 9.2). 
 
OH
OHCH3CH3CH3CH3
H3C
CH3
H H H H H
H H
H1 1'
3
513
18
20
25 21
7
10
3'
5'
 
Figure 9.2 Key HMBC NMR correlations observed for 9.5. 
 
Prenyl-1,4-benzoquinols of differing chain lengths have previously been identified 
from various marine organisms including sponges and it was not until 1975 that 9.5 was 
reported from Australian species, but although acknowledged in a review, an earlier claim to 
the isolation of 9.5 remained undocumented (Baker, 1976; Cimino et al., 1975; Cimino et al., 
1972).  It was not until the early 1990s, that the isolation of 9.5 was substantiated for the first 
time by publication of the spectral data for this compound from the Australian marine 
sponge, Spongia sp. (Lumsdon et al., 1992).  At the time, the pentaprenylated p-quinol, 9.5 was 
characterised by 1D NMR spectroscopy and the 13C NMR shifts were compared to model 
compounds in the literature (Lumsdon et al., 1992).  In this way the proton chemical shifts for 
9.5 were assigned but the carbon chemical shifts remained unassigned.  In 2001, 9.5 was also 
isolated and reported from the sponge Thorecta reticulata, collected from the Kaikoura 
Peninsula, New Zealand (Cambie et al., 2001).  As a result of that re-isolation of 9.5, it was 
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found that the 13C NMR data was identical to that previously reported (Lumsdon et al., 
1992).  However, Cambie showed that the signals of a terminal methyl group and the 
terminal olefinic proton in the 1H NMR spectrum of 9.5 were incorrectly assigned on the 
basis of a COSY NMR experiment (Lumsdon et al., 1992).  In the original assignment the 
terminal methyl group was assigned at δ 1.75 and the terminal olefinic proton was assigned 
at δ 5.30 (Lumsdon et al., 1992).  Cambie re-assigned the terminal methyl group to δ 1.60 and 
the terminal olefinic proton to δ 5.11 which is in full agreement with the COSY correlations 
observed (Cambie et al., 2001).   As a result of this study the first complete assignment of the 
13C NMR chemical shifts of 9.5 on the basis of extensive heteronuclear 2D NMR experiments 
has resulted in the complete unequivocal assignment of 9.5. 
 
9.3 Biological Evaluation and Details of Assays 
 
A 2 g sample of the Dactylospongia sp. was extracted with 3:1 MeOH:DCM and evaluated in 
several assays (antitumour, antiviral and antimicrobial) at a concentration of 50 mg/mL at 
the University of Canterbury, Christchurch, New Zealand.  This 3:1 MeOH:DCM crude 
extract of the Dactylospongia sp. displayed cytotoxic activity against the P388 (Murine 
leukaemia) cell line with an IC50 of 69,018 ng/mL and also against the slow growing BSC-1 
(African green monkey kidney) cell line (used to grow the Herpes simplex and Polio viruses).  
Antimicrobial activity was also observed with slight inhibition detected against Bacillus 
subtilis, and Trichophyton mentagrophytes.  No antimicrobial activity was detected for 
Eschericha coli, Pseudomonas aeruginosa, Candida albicans and Cladosporium.  The antimicrobial 
and antiviral assays were recently phased out at the University of Canterbury and as such, 
9.5 could not be evaluated in these assays. 
The pentaprenylated p-quinol, 9.5 was found to display moderate activity against the 
P388 murine leukaemia cell line (IC50 of 4 M when tested at 1 mg/mL).  The genus 
Dactylospongia has already been reported to contain cytotoxic constituents such as dactylolide 
(9.3) and dactylospongiaquinone (9.4).  This study therefore represents the first report for the 
antitumour activity of 9.5 and is suggested to be the bioactive constituent responsible for the 
initial activity observed.  The DCM and MeOH crude extracts were not individually assayed 
so it is possible that further bioactive metabolites could also be present in the MeOH crude 
extract of the sponge.  Whilst this may warrant future investigation, it seems certain on the 
basis of HPLC and NMR profiling that the constituents present in the MeOH crude extract 
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are not represented by the same structural class as that of the major constituent seen in the 
DCM crude extract. 
 
Further details on the biological assays are detailed in Section 10.1.12 and the Appendix. 
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Dactylospngia sp. (2004-48) 
    
 
Domain:  Eukaryota 
Kingdom:   Animalia 
Subkingdom:  Radiata 
Infrakingdom:  Spongiaria 
Phylum:   Porifera 
Subphylum:  Cellularia 
Class:    Demospongiae 
Subclass:  Ceractinomorpha 
Order:    Dictyoceratida 
Family:   Thorectidae 
Genus:   Dactylospongia 
Species:   sp. 
 
Collected by Mr Richard Goudie by SCUBA at a depth of 8-15 meters from Gunnamatta 
Beach (Lat 38° 23.59′S Long 144° 47.03′E), Victoria, Australia 
(November, 2004) 
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10.1  General Experimental Details 
 
10.1.1  Acquisition of Spectroscopic Data 
 
All organic solvents used were Analytical Reagent (AR or GR), UV Spectroscopic or HPLC 
grades with milli-Q water also being used.  Melting points (uncorrected) were determined 
using a Gallenkamp Melting Point apparatus. Optical rotations were carried out using a 1.2 
mL cell on a Jasco DIP-1000 digital polarimeter, set to the Na 589 nm wavelength. UV-Vis 
spectra were recorded on a Varian CARY 50 Bio Spectrophotometer, using MeOH or EtOH. 
In addition a UV profile was obtained from the HPLC (PDA detection) by extraction of the 
2D contour plot. IR spectra were recorded as a film (CHCl3) using a NaCl disc or as a KBr 
disc on a Perkin-Elmer, Spectrum One FTIR Spectrometer.  1H and 13C NMR spectra were 
acquired on a 500 MHz Varian INOVA Spectrometer or on a Bruker Avance 300 MHz NMR 
spectrometer in the solvents indicated, with spectra referenced to solvent signals as follows, 
CDCl3 (δ 7.26, 77.0 ppm), d6-DMSO (δ 2.50, 39.5 ppm), d6-acetone (δ 2.05, 29.8 ppm) and C6D6 
(δ 7.16, 128.1 ppm). One and two-dimensional NMR experiments included DEPT, gCOSY, 
gHSQCAD gHMBC, 1D NOE, NOESY, ROESY and CIGAR experiments. ESI-MS were 
obtained on a Micromass Platform II mass spectrometer equipped with a LC-10AD 
Shimadzu solvent delivery module (50% CH3CN/H2O at a flow rate of 0.1 mL/min) in both 
the positive and negative ionisation modes using cone voltages between 20 V and 30 V. 
HRESI-MS was carried out on an Agilent 6200 Series TOF system (ESI operation conditions 
of 8 L/min N2, 350 degrees drying gas temperature and 4000 V capillary voltage) equipped 
with an Agilent 1200 Series LC solvent delivery module (100% CH3OH at a flow rate of 0.1 
mL/min) in either positive or negative ionisation modes (in all cases the instruments were 
 
Experimental 
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calibrated using the Agilent Tuning Mix using purine as the reference compound and 
HP0921). GC-MS analyses were carried out on two separate systems. The first system 
consisted of a GC-MS Hewlett Packard 56890/5973 GC/MS Mass Selective Detector using a 
BPX5 30 m  0.25 mm ID DF of 0.25 GC column at a constant column flow of 1.0 mL/min. A 
temperature program starting at 70ºC (held for 1 minute) which was then ramped at 
10ºC/min to 280ºC and held at this temperature for 5 minutes was utilised. GC parameters 
included an injector temperature of 250ºC, detector temperature of 260ºC with injector port 
set to standard split/splitless mode and a total run time of approximately 30 minutes. The 
mass spectrometer was set to the electron impact (EI) and a mass scan range between m/z 40 
and 600. The second system consisted of a Varian Saturn 2200 GC/MS/MS and Varian CP-
3800 Gas Chromatograph using a Varian VF-5ms 30 m  0.25 mm ID DF of 0.25 GC column 
at a constant column flow of 1.0 mL/min. A temperature program starting at 60ºC (held for 1 
minute) which was then ramped at 10ºC/min to 260ºC and held at this temperature for 5 
minutes was utilised. GC parameters included an injector temperature of 250ºC, detector 
temperature of 260ºC with injector port set to standard split/splitless mode and a total run 
time of approximately 25 minutes. The mass spectrometer was set to the electron impact (EI) 
mode with a trap temperature of 200ºC and a mass scan range between m/z 40 and 450. High 
Resolution GC-MS analyses were carried out on a Bruker BioApex II 47e FTMS in EI mode. 
The direct insertion probe was used for the analysis. The sample was run at 70 eV at a source 
temperature of 200ºC. 
 
10.1.2  Isolation of Natural Products 
 
All organic solvents used were Analytical Reagent (AR or GR), UV Spectroscopic or HPLC 
grades with Milli-Q water also being used. All terrestrial and marine organisms were 
photographed ―on location‖ or upon investigation. All percentage mass recoveries were 
determined as extracted dry masses unless otherwise stated. TLC was performed on pre-
coated aluminium backed silica TLC plates (Merck silica gel 60 F254) using the solvent 
system 65:25:4 (CHCl3:MeOH:H2O) unless otherwise stated, visualised at 254 and 365 nm 
and further developed using A: iodine vapour and B: a ninhydrin dip consisting of 0.3 g 
ninhydrin in 100 mL of n-BuOH and 3 mL HOAc. Silica flash chromatography was carried 
out with Merck silica gel (60 mesh) using nitrogen a 20% stepwise solvent elution from 
100% n-hexane to 100% DCM to 100% EtOAc and finally to 100% MeOH unless otherwise 
stated. Gel permeation chromatography was performed using Sephadex LH-20 (Sigma) 
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using 100% MeOH as the eluent. Flash C18 column chromatography was carried out using a 
10% stepwise elution from H2O to MeOH and finally to DCM unless otherwise stated. Diol 
(Alltech, 35 -75 µ) flash chromatography was carried out using a 20% stepwise elution from 
100% n-hexane to 100% DCM and finally to 100% MeOH unless otherwise stated. 
 
10.1.3 High Pressure Liquid Chromatography (Analytical and Semi-preparative)  
 
All analytical HPLC analyses were performed on a Dionex P680 solvent delivery system 
equipped with a PDA100 UV detector (operated using ―Chromeleon‖ software).  Analytical 
RP-HPLC analyses were run using either the standard gradient method (0 - 2 mins 10% 
CH3CN/H2O; 14 - 24 mins 75% CH3CN/H2O; 26 - 30 mins 100% CH3CN; 32 - 40 mins 10% 
CH3CN/H2O) or an isocratic method unless otherwise stated on a Phenomenex Prodigy ODS 
(3) C18 100Å 250  4.6 (5 µ) and on a Phenomenex Luna ODS (3) C18 100Å 250  4.6 (5 µ) 
column at a flow rate of 1.0 mL/min.  All semi-preparative HPLC was carried out on a 
Varian Prostar 210 (Solvent Delivery Module) equipped with a Varian Prostar 335 PDA 
detector using STAR LC WS Version 6.0 software using either an isocratic or gradient 
method on a Phenomenex Prodigy ODS (3) 100Å C18 250  10 (5 µ) column at a flow rate of 
3.5 mL/min.  
NP-HPLC analytical analyses were carried out on Varian Prostar 210 using a Alltech 
Alltima Silica 250  4.6 (5 µ) column at a flow rate of 1.0 mL/min. Normal phase semi-
preparative HPLC were carried out on a Varian Prostar 210 using a gradient or isocratic 
method on a Alltech Alltima Silica 250  10 (5 µ) column at a flow rate of 3.5 mL/min. 
 
10.1.4  HPLC-NMR 
 
Solvents for HPLC-NMR included HPLC-NMR grade CH3CN (Chromasol V®) which has 
been glass distilled to remove impurities such as propionitrile and D2O (Collingwood, 
Melbourne, Australia) or Sigma-Aldrich (Castle Hill, NSW, Australia), 99.0% or of at least 
90%. HPLC-NMR was carried out on a 500 MHz Varian Unity INOVA Spectrometer 
(maintained at a constant temperature of 23ºC) equipped with a Varian 1H[13C] pulsed field 
gradient (PFG) flowprobe with a flow cell of 60 µL (active volume) coupled to a Varian 
Prostar 230 Solvent Delivery Module equipped with a Varian Prostar 335 PDA detector and a 
Prostar AS430 Autosampler. HPLC-NMR runs were carried out by starting the CORBA™ 
server communication between the HPLC pump and NMR and then operated with the 
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Varian VNMRJ software (version  VNMRJ 2.1b.) using isocratic HPLC conditions, on a 
Varian Polaris C18 (150 mm × 4.6 mm i.d. (5 µ) or a Varian Pursuit C18 (250 mm × 4.6 mm i.d. 
(5 µ) column at 1.0 mL/min. Varian WET solvent suppression (Smallcombe, et. al., 1995) and 
related sequences were used to suppress the CH3CN, its 13C satellites and the residual water 
peaks. For both the on-flow and stop-flow HPLC-NMR experiments a 50 µL injection was 
used monitoring at 215 and 254 nm unless otherwise stated. 
 
Smallcombe SH, Patt SL and Keifer PA. 1995. WET solvent suppression and its applications to LC 
NMR and high-resolution NMR spectroscopy. J. Mag. Res. 117: 295-303. 
 
10.1.5  GC-MS 
 
The gas chromatography–quadrupole mass spectrometry system (GC–qMS) consisted of an 
Agilent model 6890 GC, coupled to a model 5973 MS detector. A single 30 m long BPX5 
column (0.25 mm I.D.; 0.25 µm df) was used for separation of constituents present in the 
extract. The oven program was from 240C to 250C at 2C min−1, then to 320C at 4C min−1 
(hold for 10 min). The injector was set at 280C, transfer line at 280C and ion source at 
230C. The scanning mass range was from 45 to 7000 µ at an applied electron ionisation 
voltage of 70 eV. Data acquisition and processing was achieved using the Agilent MSD 
ChemStation software. 
 
10.1.6  GC×GC–FID 
 
The gas chromatograph, equipped with a flame ionisation detector (GC×GC–FID), was an 
Agilent 6890 system (Palo Alto, CA, USA) with a Longitudinal Modulation Cryogenic 
System (LMCS, Chromatographic Concepts Pty Ltd., Doncaster, Australia). The column 
configuration used with this system was a 30 m length of BPX5 phase, 0.25 mm I.D., 0.25 µm 
film thickness as a first dimension column (1D) coupled to a 1 m length of BPX50 phase, 0.1 
mm I.D., 0.1 µm df as a second dimension column (2D). All columns were from SGE 
International, Ringwood, Australia. Oven program was from 180C to 231C at 3.3C min−1, 
then to 310C at 30C min−1 (hold for 10 min). The injector and detector temperatures were 
300C and 320C, respectively, and the sampling frequency was 100 Hz. Hydrogen was used 
as a carrier gas at a flow rate of 0.9 mL min−1. A sample volume of 1 L was injected using 
the split mode at a split ratio of 10:1. The modulation period was 5 s, and temperature of the 
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modulator system (TM) was 120C. CO2 was used as a coolant in the LMCS and nitrogen as a 
flush gas at a pressure of 15 psi. An Agilent ChemStation was used for data acquisition and 
processing. 
 
10.1.7  Derivatisation of Extracts for GCxGC 
 
A 1 mg/mL stock solution of the lichen extracts (C. xanthina or C. concolor) were prepared 
using a mixture of 3:1 MeOH:DCM as the extraction solvent. Subsequently, 100 µL of each 
stock solution was transferred to individual Agilent GC autosampler vials and evaporated to 
dryness under a stream on N2 gas for 20 minutes at room temperature. To each individual 
residual crude extract 100 µL of the silylating agent mixture, [MSTFA activated III: DTE: 
NH4I (1000:2:4)] was added and the vial was sealed and heated again for 20 minutes at a 
temperature of 80C. A noticeable colour change of the lichen extract was observed after the 
addition of MSTFA from an intense yellow to a pale yellow colour in both cases. 
 
10.1.8  Crystallography  
 
Intensity data were collected with a Bruker SMART Apex CCD detector using Mo-Kα 
radiation (graphite crystal monochromator λ = 0.71073), the temperature during data 
collection was maintained at 130.0(1) using an Oxford Cryostream cooling device. Data were 
reduced using the program SAINT (Siemens, 1999). The structure was solved by direct 
methods and difference Fourier synthesis. Thermal ellipsoid plots were generated using the 
program ORTEP-3 (Farrugia, 1997) integrated within the WINGX (Farrugia, 1999) suite of 
programs.  
 
Farrugia LJ. 1997. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface 
(GUI). J. Appl. Cryst. 30: 565. 
Farrugia LJ. 1999. WinGX suite for small-molecule single-crystal crystallography. J. Appl. Cryst. 32: 
837-838. 
Siemens, SMART, SAINT, SADABS. 1999. Siemens Analytical X-ray Instruments Inc. Madison, 
Wisconsin, USA. 
 
10.1.9  Acid Hydrolysis 
 
Approximately 0.5 mg of the isolated natural product, were combined with 2.5 mL of 15% 
aqueous HCl. The reaction mixture was heated to 50C whilst stirring for 6 hours. The 
mixture was neutralised with the drop-wise addition of 5% aqueous NaOH and partitioned 
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with EtOAc. The aqueous partition evaporated under reduced pressure and the residues 
spotted on aluminum backed silica gel TLC plates along with the corresponding sugar 
moiety. The plate was developed in n-butanol:HOAc:H2O (3:1:1), air dried, sprayed with 10% 
aqueous H2SO4, and heated on a hotplate. The hydrolysis were confirmed by comparing the 
Rf to D-β-glucopyranose (Rf = 0.24), D-β--xylopyranose (Rf = 0.32) and D-β-rhamnopyranose 
(Rf = 0.37). 
 
10.1.10  Photography (Microscopy) 
 
Photomicrographs were obtained with a Nikon Coolpix 5000 digital camera mounted on a 
Nikon Labophot II microscope with polariser. Photographs of terrestrial and marine 
organisms were taken by Dr Sylvia Urban and Mr Daniel Dias. 
 
10.1.11  Chemistry software 
 
10.1.11.1 Structures and Modeling 
 
Chemical structures were drawn using ChemDraw Ultra (Ver. 6.0). 3D molecular modeling 
experiments used (MM2 minimised calculations) and NOE distance calculations were 
calculated using Chem3D (Ver 6.0).  
For further details please see http://www.cambridgesoft.com/software. 
 
10.1.11.2 Chemical Shift Predictions (1H and 13C NMR) 
 
 1H and 13C NMR chemical shifts were predicted using the Advanced Chemistry 
Development/Labs NMR (Ver. 8.0) software.  
For further details please see http://www.acdlabs.com/products. 
 
10.1.12  Biological Evaluation and Details of Assays 
 
10.1.12.1 Antitumour Assay (P388 Murine Leukaemia Cell Line) 
 
For the antitumour assay a two fold dilution series of the crude extract or compounds were 
incubated for 72 hours with P388 (Murine Leukaemia) cells. The concentration of sample 
required to reduce the P388 cell growth by 50% (comparative to control cells) was 
determined using the absorbance values obtained when the yellow dye MTT tetrazolium is 
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reduced by healthy cells to the purple coloured MTT formazan and is expressed as an IC50, 
in ng/mL. For further details see Appendix, page 366. 
 
10.1.12.2 Antiviral Assays (Herpes Simplex virus and Polio virus) 
 
The crude extract or compounds were pipetted onto 6 millimeter diameter filter paper discs 
and the solvent evaporated. The disc was then placed directly onto BSC-1 cells (African 
Green Monkey kidney), infected with either the DNA Herpes simplex virus type 1 (ATCC VR-
733) or the RNA Polio virus type 1 (ATCC VR-192) and then incubated. The assays were 
examined after 24 hours using an inverted microscope for the size of antiviral or viral 
inhibition and/or cytotoxic zones and the type of cytotoxicity. For further details see 
Appendix, page 363. 
 
10.1.12.3 Antimicrobial Assays 
 
A standardised inoculum was prepared by transferring a loop of bacterial/fungal cells, from 
a freshly grown stock slant culture, into a 10 mL vial of sterile H2O.  This was vortexed and 
compared to a 5% BaCl2 in H2O standard to standardise the cell density. This gave a cell 
density of 108 colony-forming units per mL. 10 mL of the standardised inoculum was then 
added to 100 mL of Mueller Hinton or Potato dextrose agar and mixed by swirling, giving a 
final cell density of 107 colony-forming units per mL.  5 mL of this was poured into sterile 85 
mm petri dishes. The suspensions were allowed to cool and solidify on a level surface to give 
a ‗lawn‘ of bacteria/fungi over the dish. The crude extract or compounds were pipetted onto 
6 millimeter diameter filter paper discs and their solvents evaporated. These discs were then 
placed onto the prepared seeded agar dishes (with appropriate solvent and positive controls) 
and incubated. Active antimicrobial samples displayed a zone of inhibition outside the disc, 
which was measured in millimetres as the radius of inhibition for each bacteria/fungi. The 
six organisms were Eschericha coli (G-ve ATCC 25922), Bacillus subtilis (G+ve ATCC 19659) 
and Pseudomonas aeruginosa (G-ve ATCC27853) for the bacteria and Candida albicans (ATCC 
14053), Trichophyton mentagrophytes (ATCC 28185) and Cladosporium resinae for the fungi. For 
further details see Appendix, page 362. 
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10.1.12.4 Antioxidant Assay 
 
The specimen of P. cinnabarinus collected in Mentone, Victoria (2002-03) was subjected to two 
extraction methods. Firstly, the fungus was solvent partitioned between EtOAc and water-
soluble fractions. Secondly, the fungus was triturated between DCM, MeOH and water-
soluble fractions respectively, for which 1 mg/mL and 10 mg/mL stock solutions were then 
prepared. DPPH free radical scavenging activity was determined by the method previously 
reported by Tamura, et. al 1990. For further details see Appendix, page 368. 
 
Tamura A, Sato T and Fujii T. 1990. Antioxidant activity of indapamide and its metabolite. Chemical & 
Pharmaceutical Bulletin 38: 255-257. 
 
10.1.12.5 Anti-inflammatory Assay 
 
The same stock solutions were assessed as those used for the antioxidant testing. The anti-
inflammatory property of each extract was assessed by monitoring the production of 
proinflammatory leukotrienes by stimulated porcine neutrophils as previously described for 
human neutrophils by (McColl et al., 1986). For further details see Appendix, page 370. 
 
McColl SR, Betts WH, Murphy GA and Cleland LG. 1986. Determination of 5-lipoxygenase activity in 
human polymorphonuclear leukocytes using high-performance liquid chromatography. Journal of 
Chromatography, Biomedical Applications. 378: 444-449. 
 
Natural Product Studies of Terrestrial and Marine Organisms 
 
 
332 | P a g e  
10.2 Chapter  2 Experimental  
 
Cinnabarin (2.1) 
 
Isolated as a red oily gum; IR (KBr) νmax  3386, 
3270, 2918, 2851, 1676, 1655, 1596, 1469, 1303, 
1188, 1082 cm-1; UV (MeOH) λmax nm (log ε) 205 
(3.3), 230 (3.1), 425 (2.6) and 448 (2.6); UV profile 
from HPLC (CH3CN/H2O) 235, 266, 308, 433 
and 451 nm; 1H NMR (500 MHz, d6-DMSO recorded at a constant 40C) δ 9.57 (1H, brs, 2-
NHa), 8.68 (1H, brs, 2-NHb), 7.54 (1H, m, H-7), 7.52 (1H, m, H-8), 7.47 (1H, J = 7.5 Hz, H-6), 
6.59 (1H, s, H-4), 4.87 (2H, s, H-12), 10-OH (ND), 11-OH (ND); 13C NMR (125 MHz, d6-DMSO 
recorded at a constant 40C) 177.9 (qC, C-3), 169.0 (qC, C-11), 152.2 (qC, C-2), 151.0 (qC, C-
10a), 146.2 (qC, C-4a), 142.1 (qC, C-5a), 138.1 (qC, C-9), 129.4 (CH, C-7), 126.9 (qC, C-9a), 123.8 
(CH, C-8), 114.7 (CH, C-6), 105.1 (CH, C-4), 92.4 (qC, C-1), 58.9 (CH2, C-12); ESI-MS (+ve) (25 
V) m/z 287 [M+H]+. 
ND: indicates signal was not detected 
 
 
Tramesanguin (2.2) 
 
Isolated as a red-orange oily gum; IR (KBr) 
νmax 3420, 2928, 2854, 1690, 1588, 1385, 1206, 
1195, 1024 cm-1; UV (MeOH) λmax nm (log ε) 
209 (2.9), 235 (3.0), 270 (2.6), 430 (2.7) and 447 
(2.7); UV profile from HPLC (CH3CN/H2O) 
235, 270, 403, 435 and 461 nm; 1H NMR (500 MHz, d6-DMSO recorded at a constant 40C) δ 
10.35 (1H, s, H-12), 9.80 (1H, brs, 2-NHa), 8.92 (1H, brs, 2-NHb), 8.00 (1H, d, J = 7.5 Hz, H-8), 
7.87 (1H, d, J = 7.8 Hz, H-6), 7.74 (1H, dd, J = 7.5, 7.8 Hz, H-7), 6.65 (1H, s, H-4), 10-OH (ND); 
13C NMR (125 MHz, d6-DMSO recorded at a constant 40C) 191.6 (CH, C-11), 178.0 (qC, C-3), 
168.9 (qC, C-11), 152.8 (qC, C-2), 150.6 (qC, C-10a), 148.8 (qC, C-4a), 142.2 (qC, C-5a), 131.4 
(CH, C-8), 129.1 (CH, C-7), 128.9 (qC, C-9a), 128.4 (qC, C-9), 121.8 (CH, C-6), 105.2 (CH, C-4), 
92.3 (CH, C-1); ESI-MS (+ve) (25 V) m/z 285 [M+H]+. 
ND: indicates signal was not detected 
1
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Cinnabarinic acid (2.3) 
 
Isolated as a semi-pure, orange oily gum; IR 
(KBr) νmax 3431, 2924, 2854, 1715, 1594, 1457, 
1385, 1115, 1040 cm-1; UV (MeOH) λmax nm (log 
ε) 205 (3.3), 215 (3.3), 230 (3.3), 430 (2.9) and 449 
(2.9); UV profile from HPLC (CH3CN/H2O) 
237, 265, 430 and 449 nm; 1H NMR (500 MHz, d6-DMSO recorded at a constant 40C) δ 9.73 
(1H, brs, 2-NHa), 8.80 (1H, brs, 2-NHb), 7.95 (1H, d, J = 7.75 Hz, H-8), 7.77 (1H, d, J = 8.0 Hz, 
H-6), 7.61 (1H, dd, J = 7.75, 8.0 Hz, H-7), 6.62 (1H, s, H-4), 11-OH (ND), 10-OH (ND); 13C 
NMR (125 MHz, d6-DMSO recorded at a constant 40C) 167.0 (qC, C-12), 153.2 (qC, C-2), 
151.2 (qC, C-10a), 148.4 (qC, C-4a), 143.0 (qC, C-5a), 129.6 (CH, C-7), 128.5 (CH, C-8), 121.2 
(CH, C-6), 105.8 (CH, C-4), 126.9* (qC, C-9), 129.7* (qC, C-9a), ND (C-1, C-3 and C-10); ESI-
MS (+ve) (25 V) m/z 301 [M+H]+. 
*Signals may be interchanged 
ND = Signal not detected 
 
 
Pycnoporin (2.8) 
 
 
Isolated as a red-orange oily gum; [α]23 D 
+13° (c 0.1, MeOH); IR (KBr) νmax 3431, 
3380, 2926, 2854, 1662, 1646, 1624, 1587, 
1457, 1384, 1194, 1117, 1061 cm-1; UV 
(MeOH) λmax nm (log ε) 230 (3.6), 262 
(3.3), 425 (3.3) and 449 (3.3); UV profile from HPLC (CH3CN/H2O) 237, 265, 400, 430 and 449 
nm; 1H NMR (500 MHz, d6-DMSO) and 13C NMR (125 MHz, d6-DMSO) recorded at a 
constant 40C see Table 2.3; ESI-MS (+ve) (25 V) m/z 317 [M+H]+; HRESI-MS m/z 317.0773 
([M+H]+; calculated for C15H13N2O6, 317.0695).  
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Ergosterol Peroxide (2.11) 
 
 
 Isolated as a pale yellow oil; 
IR (CHCl3) νmax  3387, 2955, 
2928, 2870, 1727, 1589, 1457, 
1378, 1261, 1174, 1104, 1074, 
1042, 102, 968 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 6.52 
(1H, d, J = 8.5 Hz, H-7), 6.26 
(1H, d, J = 8.5 Hz, H-6), 5.22 (1H, dd, J = 11.2, 15.2 Hz, H-23), 5.16 (1H, dd, J = 11.9, 15.2 Hz, 
H-22), 3.99 (1H, d, J = 5.4 Hz, H-3), 2.13 (1H, m, H-12a), 2.03 (1H, m, H-20), 1.97 (1H, m, H-2a), 
1.97 (1H, m, H-4a), 1.92 (1H, m, H-12b), 1.86 (1H, m, H-24), 1.70 (1H, m, H-2b), 1.64 (1H, m, H-
14), 1.59 (1H, m, H-9), 1.55 (2H, m, H-1), 1.48 (1H, m, H-25), 1.35 (2H, m, H-16), 1.27 (1H, m, 
H-4b), 1.24 (1H, m, H-15b), 1.24 (1H, m, H-17), 1.02 (2H, m, H-11), 1.19 (1H, m, H-15a), 0.99 
(3H, s, H-21), 0.92 (3H, d, J = 6.8 Hz, H-28), 0.90 (3H, s, H-19), 0.85 (3H, d, J = 4.9 Hz, H-26), 
0.83 (3H, s, H-18), 0.82 (3H, d, J = 4.9 Hz, H-27); 13C NMR (125 MHz, CDCl3) 135.4 (CH, C-6), 
135.2 (CH, C-22), 132.3 (CH, C-23), 130.7 (CH, C-7), 82.2 (qC, C-5), 79.3 (qC, C-8), 66.5 (CH, C-
3), 56.2 (CH, C-17), 51.7 (CH, C-14), 51.1 (CH, C-9), 44.5 (qC, C-13), 42.8 (CH, C-24), 39.7 (CH, 
C-20), 39.4 (CH2, C-4), 37.0 (qC, C-10), 36.9 (CH2, C-12), 34.7 (CH2, C-2), 30.1 (CH2, C-1), 28.6 
(CH2, C-16), 33.1 (CH, C-25), 23.4 (CH2, C-15), 20.9 (CH3, C-21), 20.6 (CH2, C-11), 19.9 (CH3, 
C-27), 19.6 (CH3, C-26), 18.2 (CH3, C-19), 17.5 (CH3, C-28), 12.9 (CH3, C-18); ESI-MS (-ve) (25 
V) m/z 427 [M-H]-. 
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10.3 Chapter 3 Experimental 
 
Compound 3.5 
 
Isolated as a yellow oil; UV (MeOH) λmax nm 
(log ε) 210 (3.7), 245 (3.6), 315 (3.0) and 346 
(2.9); UV profile from HPLC (CH3CN/H2O) 
216, 259, 330, 346 and 395 nm; 1H NMR (500 
MHz, d6-DMSO) δ 8.39 (1H, d, J = 7.8 Hz, H-9), 
8.38 (1H, s, H-4), 7.55 (1H, d, J = 7.8 Hz, H-8), 
7.43 (2H, m, H-2‘, H-6‘), 7.35 (2H, m, H-3‘, H-
5‘), 7.34 (1H, m, H-4‘), 4.02 (3H, s, H-10), 3.28 (3H, s, H-11); 13C NMR (125 MHz, d6-DMSO) 
160.9 (qC, C-1), 160.4 (qC, C-3), 150.5 (qC, C-5), 150.7 (qC, C-6), 145.4 (qC, C-7), 142.2 (qC, C-
1‘), 130.6 (CH, C-8), 130.3 (CH, C-9), 128.1 (CH, C-3‘,C-5‘), 127.3 (CH, C-2‘,C-6‘), 127.2 (qC, C-
9b), 127.1 (CH, C-4‘), 125.1 (qC, C-6a), 120.5 (CH, C-4), 118.3 (qC, C-9a), 114.4 (qC, C-3a), 60.5 
(CH3, C-11), 57.0 (CH3, C-10); ESI-MS (+ve) (25 V) m/z 335 [M+H] 
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Dilatrin (3.6) 
 
  
Isolated as a red oil; 
UV (MeOH) λmax nm 
(log ε) 214 (4.0), 280 
(3.7), 375 (3.3) and 465 
(3.1); UV profile from 
HPLC (CH3CN/H2O) 
214, 279, 360, 375 and 
474 nm; IR (KBr) νmax 
3427, 1924, 2851, 1719, 1623, 1571, 1384, 1214, 1076, 1032 cm-1; 1H NMR (500 MHz, d6-DMSO) 
δ 8.33 (1H, d, J = 7.5 Hz, H-7), 7.62 (1H, s, H-3), 7.48 (1H, d, J = 7.5 Hz, H-8), 7.30 (5H, m, H-2‘, 
H-3‘, H-4‘, H-5‘, H-6‘), 7.23 (1H, s, H-4), 4.95 (1H, bs, 3‖-OH), 4.84 (1H, d, J = 5.5 Hz, 4‖-OH), 
4.64 (1H, t, J = 9.0 Hz, H-1‖), 4.05 (1H, bs, 2‖-OH), 3.85 (3H, s, H-10), 3.46 (1H, m, H-6‖a), 3.24 
(1H, m, H-6‖b), 3.17 (1H, d, J = 4.0 Hz, 6‖-OH), 3.00 (1H, dd, J = 9.0, 9.0 Hz, H-3‖), 2.80 (1H, 
m, H-5‖), 2.72 (1H, dd, J = 5.0, 9.0 Hz, H-4‖), 2.20 (1H, t, J = 9.0 Hz, H-2‖); 1H NMR (500 
MHz, d6-acetone) δ 8.42 (1H, d, J = 7.8 Hz, H-7), 7.58 (1H, s, H-3), 7.61 (1H, d, J = 7.8 Hz, H-8), 
7.34 (5H, m, H-2‘, H-3‘, H-4‘, H-5‘, H-6‘), 7.16 (1H, s, H-4), 4.50 (1H, d, J = 8.0 Hz, H-1‖), 3.90 
(3H, s, H-10), 3.63 (1H, m, H-6‖a), 3.52 (1H, m, H-6‖b), 3.33 (1H, dd, J = 8.5, 8.5 Hz, H-3‖), 
3.04 (1H, m, H-5‖), 3.05 (1H, m, H-4‖), 2.88 (1H, m, H-2‖); 13C NMR (125 MHz, d6-DMSO) 
179.2 (qC, C-6), 152.5 (qC, C-5), 148.1 (qC, C-2), 146.7 (qC, C-9), 144.4 (qC, C-1‘), 140.4 (qC, C-
1), 131.7 (CH, C-8), 130.7 (qC, C-6a), 127.8 (qC, C-9a), 127.2 (CH, C-7), 126.9 (CH, C-2‘,C-3‘,C-
4‘,C-5‘,C-6‘), 126.2 (qC, C-3a), 124.1 (CH, C-3), 120.7 (qC, C-9b), 114.3 (CH, C-4), 103.7 (CH, C-
1‖), 77.5 (CH, C-5‖), 76.7 (CH, C-3‖), 73.8 (CH, C-2‖), 70.4 (CH, C-4‖), 61.9 (CH2, C-6‖), 56.3 
(CH3, C-10); ESI-MS (+ve) (25 V) m/z 481 [M+H]+.  
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Xiphidone (3.8) 
 
Isolated as a red oil; UV (MeOH) λmax nm 
(log ε) (3.4), 358 (3.0) and 458 (2.8); UV 
profile from HPLC (CH3CN/H2O) 217, 
251, 273, 341, 355, 373 and 462 nm; IR 
(KBr) νmax 3422, 2924, 2854, 1730, 1630, 
1594, 1385, 1359, 1211 cm-1; 1H NMR (500 
MHz, d6-DMSO) δ 10.10 (1H, brs, 6-OH), 
8.38 (1H, d, J = 8.5 Hz, H-9), 7.56 (1H, s, H-4), 7.50 (1H, d, J = 8.5 Hz, H-8), 7.38 (2H, m, H-2‘, 
H-6‘), 7.28 (3H, d, J = 7.0 Hz, H-3‘, H-4‘, H-5‘), 7.12 (1H, s, H-3), 3.96 (3H, s, H-11), 3.77 (3H, s, 
H-10); 13C NMR (125 MHz, d6-DMSO) δ 179.8 (qC, C-1), 152.3 (qC, C-2), 146.6 (qC, C-6), 144.1 
(qC, C-7), 142.9 (qC, C-5); 141.2 (qC, C-1‘), 131.2 (CH, C-8), 128.1 (CH, C-2‘,C-6‘), 128.0 (CH, 
C-3‘,C-4‘,C-5‘), 127.6 (qC, C-6a), 127.2 (CH, C-9), 126.6 (qC, C-3a), 124.8 (CH, C-4), 122.9 (qC, 
C-9b), 119.8 (qC, C-9a), 111.8 (CH, C-3), 61.2 (CH3, C-11), 55.3 (CH3, C-10); ESI-MS (+ve) (25 
V) m/z 333 [M+H]+; ESI-MS (-ve) (25 V) m/z 331 [M-H]-.  
 
Haemodorone (3.10) 
 
Isolated as a yellow oil; UV (MeOH) λmax nm 
(log ε) 205 (4.3), 255 (4.0), 345 (3.5) and 395 
(3.6); UV profile from HPLC (CH3CN/H2O) 
218, 259, 327, 344 and 393 nm; IR (KBr) νmax 
3430, 2919, 1769, 1725, 1592, 1578, 1398, 1254, 
1018, 1010 cm-1; 1H NMR (500 MHz, d6-
DMSO) and 13C NMR (125 MHz, d6-DMSO) is 
detailed in Table 3.1; 1H NMR (500 MHz, d6-acetone) δ 8.43 (1H, d, J = 7.5 Hz, H-9), 8.33 (1H, 
s, H-4), 7.62 (1H, d, J = 7.5 Hz, H-8), 7.46 (5H, m, H-2‘, H-3‘, H-4‘, H-5‘, H-6‘), 3.29 (3H, s, H-
10) (Opitz et. al., 2002); ESI-MS (-ve) (25 V) m/z 319 [M-H]-; (HRESI-MS m/z 319.0610 [M-H]-, 
(calcd for C19H11O5, 319.0685). 
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Haemodorol (3.11) 
 
Isolated as a yellow oil; UV (MeOH) 
λmax nm (log ε) 250 (4.2), 316 (3.8), 350 
(3.7) 403 (3.5);  UV profile from HPLC 
(CH3CN/H2O) λmax 215, 259, 348 and 
404 nm;  IR (KBr) νmax 3369, 2924, 1761, 
1729, 1591, 1575, 1516, 1399, 1253, 1021 
cm-1; 1H NMR (500 MHz, d6-DMSO) 
and 13C NMR (125 MHz, d6-DMSO) is detailed in Table 3.2; ESI-MS (-ve) (25 V) m/z  335.1 [M-
H]-; HRESI-MS m/z 335.0558 [M-H]- (calcd for C19H11O6, 335.0556). 
 
Haemodorose (3.12) 
 
 
Isolated as a yellow oil; [α]25D 
+13.1 (c 0.1, CH3OH); UV 
(MeOH) λmax nm (log ε) 258 
(3.5), 333 (3.0), 362 (3.0), 485 
(2.5) and 527 (2.2); UV profile 
from HPLC (CH3CN/H2O) 316, 
361, 323, 336 and 369 nm; IR 
(KBr) νmax 3421, 2924, 2854, 
1711, 1615, 1417, 1240, 1198, 
1079 cm-1; 1H NMR (500 MHz, d6-DMSO) and 13C NMR (125 MHz, d6-DMSO) is detailed in 
Table 3.3; ESI-MS (+ve) (25 V) m/z 491 [M+Na]+; HRESI-MS m/z 469.1496 [M+H]+ (calcd for 
C25H25O9, 469.1493) and 491.1313 [M+Na]+ (calcd for C25H24O9Na, 491.1313). 
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10.4 Chapter 4 Experimental 
 
Dianellin (4.1) 
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Isolated as a viscous, yellow oil as a mixture with dianellose (4.10) (in a ratio of 1:1, based on 
integration of the 1H NMR spectrum); UV (CH3CN/H2O) (mixture) λmax 226, 264, 304 and 334 
nm; 1H NMR (500 MHz, d6-DMSO) δ 9.55 (1H, brs, 1-OH), 7.47 (1H, m, H-5), 7.40 (1H, m, H-
6), 7.30 (1H, d, J = 7.5 Hz, H-7), 7.22 (1H, s, H-4), 5.31 (1H, m, 3‘-OH), 5.01 (1H, d, J = 9.0 Hz, 
H-1‘), 4.75 (1H, d, J = 4.0 Hz, 2‘-OH), 4.64 (1H, d, J = 5.5 Hz, 2‖-OH), 4.60 (1H, m, H-1‖), 3.92 
(1H, d, J = 10.5 Hz, H-6‘a), 3.69 (1H, m, H-2‖), 3.59 (1H, m, H-5‘), 3.49 (1H, m, H-6‘b), 3.48 (1H, 
m, H-5‖), 3.47 (1H, m, H-3‖), 3.37 (1H, m, H-2‘), 3.36 (1H, m, H-3‘), 3.18 (1H, m, H-4‘), 3.20 
(1H, m, H-4‖), 2.52 (3H, s, H-12), 2.24 (3H, s, H-13), 1.11 (3H, d, J = 6.5 Hz, H-6‖), ND (4‘-
OH), ND (4‖-OH), ND (3‖-OH); 13C NMR (125 MHz, d6-DMSO) 205.0 (qC, C-11), 154.4 (qC, 
C-8), 150.4 (qC, C-1), 136.0 (C-10, qC), 133.1 (qC, C-3), 127.6 (CH, C-6), 125.5 (qC, C-2), 122.6 
(CH, C-5), 119.6 (CH, C-4), 113.3 (qC, C-9), 111.0 (CH, C-7), 110.9 (CH, C-1‖), 102.8 (CH, C-
1‘), 76.3 (CH, C-3‘), 76.2 (CH, C-5‘), 73.5 (CH, C-2‘), 72.1 (CH, C-4‖), 70.8 (CH, C-3‖), 70.7 
(CH, C-2‖), 70.3 (CH, C-4‘), 68.7 (CH, C-5‖), 66.8 (CH2, C-6‘), 32.2 (CH3, C-12), 19.3 (CH3, C-
13), 18.0 (CH3, C-6‖); ESI-MS (-ve) (25 V) m/z 523 [M-H]-, ESI-MS (+ve) (25 V) m/z 559 [M+Cl]- 
ND: indicates signal was not detected 
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Dianellin (4.2) 
 
Isolated as a semi-pure unstable yellow gum 
(~70% purity, based on 1H NMR spectroscopy 
and analytical HPLC); UV (EtOAc/n-hexane) λmax 
266, 407 nm; 1H NMR (300 MHz, CDCl3) data 
identical to that previously reported (Colegate et. al., 1985; Rizzacassa and Sargent, 1988; 
Majumder and Chattopadhyay, 1985) (Chapter 4); ESI-MS (-ve) m/z 215 [M-H]-. 
 
Dianellinone (4.3) 
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Isolated as an orange gum, (~90% purity, based on 1H NMR spectroscopy); UV (EtOAc/n-
hexane) λmax 254, 429 nm; 1H NMR (300 MHz, CDCl3) data identical to that previously 
reported (Colegate et. al., 1987) (Chapter 4). 
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Stellalderol (4.9) 
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Isolated as a red-orange oil, (~90% purity based on 1H NMR spectroscopy); UV (MeOH) λmax 
(log ε) 225 (3.5), 305 (2.8) and 345 (2.7) nm; IR (KBr) νmax 3390, 2924, 2889, 1693, 1632, 1604, 
1367, 1257, 1024, 999 cm-1; 1H NMR (500 MHz, d6-DMSO) δ 9.89 (1H, brs, 5-OH), 9.63 (1H, 
brs, 1-OH), 7.40 (1H, s, H-4), 7.27 (1H, d, J = 8.3 Hz, H-7), 6.76 (1H, d, J = 8.3 Hz, H-6), 5.83 
(1H, m, 2‘-OH), 5.27 (1H, m, 4‘-OH), 5.24 (1H, d, J  = 5.5 Hz, 3‖-OH), 5.04 (1H, d, J = 5.0 Hz, 
3‘-OH), 4.97 (1H, m, 2‖-OH), 4.97 (1H, m, 4‖-OH), 4.84 (1H, d, J = 7.5 Hz, H-1‘), 4.21 (1H, d, J 
= 7.5 Hz, H-1‖), 4.01 (1H, d, J = 10.0 Hz, H-6a), 3.68 (dd, J, 5.3, 11.3 Hz, H-5a), 3.58 (1H, d, J = 
10.0 Hz, H-6b), 3.31 (1H, m, H-2‘), 3.31 (1H, m, H-5‘), 3.29 (1H, m, H-4‖), 3.17 (1H, m, H-4‘), 
3.11 (1H, m, H-3‖), 3.10 (1H, m, H-3‘), 3.01 (1H, m, H-2‖), 2.98 (1H, m, H-5b), 2.50 (3H, s, H-
12), 2.24 (3H, s, H-13); 13C NMR (125 MHz, d6-DMSO) 205.8 (qC, C-11), 149.1 (qC, C-1), 148.9 
(qC, C-5), 147.8 (qC, C-8), 131.9 (qC, C-3), 127.3 (qC, C-10), 126.1 (qC, C-2), 114.6 (CH, C-4), 
114.5 (qC, C-9), 112.7 (CH, C-7), 109.7 (CH, C-6), 104.9 (CH, C-1‖), 104.2 (CH, C-1‘), 77.2 (CH, 
C-3‘), 77.0 (CH, C-5‘), 76.9 (CH, C-3‖), 74.2 (CH, C-2‘), 74.1 (CH, C-2‖), 70.6 (CH, C-4‘), 70.4 
(CH, C-4‖), 69.2 (CH2, C-6), 66.4 (CH2, C-5‖) 32.8 (CH3, C-12), 20.4 (CH3, C-13); ESI-MS (+ve) 
m/z 549 [M+Na]+; ESI-MS (-ve) m/z 525 [M-H]-. 
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Dianellose (4.10) 
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Isolated as a yellow-brown oil (~90% purity, based on the 1H NMR spectroscopy and 
analytical HPLC); [α]25D -111.2 (c 0.11, MeOH); UV (MeOH) λmax nm (log ε) 226 (4.3), 262 (3.6), 
305 (3.3) and 337 (3.3); UV profile from HPLC (CH3CN/H2O) 226, 265, 300 and 335 nm; IR 
(KBr) νmax 3400, 2922, 1686, 1633, 1578, 1355, 1077, 1046, cm-1; 1H NMR (500 MHz, d6-DMSO) 
and 13C NMR (125 MHz, d6-DMSO) see Table 4.1; ESI-MS (-ve) m/z 509 [M-H]-, 545 [M+Cl]-; 
HRESI-MS m/z 509.1666 [M-H]- (calcd for C24H29O12 509.1665). 
 
5-hydroxydianellin (4.11) 
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Isolated as a stable orange/brown oil in a mixture (~5% purity based on integration of the 1H 
NMR spectrum); with stellalderol (4.9) (~70% purity); ESI-MS (+ve) m/z 563 [M+Na]+; ESI-
MS (-ve) m/z 539 [M-H]-. Mass spectroscopic data found to be identical to that reported 
previously (Cichewicz and Nair, 2002) (Chapter 4). 
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10.5 Chapter 5 Experimental 
 
(+)-Usnic acid (5.1) 
 
Isolated as a stable, pale yellow oil; [α]23D +211.9 (c 0.2, 
CHCl3); IR (CHCl3) νmax 3436, 2917, 1683, 1629, 1461, 
1371, 1289, 1189  cm-1; UV (MeOH) λmax nm (log ε) 220 
(3.3), 290 (3.2); UV profile from HPLC (EtOAc/n-
hexane) 253 and 281 nm; 1H NMR (500 MHz, CDCl3) δ 
18.84 (1H, s, 3-OH), 13.32 (1H, s, 8-OH), 11.04 (1H, s, 10-
OH), 5.98 (1H, s, H-4), 2.68 (3H, s, 18-CH3), 2.66 (3H, s, 15-CH3), 2.11 (3H, s, 16-CH3), 1.76 
(3H, s, 13-CH3); 13C NMR (125 MHz, CDCl3) 201.8 (qC, C-17), 200.3 (qC, C-17), 198.0 (qC, C-
1), 191.7 (qC, C-3), 179.4 (qC, C-5), 163.9 (qC, C-8), 157.5 (qC, C-10), 155.2 (qC, C-6), 109.3 (qC, 
C-9), 105.2 (qC, C-2), 103.9 (qC, C-11), 101.5 (qC, C-7), 98.3 (CH, C-4), 59.1 (qC, C-12), 32.1 (13-
CH3), 31.3 (18-CH3), 27.9 (15-CH3), 7.5 (16-CH3); ESI-MS (-ve) (25 V) m/z 343 [M-H]-. 
 
Pulvinic Acid (5.2) 
 
 
Isolated as a dark brown oil; IR (CHCl3) νmax 3307, 2917, 
1739, 1611, 1578, 1563, 1398, 1146 cm-1; UV (EtOH) λmax 
nm (log ε) 200 (4.2), 260 (4.2) and 365 (3.9); 1H NMR (500 
MHz, d6-DMSO) δ 8.14 (2H, d, J = 7.0 Hz, H-2‘/H-6‘), 
7.33 (1H, m, H-4), 7.30 (2H, m, H-3‘/H-5‘), 7.29 (2H, m, H-3/H-5), 7.19 (2H, d, J = 7.0 Hz, H-
2/H-6), 7.12 (1H, dd, J = 7.0, 7.5 Hz, H-4‘), 9-OH (ND), 12-OH (ND); 13C NMR (125 MHz, d6-
DMSO) 172.1 (qC, C-12), 169.3 (qC, C-11), 167.2 (qC, C-9), 153.1 (qC, C-8), 136.7 (qC, C-1), 
133.3 (qC, C-1‘), 130.8 (CH, C-2/C-6), 128.5 (CH, C-3‘/C-5‘), 127.9 (CH, C-3/C-5), 127.6 (CH, 
C-4), 125.8 (CH, C-2‘/C-6‘), 125.7 (CH, C-4‘), 118.3 (qC, C-7), 95.7 (qC, C-10); ESI-MS (-ve) (25 
V) m/z 307 [M-H]-. 
ND: indicates signal was not detected 
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Vulpinic Acid (5.3) 
 
Isolated as a stable, bright yellow oil; IR 
(CHCl3) νmax 3426, 2919, 2850, 1774, 1677, 
1612, 1598, 1440, 1289, 1279, 1065 cm-1; UV 
(EtOH) λmax nm (log ε) 205 (4.3), 290 (3.7) 
and 375 (3.9); 1H NMR (500 MHz, CDCl3) δ 
9-OH (ND), 8.13 (2H, dd, J = 1.5, 8.5 Hz, H-
2‘/H-6‘), 7.44 (1H, m, H-4), 7.42 (1H, m, H-4‘), 7.41 (2H, m, H-3‘/H-5‘), 7.34 (2H, dd, J = 7.0, 
7.5 Hz, H-3/H-5), 7.27 (2H, dd, J = 2.0, 8.0 Hz, H-2/H-6), 3.89 (3H, s, 13-OCH3); 13C NMR 
(125 MHz, CDCl3) 171.7 (qC, C-12), 165.9 (qC, C-11), 160.2 (qC, C-9), 154.8 (qC, C-8), 131.9 
(qC, C-1), 129.9 (CH, C-2/C-6), 128.9 (qC, C-1‘), 128.6 (CH, C-4), 128.4 (CH, C-3‘/C-5‘), 128.3 
(CH, C-4‘), 128.1 (CH, C-3/C-5), 127.8 (CH, C-2‘/C-6‘), 115.8 (qC, C-7), 105.1 (qC, C-10), 54.4 
(13-OCH3); ESI-MS (-ve) (25 V) m/z 321 [M-H]-. 
ND: indicates signal was not detected 
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Pinastric acid (5.4)  
 
Isolated as stable yellow translucent 
needles; was crystallised using a 
minimum amount of MeOH/CHCl3 
(20:80) to yield stable yellow 
translucent needles. Single X-ray 
diffraction studies were carried out and the data deposited at the Cambridge 
Crystallographic Data Centre, CCDC 617750 (see Section 10.1.8); mp 192-192.5C; IR (CHCl3) 
νmax 3384, 2956, 2933, 2863, 1775, 1679, 1619, 1603, 1514, 1440, 1370, 1307, 1276, 1253, 1183, 
1065 cm-1; IR (KBr) νmax 3436, 2959, 2931, 1772, 1674, 1602, 1515, 1443, 1370, 1330, 1309, 1279, 
1254, 1191, 1064 cm-1; UV profile from HPLC (CH3CN/H2O) 289 and 389 nm; UV (MeOH) 
λmax nm (log ε) 292 (4.39) and 383 (3.90); 1H NMR (500 MHz, CDCl3) and 13C NMR (125 MHz, 
CDCl3) see Table 5.1; 1H NMR (500 MHz, d6-DMSO) δ 13.57 (1H, s, 4-OH), 7.75 (2H, d, J = 9.0 
Hz, H-2‖/H-6‖), 7.50 (2H, ddd, J = 1.0, 2.0, 9.5 Hz, H-2‘/H-6‘), 7.45 (2H, ddd, J = 2.0, 8.5, 9.5 
Hz, H-3‘/H-5‘), 7.39 (1H, dddd, J = 1.0, 2.0, 8.5, 8.5 Hz, H-4‘), 6.99 (2H, d, J = 9.0 Hz, H-3‖/H-
5‖), 3.82 (3H, s, 1-OCH3), 3.78 (3H, s, 4‖-OCH3);  13C NMR (125 MHz, d6-DMSO) 168.5 (qC, C-
1), 167.4 (qC, C-6 or C-4), 161.9 (weak, qC, C-4 or C-6), 158.5 (qC, C-4‖), 147.0 (qC, C-3), 131.9 
(qC, C-1‘), 129.0 (CH, C-2‘/C-6‘*), 128.9 (CH, C-3‘/C-5‘*), 128.6 (CH, C-4‘), 128.5 (CH, C-
2‖/C-6‖*), 121.7 (qC, C-1‖), 113.8 (C-2 and C-3‖/C-5‖*), 101.8 (qC, C-5), 55.1 (4‖-OCH3), 53.3 
(1-OCH3); ESI-MS (-ve) (25 V) m/z 351 [M-H]-; ESI-MS (-ve) (35-77 V) m/z 351 [M-H]-, 337 [M-
CH3]-, 321 [M-OCH3]-, 307 [M-C2H5O]-, 293 [M-C2H3O2]-, 278 [M-C3H6O2]-, 277 [M- C3H5O2]-, 
264 [M-C3H4O3]-, 249 [M-C7H4]-, 205 [M-C9H7O2]-, 190 [M-C10H10O2]-; HRESI-MS m/z 351.0867 
([M-H]-; calculated for C20H15O6, 351.0869); HRESI-MS m/z 353.1024 ([M+H]+; calculated for 
C20H17O6, 353.1025). 
* signals may be interchanged 
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Pulvinic dilactone (5.7) 
 
Isolated as a stable yellow-green oil; IR (CHCl3) νmax 
3401, 2917, 1816, 1660, 1632 cm-1; UV (EtOH) λmax nm 
(log ε)  205 (4.3), 231 (4.1), 285 (4.1) and 375 (3.8); 1H 
NMR (500 MHz, CDCl3) δ 8.04 (4H, d, J = 8.0 Hz, H-
5/H-5‘/H-9/H-9‘), 7.50 (4H, dd, J = 7.0, 7.5 Hz, H-6/H-6‘/H-8/H-8‘), 7.44 (2H, dd, J = 7.0, 
6.5 Hz, H-7/H-7‘); 13C NMR (125 MHz, CDCl3) 165.7 (qC, C-3/C-3‘), 157.1 (qC, C-1/C-1‘),  
130.1 (CH, C-7/C-7‘), 129.2 (CH, C-6/C-6‘/C-8/C-8‘), 128.2 (CH, C-5/C-5‘/C-9/C-9‘), 126.4 
(qC, C-4/C-4‘), 101.4 (qC, C-2/C-2‘); ESI-MS (+ve) (25 V) m/z 291 [M+H]+. 
 
 
Calycin (5.12) 
 
 
Isolated as a stable orange oil; IR (CHCl3) νmax 3401, 
2922, 2852, 1804, 1709, 1641, 1473, 1442, 1343, 1040 cm-1; 
UV (EtOH) λmax nm (log ε) 202 (4.1), 265 (4.0), 365 (3.8) 
and 455 (3.5); 1H NMR (500 MHz, CDCl3) δ 12.60 (1H, 
brs, 10-OH), 8.19 (2H, d, J = 7.5 Hz, H-2‘/H-6‘), 7.98 
(1H, d, J = 7.5 Hz, H-3), 7.47 (2H, m, H-3‘/H-5‘), 7.45 (1H, m, H-5), 7.39 (1H, t, J = 7.5 Hz, H-
4‘), 7.32 (1H, dd, J = 7.5, 8.0 Hz, H-4), 7.23 (1H, d, J = 8 Hz, H-6); 13C NMR (125 MHz, CDCl3) 
173.1 (qC, C-7), 165.4 (qC, C-12), 160.0 (qC, C-10), 153.6 (qC, C-1), 152.8 (qC, C-9), 131.4 (CH, 
C-5), 129.1 (CH, C-4‘), 128.6 (CH, C-3‘/C-5‘), 128.3 (qC, C-1‘), 128.0 (CH, C-2‘/C-6‘), 125.8 
(CH, C-3 and C-4), 121.6 (qC, C-2), 111.1 (CH, C-6), 105.9 (qC, C-11), 107.0 (qC, C-8); ESI-MS 
(-ve) (25 V) m/z 305 [M-H]-. 
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Atranorin (5.20) 
 
 
Isolated as a unstable colourless oil; UV 
profile from HPLC (EtOAc/n-hexane) 259 
and 324 nm; 1H NMR (500 MHz, CDCl3) δ 
12.55 (1H, brs, 4-OH), 12.50 (1H, brs, 2-OH), 
11.95 (1H, brs, 2‘-OH), 10.36 (1H, s, H-8), 6.52 
(1H, s, H-5‘), 6.41 (1H, s, H-5), 3.99 (3H, s, 
10‘-OCH3), 2.69 (3H, s, 9-CH3), 2.55 (3H, s, 9‘-CH3), 2.09 (3H, s, 8‘-CH3); 13C NMR (125 MHz, 
CDCl3) 193.8 (CH, C-8), 172.7 (qC, C-7‘), 163.2 (qC, C-2‘), 152.5 (qC, C-6), 152.0 (qC, C-4‘), 
140.4 (qC, C-6‘), 117.1 (qC, C-3‘), 116.1 (CH, C-5‘), 112.9 (CH, C-5), 110.9 (qC, C-1‘), 103.2 (qC, 
C-1), 52.7 (10‘-OCH3), 25.6 (9-CH3), 24.2 (9‘-CH3), 9.7 (8‘-CH3), ND (C-2), ND (C-3), ND (C-4), 
ND (C-7); ESI-MS (-ve) (25 V) m/z 373 [M-H]-. 
ND: indicates signal was not detected 
 
5-chloroatranorin (5.21) 
 
Isolated as an unstable colourless oil 
resulting from chemical degradation of 
(5.20); partial identification 1H NMR (500 
MHz, CDCl3) δ 12.33 (1H, brs, OH), 11.96 
(1H, brs, OH), 10.36 (1H, s, H-8), 6.52 (1H, s, 
H-5‘), 3.99 (3H, s, 10-OCH3), 2.86 (3H, s, 9-
CH3), 2.54 (3H, s, 9‘-CH3), 2.09 (3H, s, 8‘-CH3) other OH not detected; partial identification 
based on gHSQCAD; 13C NMR (125 MHz, CDCl3) 193.9 (qC, C-8), 116.2 (CH, C-5‘), 52.6 (10‘-
OCH3), 24.3 (9‘-CH3), 21.3 (9-CH3), 9.9 (8‘-CH3); with all remaining quaternary carbons not 
detected; ESI-MS (-ve) (25 V) m/z 407 [M-H]-. 
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5,5‘-dichloroatranorin (5.22) 
 
Isolated as a stable colourless oil as the 
final product from the degradation of 
(5.20); IR (CHCl3) νmax 3401, 2924, 2853, 
1735, 1648, 1452, 1302, 1249, 1073 cm-1; 
UV (MeOH) λmax nm (log ε) 285 (3.7) 
and 375 (3.2); 1H and 13C NMR data see 
Table 5.2; ESI-MS (-ve) (25 V) m/z 441 [M-H]-; HRESI-MS m/z 441.0143 ([M-H]-; calculated for 
C19H15Cl2O8, 441.0222). 
 
5-chlorosekikaic acid (5.23) 
 
Isolated as a stable dark brown oil; IR 
(CHCl3) νmax 3435, 2927, 1651, 1434, 1225, 
1129 cm-1; UV (MeOH) λmax nm (log ε) 260 
(4.38), 305 (4.09); UV profile from HPLC 
(EtOAc/n-hexane) 265 and 307 nm (mixture); 
1H and 13C NMR data see Table 5.3; ESI-MS 
(-ve) (25 V) m/z 451 [M-H]; HRESI-MS m/z 451.1166 ([M-H]-; calculated for C22H24ClO8, 
451.1165). 
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Sekikaic Acid (5.24) 
 
Isolated as a unstable brown oil; UV profile 
from HPLC (EtOAc/n-hexane) 265 and 307 
nm (mixture);  1H NMR (500 MHz, CDCl3) δ 
11.64 (1H, s, 2‘-OH), 11.14 (1H, s, 2-OH), ND, 
(9‘-OH), 6.44 (1H, s, H-5‘), *6.38 (2H, s, H-
3/H-5), 3.89 (3H, s, 8-OCH3), 3.83 (3H, s, 10-
OCH3), 2.97 (2H, m, H-1‖), 2.97 (2H, m, H-1‖‘), 1.73 (2H, m, H-2‖), 1.65 (2H, m, H-2‖‘), 1.01 
(3H, t, J = 7.0 Hz, H-3‖‘), 0.98 (3H, t, J = 7.0 Hz, H-3‖); 13C NMR (125 MHz, CDCl3) 169.5 (qC, 
C-7), 165.5 (qC, C-2), 164.6 (qC, C-4), 157.2 (qC, C-2‘), 156.4 (qC, C-4‘), 149.1 (qC, C-6), 147.0 
(qC, C-6‘), 125.2 (qC, C-3‘), 111.2 (CH, C-5), 106.4 (CH, C-5‘), 104.6 (qC, C-1), 104.5 (qC, C-1‘), 
99.3 (CH, C-3), 56.2 (8-OCH3), 55.6 (10-OCH3), 39.6 (CH2, C-1‖‘), 39.3 (CH2, C-1‖), 25.7 (CH2, 
C-2‖‘), 25.4 (CH2, C-2‖), 14.7 (3‖-CH3), 14.6 (3‖‘-CH3), ND (C-9); ESI-MS (-ve) (25 V) m/z 417 
[M-H]-; HRESI-MS m/z 417.1557 ([M-H]-; calculated for C22H24O8, 417.1555). 
ND: indicates signal was not detected 
* Signals overlapped 
 
Parietin (5.25) 
 
Isolated as a stable orange powder; mp 206-206.5C; 
IR (CHCl3) νmax 3435, 1631, 1479, 1367, 1272, 1224, 
1160 cm-1; UV (MeOH) λmax nm (log ε) 265 (4.2), 285 
(4.2), 435 (4.0); UV profile from HPLC (EtOAc/n-
hexane) 264, 287 and 409 nm; 1H NMR (500 MHz, 
CDCl3) δ 12.31 (1H, s, 1-OH), 12.11 (1H, s, 11-OH), 7.62 (1H, s, H-4), 7.36 (1H, d, J = 2.5 Hz, H-
8), 7.08 (1H, s, H-2), 6.68 (1H, d, J = 2.5 Hz, H-10), 3.94 (3H, s, 16-OCH3), 2.45 (3H, s, 15-CH3); 
13C (125 MHz, CDCl3) 190.8 (qC, C-13), 182.0 (qC, C-6), 166.5 (qC, C-9), 165.2 (qC, C-11), 162.5 
(qC, C-1), 148.4 (qC, C-3), 135.2 (qC, C-5), 133.2 (qC, C-7), 124.5 (CH, C-2), 121.3 (CH, C-4), 
113.6 (qC, C-14), 110.2 (qC, C-12), 108.2 (CH, C-8), 106.7 (CH, C-10), 56.1 (16-OCH3), 22.2 (15-
CH3); ESI-MS (-ve) (25 V) m/z 283 [M-H]-. 
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10.6 Chapter 6 Experimental 
 
Violacene-2 or plocamene-C (6.3)  
 
Isolated as a stable colourless oil; 1H NMR (500 MHz, CDCl3) 
identified as a minor metabolite co-occurring as a mixture 
(~10%) with compound 8.7; δ 6.16 (1H, d, J = 13.5 Hz, H-8), 6.05 
(1H, dd, J = 8.0, 13.5 Hz, H-7), 3.89 (1H, dd, J = 4.0, 12.0 Hz, H-5), 
2.94 (1H, d, J = 15.0 Hz, H-3α), 2.88 (1H, ddd, J = 3.5, 8.0, 12.0 Hz, H-1), 2.69 (1H, d, J = 15.0 
Hz, H-3β), 2.16 (1H, m, H-6β), 2.02 (1H, m, H-6α), 1.95 (3H, s, H-9), 1.67 (3H, s, H-10); partial 
13C (125 MHz, CDCl3) 131.6 (CH, C-7), 121.3 (CH, C-8), 57.4 (CH2, C-3), 53.1 (CH, C-1), 35.4 
(CH2, C-6), 32.4 (CH3, C-10), 28.4 (CH3, C-9), ND (C-2), ND (C-4), ND (C-5); GC-MS(EI) m/z 
(rel. int.) 245 (2), 243 (6), 241 (3), 239 (5) [M+-Br]+; 207 (8), 205 (18), 203 (31) [C10H13Cl2]+; 169 
(35), 167 (100) [C10H12Cl]+; 141 (14), 131 (47), 115 (6), 91 (31). 
ND:  indicates signal was not detected. 
 
Compound 6.7  
 
Isolated as a stable, colourless oil; UV profile from HPLC (CH3CN/H2O) 
213 nm; HPLC-NMR (500 MHz, 80% CH3CN/D2O) δ 6.50 (1H, d, J = 13.0 
Hz, H-9), 6.13 (1H, d, J = 13.0 Hz, H-10), 4.54 (1H, dd, J = 4.5, 13.0 Hz, H-4), 
3.88 (1H, dd, J = 4.4, 13.0 Hz, H-2), 3.80 (1H, d, J = 11.0 Hz, H-7), 3.71 (1H, 
d, J = 11.0 Hz, H-7α), 2.65 (1H, m, H-3β), 2.49 (1H, m, H-3α), 2.32 (1H, m, H-
6β), 2.29 (1H, m, H-6α), 1.18 (3H, s, H-8); 1H NMR (500 MHz, CDCl3) δ 6.56 (1H, d, J = 13.5 Hz, H-9), 
6.07 (1H, d, J = 13.5 Hz, H-10), 4.48 (1H, dd, J = 3.5, 12.5 Hz, H-4), 3.94 (1H, d, J = 11.0 Hz, H-7β), 3.69 
(1H, dd, J = 4.0, 12.5 Hz, H-2), 3.56 (1H, d, J = 11.0 Hz, H-7α), 2.77 (1H, q, J = 12.5 Hz, H-3β), 2.58 (1H, 
ddd¸ J = 4.0, 4.0, 13.5 Hz, H-3α), 2.41 (1H, d, J = 15.5 Hz, H-6β), 2.28 (1H, d, J = 15.5 Hz, H-6α), 1.28 (3H, 
s, H-8); 13C NMR (125 MHz, CDCl3) 135.4 (CH, C-9), 119.1 (CH, C-10), 70.9 (qC, C-5), 64.6 (CH, C-2), 
51.2 (CH, C-4), 48.6 (CH2, C-6), 40.4 (CH2, C-7), 42.1 (qC, C-1), 39.1 (CH2, C-3), 27.4 (CH3, C-8); 
GC/MS(EI) m/z (rel. int.) 402 (2), 400 (3), 398 (2), 396 (0.1), [M]+; 367 (2), 365 (2), 363 (4), 361 (1) [M+-
Cl]+; 330 (2), 328 (1), 326 (3) [C10H13Br2Cl]+; 319 (5), 317 (17), 315 (22), 313 (11) [C10H9BrCl3]+; 287 (1), 285 
(16), 283 (41), 281 (33) [C10H12BrCl2]+; 249 (21), 247 (100), 245 (66) [C10H11BrCl]+; 205 (10), 203 (32), 201 
(36) [C10H11Cl2]+; 167 (24), 165 (42) [C10H10Cl]+; 153 (25), 125 (28), 115 (11), 91 (39).
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Compound 6.8 
 
Isolated as a stable, colourless oil; 1H NMR (500 MHz, CDCl3) 
identified as a minor metabolite co-occurring as a mixture (~20%) 
with compound 6.13; 1H NMR  δ 6.48 (1H, d, J = 14.0 Hz, H-9), 5.97 
(1H, d, J = 14.0 H, H-10), 4.60 (1H, dd, J = 3.5, 12.5 Hz, H -4), 4.42 (1H, 
br s, H-2), 2.92 (1H, m, H-3β), 2.48 (1H, ddd, J = 3.5, 3.5, 15.0 Hz, H-3α), 
2.19 (1H, m, H-6β), 2.10 (1H, m, H-6α), 1.70 (3H, s, H-7), 1.20 (3H, s, H-8); 13C NMR (125 MHz, 
CDCl3) 138.2 (CH, C-9), 116.9 (CH, C-10), 70.1 (qC, C-5), 60.5 (CH, C-4), 56.1 (CH, C-2), 47.9 
(CH2, C-6), 41.4 (qC, C-1), 39.3 (CH2, C-3), 33.4 (CH3, C-7), 30.4 (CH3, C-8); GC/MS(EI) m/z 
(rel. int.) 333 (0.2), 331 (1), 329 (1), 327 (0.1) [M+-Cl]+; 289 (0.6), 287 (4), 285 (9), 283 (5), [M+-
Br]+; 251 (8), 249 (35), 247 (25) [C10H13BrCl]+; 213 (14), 211 (15) [C10H12Br]+; 207 (5), 205 (10), 
203 (17) [C10H13Cl2]+; 169 (39), 167 (100) [C10H12Cl]+; 131 (35), 115 (9), 91 (27). 
 
Compound 6.13 
  
A stable colourless oil; UV profile from HPLC 
(CH3CN/H2O) 214 nm; HPLC-NMR (500 MHz, 80% 
CH3CN/D2O) δ 6.22 (1H, dd, J = 13.5, H-10), 6.00 (1H, dd, J 
= 8.0, 13.5 Hz, H-9), 4.30 (1H, dd, J = 4.0, 12.0 Hz, H-4), 2.94 
(1H, m, H-2), 2.92 (1H, d, J = 15.0 Hz, H-6β), 2.76 (1H, d, J = 
15.0 Hz, H-6α), 2.32 (1H, q, J = 15.0 Hz, H-3β), 2.18 (1H, q, J = 12.0 Hz, H-3α), 1.93 (suppressed, 
H-7), 1.58 (1H, s, H-8); 1H NMR (500 MHz, CDCl3) δ 6.15 (1H, dd, J = 1.0, 13.5 Hz, H-10), 6.03, 
(1H, dd, J = 8.0, 13.5 Hz, H-9), 4.05 (1H, dd, J = 4.0, 12.5 Hz, H-4), 3.01 (1H, d, J = 15.0 Hz, H-
6β), 2.87 (1H, ddd, J = 3.5, 7.5, 12.0 Hz, H-2), 2.72 (1H, d, J = 15.0 Hz, H-6α), 2.28 (1H, ddd, J = 
12.0, 12.5, 13.5 Hz, H-3β), 2.15 (1H, ddd, J = 4.0, 4.0, 14.0 Hz, H-3α), 1.95 (3H, s, H-8), 1.68 (3H, 
s, H-7);  13C NMR (125 MHz, CDCl3) 131.2 (CH, C-9), 121.4 (CH, C-10), 71.1 (C, C-5), 67.5 (C, 
C-1), 57.9 (CH, C-4), 56.9 (CH2, C-6), 53.4 (CH, C-2), 36.2 (CH2, C-3), 33.4 (CH3, C-8), 27.9 
(CH3, C-7); GC/MS(EI) m/z (rel. int.) 289 (0.7), 287 (2), 285 (6), 283 (4), [M+-Br]+; 251 (4), 249 
(13), 247 (11) [C10H13BrCl]+; 213 (6), 211 (7) [C10H12Br]+; 207 (4), 205 (12), 203 (16) [C10H13Cl2]+; 
169 (36), 167 (100) [C10H12Cl]+; 131 (31), 115 (5), 91 (19). 
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Mertensene (6.27)  
 
Isolated as a stable colourless oil; UV profile from HPLC 
(CH3CN/H2O) 217 and 252 nm; HPLC-NMR (500 MHz, 80% 
CH3CN/D2O) δ 6.13 (1H, d, J = 13.25 Hz, H-2‘), 5.82 (1H, d, J = 13.25 
Hz, H-1‘), 4.26 (1H, dd, J = 4.5, 13.0 Hz, H-2), 4.13 (1H, dd, J = 4.0, 13.0 
Hz, H-4), 2.53 (1H, ddd, J = 4.0, 4.0, 13.5 Hz, H-3β), 2.40 (1H, d, J = 12.0 
Hz, H-6β), 2.34 (1H, m, H-3α), 2.22 (1H, d, J = 14.0 Hz, H-6α), 1.68 (3H, s, H-7), 1.19 (3H, s, H-
8); 1H NMR (500 MHz, CDCl3) δ 6.07 (1H, d, J = 13.5 Hz, H-2‘), 5.84 (1H, d, J = 13.5 Hz, H-1‘), 
4.16 (1H, dd, J = 4.0, 12.5 Hz, H-2), 3.94 (1H, dd, J= 4.0, 12.5 Hz, H-4), 2.65 (1H, ddd, J = 4.0, 
4.0, 14.0 Hz, H-3β), 2.39 (1H, ddd, J = 12.5, 12.5, 13.5 Hz, H-3α), 2.43 (1H, d, J = 14.5 Hz, H-6β), 
2.25 (1H, d, J = 14.5 Hz, H-6α), 1.77 (3H, s, H-7), 1.27 (3H, s, H-8); 13C NMR (125 MHz, CDCl3) 
140.6 (CH, C-1‘), 119.1 (CH, C-2‘), 70.6 (qC, C-1), 67.1 (CH, C-2), 55.2 (CH, C-4), 52.6 (CH2, C-
6), 43.5 (qC, C-5), 40.5 (CH2, C-3), 26.1 (CH3, C-7), 20.0 (CH3, C-8); GC/MS(EI) m/z (rel. int.) 
289 (0.5), 287 (1), 285 (2), 283 (0.5), [M+-Cl]+; 251 (1), 249 (4), 247 (3) [C10H13BrCl]+; 245 (0.3), 
243 (2), 241 (5), 239 (5) [M+-Br]+; 207 (6), 205 (27), 203 (37) [C10H13Cl2]+; 169 (35), 167 (100) 
[C10H12Cl]+; 141 (13), 131 (26), 129 (9), 115 (7), 91 (25). 
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Compound 6.37  
 
Isolated as a stable colourless oil; UV profile from HPLC 
(CH3CN/H2O) 215 and 247 nm; HPLC-NMR (500 MHz, 80% 
CH3CN/D2O) δ 6.01 (1H, m, H-8), 5.94 (1H, m, H-7), 4.40 (1H, dd, J = 
4.0, 11.5 Hz, H-4), 4.20 (1H, br s, H-2), 2.61 (1H, m, H-3β), 2.32 (1H, m, 
H-3α), 2.24 (1H, m, H-6α), 2.17 (1H, d, J = 15.0 Hz, H-6β), 1.68 (3H, s, H-
10), 1.36 (3H, s, H-9); 1H NMR (500 MHz, CDCl3) δ 5.98 (1H, d, J = 12.5 Hz, H-8), 5.94 (1H, d, J 
= 12.5 Hz, H-7), 4.37 (1H, dd, J = 4.0, 11.5 Hz, H-4), 4.08 (1H, brs, H-2), 2.69 (1H, brt, J = 13.0 
Hz, H-3β), 2.33 (1H, dt, J = 3.5, 14.5 Hz, H-3α), 2.20 (1H, d, J = 15.0 Hz, H-6β), 2.10 (1H, d, J = 
15.0 Hz, H-6α), 1.72 (3H, s, H-10), 1.48 (3H, s, H-9); 13C NMR (125 MHz, CDCl3) 141.8 (CH, C-
7), 118.1 (CH, C-8), 70.4 (qC, C-5), 66.2 (CH, C-2*), 62.4 (CH, C-4*), 42.2 (qC, C-1), 44.8 (CH2, 
C-6*), 37.4 (CH2, C-3*), 33.1 (CH3, C-10), 26.0 (CH3, C-9); GC/MS(EI) m/z (rel. int.) 245 (0.1), 
243 (2), 241 (5) 239 (6), [M+-Cl]+; 244 (0.5), 242 (2), 240 (7), 238 (7) [C10H13Cl3]+; 207 (3), 205 
(19), 203 (31) [C10H13Cl2]+; 169 (32), 167 (100) [C10H12Cl]+; 141 (13), 139 (13), 129 (13), 127 (28), 
115 (8), 91 (26). 
*These carbon chemical shifts represent reassignments to those previously reported (Aazizi et al., 1989) and were confirmed on 
the basis of the gHSQCAD and CIGAR NMR experiments (Chapter 6). 
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10.7 Chapter 7 Experimental 
 
Filiformin (7.1) 
 
 
Isolated as a stable colourless oil; crystallised by vapour 
diffusion in a minimum amount of EtOAc/hexane (20:80) 
to yield a single, translucent rhombic crystal. Single X-ray 
diffraction studies were carried out and the data deposited 
at the Cambridge Crystallographic Data Centre, CCDC 
656114 (Section 10.1.8); mp 124.0-124.5C; UV profile extracted from HPLC (CH3CN/H2O) 
λmax 237 and 290 nm; HPLC-NMR (500 MHz, 85% CH3CN/D2O) δ 7.17 (1H, s, H-3), 6.53 (1H, 
s, H-6), 2.19 (3H, s, H-10), 1.74 (1H, m, partially suppressed H-4‘a), 1.64 (1H, ddd, J = 8.0, 11.5, 
12.0 Hz, H-5‘b), 1.53 (1H, q, J = 7.0 Hz, H-2‘), 1.29 (3H, s, H-7), 1.25, (3H, s, H-8), 0.65 (3H, d, J 
= 7.0 Hz, H-9), H-4‘b and H-5‘a, were not observed since these were fully suppressed by the 
CH3CN suppression; 1H NMR (500 MHz, CDCl3) δ 7.19 (1H, s, H-3), 6.59 (1H, s, H-6), 2.28 
(3H, s, H-10), 2.03 (1H, ddd,  J = 7.5, 9.5, 17.0 Hz, H-4‘b), 1.89 (1H, ddd, J = 2.5, 9.5, 12.0 Hz, H-
5‘a), 1.79 (1H, ddd, J = 2.5, 12.0, 14.5 Hz, H-4‘a), 1.67 (1H, ddd, J = 7.0, 11.5, 19.0 Hz, H-5‘b), 
1.50 (1H, q, J = 7.0 Hz, H-2‘), 1.38 (3H, s, H-8), 1.32 (3H, s, H-7), 0.76 (3H, d, J = 7.0 Hz, H-9); 
13C NMR (125 MHz, CDCl3) 152.4 (qC, C-1), 136.5 (qC, C-5), 130.2 (qC, C-2), 128.5 (CH, C-3), 
117.5 (CH, C-6), 114.4 (qC, C-4), 85.5 (qC, C-3‘), 46.4 (CH, C-2‘), 44.9 (qC, C-1‘), 42.1 (CH2, C-
5‘), 37.3 (CH2, C-4‘), 23.2 (CH3, C-8), 22.5 (CH3, C-10), 20.4 (CH3, C-7), 7.4 (CH3, C-9); 
GC/MS(EI) m/z (rel. int.) 296 (60), 294 (62) [M]+; 281 (96), 279 (100) [M-CH3]+; 267 (9), 265 (10) 
[C13H14BrO]+; 253 (13), 251 (13) [C12H12BrO]+; 239 (39), 237 (36) [C11H12BrO]+; 200 (36) 
[C14H16O]+; 185 (15), 172 (11), 160 (19), 145 (16), 128 (20), 115 (28), 91 (17), 77 (17). 
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Filiforminol (7.2) 
 
Isolated as a unstable colourless oil; UV profile 
extracted from HPLC (CH3CN/H2O) λmax 237 and 290 
nm; 1H NMR (500 MHz, CDCl3) δ 7.21 (1H, s, H-3), 
6.63 (1H, s, H-6), 3.86 (1H, d, J = 11.5 Hz, H-8a), 3.69 
(1H, d, J = 11.5 Hz, H-8b), 2.33 (1H, q, J = 7.5 Hz, H-
2′), 2.31 (1H, m, H-4‘a), 2.29 (3H, s, H-10), 1.96 (1H, m, H-5‘a), 1.72 (1H, m, H-4‘b), 1.66 (1H, m, 
H-5‘b), 1.33 (3H, s, H-7), 0.80 (3H, d, J = 6.5 Hz, H-9); 1H NMR (500 MHz, d6-DMSO) δ 7.18 
(1H, s, H-3), 6.65 (1H, s, H-6), 5.06 (1H, t, J = 5.5 Hz, 8-OH), 3.47 (2H, d, J = 11.5 Hz, H-8a and 
H-8b), 2.20 (3H, s, H-10), 2.07 (1H, m, H-4‘a), 1.78 (1H, m, H-5‘a), 1.74 (1H, q, J = 6.5 Hz, H-2‘), 
1.63 (1H, m, H-4‘b), 1.60 (1H, m, H-5‘b), 1.29 (3H, s, H-7), 0.64 (3H, d, J = 6.5 Hz, H-9); 13C 
NMR (125 MHz, CDCl3) 151.7 (qC, C-1), 136.5 (qC, C-5), 130.1 (qC, C-2), 128.4 (CH, C-3), 
117.3 (qC, C-4), 114.7 (CH, C-6), 87.2 (qC, C-3‘), 66.1 (CH2, C-8), 44.8 (CH, C-2‘), 43.1 (qC, C-
1‘), 41.6 (CH2, C-5‘), 32.8 (CH2, C-4‘), 22.3 (CH3, C-10), 19.8 (CH3, C-7), 7.7 (CH2, C-9); 13C 
NMR (125 MHz, d6-DMSO) 152.0 (qC, C-1), 136.0 (qC, C-5), 131.1 (qC, C-2), 128.3 (CH, C-3), 
117.5 (CH, C-6), 113.9 (qC, C-4), 87.8 (qC, C-3‘), 61.8 (CH2, C-8), 44.4 (qC, C-1‘), 41.6 (CH2, C-
5‘), 40.9 (CH, C-2‘), 32.0 (CH2, C-4‘), 22.1 (CH3, C-10), 20.0 (CH3, C-7), 7.3 (CH3, C-9); 
GC/MS(EI) m/z (rel. int.) 312 (100), 310 (94) [M]+; 294 (79), 292 (67) [C14H15BrO2]+; 279 (97), 
277 (69) [C14H14BrO]+; 267 (15), 265 (15) [C12H10BrO2]+; 253 (11), 251 (10) [C12H12BrO]+; 239 
(21), 237 (23) [C11H10BrO]+; 225 (10), 213 (26), 198 (36), 186 (10), 171 (11), 159 (10), 145 (9), 128 
(14), 115 (14), 105 (7), 91 (12), 77 (15). 
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Allolaurinterol (7.6) 
 
Isolated as a stable yellow oil; UV profile extracted from 
HPLC (CH3CN/H2O) 206 and 233 nm; HPLC-NMR (500 
MHz, 85% CH3CN/D2O) δ 7.14 (1H, s, H-3), 6.68 (1H, s, H-6), 
4.91 (1H, br s, H-8‘α), 4.81 (1H, br s, H-8‘β), 2.93 (1H, q, J = 7.0 
Hz, H-2‘), 2.19 (3H, s, H-10), 1.10 (3H, s, H-7), 0.59 (3H, d, J = 
8.0 Hz, H-9), H-4‘α, H-4‘β, H-5‘α and H-5‘β were not observed since these were fully 
suppressed by the CH3CN suppression; 1H NMR (500 MHz, CDCl3) δ 7.24 (1H, s, H-3), 6.67 
(1H, s, H-6), 4.96 (1H, br s, H-8‘β), 4.89 (1H, br s, H-8‘α), 2.96 (1H, q, J = 7.5 Hz, H-2‘), 2.51 (1H, 
m, H-4‘α), 2.47 (1H, m, H-4‘β), 2.29, (3H, s, H-10), 2.23 (1H, m, H-5‘β), 1.79 (1H, m, H-5‘α), 1.28 
(3H, s, H-7), 0.73 (3H, d, J = 7.0 Hz, H-9); 13C NMR (125 MHz, CDCl3) 158.0 (qC, C-3‘), 152.9 
(qC, C-1), 136.1 (qC, C-5), 134.0 (qC, C-2), 131.8 (CH, C-3), 118.2 (CH, C-6), 115.1 (qC, C-4), 
106.4 (CH2,  C-8), 48.5 (qC, C-1‘), 48.4 (CH, C-2‘), 34.6 (CH2, C-5‘), 27.8 (CH2, C-4‘), 25.7 (CH3, 
C-7), 22.2 (CH3, C-10), 19.6 (CH3, C-9); GC/MS(EI) m/z (rel. int.) 296 (51), 294 (59) [M]+, 281 
(100), 279 (86) [M-CH3]+, 267 (10), 265 (9) [C13H14BrO]+, 253 (14), 251 (11) [C12H12BrO]+, 239 
(33), 237 (35) [C11H11BrO]+, 200 (34) [C14H16O]+, 185 (14), 172 (10), 160 (21), 145 (16), 128 (23), 
115 (24), 91 (16), 77 (20). 
 
Bromolaurenisol (7.10) 
 
Isolated as a unstable pale yellow oil which completely 
degraded (3-5 days); UV profile extracted from HPLC 
(CH3CN/H2O) λmax 233 and 286 nm; 1H NMR (500 MHz, 
CDCl3) δ 7.23 (1H, s, H-3′), 6.64 (1H, s, H-6′), 6.04 (1H, s, 
H-6), 3.18 (1H, q, J = 7.5 Hz, H-2), 2.43 (1H, m, H-4a), 2.28 (3H, s, H-9), 2.26 (1H, m, H-5a), 1.87 
(1H, m, H-5b), 1.31 (1H, m, H-4b), 1.21 (3H, s, H-7), 0.73 (3H, d, J = 7.5 Hz, H-8); 13C NMR (125 
MHz, CDCl3) 154.8 (qC, C-3), 153.0 (qC, C-1′), 136.3 (qC, C-5′), 133.5 (qC, C-2′), 131.7 (CH, C-
3′), 118.1 (CH, C-6′), 114.9 (qC, C-4′), 98.4 (CH, C-6), 49.6 (qC, C-1), 48.6 (CH, C-2), 33.5 (CH2, 
C-5), 28.7 (CH2, C-4), 25.4 (CH3, C-7), 22.3 (CH3, C-9), 19.1 (CH3, C-8); GC/MS(EI) m/z (rel. 
int.) 376 (37), 374 (75), 372 (31) [M]+; 295 (54), 293 (45) [C15H18BrO]+; 279 (9), 277 (6) 
[C14H14BrO]+; 266 (6), 264 (6) [C13H13BrO]+; 253 (3), 251 (3) [C12H12BrO]+; 214 (100) [C15H18O]+; 
199 (38), 185 (11), 172 (16), 159 (7), 145 (6), 132 (9), 115 (9), 91 (14). 
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Cycloisoallolaurinterol (7.16) 
 
 
Isolated as an unstable colourless oil;  over a period of ca. 7-
10 days this compound was observed to degrade; [α]D23 
+33.3º (c 0.1, CHCl3); IR (CHCl3) νmax 3391, 2924, 1589, 1347, 
1308, 1145 cm-1; UV (EtOH) λmax nm (log ) 251 (4.0), 255 
(4.0), 292 (3.4); UV profile extracted from HPLC (CH3CN/H2O) 250 (3.6), 290 (3.0); 1H and 
13C NMR data see Table 7.1; GC/MS(EI) m/z (rel. int.) 294 (100), 292 (90) [M]+; 279 (55), 277 
(45) [M-CH3]+; 266 (2), 264 (3) [C13H13BrO]+; 253 (3), 251 (4) [C12H12BrO]+; 239 (33), 237 (23) 
[C11H10BrO]+; 213 (7) [C15H17O]+, 183 (13), 170 (4), 155 (4), 115 (8), 92 (6), 77(8), 51(11); HR-
GC/MS(EI) m/z (rel. int.) 292.0457 [M]+ (calcd. for C15H17BrO, 292.0463).  
 
Isoallolaurinterol (7.23) 
 
This compound could only be detected for a short period 
of time (20 minutes) by HPLC-NMR. Partial 
identification by HPLC-NMR (500 MHz, 85% 
CH3CN/D2O) δ 7.13 (1H, s, H-7), 6.68 (1H, s, H-10), 5.21 
(1H, brs, H-3), 2.79 (2H, d, J = 14.0 Hz, H-2a), 2.56 (1H, q, 
J = 7.5 Hz, H-5) 2.20 (3H, s, H-15), 2.03 (suppressed signal but observed in COSY, H-2b ), 1.66 
(3H, s, H-12, partly suppressed), 1.20 (3H, s, H-14), 0.56 (3H, d, J  = 7.5 Hz, H-13). 
O
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10.8 Chapter 8 Experimental 
 
(3Z)-chlorofucin (8.5) 
 
Isolated as a stable yellow oil; 1H NMR 
(500 MHz, CDCl3) δ 6.03 (1H, ddd, J = 
7.5, 8.0, 10.5 Hz, H-4), 5.55 (1H, dt, J = 
2.5, 11.0 Hz, H-3), 4.50 (1H, dd, J = 9.3, 
9.3 Hz, H-12), 4.30 (1H, dd, J = 3.5, 
9.5Hz, H-9), 4.22 (1H, m, H-10), 4.00 
(1H, m, H-7), 3.90 (1H, ddd, J = 35.0, 10.0, 12.0 Hz, H-13), 3.80 (1H, dt, J = 7.0, 7.0 Hz, H-6), 
3.30 (1H, ddd, J = 2.0, 9.0, 15.5 Hz, H-11b), 3.10 (1H, dd, J = 1.0, 2.5 Hz, H-1), 2.80 (1H, ddd, J 
= 1.5, 7.5, 14.5 Hz, H-5a), 2.70 (1H, ddd, J = 1.5, 7.5, 14.5 Hz, H-5b), 2.47 (1H, dd, J = 5.0, 15.5 
Hz, H-11a), 2.30 (1H, d, J = 16.0 Hz, H-8b), 2.05 (1H, ddd, J = 3.0, 9.5, 15.5 Hz, H-8a), 1.95 (1H, 
ddd, J = 2.5, 7.5, 15.0 Hz, H-14b), 1.69 (1H, ddq, J = 4.0, 7.0, 11.5 Hz, H-14a), 1.05 (1H, dd, J = 
7.5, 7.5 Hz, H-15); 13C NMR (125 MHz, CDCl3) 141.2 (CH, C-4), 110.4 (CH, C-3), 84.0 (CH, C-
6), 83.1 (qC, C-2), 82.8 (CH, C-13), 80.2 (CH, C-1), 79.2 (CH, C-9), 69.6 (CH, C-7), 61.2 (CH, C-
10), 51.6 (CH, C-12), 38.2 (CH2, C-11), 33.2 (CH2, C-8), 30.0 (CH2, C-5), 23.0 (CH2, C-14), 11.8 
(CH3, C-15); ESI-MS (+ve) (25 V) m/z 369 [M+Na]+. 
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Pacifenol (8.7) 
 
Isolated as stable colourless needles; mp 
152.0-152.5C; 1H NMR (300 MHz, CDCl3) δ 
6.04 (1H, d, J = 9.9 Hz, H-9), 5.45 (1H, dd, J = 
3.8, 13.0 Hz, H-2ax), 5.41 (1H, d, J = 9.9 Hz, H-
10), 4.69 (1H, dd, J = 5.2, 13.0 Hz, H-5ax), 2.68 
(1H, dd, J = 5.2, 15.0 Hz, H-4eq), 2.34 (1H, dd, J = 12.0, 15.0 Hz, H-4ax), 2.33 (1H, dd, J = 3.6, 
12.0 Hz, H-1eq), 2.18 (1H, d, J = 13.2 Hz, H-1ax), 1.78 (3H, s, H-12), 1.51 (3H, s, H-15), 1.29 (3H, 
s, H-14), 1.10 (3H, s, H-13); 13C NMR (75 MHz, CDCl3) 34.3 (CH2, C-1), 59.5 (CH, C-2), 69.2 
(qC, C-3), 46.2 (CH2, C-4), 74.2 (CH2, C-5), 53.4 (qC, C-6), 52.0 (qC, C-7), 99.9 (qC, C-8), 132.3 
(CH, C-9), 134.5 (CH, C-10), 77.1 (qC, C-11), 33.6 (CH3, C-12), 23.6 (CH3, C-13), 24.7 (CH3, C-
14), 25.1 (CH3, C-15); ESI-MS (-ve) (25 V) m/z 464 [M+Cl]-. 
 
Elatenyne (8.9) 
O
O
H Br
Br
H3C
H
5
8
910
11
1
 
 
Isolated as a stable yellow oil which degraded over a period of 3 months; Due to the 
instability of 8.9, a UV, and IR was unable to be acquired; Stereochemistry based on Burton 
and co-workers proposed proposed structure; 1H NMR and 13C NMR see Table 8.1 (CDCl3) 
and Table 8.2 (C6D6); GC/MS(EI) m/z (rel. int.) 329 (13), 327 (21), 325 (10) [C10H15Br2O2]+; 247 
(100), 245  (95) [C10H15BrO2]+; 179 (72), 177  (70) [C5H6BrO2]+; 151 (25), 149 (28); 105 (24); 97 
(12); 69 (5); 55 (5); 43 (13); 41 (53). 
NB: Stereochemistry of elatenyne based on J. Burton and co-workers proposed structure. 
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Cycloelatanene A (8.15) 
 
Isolated as a colourless oil; [α]D23 -79.8º (c 0.1, CHCl3); 
IR (CHCl3) νmax 2927, 2850, 2091, 1735, 1619, 1148, 
1371, 1115, 1039 cm-1; UV (MeOH) λmax nm (log ) 256 
(3.8); 1H NMR and 13C NMR see Table 8.6; HRESI-MS 
m/z 385.0541 ([M+Na]+; calculated for 
C16H24BrClNaO2, 385.0546).  
 
Cycloelatanene B (8.18) 
 
Isolated as a colourless oil; [α]D23 -62.2º (c 0.1, CHCl3); 
IR (CHCl3) νmax 2962, 2980, 2062, 1733, 1618, 1149, 
1381, 1112, 1100 cm-1; UV (MeOH) λmax nm (log ) 256 
(34.0); 1H NMR and 13C NMR see Table 8.7; HR-
GC/MS(EI) m/z (rel. int.) 364.0633 [M]+ (calcd. for 
C16H24BrClO2, 364.0628).  
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10.9 Chapter 9 Experimental 
 
The pentaprenylated p-quinol, 9.5 
 
OH
OHCH3CH3CH3CH3
H3C
CH3
1 1'
3
513
18
20
25 21
7
10
3'
5'
 
Isolated as a stable light green oil; IR (CHCl3) νmax 3392, 2965, 2924, 2855, 1659, 1494, 1449, 
1381, 1299, 1198 cm-1; UV (EtOH) λmax nm (log ε) 205 (4.4), 246 (3.9), 290 (3.2) and 343 (2.8); 
HPLC-NMR (500 MHz, 95% CH3CN/D2O) δ 6.54 (1H, d, J = 8.5 Hz, H-6‘), 6.47 (1H, d, J = 3.0 
Hz, H-3‘), 6.39 (1H, dd, J = 3.0, 8.5 Hz, H-5‘), 5.23 (1H, t, J = 7.5 Hz, H-2), 5.05 (4H, m, H-6/H-
10/H-14/H-18)*, 3.14 (2H, d, J = 7.5 Hz, H-1), 1.64 (3H, s, H-21), 1.60 (3H, s, H-20), 1.52 (12H, 
s, H-22/H-23/H-24/H-25)* with H-5α/H-9α/H-13α/H-17α, H-4α/H-8α/H-12α/H-16α, H-
5β/H-9β/H-13β/H-17β and H-4β/H-8β/H-12β/H-16β, signals being suppressed; 1H and 13C 
NMR data see Table 9.1; ESI-MS (-ve) (25 V) m/z 449 [M-H]-. 
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1A. Antimicrobial Assays (Antibacterial and Antifungal) 
 
At a known concentration the test bacteria or fungi were mixed with Mueller Hinton 
or Potato dextrose agar and poured into petri dishes so that after incubation a ‗lawn‘ of 
bacteria or fungi grew over the dish (Table 1A). The extract or isolated natural products were 
pipetted over 6 millimeter diameter filter paper discs and the solvent evaporated. These were 
then placed onto the above prepared seeded agar/dishes (with appropriate solvent and 
positive controls) and incubated. 
If the samples showed any activity against the bacteria/fungi (i.e were antimicrobial) 
zones of inhibition outside the disc would be observed (Figure 1A). This was measured in 
millimeters as the radius of inhibition and was recorded for each bacteria/fungi. 
 
Table 1A. The test bacteria and fungi. 
Bacteria Fungi 
Escherichia coli (G-ve ATCC 25922) Candida albicans (ATCC 14053) 
Bacillus subtilis (G+ve ATCC 19659) Trichophyton mentagrophytes  
(ATCC 28185) 
Pseudomonas aeruguinosa  
(G-ve ATCC 27853) 
Cladosporium resinae 
 
*B. subtilis and T. mentagrophytes are the most sensitive organisms 
 
APPENDIX 
Further Details of Biological Assays 
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Figure 1A.   Illustration of zones of inhibition (response to bacteria/fungi). 
 
1B. Antiviral Assays 
 
The extract or isolated natural products were pipetted onto 6 millimeter diameter filter paper 
discs and the solvent evaporated. These were then placed onto BSC-1 cells (African Green 
Monkey Kidney), infected with either Herpes simplex type 1 virus (ATCC VR 733) or Polio 
virus type 1 (Pfiser vaccine strain), then incubated. Assays were examined after 24 hours, 
using an inverted microscope, for the size of antiviral (i.e viral inhibition) and/or cytotoxic 
inhibition as well as the cytotoxicity. 
 
Interpretation of Results 
 
Types of cytotoxicity are scored as follows: This is a visual interpretation of how cells 
change, comparative to control cells, due to the toxic effect of the test compounds (Figures 1B 
– 1C and Table 1B). These changes may be related to the mode of action of the test 
compound. For example *7 is often associated with protein synthesis inhibitors. 
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Figure 1B. Examples of how cells change in response to types of cytotoxicity 
 
Table 1B. Antiviral result interpretation. 
Antiviral and 
Cytotoxicity (zone) 
Interpretation 
ND No discernable antiviral or cytotoxic effects 
+ - Minor effects located under the disc 
+ Antiviral or cytotoxic zone 1 – 2 mm excess radius from the disc 
(25% zone) 
2+ Antiviral or cytotoxic zone 2 – 4 mm excess radius from the disc 
(50% zone) 
3+ Antiviral or cytotoxic zone 4 – 6 mm excess radius from the disc 
(75% zone) 
4+ Antiviral or cytotoxic zone 1 – 2 mm excess radius from the disc 
(100% zone) 
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Figure 1C. Visual representation of the change in cells. 
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Figure 1C (cont). Visual representation of the change in cells. 
 
1C. Antitumour Assay (P388)  
 
For the anti-tumour assay a two fold dilution series of the crude extract or isolated natural 
product was incubated for 72 hours with P388 (Murine Leukaemia) cells. The concentration 
of sample required to reduce the P388 cell growth by 50% (comparative to control cells) was 
determined using the absorbance values obtained when the yellow dye MTT tetrazolium is 
reduced by healthy cells to the purple coloured MTT formazan (Figure 1D). 
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The result is expressed as an IC50 in ng/mL (or µM) if a sample concentration has 
been supplied or as a dilution factor (x 10-6) if a sample concentration has not been supplied. 
Results containing a < or > sign indicate that the result was off scale and that the sample 
needs to be retested at a lower or higher concentration. 
 
 
Figure 1D.  Example of micro-titre plate showing series of controls and change in colour in 
response to inhibition 
 
 
Elllis G. "Biological Assays" (Supplementary Notes). Department of Chemistry, University of 
Canterbury, Christchurch, New Zealand.  
 
Ms Gill Ellis 
Purchasing/Research Assistant 
Department of Chemistry, 
University of Canterbury, 
Christchurch New Zealand, 
Email: gill.ellis@canterbury.ac.nz 
http://www.chem.canterbury.ac.nz 
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Provided here is supplementary information on the anti-oxidant and anti-inflammatory 
assays carried out at RMIT University (Bundoora Campus), Melbourne, Victoria, Australia; 
on the fungus, Pycnoporus cinnabarinus (2002-03). 
 
1D. Antioxidants (DPPH radical scavenging) (Tamura et al., 1990). 
 
Anti-oxidants are of interest to the food industry, because they prevent rancidity, and may 
help to protect the human body against damage by reactive oxygen species. This term is used 
loosely, in which food scientists equate antioxidants to inhibitors of lipid peroxidation. 
However, free radicals generated in vivo damage many targets other than lipids, including 
proteins, DNA and small molecules (Cowan, 1997). 
        Oxygen, important in respiratory processes, is reduced in the body to active species 
that can cause damage. These include HO2 (superoxide), H2O2 (hydrogen peroxide), a by-
product of enzymatic oxidation and HO (hydroxyl radical), a radical resulting from the 
decomposition of superoxide, which is formed in respiring cells, in small amounts (Cowan, 
1997). 
Radicals are scavenged from a living system by several enzymes, including 
perioxidase, superoxide dismutase (SOD), and catalase. Oxidative lesions on DNA may be 
repaired by DNA repair enzymes. To combat the problem of reactive oxygen species SOD 
catalyses the disproportionation of superoxide to oxygen and hydrogen peroxide (Cowan, 
1997). 
               
2O2-  +  2H+    O2  + H2O2 
 
The initial goal was to test for possible anti-oxidative agents in the fungus, P. 
cinnabarinus (2002-03) in order to ascertain any inhibitory effects against free radicals 
involved with reaction of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH). The 
reduction in the concentration of the DPPH radical is followed by monitoring the decrease in 
its absorbance. 
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Results: 
 
The following assays were conducted using the 1 mg/mL sample solutions with an 
incubating time of 20 minutes (Table 1C). 
 
Table 1C.  Partitioned extracts of the fungus (P. cinnabarinus) (2002-03). 
Sample  Average Absorbance DPPH radical scavenging 
activity (%) 
  Blank 0.4799 - 
  DD1 12.1 (EtOAc) 0.4045 15.7 
  DD1 12.2 (Water) 0.4173 13.0 
  DD1 13.1 (DCM) 0.4583 4.5 
  DD1 13.2 (MeOH) 0.4344 9.5 
  DD1 13.3 (Water) 0.5284 - 
  Trollax (Control) 0.0296 93.83 
  Vitamin E (Control) 0.0365 92.39 
 
Fixed-time assay  
 
The following assay was conducted using the 1 mg/mL EtOAc sample solution, in 
recognition of the previous result (Table 1D). 
 
Table 1D.  Partitioned extracts of the fungus (P. cinnabarinus) (2002-03). 
Sample 
Run 
Absorbance 
DPPH 
Absorbance 
DPPH + 10L of 
sample 
Time (minutes) DPPH radical 
scavenging 
activity (%) 
1 0.6053 0.5984 instantaneous 1.1 
 
Formula: 
 
DPPH radical scavenging activity (%) = 1 – (Abstest/Abscontrol) x 100 
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The following assay was conducted using the 10 mg/mL( EtOAc partition) (Table 1E). 
 
Table 1E.  Partitioned EtoAc extract of the fungus (P. cinnabarinus) (2002-03). 
Sample 
Run 
Absorbance 
DPPH 
Absorbance 
DPPH + 10L of 
sample 
Time (minutes) DPPH radical 
scavenging 
activity (%) 
1 0.3836 0.2862 instantaneous 25.4 
2 0.3836 0.2458 20 minutes 35.9 
 
Biological evaluation, with respect to antioxidant activity of the EtOAc partition (DD1 12.1) 
showed anti-oxidative activity against the DPPH  radical, provided that the reaction mixture 
was left for a longer period. 
 
1E. Anti-inflammatory Assay  
[Neutrophil Lipoxygenase Inhibition (5-LO)] (McColl et al., 1986) 
 
The lipoxygenases, are soluble enzymes found in the cytosol and white blood cells. The main 
enzyme is 5-lipoxygenase which is the first enzyme in the biosynthesis of the leukotrienes. 
Upon cell activation, this enzyme translocates to the cell membrane where it becomes 
associated with a protein termed ―FLAP‖, which in necessary for leukotriene synthesis 
(Figure 1E). The 5-LO adds a hydroperoxy group to C5 on arachidonic acid. The next step in 
the pathway is the synthesis of leukotriene A4 (LTA4), the precursor to the potent 
inflammatory mediator LTB4, in addition to some isomers (Cowan, 1997). 
LTB4 can be found in inflammatory exudates and is present in the tissues in many 
inflammatory conditions including rheumatoid arthritis, psoriasis and ulcerative colitis. The 
lipoxygenase pathway also generates 5-hydroperoxyeicosa-6,8,11,14-tetraaenoic acid (5-
HPETE), which gives rise to 5-HETE and LTA. In platelets the same pathway generates 12-
HPETE. These are unstable intermediates that are converted either through enzymatic 
hydration to LTB4 or through the action of glutathione-S-transferase to LTC4, LTD4 and LTE4 
(Cowan, 1997; McColl et al., 1986). 
This extensive, yet informative assay focuses on the pathways with respect to any 
inhibition of LTB4 and its isomers, along with the inhibition of 5-HETE. Products were 
monitored via HPLC in which PGB2 and 15-HETE were used as internal standards (McColl et 
al., 1986). 
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Figure 1E. The biosynthesis of leukotrienes from arachidonic acid (Cowan, 1997). 
 
The data presented in Tables 1F and 1G show the average results obtained from 
the HPLC analyses. The blank represents 100% of the reaction, in which inhibition is 
normalised to this value. Results are calculated, in this case, by dividing the height of 
the leukotriene peak and isomers (6t-12ept-LTB4, 6t-LTB4 and LTB4) and the internal 
standard peak height (Figures 1F and 1G).  
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The same applies with the 5-HETE results and an example calculation is shown below: 
 
Example calculation: DD1 12.1 (EtOAc) at 10 mg/mL 
 
Blank (without test compound) 
 
LTB4 (Peak Height)   =   4959  =  2.257 = 100% of the reaction (0% inhibition). 
PGB2 (Peak Height)        2201 
 
EtOAc (DD1 12.1) 
 
LTB4 (Peak Height)  =  785.75  = 0.303 = 13% of the reaction, (87%inhibition). 
PGB2 (Peak Height)      2588.5 
 
Figure 1F. HPLC chromatogram showing the quantitative results of LTB4 and isomers 
inhibition. 
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Table 1F. Anti-inflammatory (LTB4) results. 
Average 
Results 
 
PGB2 
6t-12epi-
LTB4 
 
6t-LTB4 
 
LTB4 
LTB4 
Inhibitio
n 
(%) 
6t-12epi-
LTB4 (%) 
 
6t-LTB4 
(%) 
  Blank 
(Control) 
2201 1061.25 902.5 4959 0 0 0 
EtOAc 2588.5 0.0 0.0 785.75 87* 100 100 
Water 2394.25 973.25 821.5 4754 12 82 85 
DCM 2420.75 326.5 0.0 1661.25 70* 95 100 
MeOH 2355.75 985.75 830.25 4648.5 13 81 84 
Water 2602 1288.5 995.75 5622.25 4 78 83 
NDGA 
(Control) 
2308 809.5 809.5 0.0 100 84 84 
*denotes active fraction 
 
The results indicate that the greatest inhibition of LTB4 and isomers was 
observed for the EtOAc partition (DD1 12.1) with the corresponding H2O fraction (DD1 
12.2) showing 12% inhibition. 
The results for the DCM (DD1 13.1) and MeOH (DD1 13.2) fractions suggest 
that the inhibition of LTB4 and isomers are spread over these two fractions but that the 
DCM was predominantly in the more active fraction of the two. The corresponding 
water fraction (DD1 13.3) showed only a 4% inhibition. 
 
Table 1G. Anti-inflammatory (HETE) results 
Average 
Results 
15-HETE 5-HETE 5-HETE  
Inhibition 
(%) 
          Blank           651.5           1024           0 
          EtOAc           1412.25           265           88 
          Water           951.25           1222.5           18 
          DCM           1210.5           770.25           60 
          MeOH           1045           1461.25           11 
          Water           967.75           1817.75           19 
          NDGA           639.5           0           100 
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Example calculation: DD1 12.1 (EtOAc) at 10 mg/mL 
 
Blank (without test compound) 
 
5-HETE (Peak Height)   = 1024  = 1.572 = 100% of the reaction, (0% inhibition) 
15-HETE (Peak Height)     651.5 
 
EtOAc (DD1 12.1) 
 
5-HETE (Peak Height)    =  785.75  =  0.303 = 13% of the reaction, (88% inhibition) 
15-HETE (Peak Height)      2588.5               
       
 
 
Figure 1G.   HPLC chromatogram showing the quantitative results of 5-HETE inhibition 
 
The results obtained for the inhibition of the 5-HETE pathway, showed again, 
that the greatest inhibition of 5-HETE was observed in the EtOAc fraction, (88% 
inhibition), with the corresponding water fraction showing a limited value of 
inhibition. The DCM partition showed the highest value of inhibition, (60%) with the 
MeOH and Water partitions of activity. 
 
 
 
 
 
 
 
 
 
 
 
 
